<SEC-DOCUMENT>0001022079-21-000070.txt : 20210423
<SEC-HEADER>0001022079-21-000070.hdr.sgml : 20210423
<ACCEPTANCE-DATETIME>20210423160221
ACCESSION NUMBER:		0001022079-21-000070
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		62
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210423
DATE AS OF CHANGE:		20210423

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			QUEST DIAGNOSTICS INC
		CENTRAL INDEX KEY:			0001022079
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		IRS NUMBER:				161387862
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12215
		FILM NUMBER:		21849687

	BUSINESS ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094
		BUSINESS PHONE:		9735202700

	MAIL ADDRESS:	
		STREET 1:		500 PLAZA DRIVE
		CITY:			SECAUCUS
		STATE:			NJ
		ZIP:			07094

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CORNING CLINICAL LABORATORIES INC
		DATE OF NAME CHANGE:	19960903
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>dgx-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:b7a2ec7e-72b2-4b96-9989-1413b2102795,g:ecef80b4-feab-4ac1-bfc2-6019ec2f6d37,d:48a4c51f7e6947a1b3d20f42a15280c5--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:dgx="http://questdiagnostics.com/20210331" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dgx-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY18xLTEtMS0xLTA_434c7b8b-bcd1-4278-bfe5-228236c9417a">0001022079</ix:nonNumeric><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY18yLTEtMS0xLTA_e88428b5-a221-4472-9a94-f5a23e673ccb">12/31</ix:nonNumeric><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY18zLTEtMS0xLTA_8fe24a13-b7ac-4ab8-ad51-cd33ef15c7cb">2021</ix:nonNumeric><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY180LTEtMS0xLTA_4191a0de-806b-4a2e-baf8-1268f1e83e47">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY181LTEtMS0xLTA_c832ca62-3759-481e-b205-3e9c47d0d0f6">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dgx-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i94087c0a58c24d71ac0e67f043afc91a_I20210415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-04-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ie648c1d0f7124826ab1f231505fef1e4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71eadae108864617a48c288ee03da704_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a5f406ec8444737afc188d6eaf5b3df_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie646d19d5cf7459186c0619c49ea5b00_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad2c3ee49929469181f46b8451771c2e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30e7f83270134cbba57989f6c87ee5dc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6763b3092130441aa4d3e7b62a500f77_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4383ddd8bce04187905a84f784749ae5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie8041207d92044f2b46db9b98a65cc49_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c968630629445fe8e4c6a11b499ae19_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9847f3acf448409280792183ebb09888_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19684d6afbf34103a049012a6f48ef9c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd48c006babc44508fba201daabd149f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1229f5eae1bb44628fb91b7979affa6f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia93fe46925ac4e9bb7935ca7294c9f15_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0837bdde940d4fec8198129389d20b30_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31fe7b51e3304a36906e002676eabb34_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f7944d31d44461c81787b9b98e14b57_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id66c8836535840cab79f0efa55d1cee1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4f49c664e464e75a6577f2c5dbd5d00_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44d7060969104f55af57e24f5142babe_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2353c85dd054cf1943d3a8d511c4959_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i795ed9a1abc545c88b550e1eedd5d75c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i207c605753d646cb94bcf01101b0bf97_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb90cf4bc9e9485d83bb0be21e4bf3ca_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c99680609bd4fb4ac289f25c8f9e0b6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic022103456b94e4f920519555dc899e2_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41ab8be1210042b6bb81b9c60bf8605a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifae32d3d791f4367832627f55e477d07_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie15d552706e0430088071b5ee01807cd_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a26f2f8c8934f1b93702b137ab17309_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72931c6b70d14f8e8c1d97620ad67fbe_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec9454bd4f9d47f3b5eee627c27ab502_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f0cdcdd19e149f58288a99e479bfc5d_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if402423ae2b24c479ced9a86251c3483_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i20b63065eb04432ba75178f3f9ab8895_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic67cad7792d740b5a02d32b5524496e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i219be6c936d3415ca28de30c5ecdd725_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94d5c3ec8c294ad2b02b16745af5b212_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68ce47c4dd1146df8e572f0c839b6589_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee79e433c95e49c9a0a5609e33cf096b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14aa0040139a42d3b7c0bff4113965f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ic8b7e170774c4e2f95ec5ebd85bba23b_I20150701"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2015-07-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib735db70e8754b31974b71ba0360f16f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc7342da57f4a33aff95cad60d1c936_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d63d7e9761b4274807931de4482a38c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic90470dc4f4e496caf705d77fa10f616_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb591aeff91e492ea542a000f524e7ba_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iedd67844f6da45dea182ccba35b463fa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadbedddfbeb44bccac35bc1968c7198f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57106d7badad475d94a3fdc00692bdf1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if045c9990da04355aabfd81d38c5e41d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604ee99bfe964292aabcd6f1b7a316d6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8dd08a56a99d48b4a6ee1e2a7e24fcbe_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i246eef5102584ee28b17a57e7f0313fe_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i329a30ceb1f446f2b7a379a3a3609fdd_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2340158a38984ae194d149a5c95c9e3c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8a7848040184bc9a44a3890de687919_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id151570e96bf47e2b5807c317f3da3d2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb6b341327284acb8967c7a25afd49bf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4da6e7d6898a41e2a321057961de0c2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fedf49ea624406aa29fd6ba884c32c8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i878a393788d6403c92b8b90fb49da518_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90898918a80f45fcb9a06e317a5665ff_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7627047194654fc7b1f1cb6056491ceb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i901bac352fa04938b24046e76fcd794f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09a88d5cf6634758a4963ee5f06aa537_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i823a17c2df114f629409d133576bca9e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i814f0c2b21984f29aeb4ef63fc8777f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4276aed117b24b4684c477c58a926e2f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i510d256807de405f9d7a30a62b33c0d3_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i063340d2e658481d80d2f35fd862966a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic92ff83c2e994ef6b59823da5190e3e9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1d5d10bdab3470c9d09e9af10bb66bb_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6978a3b581d84bdba38eca5a17dc6a46_D20200701-20200930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-07-01</xbrli:startDate><xbrli:endDate>2020-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f8703a530294e5daab49bce5e5794c1_D20201001-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dc9a03ecce042689d1a37deafd8f119_D20210301-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-03-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1694b157a7e4e05adbfb726d63a9dfb_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifaee625cde9f46a19f40eb5a77955d58_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice8c8a53b7e44301b5d027627be99368_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9b169a1c4be4f32aab0d0b964a44035_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3abb6c012f5f45fabdd35c0f3a5e994d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>dgx:claim</xbrli:measure></xbrli:unit><xbrli:context id="ibdcc6647a3314cfe8c8e1a11819788f2_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a8b8a1360eb45169025ce2e3ff740e3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dba11073b29434b8978baa1dd517320_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2be09d01fcd644908d4f7bcba929237f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80fa10a73f264102b635c6298c5c5763_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iace971bbe9244cfb88051e717b4dc21b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36f5b862a2f64309ae325f1bd8812f84_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f4d95d055c34010ae22105b313a4c19_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic899b274b3de44a4a751b3c0cf303ca1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a6fda505e7a4e16ad43273771a429c6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i758562ef5a3244ce83bd69c73f546e0e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9e62f1f9ce94456b1cd2a528dd83efc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i25a98fa306ed41b296725d35a192e146_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28f9959f287848bf8d465e16d1d746ff_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03c3744a2bab43538ebec4cd3b356cf1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bdf51bbf7f242a3be5bed92c72c57cb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic4d4da36106e49a4a2dc103517d9f28a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i61fa9a0d6266465f843c0dcd281594b4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9e55ffc9602438bb96b19f2de74ce1b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i170cc44a7d484de4b0e68d788f39ca90_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e7fdb8aa0b74dcd8f92d2bf7a45989c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5cdb593684214c31b69e5e0f14a1dd79_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac11f459e1d042178af5545dbcf89c00_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3447dfba2db4452db6c128cbd3d017fb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifde7a741912648d2a3710f6aba0b6239_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf44f85037c240d487111d5bb5558877_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e5b35b7ea4e4d4894444db26f102438_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1719a6433f8e402a8040ef12f6efed91_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb28805c772d49adaf22a67346afc2ec_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i452e2b67663443a9b36290cf5a2aa1e6_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd123d8c628f46e5aba2e460d5deafe6_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iebb5fe74da844f1f961e8e1d2bb794b5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42e148eb5e0e4659b907643c8a63fc0c_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a2808ee150047299c3ed09ef79ab8b5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06001aa5c1104e2e9732e941f42c3fcf_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide5defc240be4dcab0b768c6f15899ab_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc9de92a860e40a589282211d1647b6f_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic87438c858c24f95bcf9ba166ab81b0e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8459599fb5c4db59c067f7d2b4152d5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6810771a2a1c4d05944123a1bf5e1b52_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46815f8f6c1c4752a37528dcfe600782_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30bb0b3b6fb2412594595890e5f1e61e_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0b6faefc1d44456895da76547e73051_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e2f380500494c60add6976b3bc32aa1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f9466da8f9f4a6aa123bbced054fed3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c126b415f014916be2b95fa29f24224_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69898b4810d540df8211bce4cdd5525d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i127c3faa32b7427d9b99ea5587e176d7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8413c530df5c4dbfb070686c9de5c5e3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i964abdb4332b41dd9081bba6b23cb70a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadb31c200e50479698a170bd1aa2fdd4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic08defe16103451e81c2c39229b0890c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bc155227aa9447ea638f9b050fb14fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12272fb69d15405f9bdaf2b4151db72f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59a13ec4490e4a7b8c12492922d70b63_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39c87593f7934842babf6575faeb22bb_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic411e7e9465f4d0ca07e2fc70dfc9403_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001022079</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_1"></div><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:94.861%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">UNITED STATES</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">SECURITIES AND EXCHANGE COMMISSION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">WASHINGTON, DC 20549</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTI2_0ca903ed-70cb-4beb-bba4-f56c1966fa16">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One) </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTI3_6867ba36-6aca-4697-b724-a62aa8751728">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV83Njk2NTgxMzk2Mzg5_86bf81b1-5f18-49e0-bd99-25af7b32f572">March 31, 2021</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Or</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:14pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTI4_2f0d70de-282f-465b-b585-f4f9e299e130">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from          to</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTI5_fe223b7b-7d7b-440d-ae34-aff75ac2ef5c">001-12215</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTMw_e597d1e3-bfca-4918-8800-cbbf4eba0aa5">Quest Diagnostics Inc</ix:nonNumeric>orporated</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:519.00pt"><tr><td style="width:1.0pt"></td><td style="width:105.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:21.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:85.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:58.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:36.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:201.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8wLTAtMS0xLTA_4e9538b3-7ae6-4f7f-84c6-dd3c56d80439">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8wLTUtMS0xLTA_6b23e0aa-1ed3-4e23-9a50-02a995bbd3cc">16-1387862</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State of Incorporation)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr><tr style="height:15pt"><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8yLTAtMS0xLTA_7372df66-6dd5-4c27-8aba-4786cdcefdb1">500 Plaza Drive</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8zLTAtMS0xLTA_685500c0-0415-4e7f-85f5-8b4f6cd90cb6">Secaucus,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8zLTEtMS0xLTA_6454ff2e-8fae-460d-a064-c5c490390b44">NJ</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8zLTItMS0xLTA_7db4732e-f73a-4655-aa83-c1afaa840254">07094</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl80LTAtMS0xLTA_659c2194-30b3-44cc-94ea-30cf529f6ba5">(973)</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl80LTEtMS0xLTA_53f81089-f208-4aef-a19f-c3c75ac5a030">520-2700</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.055%"><tr><td style="width:1.0%"></td><td style="width:30.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.753%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6NWZhYzA2NjRlZTZkNDM2NDlkMWM2NGJlNjZkMDVjNTQvdGFibGVyYW5nZTo1ZmFjMDY2NGVlNmQ0MzY0OWQxYzY0YmU2NmQwNWM1NF8xLTAtMS0xLTA_67cc5aaf-fff4-4f52-acff-242abde8b8a7">Common Stock, $0.01 Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6NWZhYzA2NjRlZTZkNDM2NDlkMWM2NGJlNjZkMDVjNTQvdGFibGVyYW5nZTo1ZmFjMDY2NGVlNmQ0MzY0OWQxYzY0YmU2NmQwNWM1NF8xLTEtMS0xLTA_f7dd2a8b-d1d7-47a7-898c-8f558fabf493">DGX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6NWZhYzA2NjRlZTZkNDM2NDlkMWM2NGJlNjZkMDVjNTQvdGFibGVyYW5nZTo1ZmFjMDY2NGVlNmQ0MzY0OWQxYzY0YmU2NmQwNWM1NF8xLTItMS0xLTA_09c2c383-0cfb-4f85-8e7a-bc321641248e">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTMx_4293d888-994a-4fef-ae99-7ec3521cc238">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTMy_087339fd-b385-4294-813d-baf0a749a04b">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:89.166%"><tr><td style="width:1.0%"></td><td style="width:42.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.794%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.473%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6OGM5MjlmNzcwZjI5NDRiZmFiMzgyZGJmM2U5MzZiZTgvdGFibGVyYW5nZTo4YzkyOWY3NzBmMjk0NGJmYWIzODJkYmYzZTkzNmJlOF8wLTAtMS0xLTA_7bca3067-d068-4b1e-aa1e-23500a672aee">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6OGM5MjlmNzcwZjI5NDRiZmFiMzgyZGJmM2U5MzZiZTgvdGFibGVyYW5nZTo4YzkyOWY3NzBmMjk0NGJmYWIzODJkYmYzZTkzNmJlOF8xLTMtMS0xLTA_0c3495d4-43b8-4c3f-8796-dbf7edfc8936">&#9744;</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6OGM5MjlmNzcwZjI5NDRiZmFiMzgyZGJmM2U5MzZiZTgvdGFibGVyYW5nZTo4YzkyOWY3NzBmMjk0NGJmYWIzODJkYmYzZTkzNmJlOF8yLTMtMS0xLTA_e157c184-eae9-4f53-8dbf-c46591900cc5">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTMz_b31d7e92-b0bd-4d12-90f5-511ae09c9acd">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of April&#160;15, 2021, there were outstanding <ix:nonFraction unitRef="shares" contextRef="i94087c0a58c24d71ac0e67f043afc91a_I20210415" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xODY3_5ea9be1d-0e27-420a-a23c-7996f7370c86">130,638,109</ix:nonFraction>  shares of the registrant&#8217;s common stock, $.01 par value.</span></div><div style="height:22.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:0.1%"></td><td style="width:0.824%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item 1. Financial Statements (unaudited)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Index to unaudited consolidated financial statements filed as part of this report:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13">Consolidated Statements of Operations for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13">March 31,</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13"> 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13"> and 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13">02</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13">0</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16">Consolidated Statements of Comprehensive Income for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16">Months Ended</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16"> March </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16">31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_19">Consolidated Balance Sheets as of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_19">March 31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_19">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_19">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_19"> and December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_19">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_19">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22">Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22">Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22">March 31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22"> and 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22">02</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22">0</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_25">Consolidated Statements of Stockholders&#8217; Equity for the Three </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_25">Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_25">March 31</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_25">, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_25">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_25"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_25">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_28">Notes to Consolidated Financial Statements</a> (unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_85">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_85">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_85">21</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_100">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_85">See Item 2. &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221;</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_100">31</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_103">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_103">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_103">31</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_13"></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMi0xLTEtMS0w_5707f964-3952-4bb0-8285-66a2db635202">2,720</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMi0zLTEtMS0w_debf5b4b-12fb-4aa4-b032-5e3257ccef82">1,822</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNS0xLTEtMS0w_b5ef0c5e-c981-44c2-8fc4-d2a53e28e9a9">1,626</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNS0zLTEtMS0w_74fec4c8-959c-41ea-96d5-75d23e1a3532">1,270</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNi0xLTEtMS0w_93b0f91d-daa0-4159-9972-8bdb9d4ee174">407</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNi0zLTEtMS0w_a8f6a88d-44e5-4294-bff3-4f9b306bbc3b">347</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNy0xLTEtMS0w_5db0d9c8-984b-4210-bb28-34cf97c0427f">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNy0zLTEtMS0w_43dced7e-0d56-4ee3-b2b5-707b1b07bd39">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfOS0xLTEtMS0w_30568554-a2ce-4e56-bfbb-26ca466fc8a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherOperatingIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfOS0zLTEtMS0w_6ea4f46f-6645-4ec9-af6b-23b9b9761d8d">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTAtMS0xLTEtMA_0492bf03-bbc9-4a59-b9a7-5f289d54b881">2,060</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CostsAndExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTAtMy0xLTEtMA_dbc5c5d0-46d4-408b-8b53-2cb2657b20ba">1,647</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTItMS0xLTEtMA_ae0ca3b2-6c40-4783-b097-6649caf28ea1">660</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTItMy0xLTEtMA_2b0bd0a5-11b1-4ede-a418-0ba3c409dca4">175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTUtMS0xLTEtMA_ba6d3cb2-2445-4165-9c3c-541e14e2e542">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTUtMy0xLTEtMA_50b8e56c-0a4f-424d-b7a6-0175f77f5ca0">41</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTYtMS0xLTEtMA_fa2bdb44-3fda-4ed2-bbd7-68a8f8f07d24">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTYtMy0xLTEtMA_4ac5444e-e45c-44ce-89c3-a4d778f4f75b">16</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating expense, net</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTctMS0xLTEtMA_12781090-ba32-430b-a9b2-c8d81b2423f0">34</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTctMy0xLTEtMA_6e7663bc-0e1b-4199-8b93-a70860045cbd">57</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTktMS0xLTEtMA_68cb98f2-e8a4-4e7f-a37a-dffc54e3baab">626</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTktMy0xLTEtMA_56a0f168-10ff-464c-885a-deefed235790">118</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjAtMS0xLTEtMA_d6a57dc7-2c36-464a-8f00-4a4deb7c1ef0">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjAtMy0xLTEtMA_8774bc60-fe5a-4214-ad6b-e2c1e9415800">26</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjEtMS0xLTEtMA_321c0498-38e1-400e-8546-de39b1d23a11">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjEtMy0xLTEtMA_58d180f9-620c-4cbb-9fad-24ea8c20e1b9">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjQtMS0xLTEtMA_cf26cf12-7b31-4614-a0dc-66d6bc1e79e5">490</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjQtMy0xLTEtMA_92fb979a-3ee2-4ccf-9da5-4d41db66e87e">106</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjUtMS0xLTEtMA_2c163f96-eea6-4760-91dd-5a40b6ee1602">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjUtMy0xLTEtMA_2389759b-1580-4484-bf9c-ca58f6dda3cb">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjYtMS0xLTEtMA_386ae93c-11e0-4aed-abff-6f830872463e">469</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjYtMy0xLTEtMA_a7dd1758-f5b6-469e-b844-988d3671d4fa">99</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMzYtMS0xLTEtMA_8e74c989-c715-4eed-a5f6-a8c23aaf3692">3.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMzYtMy0xLTEtMA_0190fd9c-9880-4b1e-bdbf-05e8688871ef">0.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDEtMS0xLTEtMA_6ce60b1a-cc8a-43f0-87ec-37e18f72afad">3.46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDEtMy0xLTEtMA_c1257c6d-b585-45a2-9bd4-078f86fbe761">0.73</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDQtMS0xLTEtMA_85bbaea0-8dab-460b-8378-fa9e9f39fe66">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDQtMy0xLTEtMA_ac1f508b-9c68-4a36-b1e0-2ae9d59140cd">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDYtMS0xLTEtMA_79e6cda0-590e-4bcd-bd44-56cc14707083">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDYtMy0xLTEtMA_7e230a04-db07-44b2-9301-8024829b4802">135</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2021 AND 2020</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.697%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMi0xLTEtMS0w_cf26cf12-7b31-4614-a0dc-66d6bc1e79e5">490</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMi0zLTEtMS0w_92fb979a-3ee2-4ccf-9da5-4d41db66e87e">106</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive loss:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation adjustment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfNS0xLTEtMS0w_3b207e93-ef81-4f58-b957-ad3b992cc239">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfNS0zLTEtMS0w_78b22e5e-32ec-4ad4-888f-cf651d8f71f6">19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in available-for-sale debt securities, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfNi0xLTEtMS0w_f53a1662-8dfc-4a88-89e4-a2f548a0fa9c">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfNi0zLTEtMS0w_f507eab5-4ffc-4c2f-97a9-fb6db80f6a97">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfOS0xLTEtMS0w_0aeafba9-7346-410b-8c8d-fe3ac36c1b40">10</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfOS0zLTEtMS0w_e699c32a-9ccc-45ca-8e4a-991c88664d1d">19</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTEtMS0xLTEtMA_f8f7207b-cc28-45bd-b93e-c6dfb817ee20">480</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTEtMy0xLTEtMA_4bcb9a7c-ae0f-4182-ad78-e7b08f697d53">87</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Comprehensive income attributable to noncontrolling interests</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTItMS0xLTEtMA_9b88933a-5879-4eec-b0aa-f464726b242a">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTItMy0xLTEtMA_d5074173-d3e1-475d-8fdf-760110e2fc61">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTMtMS0xLTEtMA_e768f93b-513b-47ab-96ad-608fd239dacf">459</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTMtMy0xLTEtMA_22fdb77e-ef5b-4a7d-af47-1a81fcd9ac60">80</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span><br/></span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_19"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARCH&#160;31, 2021 AND DECEMBER&#160;31, 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, except per share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.369%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Assets</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMy0xLTEtMS0w_6a6e8f5e-0ac0-40f0-ac7e-f12c59d1117c">1,230</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMy0zLTEtMS0w_b8bbd80a-1ad8-4109-9094-db6ae92a2879">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNC0wLTEtMS0wL3RleHRyZWdpb246OGZhNzI1MWQ3OGUyNDE1NmJkNDAzZmIzZDE3NTE3MDBfNjQ_9de05a7e-70a7-4723-9f88-4ca1efa3bfee">29</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNC0wLTEtMS0wL3RleHRyZWdpb246OGZhNzI1MWQ3OGUyNDE1NmJkNDAzZmIzZDE3NTE3MDBfNzE_d1ddf0ca-8203-4f87-857d-fa537289930d">28</ix:nonFraction> as of March 31, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNC0xLTEtMS0w_7c43beae-4e73-42cc-816f-9726cbdb18c8">1,382</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNC0zLTEtMS0w_634aa8d7-5f1f-4c35-b9e7-125e7f6b1fc7">1,520</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNS0xLTEtMS0w_b29f90d2-beaa-42cf-ad6c-d3dc75955643">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNS0zLTEtMS0w_85b120dc-4d16-440f-82cd-2617fbea8b7c">223</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNi0xLTEtMS0w_067de7c3-9f62-4692-8734-967c08de86fe">164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNi0zLTEtMS0w_47d62a38-4c24-4fb1-be5c-fb7b7d4cc8a7">157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfOC0xLTEtMS0w_d125f7c5-4023-4d60-a3d2-3f01f36603e4">2,999</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfOC0zLTEtMS0w_60499e01-04a8-4b91-91b8-6b8622ef559b">3,058</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfOS0xLTEtMS0w_f3f4c917-2e6a-4104-a75d-a62df36653f3">1,624</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfOS0zLTEtMS0w_5baa2b43-dca3-4aac-b5bc-83457a2a2e1b">1,627</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTAtMS0xLTEtMA_d247b8c9-0dc7-4371-a692-d07703bfc8b8">600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTAtMy0xLTEtMA_dc2ec8e0-ebcb-4c0b-a0cf-1bb103a6b8fb">604</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTEtMS0xLTEtMA_94e3584d-69d9-4eb6-9a4a-6e85c3151b8b">6,870</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTEtMy0xLTEtMA_d06e06f3-3d9d-4770-bfee-c769d8ce9013">6,873</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTItMS0xLTEtMA_a359896b-55d1-4d67-992a-14ab05d2796f">1,141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTItMy0xLTEtMA_180bd8a5-bc11-4f1f-847e-c51318b24afe">1,167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investments in equity method investees</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTMtMS0xLTEtMA_f5b6c4ab-2959-45c5-a857-d1722868d691">527</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTMtMy0xLTEtMA_cb658489-164c-4163-9e37-cd508f424393">521</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTQtMS0xLTEtMA_43ba50fc-e426-4281-aae4-b83121ca573f">170</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTQtMy0xLTEtMA_3117c819-4de5-422b-a8ba-c7020c08bf2c">176</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTYtMS0xLTEtMA_a1772381-fe4c-4e96-8199-9bde95cc9f85">13,931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTYtMy0xLTEtMA_45de1891-1f1a-406d-874e-b63a4f2d4f00">14,026</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjAtMS0xLTEtMA_d34af5ce-5c07-4c8a-b01c-186b5638d882">1,559</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjAtMy0xLTEtMA_c38bc4ce-ad81-4684-8404-488717a69ba5">1,633</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjEtMS0xLTEtMA_3005a542-0006-46e1-8df4-718b955db48b">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjEtMy0xLTEtMA_d49c7265-f744-4250-9efe-b4ecc8afff74">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjItMS0xLTEtMA_dde5f975-96ae-44c8-9671-493613d5b46e">146</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjItMy0xLTEtMA_7f08c990-a6e2-4370-8b6b-fd71dbddf4df">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjQtMS0xLTEtMA_ee4c59a8-5a76-4577-9fff-a52233a6d36e">1,707</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjQtMy0xLTEtMA_d89fa6cb-9d82-4d20-b2c8-44d6b1207bd2">1,776</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjUtMS0xLTEtMA_4b479cf0-8f23-4d36-a01b-66a2ea678695">4,010</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjUtMy0xLTEtMA_c218b14c-e9b1-4726-9c89-0544ee11d905">4,013</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Long-term operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjYtMS0xLTEtMA_8fef11a7-ccd7-465b-be04-d463d47a2498">503</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjYtMy0xLTEtMA_7231bcec-90ee-45a8-ab06-ed2631f58ddd">499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjctMS0xLTEtMA_655960b1-d90e-4fe7-8e88-ce3a7586ee83">842</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjctMy0xLTEtMA_26484c68-b1cd-4d9e-a89d-6deaa48e940c">847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjktMS0xLTEtMA_4372c80d-ff34-4a53-a0b5-ce541aff3345"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjktMy0xLTEtMA_732f2695-9bac-412e-b0dd-97a3ae2b693f"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzAtMS0xLTEtMA_00a49017-0bc8-4717-9a4c-de35736075e7">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzAtMy0xLTEtMA_a2d0b6c8-f057-4a56-abb8-a3f44769646d">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quest Diagnostics stockholders&#8217; equity:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzI5_47b6e572-7818-4291-95ff-6ed4666686de"><ix:nonFraction unitRef="usdPerShare" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzI5_76d34712-247b-4ade-80b8-3452ef9a9738">0.01</ix:nonFraction></ix:nonFraction> per share; <ix:nonFraction unitRef="shares" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzQz_7249b571-9ce8-4863-9df5-ec4537fa54f1"><ix:nonFraction unitRef="shares" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzQz_a2b2d6bc-560a-49af-8148-3dfa172a883b">600</ix:nonFraction></ix:nonFraction> shares authorized as of both March 31, 2021 and December 31, 2020; <ix:nonFraction unitRef="shares" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzExNw_cb3f9339-e72c-482e-b8bd-f4e00a4a1571"><ix:nonFraction unitRef="shares" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzExNw_fe5823bb-6336-4cde-997c-29cc36c56b79">217</ix:nonFraction></ix:nonFraction> shares issued as of both March 31, 2021 and December 31, 2020</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMS0xLTEtMA_838ffb60-72a4-4500-8bed-4a1406908656">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMy0xLTEtMA_cd6e02cd-9b55-47fc-8de4-52fa2f6ee84d">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzQtMS0xLTEtMA_efbbce10-cc26-46a1-82c9-4111b9c5b24d">2,824</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapitalCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzQtMy0xLTEtMA_51611063-096c-400c-a7e7-c0c2ad6381cb">2,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzUtMS0xLTEtMA_764701fe-f731-4e06-a165-f231abfadd3e">9,690</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzUtMy0xLTEtMA_9942c173-2dfd-4bc5-98e4-dac7a8ffd5cd">9,303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzYtMS0xLTEtMA_06c15a31-d55c-4bc5-a689-6476535f476d">31</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzYtMy0xLTEtMA_b0f0e77a-b7d4-4702-9ab1-33c7cc6a57fb">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjhmMTRlMWIyOGIzNjQ0ZTVhMzBhMjA5NjgyNWFhMDU3XzMw_0856f18a-1579-4224-a330-3acdc61412b0">86</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjhmMTRlMWIyOGIzNjQ0ZTVhMzBhMjA5NjgyNWFhMDU3XzM3_b0ead229-b621-4520-a3c9-58cc920ede03">84</ix:nonFraction> shares as of March 31, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzctMS0xLTEtMA_4334f9c2-c06e-49d0-8345-e213ab323d8a">5,740</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzctMy0xLTEtMA_e854b5f9-201b-4d43-8fff-00a91e72dcf5">5,366</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Quest Diagnostics stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzgtMS0xLTEtMA_a912c1c3-8248-49f8-8152-55c58072260f">6,745</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzgtMy0xLTEtMA_aca5335a-7443-4e54-98f1-f126817c3c69">6,759</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzktMS0xLTEtMA_c1332f0f-9b4d-40c6-b271-fdc08fa052c4">45</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzktMy0xLTEtMA_bc901a75-1741-42aa-87d4-de1c96c97ad7">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNDAtMS0xLTEtMA_aa4e92c7-1e20-4644-a22f-49621afcec12">6,790</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNDAtMy0xLTEtMA_268109a3-3a3b-4a58-bdfb-c02573c32043">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNDEtMS0xLTEtMA_aca3faed-db38-4073-8fa0-52f25066adce">13,931</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNDEtMy0xLTEtMA_2d0b2b44-e906-4cf0-a846-9819c9067639">14,026</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions) </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.744%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMy0xLTEtMS0w_2e2e568e-62e0-4408-92f0-4c711c655599">490</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMy0zLTEtMS0w_6dbbcbe7-c49e-450f-a5c3-995a6c50161d">106</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNS0xLTEtMS0w_96ec49f5-2a16-421e-8a04-d0ca6fee93be">101</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNS0zLTEtMS0w_59871bb6-bc9f-4f95-acc5-186379b8f0e9">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for credit losses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNi0xLTEtMS0w_844f5787-769d-4c42-b59a-f9170be2c607">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ContractWithCustomerAssetCreditLossExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNi0zLTEtMS0w_4aef03e8-8daf-41fe-a49b-ca59ee4458fe">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax (benefit) provision</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNy0xLTEtMS0w_f091924d-803f-4091-b545-593d40dedbea">17</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNy0zLTEtMS0w_d27c31c4-538b-401b-b2b4-97391ef02fbd">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfOC0xLTEtMS0w_cea0ca3f-fe75-4827-a5a2-14218542a061">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfOC0zLTEtMS0w_49e9c39e-3c6a-4ee3-97be-971768857e50">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTEtMS0xLTEtMA_061e92f9-a213-4051-9c06-22c1154c704b">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTEtMy0xLTEtMA_6db21f24-a625-4af3-b463-9d059cef20a0">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTMtMS0xLTEtMA_156c735b-65c8-4dad-9afb-b321d260883e">138</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTMtMy0xLTEtMA_1d64c84e-a847-4ec8-8ff6-50072fddde8c">85</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTQtMS0xLTEtMA_478a1000-fa25-4adf-9ce1-6d4dedfee83e">164</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTQtMy0xLTEtMA_c8ecb88a-7a13-4d5a-af7f-83c126d6e3ae">47</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTUtMS0xLTEtMA_1672c161-881c-41ca-bb40-344344af4b10">163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTUtMy0xLTEtMA_89ecc4c0-93f6-450f-9963-9dd375c19504">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets and liabilities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTctMS0xLTEtMA_fd4702dd-efeb-4001-a7fa-61f989bbab57">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTctMy0xLTEtMA_5769b5d6-39b6-4fab-999f-70367f2cc7bf">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTgtMS0xLTEtMA_5ce069d0-c01b-40f5-af94-f4163853b9f1">731</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTgtMy0xLTEtMA_709a4e6e-bea9-4133-bc80-174fc976c5e6">247</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjEtMS0xLTEtMA_b4dc1bef-ba29-4960-af22-8aae29f4e7f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjEtMy0xLTEtMA_25599550-a190-447d-be46-8eeb3fc9029e">108</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjQtMS0xLTEtMA_b790a204-af14-4793-944f-7d01592c5267">86</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjQtMy0xLTEtMA_42b95910-9ee9-43bf-ab2a-9115ba16362f">83</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in investments and other assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjYtMS0xLTEtMA_c83c225f-c976-4fdb-9d8a-b006e98337b5">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjYtMy0xLTEtMA_49ea78bb-eff5-442e-9bc5-899397146a93">15</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjctMS0xLTEtMA_56d1f7e6-8f0b-4e50-b435-73c09a2a2cfa">93</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjctMy0xLTEtMA_a95366d5-88d7-4011-aed6-14c6c0f9bedc">206</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayments of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzEtMS0xLTEtMA_c6a8e00b-fe35-4109-ab68-f6636b01514e">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzEtMy0xLTEtMA_f34b7b78-851f-41fb-ba0c-929415964ae9">801</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzItMS0xLTEtMA_9af1dfda-660d-4c64-9156-d06b83b8bcc5">410</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzItMy0xLTEtMA_ae304e71-2d51-4804-8349-deaa9a90daf8">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzMtMS0xLTEtMA_a9dad0b2-4eed-42f8-820e-d13a450a22cb">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ProceedsFromStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzMtMy0xLTEtMA_676f2207-cf89-4553-878f-27211003825f">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee payroll tax withholdings on stock issued under stock-based compensation plans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzQtMS0xLTEtMA_59037235-2c0c-4ff6-8e22-b1284a357b4c">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzQtMy0xLTEtMA_e47b08ae-9cc0-4c4b-907e-94731749afab">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzUtMS0xLTEtMA_ad6359af-33e1-48ae-9e80-5cee3a8ff433">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsOfDividendsCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzUtMy0xLTEtMA_c6c26fa3-83d5-4fc1-87a4-efc217311269">71</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzYtMS0xLTEtMA_0818706c-4b42-4cd6-b729-e8ac12eda689">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsOfDividendsMinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzYtMy0xLTEtMA_cba4fbe0-cccf-467c-a235-39412cd3edb8">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other financing activities, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzktMS0xLTEtMA_ed44a252-7c90-442d-8c63-47bbe4c8db2f">47</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzktMy0xLTEtMA_c406ef61-625a-49d9-9ebf-dd9be7e9bcc6">4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDAtMS0xLTEtMA_7331ef35-caa1-4931-a9bd-a7a4b48859d9">566</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDAtMy0xLTEtMA_1d72bf46-98ab-4900-ac82-4d930ab82db0">891</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDItMS0xLTEtMA_fb1a3f4f-67a7-4caa-8ae7-b372d95790ed">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDItMy0xLTEtMA_a79e0f86-a0eb-489a-b8aa-5e70c3bff3c5">850</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDQtMS0xLTEtMA_d9ab02df-cdda-4445-a7eb-a9c03bb8ffba">1,158</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDQtMy0xLTEtMA_6d8114cb-e234-4790-ae7b-e10dcff8471d">1,192</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents and restricted cash, end of period</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDUtMS0xLTEtMA_c1830a1b-23ae-4800-aa0d-e069bd91556c">1,230</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5f406ec8444737afc188d6eaf5b3df_I20200331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDUtMy0xLTEtMA_a62019e5-9c60-4b56-8146-ba2746a00cf0">342</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_25"></div><hr style="page-break-after:always"/><div style="min-height:27pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE THREE MONTHS ENDED MARCH&#160;31, 2021 AND 2020 </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2020</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie646d19d5cf7459186c0619c49ea5b00_I20201231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xLTEtMS0w_48423f68-8431-4caa-9b04-c6adf942ff54">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie646d19d5cf7459186c0619c49ea5b00_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0zLTEtMS0w_d438301d-d4b9-4518-92db-7d3a3e9b3f53">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad2c3ee49929469181f46b8451771c2e_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi01LTEtMS0w_fa9107f5-22b6-4a29-805d-4cefc6f584f9">2,841</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30e7f83270134cbba57989f6c87ee5dc_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi03LTEtMS0w_f24d0d63-c4db-4c2d-b591-661b511737c3">9,303</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6763b3092130441aa4d3e7b62a500f77_I20201231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi05LTEtMS0w_296c5132-25d0-4ae5-a6bf-c897c6b53fba">21</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4383ddd8bce04187905a84f784749ae5_I20201231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xMS0xLTEtMA_8586f4b2-23e6-45c0-a908-d894e9d29faf">5,366</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8041207d92044f2b46db9b98a65cc49_I20201231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xMy0xLTEtMA_22744437-73ad-4997-8b79-40010f0b5b28">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xNS0xLTEtMA_6c11ed90-f475-4f9a-88c1-885c6b2fbd13">6,809</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xOC0xLTEtMA_06b12df7-7bc0-4214-9120-e54c154ce155">82</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c968630629445fe8e4c6a11b499ae19_D20210101-20210331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMy03LTEtMS0w_364ea3d4-4eb5-4c8d-a901-00855a168593">469</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9847f3acf448409280792183ebb09888_D20210101-20210331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMy0xMy0xLTEtMA_dda61b59-07c9-4885-bd43-ee56d465cb20">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMy0xNS0xLTEtMA_a8febb34-2736-415e-a573-92027d3aac05">486</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMy0xOC0xLTEtMA_df610d6a-36a8-44b7-9299-837045903377">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19684d6afbf34103a049012a6f48ef9c_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNC05LTEtMS0w_256858b9-fce1-4b7b-9e66-2dbc47c9a844">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNC0xNS0xLTEtMA_37e2b2cc-db76-41eb-b579-200aa2e8f266">10</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c968630629445fe8e4c6a11b499ae19_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNS03LTEtMS0w_511ef1f7-b9c0-4e09-994d-fb859955cad4">82</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNS0xNS0xLTEtMA_fec064e5-6909-4fb4-9995-9e64f02cc043">82</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9847f3acf448409280792183ebb09888_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNi0xMy0xLTEtMA_311502e0-d374-4863-bbfa-61aba5e23dd7">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNi0xNS0xLTEtMA_41892c71-8735-458e-889d-8802c56df539">22</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNi0xOC0xLTEtMA_a990b05d-ada0-4666-9090-c6f27aa289de">7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNy01LTEtMS0w_096ed111-89a0-41ff-a744-84b90546eb9e">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNy0xMS0xLTEtMA_335394d7-3df5-4cd0-8858-fda1bf2263cd">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNy0xNS0xLTEtMA_fc3b1865-2b47-435c-9db7-0573ea3c6b32">5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOC01LTEtMS0w_e5e55173-0bea-4d65-9bda-fa64de0a2a84">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOC0xNS0xLTEtMA_aef527e0-cbe0-4cef-a03a-b855a954f87c">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd48c006babc44508fba201daabd149f_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOS0xLTEtMS00NDA1_c44c7353-b8e9-4cd4-8820-2458bb5f35d8">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOS01LTEtMS0w_dcc95819-114b-4960-a4d8-e6c50dbeb995">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOS0xMS0xLTEtMA_bf54ebe0-a85b-45cc-bb32-60082d663d82">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOS0xNS0xLTEtMA_ceea0962-cd7f-43e5-8ffd-718f50c571e7">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTAtNS0xLTEtMA_e8e88885-1f76-486b-b770-8516edc6b010">9</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTAtMTEtMS0xLTM0NDg_5dc30c86-126f-46d2-b19b-dcad34032564">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTAtMTUtMS0xLTM1NTc_3ae96e4b-9e43-4b76-9098-31fd68ef36e4">21</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="idd48c006babc44508fba201daabd149f_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTEtMS0xLTEtMA_2779294b-531a-40b2-8896-9cbb3b6632a8">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTEtMTEtMS0xLTA_784a5646-9bed-433e-a340-8bad068c8f6a">410</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTEtMTUtMS0xLTM1NTc_63c23c81-be2a-4446-8029-ab0d3328d50c">410</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, March 31, 2021</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1229f5eae1bb44628fb91b7979affa6f_I20210331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMS0xLTEtMA_c9abb91b-1d42-4efb-b2d6-ac06845f4de8">131</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1229f5eae1bb44628fb91b7979affa6f_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMy0xLTEtMA_87afbb4e-9671-4003-a85e-1d3ee42b829b">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia93fe46925ac4e9bb7935ca7294c9f15_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItNS0xLTEtMA_8d37b922-5551-4490-9279-2c7b7454096c">2,824</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0837bdde940d4fec8198129389d20b30_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItNy0xLTEtMA_eaf960cd-4341-40a3-95fa-b9fe8edd62b6">9,690</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i31fe7b51e3304a36906e002676eabb34_I20210331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItOS0xLTEtMA_aee6692e-05eb-4011-bc30-90a99805c823">31</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f7944d31d44461c81787b9b98e14b57_I20210331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMTEtMS0xLTA_47fad0e6-8ae2-4148-948a-4a5800a9e80f">5,740</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id66c8836535840cab79f0efa55d1cee1_I20210331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMTMtMS0xLTA_bd283c53-6f0f-4e82-9662-d1909b28ed96">45</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMTUtMS0xLTA_ef02dd6f-9576-49f9-b0b9-01de73f421a2">6,790</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMTgtMS0xLTA_a338dd1e-fc87-4c96-8b11-1ef2577faca4">79</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.025%"><tr><td style="width:1.0%"></td><td style="width:28.626%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.440%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.222%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.012%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the Three Months Ended March 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quest Diagnostics Stockholders&#8217; Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares of<br/>Common Stock<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common<br/>Stock</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained<br/>Earnings</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Compre-<br/>hensive Loss</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury<br/>Stock, at<br/>Cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-<br/>controlling<br/>Interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stock-<br/>holders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Redeemable Non-controlling Interest</span></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, December 31, 2019</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4f49c664e464e75a6577f2c5dbd5d00_I20191231" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xLTEtMS0w_070f796a-b766-4e8b-bad4-719e0a2da260">133</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4f49c664e464e75a6577f2c5dbd5d00_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0zLTEtMS0w_e2ce89bb-38a7-4b5c-a8c9-a7344a003c37">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44d7060969104f55af57e24f5142babe_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi01LTEtMS0w_5e110915-84f5-4720-8858-b81a913a2685">2,722</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2353c85dd054cf1943d3a8d511c4959_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi03LTEtMS0w_83b3a658-253a-451d-bdd2-131a19a4a7ad">8,174</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i795ed9a1abc545c88b550e1eedd5d75c_I20191231" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi05LTEtMS0w_709c0607-7dde-455f-b7f3-bebd3570fd6a">39</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207c605753d646cb94bcf01101b0bf97_I20191231" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xMS0xLTEtMA_29123c95-be23-4c6b-b313-2636871d2cbf">5,218</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb90cf4bc9e9485d83bb0be21e4bf3ca_I20191231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xMy0xLTEtMA_956f238b-a2f0-4d26-875f-31db47b1b98f">46</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xNS0xLTEtMA_faee0673-dbc1-48bc-a73d-ba11f8f69210">5,687</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xOC0xLTEtMA_81d80ef7-68dc-4fdb-988c-ebc5f27dea33">76</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c99680609bd4fb4ac289f25c8f9e0b6_D20200101-20200331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMy03LTEtMS0w_567cbb6b-5fb3-4422-89ec-c2e524f1e617">99</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic022103456b94e4f920519555dc899e2_D20200101-20200331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMy0xMy0xLTEtMA_bd485d86-ff27-47e5-bcaa-8ea40b42becd">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMy0xNS0xLTEtMA_70cef85f-8732-42ba-a04c-d15dfc34dece">105</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:TemporaryEquityNetIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMy0xOC0xLTEtMA_880fd432-f7c2-4424-87f6-557bd67fd799">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive loss, net of taxes</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i41ab8be1210042b6bb81b9c60bf8605a_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNC05LTEtMS0w_5c81baf1-dc8f-483d-9d00-82eefcee9afd">19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNC0xNS0xLTEtMA_3d667edb-fccb-417d-8d81-c816fa8d5b83">19</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dividends declared</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c99680609bd4fb4ac289f25c8f9e0b6_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNS03LTEtMS0w_07940e07-a8a7-46de-8dab-c1b8913422e2">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:DividendsCommonStockCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNS0xNS0xLTEtMA_23ae8751-3a42-40de-9fff-8a8bcfa61feb">76</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Distributions to noncontrolling interest partners</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic022103456b94e4f920519555dc899e2_D20200101-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNi0xMy0xLTEtMA_08fefaa7-1bf3-4672-a7d8-ea1f2babb0f2">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNi0xNS0xLTEtMA_681fc313-1a04-45aa-9c7c-eab4ab7cb092">6</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNi0xOC0xLTEtMA_91737315-1fb4-4020-a2e2-5ab94c888e22">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under benefit plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNy01LTEtMS0w_29809666-76ee-404a-88a0-921b53fc8b27">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNy0xMS0xLTEtMA_8f8f36cb-99db-4e90-b073-c7f614cedb3c">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNy0xNS0xLTEtMA_30a7131c-35a0-443e-98f3-1a57f5ba2d5b">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOC01LTEtMS0w_fc9cdae6-c33e-452d-a405-3b36d5f40e7c">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOC0xNS0xLTEtMA_f623fb6c-1545-47e6-9d24-325e276535d4">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie15d552706e0430088071b5ee01807cd_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOS0xLTEtMS0w_8e8280af-c174-4237-9722-f4b042643dea">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOS01LTEtMS0w_55b668f7-b184-46c7-a42f-73176b064f81">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOS0xMS0xLTEtMA_3f47836e-003c-4921-8882-e747ecfa4db5">68</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOS0xNS0xLTEtMA_e7abe80b-1692-46d2-bd30-de4de4530f49">80</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTAtNS0xLTEtMA_890c2221-ad11-484b-ad1c-c8a95eada8e3">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTAtMTUtMS0xLTA_bbb1811b-a5d3-453c-81c0-3195869d9262">13</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchases of treasury stock</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie15d552706e0430088071b5ee01807cd_D20200101-20200331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTEtMS0xLTEtMA_50f09dea-4361-4056-9a4c-0b9b2983e36f">1</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTEtMTEtMS0xLTA_cbe12ede-4c74-46a6-a31e-a16100ada5d7">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTEtMTUtMS0xLTA_2cd62f29-8602-4b45-99eb-2d39c148c1f2">75</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">Balance, March 31, 2020</span></td><td colspan="2" style="border-bottom:2pt solid #000;border-top:1.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2a26f2f8c8934f1b93702b137ab17309_I20200331" decimals="-6" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMS0xLTEtMA_256d5624-2e99-43d2-8cda-781c13ca3279">134</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a26f2f8c8934f1b93702b137ab17309_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMy0xLTEtMA_10e8bb84-9192-41c7-a452-de4f7fd7f7c8">2</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72931c6b70d14f8e8c1d97620ad67fbe_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItNS0xLTEtMA_5229e38d-35d6-4303-ac9d-a5e1f49def44">2,738</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec9454bd4f9d47f3b5eee627c27ab502_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItNy0xLTEtMA_d7c1ec62-5c26-4e57-bb60-d7d2dd45d9e9">8,197</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4f0cdcdd19e149f58288a99e479bfc5d_I20200331" decimals="-6" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItOS0xLTEtMA_3e7002b7-d10f-41db-af72-0db6725ee201">58</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if402423ae2b24c479ced9a86251c3483_I20200331" decimals="-6" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMTEtMS0xLTA_9e4e5778-ab4b-4a29-80e1-3bb3e997067f">5,222</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20b63065eb04432ba75178f3f9ab8895_I20200331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMTMtMS0xLTA_ce95fbe9-d4d7-4542-b2e6-db73ba08d738">46</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5f406ec8444737afc188d6eaf5b3df_I20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMTUtMS0xLTA_84ab7ff6-76be-4cbf-93ee-6edd65852c71">5,703</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5f406ec8444737afc188d6eaf5b3df_I20200331" decimals="-6" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMTgtMS0xLTA_68c26016-6690-486b-b3b4-65c1f4349e69">76</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.242%"><tr><td style="width:1.0%"></td><td style="width:28.561%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.424%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.345%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_28"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_31"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zMS9mcmFnOjM4ZDlmYjJkNjc1MzRkZjRiYWQwN2JiNWJhNDU1YmU3L3RleHRyZWdpb246MzhkOWZiMmQ2NzUzNGRmNGJhZDA3YmI1YmE0NTViZTdfMTc1NA_deca462a-0725-4023-9485-e349759f4a7d" continuedAt="iad3c115c2b05437499f8a06f2b69fca8" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="iad3c115c2b05437499f8a06f2b69fca8" continuedAt="i875cc6b28cdd4437b8c4646fc8fc4abc"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i875cc6b28cdd4437b8c4646fc8fc4abc">&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</ix:continuation>  </span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_34"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIzMA_119d2eb0-8b18-436b-ad82-7783536affac" continuedAt="i425934b94e694225ba4d43e1f80b0baa" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><div style="text-indent:29.25pt"><span><br/></span></div><ix:continuation id="i425934b94e694225ba4d43e1f80b0baa" continuedAt="iee75642f68da4ea3a01e1fe805661723"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIwMw_76c316e6-068f-4e04-a3cc-68653d6b523f" escape="true">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#8220;COVID-19&#8221;) continues to spread and severely impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three months ended March&#160;31, 2021 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIyMQ_e5dff932-010d-4f8f-83e7-dd156f1f008b" escape="true">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</ix:nonNumeric> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIxNw_6eab7cec-bd95-4e2c-a796-53d6cc8fc2e1" continuedAt="i3a7781830da342aea32a5330a6ee529e" escape="true">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iee75642f68da4ea3a01e1fe805661723"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3a7781830da342aea32a5330a6ee529e">allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</ix:continuation></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIxOA_c072650a-b040-4b11-accf-3c6e13407be8" escape="true">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RleHRyZWdpb246ZGU0ZjhiMjg4YWM2NDEyNmJlMTgyZmNmN2FlNzE1NjlfODEy_4e77e20e-88f0-4a85-b499-ac4abd3902a4" continuedAt="i1590d44e8d1a426d95c111c647ce1fa1" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i1590d44e8d1a426d95c111c647ce1fa1"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RleHRyZWdpb246ZGU0ZjhiMjg4YWM2NDEyNmJlMTgyZmNmN2FlNzE1NjlfODI5_a0d1ecd7-3582-432c-b96e-6344b4a330da" continuedAt="i334729e022ec473cb83f3469531b83d1" escape="true">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i334729e022ec473cb83f3469531b83d1"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfNy0xLTEtMS0w_f8e73ff7-bcb6-4db7-a590-c2bc92fa7dfe">469</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfNy0zLTEtMS0w_d9a2ba6f-d750-42e6-8a2c-f3e95d65d54d">99</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfOC0xLTEtMS0w_5862d104-3d28-4000-adc2-46620c0a593d">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" format="ixt:zerodash" name="us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfOC0zLTEtMS0w_a1d709b2-98c7-4757-951b-d6546d7bd2b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfOS0xLTEtMS0w_ca3efba3-7fdc-45a1-98d9-c4597bf7544e">468</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfOS0zLTEtMS0w_51273225-72d8-4457-b5ad-f3ae7c72d331">99</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTEtMS0xLTEtMA_85bbaea0-8dab-460b-8378-fa9e9f39fe66">133</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTEtMy0xLTEtMA_ac1f508b-9c68-4a36-b1e0-2ae9d59140cd">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTMtMS0xLTEtMA_d3c10217-8047-481c-bdcc-d1fde4e60cac">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTMtMy0xLTEtMA_fcbb0606-2443-498c-9d31-cfdf0ab2352c">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTQtMS0xLTEtMA_79e6cda0-590e-4bcd-bd44-56cc14707083">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTQtMy0xLTEtMA_7e230a04-db07-44b2-9301-8024829b4802">135</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTctMS0xLTEtMA_dd758091-3dc3-47f1-8910-2e816564e6aa">3.52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTctMy0xLTEtMA_335d14ea-df46-43a4-bc5f-4fc91eaa23a3">0.74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMjItMS0xLTEtMA_e07c591a-3a64-4f4a-a203-1efc5291f69d">3.46</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMjItMy0xLTEtMA_d90ab3be-e8df-44a6-a53c-cbbf484a5b0d">0.73</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RleHRyZWdpb246ZGU0ZjhiMjg4YWM2NDEyNmJlMTgyZmNmN2FlNzE1NjlfODMx_3d916cd8-6826-4a9b-9364-459769bac47b" continuedAt="i92311d56b9b845728d857bc0de900161" escape="true">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i92311d56b9b845728d857bc0de900161"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjdjOGNmOWMyODVhMDRkMGZhZmI0MjliZmNhNzkwZjM0L3RhYmxlcmFuZ2U6N2M4Y2Y5YzI4NWEwNGQwZmFmYjQyOWJmY2E3OTBmMzRfMi0xLTEtMS0w_803f6ef3-c69b-48ca-9400-7938c8fe7b96">1</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjdjOGNmOWMyODVhMDRkMGZhZmI0MjliZmNhNzkwZjM0L3RhYmxlcmFuZ2U6N2M4Y2Y5YzI4NWEwNGQwZmFmYjQyOWJmY2E3OTBmMzRfMi0zLTEtMS0w_df219823-019d-40b1-b55c-11f13f9241df">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_43"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80My9mcmFnOmVhYzdjNjRlZDdmZDQ3ZjY5YWJjODk0MDc0YjJiZGRjL3RleHRyZWdpb246ZWFjN2M2NGVkN2ZkNDdmNjlhYmM4OTQwNzRiMmJkZGNfNDIzNA_eef97a46-92b5-42a5-ae6b-2d5a8eb1fece" continuedAt="ide87191f85674447ab9ccb39d0f9a258" escape="true">BUSINESS ACQUISITIONS</ix:nonNumeric></span></div><div><span><br/></span></div><div><ix:continuation id="ide87191f85674447ab9ccb39d0f9a258" continuedAt="ibf228c9f67a74f0b975239fed3bdac66"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 6, 2021, the Company entered into a definitive agreement to acquire the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma.  The transaction, which is expected to close in mid-2021, remains subject to customary closing conditions.</span></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibf228c9f67a74f0b975239fed3bdac66">&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_46"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNzY5NjU4MTQwMzcyNw_022b0c4c-25ca-4d3f-b6d3-783188cb38cd" continuedAt="i150ce5a579d14f63b7697ae14669942c" escape="true">FAIR VALUE MEASUREMENTS  </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i150ce5a579d14f63b7697ae14669942c" continuedAt="i10c4d246161448339c401f3ab252e501"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNzY5NjU4MTQwMzcyNA_0535a13d-8642-4689-9172-1adf6dbf818c" continuedAt="id49f75e539084b9dbb7d07e49ad77339" escape="true">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</ix:nonNumeric></span></div><ix:continuation id="id49f75e539084b9dbb7d07e49ad77339"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:46.260%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNi0xLTEtMS0w_bf96e31c-8512-418f-8151-1bce6c1b15f4">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNi0zLTEtMS0w_90adb924-8a8a-4266-9fda-6ef80cad7d67">71</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNi01LTEtMS0w_de975a7b-3c90-4893-83ac-0a4e64d1aeb3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNi03LTEtMS0w_8ff89d53-340d-4169-9c0c-434940b60293">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNy0xLTEtMS0w_821cf0f6-c1e2-4ffe-a954-f6d055877651">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNy0zLTEtMS0w_526d1dc9-bd91-4493-bc3c-5bbcca366a2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNy01LTEtMS0w_7db94472-b41f-4dd9-a980-5133cea2a27d">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNy03LTEtMS0w_9919c5a3-5d4e-4983-92d7-fa1a76b7e7be">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfOS0xLTEtMS0w_e1782092-bcd2-4277-a899-c5901d66c0fb">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfOS0zLTEtMS0w_9af744d9-31ee-4230-af9d-a2f0fa2883b3">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfOS01LTEtMS0w_c28add00-8c94-49cc-832f-5c4fff609c6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfOS03LTEtMS0w_ebbf6f4f-fc06-4662-8167-49dff4785cc3">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTItMS0xLTEtMA_e85c6d70-3edb-47f8-be4a-903c4e9d7b76">125</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTItMy0xLTEtMA_ea42e5c2-e3bc-4d74-a5a2-19b1ec6fd9a8">71</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTItNS0xLTEtMA_2e0fac3d-4061-4edd-b798-3877f40855dd">52</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTItNy0xLTEtMA_8552c1b4-fdf9-421a-8638-d5457c6c1252">2</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTUtMS0xLTEtMA_5fa6c93f-db32-44f3-80b1-aeb5b8b6f472">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTUtMy0xLTEtMA_89471c9d-cd58-4941-bfb9-f78e46819a14">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTUtNS0xLTEtMA_2038ab6a-2390-419e-9f19-964ed07c515c">132</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTUtNy0xLTEtMA_66f3e79c-cf84-46de-9917-0b48bbda5be5">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMjItMS0xLTEtMA_65e9762d-8241-44ef-acae-e175b6219d3b">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMjItMy0xLTEtMA_2a74f5a3-f4e5-4077-99a9-971b8db585ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMjItNy0xLTEtMA_957f43d3-62a3-489e-8ca7-8f06c1e3f710">79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.191%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.345%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.198%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.372%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMy0xLTEtMS0w_f2884811-c6cd-4e6e-9d4a-8121c60912de">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231" decimals="-6" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMy0zLTEtMS0w_58d07d69-8f71-4a75-8ddb-5684b7398941">67</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMy01LTEtMS0w_5a92a490-6e9d-4cec-9f30-235e6d5b5b14">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:TradingSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMy03LTEtMS0w_0bd9f252-8e4f-4856-bf15-477e30aeaa9a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNC0xLTEtMS0w_ba912736-9588-4d32-848c-f76fc3f48237">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNC0zLTEtMS0w_468888c8-aa05-47c2-8a85-30cd538cb7d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231" decimals="-6" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNC01LTEtMS0w_6cee07dc-9652-4b83-8a64-13a8408a9173">50</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:CashSurrenderValueFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNC03LTEtMS0w_98ff8245-b0eb-4660-b90a-91fe5304c311">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNS0xLTEtMS0w_f910be8f-a367-456a-80f5-5189d165f7c9">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNS0zLTEtMS0w_ccfca975-16df-496a-b7bf-016096a6c35d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNS01LTEtMS0w_7b6c16e5-d19b-4588-9ae8-d9727fc1fe84">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNS03LTEtMS0w_cd8ef568-a31d-4638-b05b-a846b11b8972">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTAtMS0xLTEtMA_ffabd768-23cd-46db-839c-f9fd872ce8a8">129</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTAtMy0xLTEtMA_f6a0d95d-67cf-4503-b76a-1019b635b789">67</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTAtNS0xLTEtMA_7d595b21-0742-4f82-b192-5fe049f037ca">50</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231" decimals="-6" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTAtNy0xLTEtMA_7de0e0d9-0c8c-4692-abd9-1154c08e5eff">12</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTMtMS0xLTEtMA_2dc4585d-7847-4106-aee3-98024d783b8b">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTMtMy0xLTEtMA_316a2ffe-e36d-4506-8ba4-3d1dd12b5788">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTMtNS0xLTEtMA_c1a9a0d2-2e3d-48ef-a8f6-ee4e5796fe76">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTMtNy0xLTEtMA_0fa19664-ea99-4d01-b95d-589771e17396">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMjEtMS0xLTEtMA_fa0fc8d1-4b8a-4ced-b2bb-88f792691b07">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231" decimals="-6" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMjEtMy0xLTEtMA_861cf3fe-cc07-44b3-920e-a1fa467a4226">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231" decimals="-6" name="us-gaap:RedeemableNoncontrollingInterestEquityFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMjEtNy0xLTEtMA_33889dba-0779-4cf9-bffc-04e6314b416c">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i10c4d246161448339c401f3ab252e501"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="ic8b7e170774c4e2f95ec5ebd85bba23b_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNDc3OA_3cd40039-b3e9-4dc5-a071-3b56daa9b5b3">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March 31, 2021, the Company recorded an $<ix:nonFraction unitRef="usd" contextRef="ib735db70e8754b31974b71ba0360f16f_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNDM5ODA0NjUxOTY0NA_1f6059bf-827b-4ab7-9670-ff67bcf07dd2">8</ix:nonFraction>&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of March&#160;31, 2021 and December&#160;31, 2020, the fair value of the Company&#8217;s debt was estimated at $<ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNDM5ODA0NjUyMDM4Mw_0f3c9fb3-6186-4711-83c4-725450c33574">4.4</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNTc0Ng_8a52e85a-118b-43e6-b0b8-9ff8768c5262">4.6</ix:nonFraction> billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div></ix:continuation><div style="text-indent:29.25pt"><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfMTI1MQ_92770fa0-9abe-4340-961e-4dfa685fc425" continuedAt="i510146bcef9c438684b5e8a7f4ea6e5b" escape="true">GOODWILL AND INTANGIBLE ASSETS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i510146bcef9c438684b5e8a7f4ea6e5b" continuedAt="i0a43c2f450404af5af2330c47cba2608"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfMTI0NA_eba8550a-03ea-4113-bee9-3ec6e74282fe" continuedAt="i67321e0b2ddf4ca78d6e7452717c6629" escape="true">The changes in goodwill for the three months ended March&#160;31, 2021 and for the year ended December&#160;31, 2020 were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i67321e0b2ddf4ca78d6e7452717c6629"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.906%"><tr><td style="width:1.0%"></td><td style="width:57.589%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.175%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMS0xLTEtMS0w_19f0e71c-8dad-4dae-bd91-82baf5d5ecc9">6,873</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMS0zLTEtMS0w_c247d3ba-30d4-4e57-8855-1692e80321fc">6,619</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMi0xLTEtMS0w_82f86c6b-8679-479f-96da-9c2c3b0055ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc7342da57f4a33aff95cad60d1c936_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMi0zLTEtMS0w_f03fee8b-0fd2-4364-821f-60a7c8e70baf">247</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMy0xLTEtMS0w_5f91a53f-2979-4b54-9c9e-d7b68875b60e">3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcc7342da57f4a33aff95cad60d1c936_D20200101-20201231" decimals="-6" name="us-gaap:GoodwillPeriodIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMy0zLTEtMS0w_e72f1f5c-153d-4a22-8b15-afa72db51379">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfNy0xLTEtMS0w_a1ddedb2-53c8-42b6-813f-a53861ae4dcf">6,870</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfNy0zLTEtMS0w_230cbaa0-b109-42b6-b564-6782392c1996">6,873</ix:nonFraction>&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i0a43c2f450404af5af2330c47cba2608"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of March&#160;31, 2021 and December&#160;31, 2020 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy, Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining <ix:nonFraction unitRef="number" contextRef="i0d63d7e9761b4274807931de4482a38c_I20201231" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfNzY5NjU4MTM5NzIyMg_9cbef2c7-dd3b-4fd5-ac13-54e2e0b6d2a7">56</ix:nonFraction>% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfMTI0OA_e2a64112-09e2-4460-a619-332198039f85" continuedAt="i6eecd71716884f21a9a7c0a23e9e4f2c" escape="true">Intangible assets as of March&#160;31, 2021 and December&#160;31, 2020 consisted of the following:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt"><ix:continuation id="i6eecd71716884f21a9a7c0a23e9e4f2c"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:21.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.017%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.724%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.776%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.727%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic90470dc4f4e496caf705d77fa10f616_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy0xLTEtMS0w_fd36e39e-8b58-4580-9990-ba7eee87cd4c">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb591aeff91e492ea542a000f524e7ba_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy0zLTEtMS0w_fa9260e2-c901-41a5-931c-e946e209d228">1,481</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb591aeff91e492ea542a000f524e7ba_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy01LTEtMS0w_bd10a2c1-9243-4188-8be5-8193855cbc69">659</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb591aeff91e492ea542a000f524e7ba_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy03LTEtMS0w_e5d74e27-a683-46f0-b194-3999a70e20c1">822</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd67844f6da45dea182ccba35b463fa_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy05LTEtMS0w_f091906b-22a7-4e32-957d-d1056aeb4a6c">1,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iedd67844f6da45dea182ccba35b463fa_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy0xMS0xLTEtMA_436a726e-b92f-4d0b-8a4f-3491f3212084">638</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iedd67844f6da45dea182ccba35b463fa_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy0xMy0xLTEtMA_e0bc2c30-3766-4c0b-a5d4-8229cbef0cb8">841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iadbedddfbeb44bccac35bc1968c7198f_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC0xLTEtMS0w_925a9b68-25c3-4c80-abfb-2fd71dbcb143">9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57106d7badad475d94a3fdc00692bdf1_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC0zLTEtMS0w_11e26a3b-6d70-453f-b96a-3af03151b52b">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i57106d7badad475d94a3fdc00692bdf1_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC01LTEtMS0w_efad2f67-a604-40c7-b443-c33042521b49">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57106d7badad475d94a3fdc00692bdf1_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC03LTEtMS0w_9c254d64-aae4-44ab-b687-0c7157a057a9">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if045c9990da04355aabfd81d38c5e41d_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC05LTEtMS0w_faeec7cc-3770-4d6b-8a02-1fb7189dcbe2">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if045c9990da04355aabfd81d38c5e41d_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC0xMS0xLTEtMA_8cc85106-0f10-42b8-ab80-78a30cf17eb0">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if045c9990da04355aabfd81d38c5e41d_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC0xMy0xLTEtMA_19c3efc8-4109-43fd-b340-f423febb527c">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i604ee99bfe964292aabcd6f1b7a316d6_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS0xLTEtMS0w_c4724351-1bb3-4b3a-83da-85d2c1330da5">15</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dd08a56a99d48b4a6ee1e2a7e24fcbe_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS0zLTEtMS0w_98a08fea-7573-448e-b9ad-6cb1edafb0de">140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dd08a56a99d48b4a6ee1e2a7e24fcbe_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS01LTEtMS0w_7319f6f9-03e0-4a3d-af49-b623d2d0cf01">68</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dd08a56a99d48b4a6ee1e2a7e24fcbe_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS03LTEtMS0w_ff64d55c-bf57-428f-9bf0-b5f858e939b5">72</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246eef5102584ee28b17a57e7f0313fe_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS05LTEtMS0w_60462fc4-6e3b-4416-80f6-3b212b716572">141</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i246eef5102584ee28b17a57e7f0313fe_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS0xMS0xLTEtMA_87ef9c2a-5e10-4b38-891b-71b442c0e969">65</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i246eef5102584ee28b17a57e7f0313fe_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS0xMy0xLTEtMA_5599d677-9591-4a34-a9d0-ae3bc82bdbb4">76</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i329a30ceb1f446f2b7a379a3a3609fdd_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi0xLTEtMS0w_e7ebaecf-050d-4494-b99a-948ae26a3789">5</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2340158a38984ae194d149a5c95c9e3c_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi0zLTEtMS0w_4583ca33-82c1-49e1-b6d5-5ed0d4639117">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2340158a38984ae194d149a5c95c9e3c_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi01LTEtMS0w_8342312a-b251-4686-81ca-df404298c8d1">98</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2340158a38984ae194d149a5c95c9e3c_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi03LTEtMS0w_414c9043-e3ae-41e1-8eda-2c2e9cce5a66">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a7848040184bc9a44a3890de687919_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi05LTEtMS0w_5a101fd4-ee4d-41a2-98ba-6a235d705a7d">108</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8a7848040184bc9a44a3890de687919_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi0xMS0xLTEtMA_09cc4927-af20-4602-bd7f-6e829be83d08">95</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8a7848040184bc9a44a3890de687919_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi0xMy0xLTEtMA_51e11ddf-f27b-4e38-af10-9365a09c3ac8">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id151570e96bf47e2b5807c317f3da3d2_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy0xLTEtMS0w_33d89fef-244c-4480-adee-c872e12eca52">17</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6b341327284acb8967c7a25afd49bf_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy0zLTEtMS0w_7ed52b02-1b1e-421d-a453-ca16a7c1598a">1,732</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb6b341327284acb8967c7a25afd49bf_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy01LTEtMS0w_f005acc1-9c34-43b7-9d6c-f684373de200">827</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6b341327284acb8967c7a25afd49bf_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy03LTEtMS0w_82daf21d-4288-4f74-a4e4-bfe149467085">905</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da6e7d6898a41e2a321057961de0c2c_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy05LTEtMS0w_1888bb23-759f-4467-b113-de78ea32d273">1,731</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4da6e7d6898a41e2a321057961de0c2c_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy0xMS0xLTEtMA_0b906697-ae02-4121-b73f-3f5f89231be8">800</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4da6e7d6898a41e2a321057961de0c2c_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy0xMy0xLTEtMA_43fdf8ef-f2f7-407d-afc4-700af8ff4585">931</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fedf49ea624406aa29fd6ba884c32c8_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTAtMy0xLTEtMA_3d6ac24e-6c00-4014-8bed-b6ac4ee19244">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fedf49ea624406aa29fd6ba884c32c8_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTAtNy0xLTEtMA_2f1ca6ef-8ad2-4a6c-8c42-e990be34689f">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i878a393788d6403c92b8b90fb49da518_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTAtOS0xLTEtMA_65150016-5472-4cc1-a1be-bbc7d8abdce8">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i878a393788d6403c92b8b90fb49da518_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTAtMTMtMS0xLTA_dec88ef3-a17c-4e60-bf4a-ddff6e45efd5">235</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90898918a80f45fcb9a06e317a5665ff_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTItMy0xLTEtMA_70cf4899-f5a9-406f-821b-5c35a9435d6e">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90898918a80f45fcb9a06e317a5665ff_I20210331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTItNy0xLTEtMA_9f9b5bb0-60e1-4b42-888a-78ccfa53eb10">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7627047194654fc7b1f1cb6056491ceb_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTItOS0xLTEtMA_c095e92a-d4ea-4ddb-b79b-59d7589b538a">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7627047194654fc7b1f1cb6056491ceb_I20201231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTItMTMtMS0xLTA_78750499-371d-4ca9-ba06-094d752833eb">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtMy0xLTEtMA_96e711a5-a786-4df1-b29a-6182ae80aba0">1,968</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtNS0xLTEtMA_395c230a-8183-4819-9a50-16f3c3f76fe6">827</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtNy0xLTEtMA_ded0dcbe-a091-4acf-8295-ceb4da514595">1,141</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtOS0xLTEtMA_9c7bfbcc-01ff-43d0-b9ee-17bccce84db7">1,967</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtMTEtMS0xLTA_e9ea6567-3517-4f81-995f-e585844c0ac9">800</ix:nonFraction>)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtMTMtMS0xLTA_252eab75-83a5-40e8-808e-89235a8d0749">1,167</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfMTIyNg_28348343-f35a-4163-b4b0-a829d3c5f098" continuedAt="i3c54f6ff4526440e9485bd5bdc0de427" escape="true">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2021 is as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i3c54f6ff4526440e9485bd5bdc0de427"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.935%"><tr><td style="width:1.0%"></td><td style="width:72.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.972%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfMS0xLTEtMS0w_2615b268-3d2f-4087-8c86-d0f2d44046ce">74</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfMi0xLTEtMS0w_7e57062c-5adf-4d05-9e8c-e9d6c321e77f">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfMy0xLTEtMS0w_9500047f-3376-45dc-8ca8-ead0132bb18e">96</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfNC0xLTEtMS0w_19147456-5209-4562-8ef4-fbe664437044">93</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfNS0xLTEtMS0w_cbf09f26-c80e-48e2-a95e-0e9e96c50e75">92</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfNi0xLTEtMS0w_31d3a9c7-29c4-46f5-ac18-938753712be4">86</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfNy0xLTEtMS0w_b2051300-413d-4264-b257-de202bcf441c">366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfOC0xLTEtMS0w_22751cb1-94a0-4169-afb0-af4128d7de3b">905</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_55"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNTAxNg_948fc7f4-1cfa-4d65-a2dc-6b2a47718344" continuedAt="ibd4701ce963d429faeace747fe7f6e83" escape="true">FINANCIAL INSTRUMENTS </ix:nonNumeric></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibd4701ce963d429faeace747fe7f6e83" continuedAt="i5ba077f9984b4d58bcc648ed068986b1">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:DerivativesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNTAzNg_a44941fb-c654-461c-9418-78d2209cd39d" continuedAt="i17f6e21a68534a91b5cc612d4aef04c0" escape="true">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. </ix:nonNumeric></ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i5ba077f9984b4d58bcc648ed068986b1" continuedAt="iff648904439c42c6a94ceccc3d5ecb9e"><ix:continuation id="i17f6e21a68534a91b5cc612d4aef04c0"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $<ix:nonFraction unitRef="usd" contextRef="i901bac352fa04938b24046e76fcd794f_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfMzM0Ng_24ba9574-203b-403d-9a2e-22752f7f3a94"><ix:nonFraction unitRef="usd" contextRef="i09a88d5cf6634758a4963ee5f06aa537_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfMzM0Ng_f594e093-ba33-47a6-ad5e-8ddd52a952fc">1</ix:nonFraction></ix:nonFraction>&#160;million as of both March&#160;31, 2021 and December&#160;31, 2020.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNDM5ODA0NjUxOTI0Ng_e3fae644-7887-4e0a-9174-2e23039337c4">1</ix:nonFraction>&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNTAxMA_46bcfd2d-feb2-40d6-bc68-a08813d4ba65" continuedAt="i37daf96c78774255bfe1d605fa355452" escape="true">As of March&#160;31, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</ix:nonNumeric></span></div><ix:continuation id="i37daf96c78774255bfe1d605fa355452"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"></td><td style="width:18.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.313%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.315%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i823a17c2df114f629409d133576bca9e_I20210331" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOmQyNDc2YTllZjZiYTRkNTBhNGYxMmIzMTQ3MzdlNjQyL3RhYmxlcmFuZ2U6ZDI0NzZhOWVmNmJhNGQ1MGE0ZjEyYjMxNDczN2U2NDJfMi01LTEtMS0w_ba75a788-b165-48ce-a581-7f46cdc40d43">48</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i814f0c2b21984f29aeb4ef63fc8777f0_I20201231" decimals="-6" name="us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOmQyNDc2YTllZjZiYTRkNTBhNGYxMmIzMTQ3MzdlNjQyL3RhYmxlcmFuZ2U6ZDI0NzZhOWVmNmJhNGQ1MGE0ZjEyYjMxNDczN2U2NDJfMi05LTEtMS0w_4233101f-30ff-4522-891a-271ab3830576">51</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iff648904439c42c6a94ceccc3d5ecb9e" continuedAt="i90f60b70fad14fe1b2bd1f8a5ddd0208"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNTAxOA_9d37c5aa-500a-4673-afd1-987661a68290" continuedAt="i77b7d83bc3904211bdd0f601b59c3817" escape="true">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three months ended March&#160;31, 2021 and 2020:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i77b7d83bc3904211bdd0f601b59c3817"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.742%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.746%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfMy0zLTEtMS0w_fa2bdb44-3fda-4ed2-bbd7-68a8f8f07d24">4</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfMy01LTEtMS0w_4ac5444e-e45c-44ce-89c3-a4d778f4f75b">16</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4276aed117b24b4684c477c58a926e2f_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfNi0zLTEtMS0w_d71491fb-622d-4adb-918f-f46f317fb93a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i510d256807de405f9d7a30a62b33c0d3_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfNi01LTEtMS0w_29b5f776-9f39-4ae2-a2f8-f839554cb5d7">69</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i063340d2e658481d80d2f35fd862966a_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfNy0zLTEtMS0w_5740d96d-f0d6-4bd1-8bce-081769ca2533">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic92ff83c2e994ef6b59823da5190e3e9_D20200101-20200331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfNy01LTEtMS0w_49accbfa-d1a6-469b-bfc7-9d7f4d73aa89">69</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="i90f60b70fad14fe1b2bd1f8a5ddd0208" continuedAt="i84d35bfda3b64df09fb379d5b8914158">&#160;&#160;&#160;&#160;</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i84d35bfda3b64df09fb379d5b8914158">A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</ix:continuation>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMjk5Mg_bf5429d8-4d04-48db-8ff1-37f03525382b" continuedAt="i1aacbe2fa8a84db6b2970a0c3d8e4c0d" escape="true">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ix:nonNumeric></span></div><ix:continuation id="i1aacbe2fa8a84db6b2970a0c3d8e4c0d" continuedAt="i75155fe926a14badb4b155223b5734c5"><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 7); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2021, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTA5MQ_fcdb4e2d-aaed-494a-a365-53e75717f172">0.62</ix:nonFraction> per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="ic1d5d10bdab3470c9d09e9af10bb66bb_D20200401-20200630" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTIyNA_26a2bb23-3a42-41b0-9c60-495601aeaca7"><ix:nonFraction unitRef="usdPerShare" contextRef="i6978a3b581d84bdba38eca5a17dc6a46_D20200701-20200930" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTIyNA_3c13c964-b4af-4b65-8444-f7b13b42b210"><ix:nonFraction unitRef="usdPerShare" contextRef="i2f8703a530294e5daab49bce5e5794c1_D20201001-20201231" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTIyNA_9204c008-1849-4b5f-b98a-173e850e6849"><ix:nonFraction unitRef="usdPerShare" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTIyNA_b30ae346-7132-49b8-add0-3cb3e6d9bb0a">0.56</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $<ix:nonFraction unitRef="usd" contextRef="i5dc9a03ecce042689d1a37deafd8f119_D20210301-20210331" decimals="INF" format="ixt:numdotdecimal" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTA5OTUxMTYzMzMyOA_59acab79-8a76-4845-ada8-4318eeb09022"><ix:nonFraction unitRef="usd" contextRef="if1694b157a7e4e05adbfb726d63a9dfb_D20210201-20210228" decimals="INF" format="ixt:numdotdecimal" name="dgx:StockRepurchaseProgramAdditionalAmountAuthorized" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTA5OTUxMTYzMzMyOA_8b5056b1-47cd-4488-8d60-700fb09057ed">1</ix:nonFraction></ix:nonFraction>&#160;billion. As of March&#160;31, 2021, $<ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTY0OTI2NzQ0NDY4NQ_79c7e70a-a30a-4c86-9e01-a5edea4dbae3">2.5</ix:nonFraction> billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTY0OTI2NzQ0NDY5NA_bf388df8-cc97-4181-b303-55e83f928dd3">3.4</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTY0OTI2NzQ0NDY4MQ_17a0c67b-6194-4e16-9dc7-b8989e68fbf6">410</ix:nonFraction> million.</span></div></ix:continuation><div style="text-indent:-36pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i75155fe926a14badb4b155223b5734c5"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2020, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTcyOQ_62316c00-0796-4c9a-bad1-a2e51b3fc5c9">0.7</ix:nonFraction> million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTc2Mw_53de591b-52cf-4465-af8c-c6864aab7869">75</ix:nonFraction> million.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the three months ended March&#160;31, 2021 and 2020, the Company reissued <ix:nonFraction unitRef="shares" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTg2Mg_22223ae2-1c2b-4639-87f4-b71e275b0ce3">0.6</ix:nonFraction> million shares and <ix:nonFraction unitRef="shares" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTg3Ng_7cebdf9a-3654-4017-87d9-b51aafddec5b">1.1</ix:nonFraction> million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an <ix:nonFraction unitRef="number" contextRef="ic8b7e170774c4e2f95ec5ebd85bba23b_I20150701" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMjI2Mg_3cd40039-b3e9-4dc5-a071-3b56daa9b5b3">18.9</ix:nonFraction>% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 5.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_61"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:CashFlowSupplementalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RleHRyZWdpb246MzMwYTNhNzA4NTYwNDAwMzg3ZjQ5NDc1ZDU3NjkzM2NfMjc1OQ_1b57094d-60ba-4129-8f37-fd438f735d3e" continuedAt="i5a36161ac2bd4ee0b11e1e44192edf27" escape="true">SUPPLEMENTAL CASH FLOW AND OTHER DATA</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i5a36161ac2bd4ee0b11e1e44192edf27"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RleHRyZWdpb246MzMwYTNhNzA4NTYwNDAwMzg3ZjQ5NDc1ZDU3NjkzM2NfMjc1NQ_e1c23604-fdd4-4a0d-a2c1-dfa72ce0b5a4" continuedAt="i7dc0847e35bd475bb353767039bf9dff" escape="true">Supplemental cash flow and other data for the three months ended March&#160;31, 2021 and 2020 was as follows:</ix:nonNumeric></span></div><ix:continuation id="i7dc0847e35bd475bb353767039bf9dff"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMi0xLTEtMS0w_698d104f-3a2a-4b87-a251-80dce7a89cf4">74</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMi0zLTEtMS0w_224fac26-2fb8-4a4b-b4f6-4e80a654d93c">60</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMy0xLTEtMS0w_5db0d9c8-984b-4210-bb28-34cf97c0427f">27</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMy0zLTEtMS0w_58857add-56d8-46e5-9996-8234414a7c68">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNC0xLTEtMS0w_f6681f7f-1a5c-4d3a-9489-c4240e02c5a5">101</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNC0zLTEtMS0w_0027a07a-a3e4-4e0b-808a-4a27f83659b2">85</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNi0xLTEtMS0w_a29d5885-40ce-40cc-b717-b13571000d10">38</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNi0zLTEtMS0w_44d6cc8d-2351-43b5-bc50-8128256c81f9">42</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNy0xLTEtMS0w_7adc689e-ce1a-4a45-9f73-faafc3b4affd">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:InterestAndDividendIncomeOperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNy0zLTEtMS0w_8aa85aca-48a4-49eb-9484-2d837fcc8422">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfOC0xLTEtMS0w_3a31329f-df84-43e7-adac-421ac63c0a42">38</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfOC0zLTEtMS0w_f32fc28e-70f0-4e9d-b838-c87eb3db3d80">41</ix:nonFraction>)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTAtMS0xLTEtMA_1ddba5e0-d531-4eb4-8590-0c48c998f1c5">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:InterestPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTAtMy0xLTEtMA_7c7f0f02-e005-42e0-b998-360c09d3901a">48</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTEtMS0xLTEtMA_4fcfa64f-51fd-4057-a68b-089158f01463">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncomeTaxesPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTEtMy0xLTEtMA_5b416b9c-296d-431f-a949-51efd4a93c98">18</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTMtMS0xLTEtMA_86cff41f-3a0c-4e16-b6d2-b4fbe8ea6d4f">30</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTMtMy0xLTEtMA_0d929cb3-ea87-41bf-8e44-70f716659368">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTUtMS0xLTEtMA_5c971e67-f4d1-4667-9a45-a258a2546447">82</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a5f406ec8444737afc188d6eaf5b3df_I20200331" decimals="-6" name="us-gaap:DividendsPayableCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTUtMy0xLTEtMA_55f121f0-a700-4314-8920-8dfb532351cb">75</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTgtMS0xLTEtMA_d2b7deb8-fd23-4889-be6d-55f96e389d7a">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:FairValueOfAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTgtMy0xLTEtMA_c2fbf2bc-34d8-4eaa-ad13-aca0d33265cd">131</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTktMS0xLTEtMA_69b7c7dc-7fd8-45fc-8bd4-f57fa5d446a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:LiabilitiesAssumed1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTktMy0xLTEtMA_0ffbf919-a698-4a9e-9927-5e140246561b">20</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjAtMS0xLTEtMA_173881a2-57d7-406a-ad0d-2b99dc56e356">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="dgx:FairValueOfNetAssetsAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjAtMy0xLTEtMA_7f96d9b4-3be7-451a-9c63-499a60d33973">111</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjMtMS0xLTEtMA_d61f144b-4984-4ee8-8abf-a50512fdb979">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:CashAcquiredFromAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjMtMy0xLTEtMA_1afd35ef-cfd3-4889-9cdf-e3fc94b09ef3">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjQtMS0xLTEtMA_49decafa-f3a9-43f3-a7ac-5a87a7f11b93">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjQtMy0xLTEtMA_54e8314b-e233-4802-80c0-5a75ed91fbd1">108</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMzEtMS0xLTEtMA_b49faf81-8bba-49dd-920f-4da60d61a587">36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMzEtMy0xLTEtMA_a2d0caec-f6fe-45c2-8dbd-a4b97dfacf73">32</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfOTIwMg_a99c7940-8d11-44f2-aba1-aac78a73d427" continuedAt="i3c592aac9def4be4a571851565377ba9" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i3c592aac9def4be4a571851565377ba9" continuedAt="i9f4bbfd95875494bae59b94245eebe8a"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $<ix:nonFraction unitRef="usd" contextRef="ifaee625cde9f46a19f40eb5a77955d58_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTEx_8d7c72fc-935d-40ae-a18d-57e5cf0d6ed7">100</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="ice8c8a53b7e44301b5d027627be99368_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfNDM5ODA0NjUyNjgxNw_18522b79-a313-469b-815a-00123ad5885f">600</ix:nonFraction>&#160;million secured receivables credit facility and $<ix:nonFraction unitRef="usd" contextRef="id9b169a1c4be4f32aab0d0b964a44035_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTY0_01568ae5-8ceb-44ee-bfe4-dd702a99ca68">150</ix:nonFraction>&#160;million under its $<ix:nonFraction unitRef="usd" contextRef="i3abb6c012f5f45fabdd35c0f3a5e994d_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfNDM5ODA0NjUyNjg0NA_a45b9195-0272-4679-b55d-ff15b08d9302">750</ix:nonFraction>&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i9f4bbfd95875494bae59b94245eebe8a" continuedAt="i2396e0265fe44f00b1766e4f8152fef6"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, to ensure the Company&#8217;s performance or payment to third parties, $<ix:nonFraction unitRef="usd" contextRef="ice8c8a53b7e44301b5d027627be99368_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfNjQ0_612a0a04-9929-42e0-b62a-03901ea9514f">70</ix:nonFraction> million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2021.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  No liability has been recorded for any of these potential contingent obligations.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, <ix:nonFraction unitRef="claim" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTY0OTI2NzQ1NzI2Ng_5a5eed12-71be-45ac-9c41-92ce9fc2de3c">two</ix:nonFraction> putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the <ix:nonFraction unitRef="claim" contextRef="ibdcc6647a3314cfe8c8e1a11819788f2_I20201031" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTY0OTI2NzQ1NzI3MQ_6ee08e81-f493-49fb-a4aa-1881f9b7d9c7">two</ix:nonFraction> lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  The Company plans to vigorously defend this matter and has filed a motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i2396e0265fe44f00b1766e4f8152fef6" continuedAt="i9d2bb5b9ce234533ae413769dd8fd35d"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2021, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $<ix:nonFraction unitRef="usd" contextRef="i4a8b8a1360eb45169025ce2e3ff740e3_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfNzkwOQ_f678f8ff-d445-4edf-909c-507bb59b770f">2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i9dba11073b29434b8978baa1dd517320_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LitigationReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTY0OTI2NzQ1NzQxOA_ba59b839-5466-4426-943e-39a666f40f78">1</ix:nonFraction> million as of March&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9d2bb5b9ce234533ae413769dd8fd35d">&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $<ix:nonFraction unitRef="usd" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfOTAyMg_266c634c-cd81-4567-b64b-e84117da7e54">142</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:MalpracticeLossContingencyAccrualUndiscounted" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfOTAyOQ_4003271d-fc9f-4611-a2af-db7a243c5021">138</ix:nonFraction> million as of March&#160;31, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_67"></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfMjM1MQ_83bbe453-1a8d-4774-9233-d7c76c217b87" continuedAt="i10e444c9290a4954a7cd3aaef46f058c" escape="true">BUSINESS SEGMENT INFORMATION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i10e444c9290a4954a7cd3aaef46f058c" continuedAt="i587f198807174aa0be18cdd1d7a6b0a4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than <ix:nonFraction unitRef="number" contextRef="i2be09d01fcd644908d4f7bcba929237f_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfODAx_513a9c56-569d-4d7c-8703-3c624cf2a359"><ix:nonFraction unitRef="number" contextRef="i80fa10a73f264102b635c6298c5c5763_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfODAx_af395924-3ce5-4d6c-aa81-03ce00b03bb7">95</ix:nonFraction></ix:nonFraction>% of net revenues in 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2021, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfMjM1NQ_6c1e1a2c-43b5-4a12-a6e3-370d2ea9c360" continuedAt="i25b0009f7edb47afa60a9b2e940e9c49" escape="true">The following table is a summary of segment information for the three months ended March&#160;31, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i25b0009f7edb47afa60a9b2e940e9c49"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace971bbe9244cfb88051e717b4dc21b_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMy0xLTEtMS0w_12b5497c-7d85-4e93-9e76-bbafd0b1199c">2,643</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f5b862a2f64309ae325f1bd8812f84_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMy0zLTEtMS0w_2b5a7187-2528-442e-aced-615c112a2055">1,744</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f4d95d055c34010ae22105b313a4c19_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfNC0xLTEtMS0w_612949e9-6741-4340-903d-f4f0202266ed">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic899b274b3de44a4a751b3c0cf303ca1_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfNC0zLTEtMS0w_269d051b-656c-4bb3-8726-221859248fa1">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfNS0xLTEtMS0w_83c44d01-1399-4be6-865c-3c645e2d93d0">2,720</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfNS0zLTEtMS0w_26a180c2-6e42-4b03-9572-54552f38422e">1,822</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iace971bbe9244cfb88051e717b4dc21b_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfOC0xLTEtMS0w_04e6d49a-dae4-464a-aa42-1cc22cc155a4">712</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36f5b862a2f64309ae325f1bd8812f84_D20200101-20200331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfOC0zLTEtMS0w_8c40bb33-8e86-405e-84fb-0808f28b4c15">205</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f4d95d055c34010ae22105b313a4c19_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfOS0xLTEtMS0w_6349f2a7-13e7-4071-a89b-d20772e713b4">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic899b274b3de44a4a751b3c0cf303ca1_D20200101-20200331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfOS0zLTEtMS0w_ebfa1d3b-3517-4ef1-a39a-07a889c2c5eb">9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a6fda505e7a4e16ad43273771a429c6_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTAtMS0xLTEtMA_1e28a356-bd88-4850-91b8-6c5d6aa77112">61</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i758562ef5a3244ce83bd69c73f546e0e_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTAtMy0xLTEtMA_9c2617f9-c5c2-44ff-82c9-42ff6c6ca80b">39</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTEtMS0xLTEtMA_ed850ac4-550a-4f56-8bf7-02cf55f8c6aa">660</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTEtMy0xLTEtMA_f43ad472-bcd6-4f30-a287-8411eb8e9adc">175</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTItMS0xLTEtMA_12781090-ba32-430b-a9b2-c8d81b2423f0">34</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTItMy0xLTEtMA_6e7663bc-0e1b-4199-8b93-a70860045cbd">57</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTMtMS0xLTEtMA_68cb98f2-e8a4-4e7f-a37a-dffc54e3baab">626</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTMtMy0xLTEtMA_56a0f168-10ff-464c-885a-deefed235790">118</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTQtMS0xLTEtMA_d6a57dc7-2c36-464a-8f00-4a4deb7c1ef0">153</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTQtMy0xLTEtMA_8774bc60-fe5a-4214-ad6b-e2c1e9415800">26</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTUtMS0xLTEtMA_321c0498-38e1-400e-8546-de39b1d23a11">17</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTUtMy0xLTEtMA_58d180f9-620c-4cbb-9fad-24ea8c20e1b9">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTgtMS0xLTEtMA_cf26cf12-7b31-4614-a0dc-66d6bc1e79e5">490</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTgtMy0xLTEtMA_92fb979a-3ee2-4ccf-9da5-4d41db66e87e">106</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTktMS0xLTEtMA_2c163f96-eea6-4760-91dd-5a40b6ee1602">21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTktMy0xLTEtMA_2389759b-1580-4484-bf9c-ca58f6dda3cb">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMjAtMS0xLTEtMA_386ae93c-11e0-4aed-abff-6f830872463e">469</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMjAtMy0xLTEtMA_a7dd1758-f5b6-469e-b844-988d3671d4fa">99</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i587f198807174aa0be18cdd1d7a6b0a4"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfNzY5NjU4MTM5NzUzOA_303bc134-a792-4254-9d8f-0536023cea6f" continuedAt="i2511a5773d5142fdb2291dd932749640" escape="true">Net revenues by major service were as follows:</ix:nonNumeric></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="i2511a5773d5142fdb2291dd932749640"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9e62f1f9ce94456b1cd2a528dd83efc_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfMy0xLTEtMS0zOTk4_3920a611-97b0-4b31-937a-31c2cd9f81ab">1,032</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25a98fa306ed41b296725d35a192e146_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfMy0zLTEtMS0zOTk4_b02d4ebb-ff17-454d-bbd9-8c8df53266e7">945</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28f9959f287848bf8d465e16d1d746ff_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNC0xLTEtMS0zOTk4_0c5b3141-c75c-4322-88f6-057ec8dbc274">828</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03c3744a2bab43538ebec4cd3b356cf1_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNC0zLTEtMS0zOTk4_a1da4838-b101-47f6-9d41-c5a5d6a2cd46">24</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bdf51bbf7f242a3be5bed92c72c57cb_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNS0xLTEtMS0zOTk4_c94941d1-fba9-4858-a149-ef4155c843e7">653</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic4d4da36106e49a4a2dc103517d9f28a_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNS0zLTEtMS0zOTk4_0c8ba84a-7f35-4f1e-a572-357675dfca76">641</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i61fa9a0d6266465f843c0dcd281594b4_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNi0xLTEtMS0zOTk4_cf16daa8-9010-4909-bb24-6a7d7e4d0f0c">130</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9e55ffc9602438bb96b19f2de74ce1b_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNi0zLTEtMS0zOTk4_003762ad-8c8d-40fb-923e-9eaa027fd8c7">134</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i170cc44a7d484de4b0e68d788f39ca90_D20210101-20210331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNy0xLTEtMS0zOTk4_05495a4d-9ae7-49b7-b93c-0d7daeb3b083">77</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e7fdb8aa0b74dcd8f92d2bf7a45989c_D20200101-20200331" decimals="-6" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNy0zLTEtMS0zOTk4_7cefde4f-d7dd-4700-adf2-2ef00ac21dd0">78</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfOC0xLTEtMS00NTg4_a814217d-19d0-46a9-a7d6-28ae9dd7c194">2,720</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfOC0zLTEtMS00NTg4_7613795b-3f47-44fe-8649-d4f5fc10fd78">1,822</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMjM3OA_abc31f52-cc98-4950-a8b3-c7953acd9774" continuedAt="i19036826af0d4725bf8747b540575177" escape="true">RELATED PARTIES</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i19036826af0d4725bf8747b540575177"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's equity method investees primarily consist of its clinical trials central laboratory services joint venture (see Note 14), a diagnostic information services joint venture, and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  During the three months ended March&#160;31, 2021 and 2020, the Company recognized net revenues of $<ix:nonFraction unitRef="usd" contextRef="i5cdb593684214c31b69e5e0f14a1dd79_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMzQ1_9e57c950-85fc-4db7-a070-f135f5dd88e1">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iac11f459e1d042178af5545dbcf89c00_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMzUy_99cae39b-6b9c-4df6-b388-87d26d683e39">9</ix:nonFraction> million, respectively, associated with diagnostic information services provided to its equity method investees.  As of March&#160;31, 2021 and December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i3447dfba2db4452db6c128cbd3d017fb_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfNjg0_b2044353-4aa6-45db-bfbf-673c9ee6243a">5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ifde7a741912648d2a3710f6aba0b6239_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTY0OTI2NzQ0NDI0MQ_443ac32d-467f-401b-9a19-a71a2175cffd">3</ix:nonFraction> million, respectively, of accounts receivable from equity method investees related to such services.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2021 and 2020, the Company recognized income of $<ix:nonFraction unitRef="usd" contextRef="idf44f85037c240d487111d5bb5558877_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTQxNQ_63f43565-d426-4e6e-9c9a-04452be12199">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i0e5b35b7ea4e4d4894444db26f102438_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTY0OTI2NzQ0NDY3NQ_b44bdba5-0f30-4462-a352-9d4c74668493">4</ix:nonFraction> million, respectively, associated with the performance of certain corporate services, including transition services, for its equity method investees, classified within selling, general and administrative expenses.  As of March&#160;31, 2021 and December&#160;31, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i1719a6433f8e402a8040ef12f6efed91_I20210331" decimals="-6" format="ixt:numdotdecimal" name="dgx:OtherAccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTkwOA_26cbdc33-1485-4e54-b969-db5ba9a7b64b">1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ibb28805c772d49adaf22a67346afc2ec_I20201231" decimals="-6" format="ixt:numdotdecimal" name="dgx:OtherAccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTkxNQ_91687cf8-5c3d-4a9a-979c-8ab460169771">3</ix:nonFraction> million, respectively, of other receivables from equity method investees included in prepaid expenses and other current assets related to these service agreements and other transition related items.  In addition, accounts payable and accrued expenses as of both March&#160;31, 2021 and December&#160;31, 2020 included $<ix:nonFraction unitRef="usd" contextRef="i3447dfba2db4452db6c128cbd3d017fb_I20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMjE4Ng_ab62aef9-8d25-4bc5-9f81-d90a8112042b"><ix:nonFraction unitRef="usd" contextRef="ifde7a741912648d2a3710f6aba0b6239_I20201231" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMjE4Ng_ff5d4a29-8c1b-4191-9ae5-b4005cc95878">1</ix:nonFraction></ix:nonFraction> million due to equity method investees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2021 and 2020, the Company received dividends from its equity method investees of $<ix:nonFraction unitRef="usd" contextRef="i5cdb593684214c31b69e5e0f14a1dd79_D20210101-20210331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTY0OTI2NzQ0NDk3NA_49e9b4a4-39a1-4b4e-864d-5cdc0a159518">16</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="iac11f459e1d042178af5545dbcf89c00_D20200101-20200331" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDividendsReceived" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTY0OTI2NzQ0NDk2OQ_f81efa5f-77c6-4e74-911f-77b48e3fc9ab">5</ix:nonFraction> million, respectively.</span></div></ix:continuation><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_73"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMzYwOA_ad960876-050e-47de-99b5-2de02879e702" continuedAt="i0e8e9216ab754d5d8de40b35ea627e5e" escape="true">REVENUE RECOGNITION</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i0e8e9216ab754d5d8de40b35ea627e5e" continuedAt="i1e81d65f53bd43c1b37094ad3be40760"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over <ix:nonFraction unitRef="number" contextRef="i80fa10a73f264102b635c6298c5c5763_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMTMx_a1648dee-7370-427a-aca4-765b11fb480c"><ix:nonFraction unitRef="number" contextRef="i2be09d01fcd644908d4f7bcba929237f_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMTMx_f35f6e15-7d93-40e1-81f8-260761ffd21b">95</ix:nonFraction></ix:nonFraction>% of the Company&#8217;s total net revenues for the three months ended March&#160;31, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div></ix:continuation><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:81pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUEST DIAGNOSTICS INCORPORATED AND SUBSIDIARIES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS &#8211; CONTINUED</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in millions, unless otherwise indicated)</span></div><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i1e81d65f53bd43c1b37094ad3be40760"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMzYwNA_3e1e7ccf-2e67-4e79-8eb1-1081a3619b30" continuedAt="i142dcadf3ffa403ea254f4da3565b753" escape="true">The approximate percentage of net revenue by type of customer was as follows:</ix:nonNumeric></span></div><ix:continuation id="i142dcadf3ffa403ea254f4da3565b753"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i452e2b67663443a9b36290cf5a2aa1e6_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMy0xLTEtMS0w_361b0d56-120d-4066-8e87-957beef688b9">38</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icd123d8c628f46e5aba2e460d5deafe6_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMy0zLTEtMS0w_97695a61-9203-4c56-a7cf-6a9bbb6eb275">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iebb5fe74da844f1f961e8e1d2bb794b5_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNC0xLTEtMS0w_b8ad52e4-98bd-4d1c-9c82-18c5d4957f99">2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i42e148eb5e0e4659b907643c8a63fc0c_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNC0zLTEtMS0w_3edb8493-eda5-42d4-adc8-d6598b7b4dd0">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6a2808ee150047299c3ed09ef79ab8b5_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNS0xLTEtMS0w_1d321a09-aac7-4047-8f2f-2035cc198be2">40</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06001aa5c1104e2e9732e941f42c3fcf_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNS0zLTEtMS0w_663c90fc-10f8-48c9-9af0-85d9325e9f23">37</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ide5defc240be4dcab0b768c6f15899ab_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNi0xLTEtMS0w_36b6800e-1858-422e-a7c6-29a01c023d62">10</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibc9de92a860e40a589282211d1647b6f_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNi0zLTEtMS0w_f84bfc34-ea33-47aa-8d00-f05a42add8d2">14</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic87438c858c24f95bcf9ba166ab81b0e_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNy0xLTEtMS0w_eadff93d-cae4-47f7-8abc-988bb1929e7e">35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8459599fb5c4db59c067f7d2b4152d5_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNy0zLTEtMS0w_fc53813a-feac-47bd-ba86-567a180cb127">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6810771a2a1c4d05944123a1bf5e1b52_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfOC0xLTEtMS0w_ce39c51a-265c-42a3-a2b5-2535ee940c5a">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i46815f8f6c1c4752a37528dcfe600782_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfOC0zLTEtMS0w_15f6507e-92af-440e-877d-9234ccc7fdc5">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iace971bbe9244cfb88051e717b4dc21b_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfOS0xLTEtMS0w_f7122d46-9fa5-4cc6-bfb3-b04e5c9da576">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i36f5b862a2f64309ae325f1bd8812f84_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfOS0zLTEtMS0w_ec4cac17-9692-48ed-9e2e-be95eb805e97">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i30bb0b3b6fb2412594595890e5f1e61e_D20210101-20210331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMTAtMS0xLTEtMA_6482b0cc-dfe3-4b68-9971-92eee3a8eb52">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id0b6faefc1d44456895da76547e73051_D20200101-20200331" decimals="2" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMTAtMy0xLTEtMA_fc700faa-b4b3-4fb2-b137-bcfc38580c3e">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMTEtMS0xLTEtMA_a73f1c76-116a-4884-b566-7bfc6dd6badd">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331" decimals="INF" name="dgx:PercentageofNetRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMTEtMy0xLTEtMA_ecb21d14-c8cb-472f-9202-62b69b24410c">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="dgx:AccountsReceivableDisaggregationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMzYwMg_ca7c94e4-b886-4949-a430-fd00843c6a7e" continuedAt="ie50770c681f94944b4f371510d9e21dc" escape="true">The approximate percentage of net accounts receivable by type of customer was as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="ie50770c681f94944b4f371510d9e21dc"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3e2f380500494c60add6976b3bc32aa1_I20210331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfMi0xLTEtMS0w_59f34879-6a25-45a0-938c-d8cfa1d63df9">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4f9466da8f9f4a6aa123bbced054fed3_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfMi0zLTEtMS0w_3cb0de1d-0998-40ed-b995-8eb574ccf23b">34</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2c126b415f014916be2b95fa29f24224_I20210331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfMy0xLTEtMS0w_bcee0a12-cd66-47e2-b085-397978cd65ff">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i69898b4810d540df8211bce4cdd5525d_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfMy0zLTEtMS0w_24216279-75c9-4308-8b38-a8d12d17e081">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i127c3faa32b7427d9b99ea5587e176d7_I20210331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNC0xLTEtMS0w_d8518f2c-ab97-452a-ae6c-8e8fdea18272">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8413c530df5c4dbfb070686c9de5c5e3_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNC0zLTEtMS0w_f7a625a6-06e4-4e08-9658-8d4f51a1e0bd">46</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i964abdb4332b41dd9081bba6b23cb70a_I20210331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNS0xLTEtMS0w_2d72228a-a605-4417-934e-24083fff4516">13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iadb31c200e50479698a170bd1aa2fdd4_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNS0zLTEtMS0w_009ef276-80bd-4fe0-8fe6-3f5cb588bfa4">11</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic08defe16103451e81c2c39229b0890c_I20210331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNi0xLTEtMS0w_059b6466-7064-4db0-ac53-2c48cef802d0">96</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0bc155227aa9447ea638f9b050fb14fb_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNi0zLTEtMS0w_22bfa81c-596f-4f02-8c91-cf940350e31d">97</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i12272fb69d15405f9bdaf2b4151db72f_I20210331" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNy0xLTEtMS0w_64227398-2533-4373-a2d5-2002411b450b">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i59a13ec4490e4a7b8c12492922d70b63_I20201231" decimals="2" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNy0zLTEtMS0w_b3044a4f-fdf0-4001-bba7-6810d931474e">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfOC0xLTEtMS0w_8b5b57ef-727e-4f3c-a2a0-17d026c4ee27">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i71eadae108864617a48c288ee03da704_I20201231" decimals="INF" name="dgx:PercentageofNetAccountsReceivable" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfOC0zLTEtMS0w_8e3a9bb8-d46b-40d4-b995-e6e2b29d6478">100</ix:nonFraction>&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV84Mi9mcmFnOmUyYTk1ODIwNzBhYjQwNWJiN2NjMTYyOGU4ODY1YjRkL3RleHRyZWdpb246ZTJhOTU4MjA3MGFiNDA1YmI3Y2MxNjI4ZTg4NjViNGRfMTI0OA_6f1b40b4-7da4-4e04-8ad4-ae557ad7cdda" continuedAt="i4504e09ac09d495f8381b9f8e1cfe73b" escape="true">SUBSEQUENT EVENTS</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i4504e09ac09d495f8381b9f8e1cfe73b"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its <ix:nonFraction unitRef="number" contextRef="i39c87593f7934842babf6575faeb22bb_I20210401" decimals="2" name="dgx:EquityMethodInvestmentOwnershipPercentDisposedOf" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV84Mi9mcmFnOmUyYTk1ODIwNzBhYjQwNWJiN2NjMTYyOGU4ODY1YjRkL3RleHRyZWdpb246ZTJhOTU4MjA3MGFiNDA1YmI3Y2MxNjI4ZTg4NjViNGRfNzY5NjU4MTM5OTY4NA_b57fdcc2-983b-4c5e-b355-8753620da8e2">40</ix:nonFraction>% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner for $<ix:nonFraction unitRef="usd" contextRef="i39c87593f7934842babf6575faeb22bb_I20210401" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV84Mi9mcmFnOmUyYTk1ODIwNzBhYjQwNWJiN2NjMTYyOGU4ODY1YjRkL3RleHRyZWdpb246ZTJhOTU4MjA3MGFiNDA1YmI3Y2MxNjI4ZTg4NjViNGRfMTY0OTI2NzQ0NTU4OQ_f390a4e1-0e45-4b75-a5f9-e7a5c08c7c66">760</ix:nonFraction>&#160;million in an all-cash transaction.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, the Company expects to record a pre-tax gain during the second quarter of 2021 of approximately $<ix:nonFraction unitRef="usd" contextRef="ic411e7e9465f4d0ca07e2fc70dfc9403_D20210401-20210630" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV84Mi9mcmFnOmUyYTk1ODIwNzBhYjQwNWJiN2NjMTYyOGU4ODY1YjRkL3RleHRyZWdpb246ZTJhOTU4MjA3MGFiNDA1YmI3Y2MxNjI4ZTg4NjViNGRfNDM5ODA0NjUxNjM3NA_872b50c3-deb1-47f3-9241-2e2c948fa3ba">310</ix:nonFraction>&#160;million.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of complementary lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Company </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostic Information Services</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Quest Diagnostics empowers people to take action to improve health outcomes.  We use our extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.  Our diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  We provide services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  We offer the broadest access in the United States to diagnostic information services through our nationwide network of laboratories, patient service centers and phlebotomists in physician offices and our connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  We are the world's leading provider of diagnostic information services.  We provide interpretive consultation with one of the largest medical and scientific staffs in the industry.  Our DIS business makes up greater than 95% of our consolidated net revenues.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We assess our revenue performance for the DIS business based upon, among other factors, volume (measured by test requisitions) and revenue per requisition. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Each requisition accompanies patient specimens, indicating the test(s) to be performed and the party to be billed for the test(s).   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Revenue per requisition is impacted by various factors, including, among other items, the impact of fee schedule changes (i.e., unit price), test mix, payer mix, and the number of tests per requisition. Management uses number of requisitions and revenue per requisition data to assist with assessing the growth and performance of the business, including understanding trends affecting number of requisitions, pricing and test mix.  Therefore, we believe that information related to changes in these metrics from period to period are useful information for investors as it allows them to assess the performance of the business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Diagnostic Solutions</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In our Diagnostic Solutions ("DS") businesses, which represent the balance of our consolidated net revenues, we offer a variety of solutions for life insurers and healthcare organizations and clinicians.  We are the leading provider of risk assessment services for the life insurance industry.  In addition, we offer healthcare organizations and clinicians robust information technology solutions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">First Quarter Highlights</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:60.958%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.576%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.388%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.578%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share data)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,720</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,822</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$2,643</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1,744</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue per requisition change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">20.5%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">25.6%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Organic requisition volume change</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">21.6%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)%</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS revenues</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$77</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$78</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$469</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$99</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$3.46</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.73</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$731</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$247</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further discussion of the year-over-year changes for the three months ended March 31, 2021 compared to the three months ended March 31, 2020, see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID - 19</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As a novel strain of coronavirus (COVID-19) continues to spread and severely impact the economy of the United States and other countries around the world, we are committed to being a part of the coordinated public and private sector response to this unprecedented challenge. We have made substantial investments to expand the amount of COVID-19 testing available to the country and are currently capable of performing approximately 300,000 COVID-19 molecular diagnostic tests per day to aid in the diagnosis of COVID-19 and approximately 350,000 COVID-19 antibody tests per day to aid in the detection of immune response. We have been effectively managing challenges in the global supply chain; and, at this point, we have sufficient supplies to conduct our business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During 2020 and the first quarter of 2021, our testing volume and revenues were materially impacted by the COVID-19 pandemic.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During January and February 2020, we experienced growth in DIS revenues and volume compared to the prior year period. However, in March 2020, we experienced a material decline in testing volume due to the COVID-19 pandemic.  During May and June 2020, we began to experience a recovery in base testing volume (which excludes COVID-19 testing), which continued in the second half of 2020 and the first quarter of 2021.  For the first quarter of 2021, our base testing volume, excluding volume associated with recent acquisitions and recent agreements associated with our Professional Laboratory Services offerings, was 7.9% below our historical first quarter of 2019 levels.  We estimate that the impact of weather negatively impacted the comparison by 1%.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in base testing volume was driven by federal, state and local governmental policies and initiatives designed to reduce the transmission of COVID-19, a significant reduction in physician office visits, the cancellation of elective medical procedures, customers closing or severely curtailing their operations (voluntarily or in response to government orders), and the adoption of work-from-home policies, all of which have had, and may continue to have, an impact on our operating results, financial position and cash flows, including base testing volume. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning during the second quarter of 2020, we experienced growing demand for COVID-19 testing services and we expanded our capacity throughout 2020 in order to satisfy the demand, which has had a significant impact on our testing volumes.  Since the fourth quarter of 2020, demand for COVID-19 testing has decreased reflecting an industry-wide trend.  Compared to the fourth quarter of 2020, our net revenues associated with COVID-19 testing in the first quarter of 2021 declined by 27.9%.  We expect demand for COVID-19 testing to continue to decline throughout 2021 as more people become vaccinated.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, our revenue per requisition has been positively impacted by favorable mix, driven in large part by COVID-19 molecular testing. In April 2020 the Centers for Medicare and Medicaid Services ("CMS") announced that it would increase the reimbursement for certain COVID-19 molecular tests making use of high-throughput technologies developed by the private sector that allow for increased testing capacity, faster results, and more effective means of combating the spread of the virus to $100 per test, effective April 14, 2020. Beginning January 1, 2021, Medicare changed the base reimbursement rate for COVID-19 diagnostic tests run on high-throughput technologies to $75 per test with an additional payment of $25 per test if the laboratory (1) completes the test in two calendar days or less and (2) completes the majority of its COVID-19 tests that use high throughput technology in two calendar days or less for all of its patients in the previous month.  Certain healthcare insurers have now moved to a similar reimbursement model for COVID-19 molecular tests.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the COVID-19 pandemic&#8217;s impact on our consolidated results of operations, financial position and cash flows will be primarily driven by: the severity and duration of the COVID-19 pandemic; healthcare insurer, government, and client payer reimbursement rates for COVID-19 molecular testing; the COVID-19 pandemic&#8217;s impact on the U.S. healthcare system and the U.S. economy; and the timing, scope and effectiveness of federal, state and local governmental responses to the COVID-19 pandemic. We may also be impacted by changes in the severity of the COVID-19 pandemic at different times in the various cities and regions where we operate and offer services. Even after the COVID-19 pandemic has moderated and the business and social distancing restrictions have eased, we may continue to experience similar effects to our businesses, consolidated results of operations, financial position and cash flows.  In the longer term, given the many challenges that hospitals will face, we may have more opportunities to partner with hospitals to help achieve their laboratory strategies, and the COVID-19 pandemic may also be a further catalyst for consolidation in the laboratory testing industry.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreement to Acquire the Outreach Laboratory Services Business of Mercy Health</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On March 6, 2021, we entered into a definitive agreement to acquire the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma.  The transaction, which is expected to close in mid-2021, remains subject to customary closing conditions.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Ownership Interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Solutions") to IQVIA Holdings, Inc. ("IQVIA")</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, we sold our 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions, our clinical trials central laboratory services joint venture, to IQVIA, our joint venture partner for $760&#160;million in an all-cash transaction.  Prior to the transaction, we accounted for our minority interest as an equity method investment.  As a result of the transaction, we expect to record a pre-tax gain during the second quarter of 2021 of approximately $310&#160;million. </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, we will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of complementary lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Medicare Sequestration</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In April 2021, the suspension of Medicare sequestration, which has resulted in a small benefit to us in the form of higher reimbursement rates for diagnostic testing services performed on behalf of Medicare beneficiaries, was extended through the end of 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Invigorate Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We are engaged in a multi-year program called Invigorate, which is designed to reduce our cost structure and improve our performance.  We currently aim annually to deliver savings of approximately 3% of our costs.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Invigorate has consisted of several flagship programs, with structured plans in each, to drive savings and improve performance across the customer value chain.  These flagship programs include: organization excellence; information technology excellence; procurement excellence; field and customer service excellence; lab excellence; and revenue services excellence.  In addition to these programs, we have identified key themes to change how we operate including reducing denials and patient price concessions; further digitizing our business; standardization and automation; and optimization initiatives in our lab network and patient service center network.  We believe that our efforts to standardize our information technology systems, equipment and data also foster our efforts to strengthen our foundation for growth and support the value creation initiatives of our clinical franchises by enhancing our operational flexibility, empowering and enhancing the customer experience, facilitating the delivery of actionable insights and bolstering our large data platform.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, we incurred $15&#160;million of pre-tax charges under our Invigorate program primarily consisting of systems conversion and integration costs, all of which result in cash expenditures. Additional restructuring charges may be incurred in future periods as we identify additional opportunities to achieve further cost savings.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;There have been no significant changes to our critical accounting policies from those disclosed in our 2020 Annual Report on Form 10-K</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of New Accounting Standards</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adoption of new accounting standards, if any, is discussed in Note 2 to the interim unaudited consolidated financial statements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The impact of recent accounting pronouncements not yet effective on our consolidated financial statements is also discussed in Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following tables set forth certain results of operations data for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.095%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.529%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(dollars in millions, except per share amounts)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">899&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">898&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,270&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">356&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,060&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,647&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense):</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total non-operating expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">493.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective income tax rate</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings per common share attributable to Quest Diagnostics' common stockholders</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.73&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NM - Not Meaningful</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table sets forth certain results of operations data as a percentage of net revenues for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.641%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.670%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.671%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS businesses </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating costs and expenses and other operating income:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 16.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating costs and expenses, net </span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.7&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Results</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended March&#160;31, 2021 were affected by certain items that on a net basis reduced diluted earnings per share by $0.30 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $29 million ($27 million in amortization of intangible assets and $2 million in equity in earnings of equity method investees, net of taxes) or $0.16 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.68pt">pre-tax charges of $17 million ($7 million in cost of services and $10&#160;million in selling, general and administrative expenses), or $0.10 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $4 million in cost of services, or $0.03 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic including incremental costs incurred primarily to protect the health and safety of our employees and customers; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a pre-tax non-cash impairment to the carrying value of an equity method investment of $8 million, or $0.04 per diluted share, recorded in equity in earnings of equity method investees, net of taxes; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $4 million, or $0.03 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Results for the three months ended March&#160;31, 2020 were affected by certain items that on a net basis reduced diluted earnings per share by $0.21 as follows:</span></div><div style="padding-left:72pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax amortization expense of $28 million ($25 million in amortization of intangible assets and $3 million in equity in earnings of equity method investees, net of taxes) or $0.15 per diluted share;</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $16 million ($7 million in cost of services and $9 million in selling, general and administrative expenses), or $0.09 per diluted share, primarily associated with systems conversions and integration incurred in connection with further restructuring and integrating our business; and</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-tax charges of $9 million ($1 million in cost of services, $3 million in selling, general and administrative expenses and $5 million in other operating expense, net), or $0.03 per diluted share, representing the impact of certain items resulting from the COVID-19 pandemic including certain asset impairment charges, and incremental costs incurred primarily to protect the health and safety of our employees and customers and to transition certain employees to a remote work environment; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">excess tax benefits associated with stock-based compensation arrangements of $8 million, or $0.06 per diluted share, recorded in income tax expense.</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenues</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues for the three months ended March&#160;31, 2021 increased by 49.3% compared to the prior year period. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;DIS revenues for the three months ended March&#160;31, 2021 increased by 51.5% compared to the prior year period.  For the three months ended March&#160;31, 2021:</span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Organic revenue and acquisitions contributed approximately 48.5% and 3.0%, respectively, to DIS revenue growth compared to the prior year period.  Organic revenue growth was driven by demand for COVID-19 molecular testing and, to a lesser extent, growth in the base business.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenues in the base business (including the impact of recent acquisitions) increased by 5.1% compared to the prior year period, which was negatively impacted in March 2020 as a result of the COVID-19 pandemic.  Compared to historical levels in the first quarter of 2019, revenues in the base business, excluding revenue associated with recent acquisitions and recent agreements associated with our Professional Laboratory Services offerings, decreased by 5.5%.  We estimate that the impact of weather negatively impacted the comparison by 0.8%.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">DIS volume increased by 25.6% with organic volume and acquisitions contributing approximately 21.6% and 4.0%, respectively.  Organic volume growth was driven by demand for COVID-19 molecular testing and, to a lesser extent, growth in the base business. </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing volume in the base business (including the impact of recent acquisitions) continued to recover and was up 5.0% compared to the prior year period, which was negatively impacted in March 2020 as a result of the COVID-19 pandemic.  Compared to historical levels in the first quarter of 2019, testing volume in the base business, excluding volume associated with recent acquisitions and recent agreements associated with our Professional Laboratory Services offerings, decreased by 7.9%.  We estimate that the impact of weather negatively impacted the comparison by 1%.</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue per requisition increased by 20.5% compared to the prior year period primarily due to favorable mix, driven in large part by COVID-19 molecular testing.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cost of services consists principally of costs for obtaining, transporting and testing specimens as well as facility costs used for the delivery of our services.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, cost of services increased by $356 million compared to the prior year period.  The increase was primarily driven by higher variable expenses related to increased testing volumes as well as test mix and a higher supply cost associated with COVID-19 testing, and, to a lesser extent, additional operating costs associated with our acquisitions.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses ("SG&amp;A")</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A consist principally of the costs associated with our sales and marketing efforts, billing operations, credit loss expense and general management and administrative support as well as administrative facility costs.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;SG&amp;A increased by $60 million for the three months ended March&#160;31, 2021, compared to the prior year period, primarily driven by higher variable expenses to support our increase in testing volumes as well as higher costs associated with changes in the value of our deferred compensation obligations.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The change in the value of our deferred compensation obligations is largely offset by gains or losses due to the changes in the value of the associated investments, which are recorded in other income (expense), net.  For further details regarding our deferred compensation plans, see Note 17 to the audited consolidated financial statements in our 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Amortization Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021, amortization expense increased by $2 million compared to the prior year period as a result of recent acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other operating expense, net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other operating expense, net includes miscellaneous income and expense items and other charges related to operating activities.&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2020, other operating expense, net primarily represents certain costs incurred as a result of the COVID-19 pandemic and resulting impact on the economy including certain asset impairment charges.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Interest Expense, Net</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest expense, net decreased for the three months ended March&#160;31, 2021 compared to the prior year period, primarily driven by lower interest rates due to recent refinancing transactions, including the termination of our interest rate swap agreements in April 2020, which resulted in a deferred gain that is being amortized as a reduction of interest expense, net over the remaining term of the associated debt.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Other Income (Expense), Net </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Other income (expense), net represents miscellaneous income and expense items related to non-operating activities, such as gains and losses associated with investments and other non-operating assets.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, other income (expense), net increased by $20 million compared to the prior year period primarily due to changes in the value of investments in our deferred compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Income Tax Expense</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Income tax expense for the three months ended March&#160;31, 2021 and 2020 was $153 million and $26 million, respectively.  The increase in income tax expense for the three months ended March&#160;31, 2021 compared to the prior year period was primarily driven by an increase in income before income taxes and equity in earnings of equity method investees.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021 and 2020, the effective income tax rate was 24.6% and 22.0%, respectively.  The effective income tax rate benefited from $4 million and $8 million of excess tax benefits associated with stock-based compensation arrangements for the three months ended March&#160;31, 2021 and 2020, respectively.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity in Earnings of Equity Method Investees, Net of Taxes</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Equity in earnings of equity method investees, net of taxes increased for the three months ended March&#160;31, 2021 by $3 million compared to the prior year period primarily due to the demand for COVID-19 testing services, partially offset by an $8 million non-cash impairment to the carrying value of an equity method investment.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_91"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We address our exposure to market risks, principally the risk of changes in interest rates, through a controlled program of risk management that includes the use of derivative financial instruments.  We do not hold or issue derivative financial instruments for speculative purposes.  We seek to mitigate the variability in cash outflows that result from changes in interest rates by maintaining a balanced mix of fixed-rate and variable-rate debt obligations.  In order to achieve this objective, we have historically entered into interest rate swap agreements.  Interest rate swap agreements involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements are recognized as an adjustment to interest expense, net.  We believe that our exposures to foreign exchange impacts and changes in commodity prices are not material to our consolidated results of operations, financial position or cash flows. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2021 and December&#160;31, 2020, the fair value of our debt was estimated at approximately $4.4 billion and $4.6 billion, respectively, principally using quoted prices in active markets and yields for the same or similar types of borrowings, taking into account the underlying terms of the debt instruments.  As of March&#160;31, 2021 and December&#160;31, 2020, the estimated fair value exceeded the carrying value of the debt by $378 million and $597 million, respectively.  A hypothetical 10% increase in interest rates (representing 23 basis points as of March&#160;31, 2021 and 17 basis points as of December&#160;31, 2020) would potentially reduce the estimated fair value of our debt by approximately $94 million and $82 million as of March&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Borrowings under our secured receivables credit facility and our senior unsecured revolving credit facility are subject to variable interest rates.  Interest on our secured receivables credit facility is based on either commercial paper rates for highly rated issuers, or LIBOR, plus a spread.  As of March&#160;31, 2021, interest on our senior unsecured revolving credit facility is based on certain published rates plus an applicable margin based on changes in our public debt ratings and our leverage ratio. As such, our borrowing cost under this credit arrangement is subject to fluctuations in interest rates, our leverage ratio and changes in our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">public debt ratings.  As of March&#160;31, 2021, the borrowing rates under these debt instruments were: for our secured receivables credit facility, commercial paper rates for highly-rated issuers or LIBOR, plus a spread of 0.825% to 0.950%; and for our senior unsecured revolving credit facility, LIBOR plus 1.125%.  As of March&#160;31, 2021, there were no borrowings outstanding under either our $600&#160;million secured receivables credit facility or our $750&#160;million senior unsecured revolving credit facility.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A hypothetical 10% change to the variable rate component of our variable rate indebtedness would not materially change our annual interest expense. &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding our outstanding debt, see Note 13 to the audited consolidated financial statements included in our 2020 Annual Report on Form 10-K.  For details regarding our financial instruments and hedging activities, see Note 7 to the interim unaudited consolidated financial statements and Note 15 to the audited consolidated financial statements included in our 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Associated with Investment Portfolio</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our investment portfolio primarily includes equity investments comprised mostly of strategic holdings in privately and publicly held companies.  These securities are exposed to price fluctuations and are generally concentrated in the life sciences and healthcare industries.  Equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) with readily determinable fair values are measured at fair value with changes in fair value recognized in net income. Equity investments that do not have readily determinable fair values are measured at cost minus impairment, if any, plus or minus changes resulting from observable price changes.  We regularly evaluate these equity investments to determine if there are any indicators that the investment is impaired.  The carrying value of our equity investments that do not have readily determinable fair values was $25&#160;million as of March&#160;31, 2021.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We do not hedge our equity price risk.  The impact of an adverse movement in equity prices on our holdings in privately held companies cannot be easily quantified, as our ability to realize returns on investments depends on, among other things, the enterprises&#8217; ability to raise additional capital or derive cash inflows from continuing operations or through liquidity events such as initial public offerings, mergers or private sales.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our March&#160;31, 2021 financial statements, we considered whether the carrying values of our investments were impaired and concluded that no such impairment existed.  However, should the impact of the COVID-19 pandemic be worse than currently expected, it is possible that we could incur impairment charges in the future.</span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.377%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.263%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(dollars in millions)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">731&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">484&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(93)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(206)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(566)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(891)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">325&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents and restricted cash</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(850)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">922&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents </span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Cash and cash equivalents consist of cash and highly-liquid short-term investments.  Cash and cash equivalents as of March&#160;31, 2021 totaled $1,230 million, compared to $1,158 million as of December&#160;31, 2020. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2021, approximately 3% of our $1,230 million of consolidated cash and cash equivalents were held outside of the United States.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Operating Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash provided by operating activities for the three months ended March&#160;31, 2021 and 2020 was $731 million and $247 million, respectively.  The $484 million increase in net cash provided by operating activities for the three months ended March&#160;31, 2021, compared to the prior year period was primarily a result of:</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher operating income in 2021 as compared to 2020; and, to a lesser extent,</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing of movements in our working capital accounts; partially offset by </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">higher performance-based compensation payments in 2021 compared to 2020.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Days sales outstanding ("DSO"), a measure of billing and collection efficiency, was 46 days as of both March&#160;31, 2021 and December&#160;31, 2020 and 51 days as of March&#160;31, 2020.  The changes in our DSO is partially due to recent fluctuations in our monthly revenue due to the impact of the COVID-19 pandemic.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Investing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in investing activities for the three months ended March&#160;31, 2021 and 2020 was $93 million and $206 million, respectively.  This $113 million decrease in cash used in investing activities for the three months ended March&#160;31, 2021, compared to the prior year period was primarily a result of a $108 million decrease in net cash paid for business acquisitions.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows from Financing Activities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net cash used in financing activities for the three months ended March&#160;31, 2021 and 2020 was $566 million and $891 million, respectively.  This $325 million decrease in cash used in financing activities for the three months ended March&#160;31, 2021, compared to the prior year period was primarily a result of: </span></div><div><span><br/></span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an $800 million decrease in repayments of debt; partially offset by</span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $335 million increase in repurchases of our common stock (see "Share Repurchase Program" for further details); </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $63 million decrease in proceeds from the exercise of stock options, which was a result of a decrease in the volume of stock options exercised compared to the prior year; and </span></div><div style="padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a $46 million change in bank overdrafts, which are generally settled in cash the following day.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2020, we redeemed in full the outstanding indebtedness under our senior notes due January 2020 and senior notes due March 2020 using proceeds from the issuance, in December 2019, of the 2.95% senior notes due June 2030, along with cash on hand.  During both the three months ended March&#160;31, 2021 and 2020, there were no borrowings or repayments under our secured receivables credit facility or senior unsecured revolving credit facility.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Program</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2021, our Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, our Board of Directors declared a quarterly cash dividend of $0.56 per common share. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February and March 2021, our Board of Directors increased the size of our share repurchase program by $1&#160;billion.  As of March&#160;31, 2021, $2.5 billion remained available under our share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchases</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, we repurchased 3.4 million shares of our common stock for $410 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2020, we repurchased 0.7 million shares of our common stock for $75 million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Method Investees</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our equity method investees primarily consist of our clinical trials central laboratory services joint venture (which we sold our ownership interest in during April 2021), a diagnostic information services joint venture, and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  Such investees are accounted for under the equity method of accounting.  Our investment in equity method investees is less than 5% of our consolidated total assets.  Our proportionate share of income before income taxes associated with our equity method investees is less than 5% of our consolidated income before income taxes and equity in earnings of equity method investees.  We have no material unconditional obligations or guarantees to, or in support of, our equity method investees and their operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In conjunction with the preparation of our March&#160;31, 2021 financial statements, we considered whether the carrying values of our equity method investments were impaired and, during the three months ended March 31, 2021, we recorded an $8&#160;million impairment charge for one of the investments.  Should the impact of the COVID-19 pandemic be worse than currently expected, it is possible that we could incur additional impairment charges in the future.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding related party transactions with our equity method investees, see Note 12 to the interim unaudited consolidated financial statements and Note 20 to the audited consolidated financial statements in our 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Requirements and Capital Resources </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We estimate that we will invest approximately $350 million to $400&#160;million during 2021 for capital expenditures, to support and grow our existing operations, principally related to investments in information technology, laboratory equipment and facilities, including COVID-19 testing equipment and completion of our new multi-year laboratory construction in New Jersey, and  investments in our advanced diagnostics and consumer growth strategies.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the second quarter of 2021, we expect to launch an accelerated share repurchase in the amount of approximately $1.5 billion.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Together with the Quest Diagnostics Foundation, during 2020 we launched a multi-year initiative to reduce health disparities in underserved communities, including those impacted by the COVID-19 pandemic.  As part of this initiative, we plan to offer testing services and fund a range of initiatives estimated to total more than $100 million aimed at improving access to testing and awareness of the value of diagnostic insights in managing overall health, a significant portion of which will occur in 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2021, we had $1.3 billion of borrowing capacity available under our existing credit facilities, including $530&#160;million available under our secured receivables credit facility and $750 million available under our senior unsecured revolving credit facility.  There were no borrowings under these credit facilities as of March&#160;31, 2021.   In support of our risk management program, to ensure our performance or payment to third parties, $70&#160;million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2021.  The secured receivables credit facility includes a $250 million loan commitment which matures in October 2021, and a $250 million loan commitment and a $100 million letter of credit facility which mature in October 2022.  The senior unsecured revolving credit facility matures in March 2023. For further details regarding the credit facilities, see Note 13 to the audited consolidated financial statements in our 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our secured receivables credit facility is subject to customary affirmative and negative covenants, and certain financial covenants with respect to the receivables that comprise the borrowing base and secure the borrowings under the facility. Our senior unsecured revolving credit facility is also subject to certain financial covenants and limitations on indebtedness.  As of March&#160;31, 2021, we were in compliance with all such applicable financial covenants.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;We believe that our cash and cash equivalents and cash from operations, together with our borrowing capacity under our credit facilities, will provide sufficient financial flexibility to fund seasonal and other working capital requirements, capital expenditures, debt service requirements and other obligations, cash dividends on common shares, share repurchases and additional growth opportunities for the foreseeable future.  However, should it become necessary, we believe that our credit profile should provide us with access to additional financing in order to fund normal business operations, make interest payments, fund growth opportunities and satisfy upcoming debt maturities. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_97"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Some statements and disclosures in this document are forward-looking statements.  Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;project,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;plan&#8221; or &#8220;continue.&#8221;  These forward-looking statements are based on our current plans and expectations and are subject to a number of risks and uncertainties that could cause our plans and expectations, including actual results, to differ materially from the forward-looking statements.  Risks and uncertainties that may affect our future results include, but are not limited to, impacts of the COVID-19 pandemic and measures taken in response, adverse results from pending or future government investigations, lawsuits or private actions, the competitive environment, the complexity of billing, reimbursement and revenue recognition for clinical laboratory testing, changes in government regulations, changing relationships with customers, payers, suppliers and strategic partners and other factors discussed in our most recently filed Annual Report on Form 10-K and subsequently filed Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including those discussed in the &#8220;Business,&#8221; &#8220;Risk Factors,&#8221; &#8220;Cautionary Factors that May Affect Future Results&#8221; and &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; sections of those reports.</span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Item 2. "Management's Discussion and Analysis of Financial Condition and Results of Operations."</span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management, including our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined under Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended).  Based upon that evaluation, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2021, there were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934, as amended) that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_106"></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PART II - OTHER INFORMATION</span></div><div style="text-align:center"><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;See Note 10 to the interim unaudited consolidated financial statements for information regarding the status of legal proceedings involving the Company.</span></div><div><span><br/></span></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.  Risk Factors</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;Item 1A. of our Annual Report on Form 10-K for the year ended December 31, 2020 includes a discussion of our risk factors. There have been no material changes in the risk factors described in such report.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_115"></div><hr style="page-break-after:always"/><div style="min-height:31.5pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The table below sets forth the information with respect to purchases made by or on behalf of the Company of its common stock during the first quarter of 2021.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.844%"><tr><td style="width:1.0%"></td><td style="width:45.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.234%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.560%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ISSUER PURCHASES OF EQUITY SECURITIES</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares<br/>Purchased</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average Price<br/>Paid per Share</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Number of<br/>Shares Purchased<br/>as Part of Publicly<br/>Announced Plans<br/>or Programs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approximate</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dollar Value of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares that May</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Yet Be Purchased</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Under the Plans</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">or Programs</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(in thousands)</span></div></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1, 2021 &#8211; January 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">917,139&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.45&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2021 &#8211; February 28, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383,227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120.11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,383,227&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,751,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1, 2021 &#8211; March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.57&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,994,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115.42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share Repurchase Program (A)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,378,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,378,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,506,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Transactions (B)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183,894&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117.97&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(A)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">Since the share repurchase program&#8217;s inception in May 2003, our Board of Directors has authorized $11 billion of share repurchases of our common stock through March&#160;31, 2021.  The share repurchase authorization has no set expiration or termination date.  In each of February and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1 billion.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(B)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">Includes: (1) shares delivered or attested to in satisfaction of the exercise price and/or tax withholding obligations by holders of stock options (granted under the Company&#8217;s Amended and Restated Employee Long-Term Incentive Plan) who exercised options; and (2) shares withheld (under the terms of grants under the Amended and Restated Employee Long-Term Incentive Plan) to offset tax withholding obligations that occur upon the delivery of outstanding common shares underlying restricted stock units and performance share units.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-indent:18pt"><span><br/></span></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div style="-sec-extract:summary;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:6.02pt">Exhibits </span></div><div><span><br/></span></div><div style="padding-left:27pt;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Exhibits:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:8.709%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.091%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312021ex311.htm">Rule 13a-14(a) Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312021ex312.htm">Rule 13a-14(a) Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312021ex321.htm">Section 1350 Certification of Chief Executive Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312021ex322.htm">Section 1350 Certification of Chief Financial Officer</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="dgx03312021ex101.htm">Form of Quest Diagnostics Incorporated 2021 Equity Award Agreement </a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document  - dgx-20210331.xsd</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document - dgx-20210331_cal.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document - dgx-20210331_def.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document - dgx-20210331_lab.xml</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document - dgx-20210331_pre.xml</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i48a4c51f7e6947a1b3d20f42a15280c5_7">Table of Contents </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Signatures</span></div><div style="margin-bottom:8pt;margin-top:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;23, 2021 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quest Diagnostics Incorporated</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:35.087%"><tr><td style="width:1.0%"></td><td style="width:10.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and President</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mark J. Guinan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div id="i48a4c51f7e6947a1b3d20f42a15280c5_124"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>dgx03312021ex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7cd3b0dd0d5148e89ca2d7e6d5fb12ea_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Quest Diagnostics Incorporated</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">2021 Equity Award Agreement</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Equity Award Agreement (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) dated as of &#91;Grant Date&#93; (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) between Quest Diagnostics Incorporated, 500 Plaza Drive, Secaucus, NJ 07094 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and the employee to whom the awards described herein are made (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) is subject in all respects to the Company&#8217;s Amended and Restated Employee Long-Term Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  All references to &#8220;Shares&#8221; mean shares of the Company&#8217;s Common Stock.</font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">This Agreement and the awards described herein are effective as of the grant date but shall be canceled if the Employee fails to complete, not later than thirty (30) days after such awards are communicated electronically to the Employee, all the steps to accept the Options (as hereinafter defined) electronically at the Fidelity Net Benefits website (https&#58;&#47;&#47;nb.fidelity.com) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Site</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8221;), including without limitation acknowledging that the Employee has read all of the documentation provided at the Site and confirming acceptance of the Options.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">If the Site does not reflect confirmation of acceptance of the Options by Midnight on the thirtieth (30</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:700;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">) day after the awards described herein are communicated electronically to the Employee, this Agreement, and the awards described herein, shall be cancelled.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">The Employee&#8217;s taking the necessary steps so that the Site reflects confirmation of acceptance for the Options will suffice to reflect the Employee&#8217;s acceptance of the RSUs (as hereinafter defined) and the Performance Shares (as hereinafter defined) as well as the Options.  Thus, it is not necessary for the Employee to make a separate electronic acceptance of the RSUs or the Performance Shares. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you are not a United States citizen or resident as such term is defined by the Internal Revenue Code and you are employed outside the United States, please consult the &#8220;International Supplement&#8221; attached as Appendix B to this Agreement.  The International Supplement amends certain terms and conditions of this Agreement as they apply to individuals employed outside the United States.</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AWARDS COVERED BY THIS AGREEMENT</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Award of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company hereby awards stock options (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Option</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to the Employee under the Plan.  The number of Options awarded to the Employee is indicated at the Site.  Each Option entitles the Employee, subject to the terms and conditions of this Agreement and the Plan, to purchase from the Company at the exercise price set forth for the Options at the Site (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) one Share (an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Option Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Options shall vest and become exercisable on the terms set forth in Section&#160;4.  The Options shall expire on, and no Option Shares may be purchased pursuant to this Agreement after, the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">tenth anniversary of the Grant Date (such tenth anniversary is referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Option Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  The Compensation Committee of the Board of Directors of the Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Compensation Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) may, in its sole discretion, convert any or all of the Options at any time to a stock-settled stock appreciation grant.  The Options are not intended to be &#8220;incentive stock options&#8221; within the meaning of Section&#160;422 of the Internal Revenue Code of 1986, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and this Agreement shall be construed and interpreted in accordance with such intention.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Share Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company hereby awards restricted share units (each, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">RSU</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to the Employee under the Plan.  The number of RSUs awarded to the Employee is indicated at the Site.  Each RSU corresponds to one Share and constitutes a contingent and unsecured promise of the Company to pay the Employee one Share for each vested RSU, subject to the terms and conditions set forth in the Plan and this Agreement.  The RSUs shall vest and convert to Shares on the terms set forth in Section 4.  For purposes of this Agreement, an &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">RSU Share</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means a Share delivered upon conversion of an RSU.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Capitalized terms used in this Section&#160;3 without definition have the meanings set forth in Appendix A.  The Employee shall be eligible to receive and vest in Shares as provided in this Section&#160;3 and Section&#160;7 based on (a)&#160;the number of target performance shares indicated for the Employee at the Site (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Target Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) and (b)&#160;the Company&#8217;s performance during the Performance Period.  Performance will be measured as of the end of the performance period that began on January 1, 2021 and will continue through December 31, 2023 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).  35% of the Target Performance Shares will be earned based on the annual compounded growth of Base Business Net Revenues (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Base Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Revenue Growth</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) during the Performance Period, determined by comparing the Company&#8217;s Base Business Net Revenues for the Final Year of the Performance Period (as reported by the Company for the relevant year) with the Company&#8217;s Base Business Net Revenues for the Baseline Year (as reported by Company for the year).  After the Performance Period, Base Business Revenue Growth will be calculated and the number of Shares to be issued (subject to vesting under Section&#160;7 and withholding of taxes under Section&#160;14) in respect of the Base Business Revenue Growth performance measure shall be based upon the following formula (such Shares, and the Shares determined using the COVID-19 Net Revenue, Average ROIC, and Relative TSR performance measures described below in this Section&#160;3 being &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Earned Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;)&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:42.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Annual Compounded Base Business Revenue Growth*</font></td><td colspan="3" style="border-top:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Earnings Multiple&#8221;* multiplied by 35% of  Target Performance Shares &#61; Earned Performance Shares</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater Than or Equal to %&#160;&#160;&#160;&#160;</font></div><div style="padding-right:-5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater Than or Equal to % but Less Than or Equal to %&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;...</font></div></td><td colspan="3" style="border-top:1pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 x 35% x Target Performance Shares</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 x 35% x Target Performance Shares </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equal to %</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 x 35% x Target Performance Shares</font></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less Than %</font></td><td colspan="3" style="border-bottom:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 x 35% x Target Performance Shares</font></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*The Earnings Multiple for Base Business Revenue Growth between the percentages designated in the above table will be interpolated.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15% of the Target Performance Shares will be earned based on the Company&#8217;s cumulative COVID-19 Net Revenue (as defined in Appendix A) during the Performance Period.  After the Performance Period, the COVID-19 Net Revenue will be calculated and the number of Earned Performance Shares to be issued (subject to vesting under Section&#160;7 and withholding of taxes under Section&#160;14) in respect of the COVID-19 Net Revenue performance measure shall be based upon the following formula&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:42.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">COVID-19 Net Revenue (mm)*</font></td><td colspan="3" style="border-top:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Earnings Multiple&#8221;* multiplied by 15% of  Target Performance Shares &#61; Earned Performance Shares</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater Than or Equal to $&#160;&#160;&#160;&#160;</font></div><div style="padding-right:-5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equal to $&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;</font></div></td><td colspan="3" style="border-top:1pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 x 15% x Target Performance Shares</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 x 15% x Target Performance Shares </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equal to $</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 x 15% x Target Performance Shares</font></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less Than $</font></td><td colspan="3" style="border-bottom:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 x 15% x Target Performance Shares</font></td></tr></table></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*The Earnings Multiple for COVID-19 Net Revenue between the percentages designated in the above table will be interpolated.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">30% of the Target Performance Shares will be earned based on the Company&#8217;s Average ROIC (as defined in Appendix A) during the Performance Period.  After the Performance Period, the Average ROIC will be calculated and the number of Earned Performance Shares to be issued (subject to vesting under Section&#160;7 and withholding of taxes under Section&#160;14) in respect of the Average ROIC performance measure shall be based upon the following formula&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:42.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Average ROIC*</font></td><td colspan="3" style="border-top:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Earnings Multiple&#8221;* multiplied by 30% of  Target Performance Shares &#61; Earned Performance Shares</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater Than or Equal to %&#160;&#160;&#160;&#160;</font></div><div style="padding-right:-5.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Greater Than or Equal to % but Less Than or Equal to %&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;...</font></div></td><td colspan="3" style="border-top:1pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2 x 30% x Target Performance Shares</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1 x 30% x Target Performance Shares </font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equal to %</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25 x 30% x Target Performance Shares</font></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less Than %</font></td><td colspan="3" style="border-bottom:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 x 30% x Target Performance Shares</font></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*The Earnings Multiple for Average ROIC between the percentages designated in the above table will be interpolated.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The remaining 20% of the Target Performance Shares will be earned based on the Company&#8217;s Relative TSR (as defined in Appendix A) during the Performance Period.  After the Performance Period, the Relative TSR will be calculated and the number of Earned Performance Shares to be issued (subject to vesting under Section&#160;7 and withholding of taxes under Section&#160;14) in respect of the Relative TSR performance measure shall be based upon the following formula&#58;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"></td><td style="width:42.690%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.110%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Relative TSR*</font></td><td colspan="3" style="border-top:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8220;Earnings Multiple&#8221;* multiplied by 20% of Target Performance Shares &#61; Earned Performance Shares</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Greater Than or Equal to Percentile</font></td><td colspan="3" style="border-top:1pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2 x 20% x Target Performance Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equal to Percentile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1 x 20% x Target Performance Shares</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equal to  Percentile</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5 x 20% x Target Performance Shares</font></td></tr><tr><td colspan="3" style="border-bottom:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less Than  Percentile</font></td><td colspan="3" style="border-bottom:2pt solid #008000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0 x 20% x Target Performance Shares</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*The Earnings Multiple for Relative TSR between the percentiles designated in the above table will be interpolated.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The aggregate number of Earned Performance Shares will equal the sum of the number of Performance Shares earned in respect of the Base Business Revenue Growth performance measure, the number of Performance Shares earned in respect of the COVID-19 Net Revenue performance measure, the number of Earned Performance Shares earned in respect of the Average ROIC performance measure and the number of Earned Performance Shares earned in respect of the Relative TSR performance measure.  The maximum number of Earned Performance Shares is 2x the number of Target Performance Shares.</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">STOCK OPTIONS AND RESTRICTED SHARE UNITS</font></div><div style="margin-bottom:12pt;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Options and RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">General Vesting Requirements for Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as otherwise provided below, the Options shall vest and become exercisable on the vesting dates set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Option Vesting Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), provided that the Employee remains in continuous employment with the Company Group (as defined in Section 23) through the applicable Option Vesting Date.  Options shall be exercisable only to the extent vested.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Option Vesting Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting Percent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cumulative</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First anniversary of Grant Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;33.3%&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;33.3%</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Second anniversary of Grant Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;33.3%&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;66.6%</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third anniversary of Grant Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;33.4%&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;100%</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">General Vesting Requirements and Conversion Rules for RSUs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as otherwise provided in this Agreement, the RSUs shall vest on the vesting dates set forth below (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">RSU Vesting Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), provided that the Employee remains in continuous employment with the Company Group through the applicable RSU Vesting Date.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">RSU Vesting Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting Percent</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cumulative</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">First anniversary of Grant Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;33.3%&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;33.3%</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Second anniversary of Grant Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;33.3%&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;66.6%</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third anniversary of Grant Date&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;33.4%&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;100%</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the case of an Employee who continues in employment through an RSU Vesting Date, the RSUs that vest on that RSU Vesting Date will convert to Shares as soon as practicable, and in all cases within fourteen (14) days, after the RSU Vesting Date.  In the case of RSUs that vest as provided in Sections 4(d) through 4(f), the RSUs, although vested, will not convert to shares by virtue of having vested and instead will convert to Shares as soon as practical, and in all cases within fourteen (14) days, after each remaining RSU Vesting Date following the relevant vesting event specified in Sections 4(d) through 4(f)&#59; in other words, the RSUs will convert to Shares as though the Employee&#8217;s employment had continued through the applicable RSU Vesting Date.  In all cases, upon conversion, the RSU Shares, net of required tax withholding as described in Section 14 below, shall be transferred into the Employee&#8217;s account at the Company&#8217;s dedicated broker.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee&#8217;s employment terminates for any reason other than those described in Section 4(d) through 4(f) prior to the third anniversary of the Grant Date, any Options and any RSUs that have not vested as of the date of termination of employment (the Employee&#8217;s &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) will be canceled.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death and Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee&#8217;s employment terminates due to death or Disability (as defined in Section 23), all Options and all RSUs shall immediately vest.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If within two years following the date of a Change in Control (as defined in the Plan), the Employee&#8217;s employment is terminated by the Company Group (or its successor) without Cause (as defined in Section 23) or the Employee resigns from his or her employment for Good Reason (as defined in Section 23), then all Options and all RSUs shall immediately vest on the Employee&#8217;s Termination Date. Notwithstanding the preceding sentence, in the event of a Change in Control in which the Company is not the surviving entity, and the surviving entity or successor to the Company does not agree to assume the Company&#8217;s obligations with respect to the Options under this Equity Award Agreement or to grant the Employee a Replacement Award (as defined in Section 23), then all Options and all RSUs shall vest immediately prior to the Change in Control in such a manner that will enable the Employee to participate in the Change in Control with respect to the Shares issuable upon exercise of the Options and conversion of the RSUs on the same basis as other holders of the Company&#8217;s outstanding Common Stock.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If on or after the first anniversary of the Grant Date, the Employee&#8217;s employment with the Company Group terminates due to Retirement (as defined in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 23), the Employee will immediately vest in any Options and any RSUs that have not vested as of the Termination Date. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.&#160;&#160;&#160;&#160;  The Employee may exercise Options in accordance with the procedures specified by the Company from time to time.  The Exercise Price of Options shall be paid in full with, or in a combination of&#58; (a)&#160;cash&#59; (b)&#160;Shares that are owned by the Employee and are fully vested and freely transferable by the Employee, duly endorsed or accompanied by stock powers executed in blank&#59; (c) a net share settlement procedure&#59; or (d)&#160;through the withholding of Shares subject to the Options.  The Company in its discretion may permit the Employee (if the Employee owns Shares that are fully vested and fully transferable by the Employee) to &#8220;attest&#8221; to his&#47;her ownership of the number of Shares required to pay all or part of the purchase price (and not require delivery of the Shares), in which case the Company will deliver to the Employee the number of Shares to which the Employee is entitled, net of the &#8220;attested&#8221; Shares.  If payment is made in whole or in part with Shares (including through the withholding of Shares subject to Options), the value of such Shares shall be the mean of its high and low prices on the New York Stock Exchange Composite list (or such other stock exchange as shall be the principal public trading market for the Shares) on the day of exercise.  No &#8220;reload&#8221; or other option will be granted by reason of any such exercise.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise of Option After Termination of Employment, Death, Disability or Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions covering the exercise of the Options following termination of employment are as follows, provided that in no event may any Options be exercised after the Option Expiration Date&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination in General</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee&#8217;s employment terminates for any reason other than those described in Section&#160;6(b) through 6(d), the Options that have vested simultaneously with or before the Employee&#8217;s termination of employment may be exercised for ninety&#160;(90) days following such termination (but not beyond the Option Expiration Date) and such vested Options shall thereafter expire and cease to be exercisable.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee shall die while employed, then any Options that are vested and exercisable (including any Options that become vested and exercisable under Section 4(d)) may be exercised through the fifth anniversary of the date of termination (but not beyond the Option Expiration Date) and shall thereafter expire.  If the Employee shall die after termination of employment but while all or any portion of the Options are still exercisable, they shall remain exercisable through the first anniversary of the date of death but not beyond the Option Expiration Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee&#8217;s employment shall terminate due to Disability, then any Options that are vested and exercisable (including any Options that become vested and exercisable under Section 4(d)), may be exercised through the fifth anniversary of the date of termination (but not beyond the Option Expiration Date) and shall thereafter expire.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee&#8217;s employment with the Company Group terminates due to Retirement, then any Options that are vested and exercisable (including any Options that become vested and exercisable under Section&#160;4(f)) may be exercised through the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">fifth anniversary of the date of termination (but not beyond the Option Expiration Date) and shall thereafter expire.</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PERFORMANCE SHARES</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting of Performance Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Performance Share Vesting Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as otherwise provided in this Agreement, Earned Performance Shares will vest at the end of the vesting period beginning on the Grant Date and continuing through February 18, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Performance Share Vesting Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), provided that the Employee remains in continuous employment with the Company Group through the end of the Performance Share Vesting Period.  Earned Performance Shares, net of required tax withholding as described in Section 14 below, will be transferred into the Employee&#8217;s account at the Company&#8217;s dedicated broker as soon as practicable after the final calculation of the number of Earned Performance Shares but in any event on or prior to March 15, 2024.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Change in Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If a Change in Control occurs prior to the end of the Performance Share Vesting Period then a number of Earned Performance Shares shall be calculated as of the Change in Control and shall be equal to the greater of&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;the number of Earned Performance Shares that would be awarded if the calculation under Section&#160;3 were based on the most recent fiscal year end results of the Company (rather than the Final Year of the Performance Period)&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;the number of Target Performance Shares. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Such Earned Performance Shares shall not vest solely by virtue of the occurrence of the Change in Control but shall instead remain subject to vesting, and shall be transferred into the Employee&#8217;s account at the Company&#8217;s dedicated broker, as provided in Section 7(a)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that in the event of a Change in Control in which the Company is not the surviving entity, and the surviving entity or successor to the Company does not agree to assume the Company&#8217;s obligations with respect to the Performance Shares under this Equity Award Agreement or to grant the Employee a Replacement Award, such Earned Performance Shares, net of required tax withholding as described in Section 14 below, will be transferred to the Employee&#8217;s account at the Company&#8217;s dedicated broker within five business days after the consummation of the Change in Control.  If within two years following the date of a Change in Control, the Employee&#8217;s employment is terminated by the Company Group (or successor to the Employee&#8217;s employer within the Company Group) without Cause or the Employee resigns from his or her employment for Good Reason, the Employee shall immediately vest in the number of Earned Performance Shares calculated in accordance with the first sentence of this Section 7(b), and (to the extent not previously transferred pursuant to the preceding sentence) such Earned Performance Shares, net of required tax withholding as described in Section&#160;14 below, will be transferred to the Employee&#8217;s account at the Company&#8217;s dedicated broker within five business days after the Employee&#8217;s Termination Date.  If (and only if) the Company continues to file annual reports pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">amended, following the Change in Control, including for the Final Year of the Performance Period, then following the end of the Performance Period, to the extent that the number of Earned Performance Shares calculated pursuant to Section&#160;3 exceeds the number of Earned Performance Shares calculated pursuant to the first sentence of this Section 7(b), the full amount of Earned Performance Shares resulting from the calculation in accordance with Section&#160;3 (net of the number of Earned Performance Shares, if any, previously delivered or withheld for taxes under the preceding two sentences) will be so transferred as provided in Section&#160;7(a).  If the Employee terminates employment prior to the Change in Control, the Earned Performance Shares will vest, be pro-rated or be canceled, as applicable, in accordance with Section&#160;7(c).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustments to Earned Performance Shares and Vesting of Earned Performance Shares on Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Employee (or, in the case of death, the Employee&#8217;s beneficiary or estate) shall be entitled to receive 100% of the Earned Performance Shares calculated pursuant to Section&#160;3, and such Earned Performance Shares shall not be subject to a service-based vesting requirement, if prior to the end of the Performance Share Vesting Period (x) the Employee&#8217;s employment terminates by reason of death or Disability or (y) the Employee&#8217;s employment terminates by reason of Retirement on or after the first anniversary of the Grant Date.  Such Earned Performance Shares (if any) will be delivered as provided in Section&#160;7(a) or Section 7(b), if applicable.  The number of Earned Performance Shares calculated pursuant to Section&#160;3 to which the Employee is entitled will be adjusted in the following circumstances&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Employment Generally</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee&#8217;s employment terminates prior to the end of the Performance Share Vesting Period for any reason other than death, Disability, Retirement on or after the first anniversary of the Grant Date or the circumstances described in Section 7(b) or 7(c)(ii), all of the Target Performance Shares will be canceled and none of the Earned Performance Shares will vest.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Involuntary Termination without Cause or Divestiture</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If prior to the end of the Performance Share Vesting Period the Employee&#8217;s employment is terminated by the Company Group without Cause or as a result of&#160;a divestiture and the Employee is employed by the divested or purchasing entity, then, notwithstanding the provision of Section&#160;7(c)(i), the Employee shall vest in the number of Earned Performance Shares determined by multiplying the Earned Performance Shares by a fraction (A)&#160;the numerator of which is the number of full months that the Employee was employed by the Company Group during the Performance Share Vesting Period and (B)&#160;the denominator of which is the number of months in the Performance Share Vesting Period&#59; and the balance of the Earned Performance Shares will be canceled.</font></div><div style="margin-bottom:12pt;padding-right:-18pt;text-align:center;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TERMS AND CONDITIONS APPLICABLE TO ALL AWARDS</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cancellation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Employee acknowledges and agrees that, in consideration for the Employee&#8217;s being granted the award covered by this Agreement, the Employee shall abide by the terms and conditions of the restrictive covenant agreement attached hereto as Appendix C (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Restrictive Covenant Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), which terms and conditions are </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">incorporated herein by reference.  Notwithstanding anything to the contrary contained herein, this Agreement shall expire and be canceled, the Employee will not vest in any additional Options, the Employee may not exercise any Options, whether or not vested, and all RSUs, RSU Shares, Target Performance Shares (whether or not vested or earned) and Earned Performance Shares shall be canceled if&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Employee shall cause the Company or any other member of the Company Group to suffer financial harm or damage to its reputation (either before or after termination of employment) through (x)&#160;dishonesty, (y)&#160;violation of law in the course of the Employee&#8217;s employment or violation of the Company&#8217;s Corporate Compliance Manual and compliance bulletins or other written policies or (z)&#160;material deviation from the duties owed the Company Group by the Employee&#59; or</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Employee is subject to the Executive Share Ownership Policy, as such policy may be amended from time to time (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), and the Employee makes any false attestation under the Ownership Policy&#59; or</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the Employee violates the terms of the Restrictive Covenant Agreement or any other confidentiality, non-solicit or non-compete obligation, or any other restrictive covenant set forth in any agreement between the Employee and the Company or any other member of the Company Group, or otherwise pursuant to any written policy of the Company or any other member of the Company Group (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Restrictive Covenant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company may require the Employee to provide a written certification or other evidence, from time to time in the Company&#8217;s sole discretion, to confirm that no cancellation event identified in clauses (a), (b) or (c) above has occurred, including upon or following a termination of employment for any reason and&#47;or during a specified period of time prior to the exercise of any Options or the scheduled delivery of any Option Shares, RSU Shares or Earned Performance Shares.  If the Employee fails to provide any required certification or other evidence by the specified deadline, the Company shall have the right to cancel the Employee&#8217;s awards and&#47;or, as discussed in the next paragraph, to cause the exercise of any Option and the delivery of any Option Shares, RSU Shares or Earned Performance Shares under this Agreement to be rescinded (and if the Employee has previously sold the Shares issued pursuant to this Agreement, the Employee would be required to pay back to the Company the pre-tax proceeds received from the sale of such Shares).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Employee understands that the cancellation of any awards or rights under this Agreement is only one of the remedies that potentially may be asserted against the Employee for injuries or damages sustained by the Company or any other member of the Company Group as a result of any action described in this Section 8 or a violation of any Restrictive Covenant.  Such cancellation shall be in addition to any equitable and legal rights the Company or any other member of the Company Group has or may have and shall not constitute a release of any claim that the Company or any other member of the Company Group may have for damages, past, present, or future.  In addition, a breach by the Employee of any provisions of any Restrictive Covenant that occurs after any exercise of any Option or delivery of Shares pursuant to this Agreement (including any breach occurring after termination of employment) shall cause the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">exercise of the Option and the delivery of any Option Shares, RSU Shares or Earned  Performance Shares under this Agreement to be rescinded (and if the Employee has previously sold the Shares issued pursuant to this Agreement, the Employee would be required to pay back to the Company the pre-tax proceeds received from the sale of such Shares).  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Executive Share Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Employees Subject to Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration of the grant of the awards under this Agreement, the Employee agrees that, if the Employee is or becomes subject to the Ownership Policy, the Options and all Option Shares, the RSUs and all RSU Shares, the Target Performance Shares and all Earned Performance Shares shall be subject to cancellation pursuant to Section (8)(b) of this Agreement and all Options, Option Shares, RSUs, RSU Shares, Target Performance Shares, Earned Performance Shares and shares of restricted stock granted to the Employee by the Company prior to the date hereof (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Prior Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) shall be subject to cancellation pursuant to Section 8(b) of this Agreement (for false attestation under the Ownership Policy), the Shares obtained on exercise of such Prior Awards after the date hereof shall be subject to the Ownership Policy pursuant to Section&#160;9(b) of this Agreement and the terms of Sections 8 and 9(b) hereof are made a part of the terms of each of the Prior Awards.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Shares Subject to Ownership Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee is subject to the Ownership Policy, any Shares issued under this Agreement or pursuant to any Prior Award (in each case net of tax withholdings) are subject to such Policy.  The Employee hereby acknowledges and agrees that the investment risk associated with the retention of any Shares, whether pursuant to the Ownership Policy or otherwise, is the sole responsibility of the Employee and the Employee hereby holds the Company and each other member of the Company Group harmless against any claim of loss related to the retention of the Shares.</font></div><div style="margin-bottom:12pt;text-indent:90pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Transferability&#59; Voting Rights and Dividends.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The awards and rights under this Agreement shall not be transferable other than by will or the laws of descent and distribution.  The Options may be exercised during the lifetime of the Employee only by the Employee except in the case of the Employee&#8217;s Disability, in which case the Options may be exercised by the Employee&#8217;s legal representative.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Voting and Dividend Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Employee will not have any voting, dividend or other rights as a stockholder with respect to any Option Shares, RSUs, RSU Shares, Target Performance Shares or Earned Performance Shares prior to the date on which he&#47;she is recorded as the holder of such Option Shares, RSU Shares or Earned Performance Shares on the records of the Company&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that until RSUs convert to Shares, if the Company declares and pays a regular or ordinary dividend on its Common Stock, the Employee will be paid a dividend equivalent for vested and unvested RSUs, but no dividend equivalents will be paid on any RSUs that are canceled.  The Employee understands that the Option Shares will not be issued to the Employee until after (and to the extent that) Options are exercised, that Shares will not be issued to the Employee in respect of RSUs until after (and to the extent that) RSUs convert to Shares and that, except as provided in Section&#160;7(b), Earned Performance Shares will </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">not be issued to the Employee until after the final calculation of the Earnings Multiple as contemplated by Section&#160;3 and any adjustment under Section&#160;7, it being understood that such issuance shall occur in any event on or prior to March&#160;15, 2024.  The Employee further understands that all deliveries of Shares under this Agreement shall be net of required tax withholding as described in Section&#160;14 below.  Until Shares have been delivered to or on behalf of the Employee in respect of any RSUs or Earned Performance Shares, the Employee shall have only the rights of a general unsecured creditor.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Until Shares are transferred to the Employee&#8217;s account at the Company&#8217;s dedicated broker or the Employee otherwise receives possession of any such Shares, the Employee shall have no right to sell, assign, transfer, pledge or otherwise encumber Shares in any manner.  Any purported attempt to sell, assign, transfer, pledge or otherwise encumber any award under this Agreement will be void and shall result in the cancellation of such award.  Unless otherwise provided at the time of such transfer or delivery to the Employee of any Shares issued in respect of vested RSUs or Earned Performance Shares or Shares issued upon full or partial exercise of the Options, upon such transfer or delivery to the Employee the Shares will not be subject to any restrictions on transfer other than those that may arise under the securities laws or the Company&#8217;s policies, but the Shares shall remain subject to cancellation as provided in Section&#160;8.   </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Consideration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration for the awards under this Agreement, the Employee hereby agrees to be bound by the Restrictive Covenant Agreement and all other Restrictive Covenants applicable to the Employee. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Clawback</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By accepting the awards under this Agreement the Employee agrees that all awards hereunder, and any other awards granted to the Employee under the Plan or any other equity or cash incentive plan of the Company (whether before or after the date of this Agreement), shall be subject to cancellation and recoupment by the Company, and shall be repaid by the Employee to the Company, to the extent required by law, regulation or listing requirement, or as determined in accordance with any Company incentive compensation recoupment policy, in each case, as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">The Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Plan is incorporated herein by reference.  The Employee acknowledges that he&#47;she has read the terms of the Plan and that those terms shall govern in the event of any conflict with the terms of this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The partial or full exercise of any Option, the transfer of Shares upon conversion of any vested RSUs and the delivery of any Earned Performance Shares under this Agreement will result in the Employee&#8217;s recognition of income for U.S. federal income tax purposes and shall be subject to tax and tax withholdings as appropriate.  The Company or any other member of the Company Group that employs the Employee may make such provisions and take such steps as it may deem necessary or appropriate for the withholding of all federal, state, local and other taxes required or permitted by law to be withheld with respect to the exercise of any Options.  On the delivery of Shares upon conversion of any RSUs and upon payment of any Earned Performance Shares, the Company will reduce the number of Shares to be delivered to the Employee by the amount of the taxes due (with the Shares valued at </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the mean of its high and low prices on the New York Stock Exchange Composite list (or such other stock exchange as shall be the principal public trading market for the Shares) on the date that the Shares are valued for purposes of reporting compensation for Federal income tax purposes).  The Company or any other member of the Company Group that employs the Employee shall have the authority to make arrangements for payment of the Employee&#8217;s share of any employment&#47;payroll taxes (including Federal Insurance Contributions Act taxes), whether imposition of such taxes occurs upon exercise of Options, conversion of RSUs, transfer of Earned Performance Shares or at some other time.  In particular, the Employee authorizes his or her employer to withhold such taxes from any payroll or other payment or compensation owed to the Employee, subject to the limitations imposed under Section&#160;409A of the Code.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 15&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Consent Requirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Company shall at any time determine that any consent (as hereinafter defined) is necessary or desirable as a condition of, or in connection with, the granting of the Options, the issuance or purchase of Shares or other rights hereunder, or the taking of any other action hereunder (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Plan Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then no such Plan Action shall be taken, in whole or in part, unless and until such consent shall have been effected or obtained to the full satisfaction of the Company.  The term &#8220;consent&#8221; as used herein with respect to any action referred to in this Section&#160;15 means (a)&#160;any and all listings, registrations or qualifications in respect thereof upon any securities exchange or under any federal, state or local law, rule or regulation, (b)&#160;any and all written agreements and representations by the Employee with respect to the disposition of Shares, or with respect to any other matter, which the Company shall deem necessary or desirable to comply with the terms of any such listing, registration or qualification or to obtain an exemption from the requirement that any such listing, qualification or registration be made, (c)&#160;any and all consents, clearances and approvals in respect of a Plan Action by any governmental or other regulatory bodies, and (d)&#160;any and all consents or authorizations required to comply with, or required to be obtained under, applicable local law or otherwise required by the Company.  Nothing herein shall require the Company to list, register or qualify the Shares on any securities exchange.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Invalidity and Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If any provision of this Agreement is deemed invalid or unenforceable, either in whole or in part, this Agreement shall be deemed amended to delete or to modify, as set forth in this Section, the offending provision or provisions and to alter the bounds of this Agreement in order to render it valid and enforceable.  The Company and the Employee specifically request that any court having jurisdiction over any dispute relating to this Agreement modify, if possible, any offending provision so that such provision will be enforceable to the maximum extent permitted by law.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">No Entitlements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement is not an employment agreement, and nothing in this Agreement or the Plan shall alter an Employee&#8217;s status as an &#8220;at-will&#8221; employee of the Company Group subject to the rights (if any) that the Employee may have under any employment agreement existing between any member of the Company Group and the Employee.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Enforcement by Successors and Assigns</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The Company and any of its successors or assignees may enforce the Company&#8217;s rights under this Agreement.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Other than with respect to any Restrictive Covenant and the Ownership Policy, this Agreement constitutes the entire agreement between the Company and the Employee regarding the Options, the RSUs and the Performance Shares.  No modification of this Agreement will have any force or effect unless such modification is in writing, signed by the Chief Executive Officer (or by the Senior Vice President, Chief Human Resources Officer or successor officer) of the Company and the Employee, and expressly indicates an intent to modify this Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Interpretation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Any dispute, disagreement or matter of interpretation which shall arise under the Agreement shall be finally determined by the Compensation Committee in its absolute discretion.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement and all rights hereunder shall be governed by, and construed and interpreted in accordance with, the laws of the state of New York applicable to contracts made and to be performed entirely within such state (without reference to its principles of conflicts of law).  Each of the parties hereto hereby irrevocably and unconditionally submits, for itself and its property, to the exclusive jurisdiction of any New York state court or federal court of the United States of America sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating to this Agreement, or for recognition or enforcement of any judgment, and each of the parties hereto hereby irrevocably and unconditionally agrees that all claims in respect of any such action or proceeding may be heard and determined in any such New York state court or, to the extent permitted by law, in such federal court.  Each of the parties hereto agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by law.  Each of the parties hereto irrevocably and unconditionally waives, to the fullest extent it may legally and effectively do so, any objection that it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Agreement in state or federal court in New York City.  Each of the parties hereto hereby irrevocably waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or proceeding in any such court.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  It is the intention and understanding of the parties that the RSUs are either exempt from or comply with the provisions of Section 409A of the Code, and that none of the Options or the Performance Shares provide for a deferral of compensation subject to Section 409A of the Code.  This Agreement shall be interpreted and administered to give effect to such intention and understanding and to avoid the imposition on the Employee of any tax, interest or penalty under Section 409A of the Code in respect of any Options, RSUs or Performance Shares.  Notwithstanding any other provision of this Agreement, the Employee&#8217;s consent shall not be required for any amendment to this Agreement which, in the reasonable, good faith judgment of the Company, is necessary or appropriate to avoid the imposition on the Employee of any tax, interest or penalty under Section 409A of the Code.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Defined Terms</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  As used in this Equity Award Agreement, the following terms have the meanings indicated below&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;as to any Employee who is a party to an employment agreement with the Company or any other member of the Company Group which contains a definition of &#8220;cause,&#8221; the definition set forth in such employment agreement&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;as to any Employee who is not a party to such an employment agreement but who is eligible to receive severance under a severance plan of the Company or any other member of the Company Group (other than the Quest Diagnostics Incorporated Severance Pay Plan) which contains a definition of &#8220;cause&#8221;, the definition set forth in such severance plan&#59; and </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;as to any other Employee&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;repeated failure or refusal to perform duties and responsibilities of his or her job as required by the Employee&#8217;s employer (other than any such failure resulting from the Employee&#8217;s incapacity due to physical or mental illness)&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;violation of any fiduciary duty or duty of loyalty owed to the Company or any other member of the Company Group, including without limitation any acts of theft or dishonesty&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;conduct or misconduct that is or threatens to be injurious to the Company or any other member of the Company Group or that harms or threatens to harm the reputation or financial position of the Company or any other member of the Company Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;the commission of conduct that meets the definition of any felony under state or federal law, or conviction of, or plea of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> to, any other criminal charge that is or threatens to be injurious to the Company or any member of the Company Group&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)&#160;&#160;&#160;&#160;willful conduct that violates the Company&#8217;s Corporate Compliance Manual, compliance bulletins or other written policies&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)&#160;&#160;&#160;&#160;(x) obstructing or impeding, (y) endeavoring to influence, obstruct or impede or (z) failing to cooperate with a Company investigation, whether or not related to the Employee&#8217;s employment, or the willful destruction of or willful failure to preserve documents or other material known to be relevant to any such investigation&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)&#160;&#160;&#160;&#160;being found liable in any Securities and Exchange Commission or other civil or criminal securities law action&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)&#160;&#160;&#160;&#160;other egregious conduct that has or could have a serious and detrimental impact on the Company or any other member of the Company Group. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Company Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Company Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means (i) the Company, (ii)&#160;any company or other entity in which the Company owns at least a 50% interest within the meaning of Section 424(f) of the Code, and (iii) any company or other entity in which the Company owns at least a 20% interest within the meaning of Section 424(f) of the Code and which the Administrator has designated as a member of the Company Group for purposes of awards under the Plan.  References to employment by or with the Company Group shall be understood to refer to employment by or with the Company or any other member of the Company Group.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means permanent and total disability as determined under the Company&#8217;s long-term disability program for employees then in effect.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;as to any Employee who is a party to an employment agreement with the Company or any other member of the Company Group which contains a definition of &#8220;good reason,&#8221; the definition set forth in such employment agreement&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;as to any Employee who is not a party to such an employment agreement but who is eligible to receive severance under a severance plan of the Company or any member of the Company Group which contains a definition of &#8220;good reason,&#8221; the definition set forth in such severance plan&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;as to any other Employee, the termination of the Employee&#8217;s employment by the Employee after one of the following events, provided that the Employee&#8217;s termination of employment occurs within sixty (60) days after the occurrence of any such event&#58; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)&#160;&#160;&#160;&#160;any material change in the duties, responsibilities or status (including reporting responsibilities) of the Employee that is inconsistent in any material and adverse respect with the Employee&#8217;s position(s), duties, responsibilities or authority with his or her employer immediately prior to such Change in Control (including any material and adverse diminution of such duties or responsibilities)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that Good Reason shall not be deemed to occur upon a change in duties, responsibilities (other than reporting responsibilities) or status that is solely and directly a result of the Company no longer being a publicly traded entity and does not involve any other event set forth in this paragraph (d)&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;a material reduction in the Employee&#8217;s aggregate rate of annual base salary, annual bonus opportunity and equity incentive </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">compensation target opportunity (including any material and adverse change in the formula for such targets) as in effect immediately prior to such Change in Control&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)&#160;&#160;&#160;&#160;the Employee&#8217;s employer requiring the Employee to be based at any office or location more than fifty (50) miles from the office where the Employee is located at the time of the Change in Control and as a result causing the Employee&#8217;s commute from his residence at the time of the Change in Control to the new location to increase by more than fifty (50) miles&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)&#160;&#160;&#160;&#160;a material reduction in the Employee&#8217;s retirement, welfare, perquisite (if any) and other benefits taken as a whole, unless the Employee is permitted to participate in other plans providing the Employee with materially equivalent benefits in the aggregate (at materially equivalent or lower cost with respect to welfare benefit plans)&#59; </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that an event described in (A) through (D) above shall permit an Employee to terminate his or her employment for Good Reason only if written notice of such event has been provided by the Employee to his or her employer and the employer failed to cure such action within thirty (30) days following receipt of such notice.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Replacement Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Replacement Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means an equity award that is made by the surviving entity in a Change in Control in substitution for Options, RSUs or Performance Shares covered by this Equity Award Agreement and that, in the sole judgment of the Compensation Committee, affords the Employee economic opportunity and protections in the event of termination of employment that are at least as favorable to the Employee in the aggregate as the economic opportunity and protections afforded by the terms of the Options, RSUs or Performance Shares, as the case may be, set forth in this Equity Award Agreement.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Retirement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; means the voluntary cessation of employment by the Employee upon the attainment of age sixty (60) and the completion of not less than five (5) completed years of service with the Company or any other member of the Company Group&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that there is no basis for the Company or any member of the Company Group to terminate the employment of the Employee for Cause at the time of the Employee&#8217;s voluntary cessation of employment.</font></div><div style="margin-bottom:12pt;text-indent:76.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 24.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Leave of Absence and Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Leave of Absence</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Unless the Administrator expressly provides otherwise, the Employee&#8217;s employment with the Company Group will be deemed to have terminated when the Employee is no longer employed by or in a service relationship with the Company or another member of the Company Group (including by reason of a member of the Company Group ceasing to be such a member)&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">however</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">, that the Employee&#8217;s employment will not be deemed to have terminated during a bona fide leave of absence approved by the Employee&#8217;s direct employer for medical, personal, educational and&#47;or other permissible </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">purposes pursuant to policies of the Company Group as in effect from time to time if such absence does not exceed six months or, if longer, so long as the Participant retains a right by statute or by contract to return to employment or other service relationship with the Company Group.  The Employee&#8217;s leave of absence shall be considered &#8220;bona fide&#8221; only if there is a reasonable expectation that the Employee will return to perform services for the employer.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Transfers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  If the Employee shall be transferred from the Company to another member of the Company Group or vice versa or from one member of the Company Group to another, the Employee&#8217;s employment shall not be deemed to have terminated for purposes of this Equity Award Agreement.  If, while the Employee is employed by a member of the Company Group, such entity shall cease to be a member of the Company Group (whether by virtue of a sale, spin-off or other disposition or otherwise) and the Employee is not thereupon transferred to and employed by the Company or another member of the Company Group, then the Employee&#8217;s employment will be treated as a termination due to a divestiture on the date that the Employee&#8217;s employer ceases to be a member of the Company Group, and the provisions of Section 7(c)(ii) (Performance Shares) shall govern, as applicable.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">SECTION 25.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Acknowledgements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By accepting this Equity Award Agreement, the Employee agrees that he&#47;she has received and reviewed a copy of&#58;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Prospectus (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">link to Prospectus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">) relating to the Company&#8217;s Employee Equity Participation Program&#59; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Quest Diagnostics Incorporated 2020 Annual Report on Form&#160;10-K (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">link to 2020 Annual Report</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">)&#59;  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the Company&#8217;s Policy for Purchasing and Selling Securities (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) (link to</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> Trading Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">).  The Employee further agrees to fully comply with the terms of the Policy&#59; and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;the Eligibility Policy.</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Quest Diagnostics Incorporated</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Performance Shares Award Terms</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2021 &#8211; 2023 Performance Period</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Base Business Net Revenues</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The net revenues of the Company&#8217;s business excluding COVID-19 revenues.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Base Business Net Revenues for the Baseline Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; The Company&#8217;s net revenues during the Baseline Year were $6,714.5 million.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Baseline Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; 2020.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">COVID-19 Net Revenue</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#58; &#8211; The Company&#8217;s net revenues during the Performance Period that are related to the Company&#8217;s COVID-19 testing products and services, including, without limitation, revenues related to COVID-19 testing, including Nuclear Acid Amplification (including PCR), serology, antigen, viral sequencing, genotyping and other immunological testing solutions.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Final Year</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; The Company&#8217;s Fiscal Year ended December&#160;31, 2023.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Performance Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; January&#160;1, 2021 through December&#160;31, 2023.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">ROIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; NOPAT&#47;Invested Capital.</font></div><div style="margin-bottom:12pt;padding-left:54pt;text-indent:-54pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">NOPAT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; (Income from continuing operations &#8211; net income attributable to non-controlling interests) + (gross interest expense x (1 &#8211; statutory tax rate)).</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Invested Capital</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; Average total Quest Diagnostics stockholders equity + average total debt.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Average ROIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; Average of the Annual Average ROIC for each year in the Performance Period.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Annual Average ROIC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; For a given year within the Performance Period, NOPAT&#47;Invested Capital.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Peer Index</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; The companies listed in the S&#38;P 500 Health Care Industry Index at the start of the Performance Period. The Compensation Committee may, in its sole discretion, adjust the Peer Index in the event of&#58; (i) the merger of two members of the Peer Index&#59; (ii) the acquisition of a member of the Peer Index by another member of the Peer Index&#59; (iii) the acquisition of a member of the Peer Index by a company that is not a member of the Peer Index&#59; and (iv) a split of a member of the Peer Index (in which case the Compensation Committee may, in its sole discretion, include both companies in the Peer Index).  A Peer Company shall remain in the Peer Index following its bankruptcy or delisting (and shall be listed at the bottom of the Peer Index).  </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Relative TSR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; The percentile rank of the Company&#8217;s TSR as compared to the TSR of each member of the Peer Index, determined by dividing the number of members of the Peer Index </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with TSR equal to or lower than the Company&#8217;s TSR for the Performance Period by the total number of members of the Peer Index minus 1.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Total Shareholder Return or TSR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; The change in a company&#8217;s stock price over the Performance Period (</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">counting any dividends paid as if such dividends were reinvested at the time of issuance)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> divided by that company&#8217;s stock price at the beginning of the Performance Period, expressed as a percentage.  T</font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">he stock price at the beginning of the Performance Period shall be calculated using the relevant company&#8217;s 20 trading-day average closing stock price leading up to, but not including, January 1, 2021. The stock price at the end of the Performance Period shall be calculated using the relevant company&#8217;s 20 trading-day average closing stock price leading up to, and including, December 31, 2023.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">   </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">Performance Share Vesting Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; February 18, 2021 through February 18, 2024.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix B</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">International Supplement</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This International Supplement amends certain terms and conditions of, and is made a part of, the Quest Diagnostics Incorporated Equity Award Agreement dated as of &#91;Grant Date&#93;, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;) to which this International Supplement is attached as Appendix B.  This International Supplement applies to awards made to individuals who are not United States citizens or residents, as such term is defined by the Internal Revenue Code, and who are employed outside the United States.  Capitalized terms that are used without definition in this International Supplement have the meanings set forth in the Agreement.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Provisions applicable to all individuals who are not United States citizens or residents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Section 4(d) is amended to provide that if the Employee&#8217;s employment shall terminate as a result of a medical condition for which the Employee receives disability income benefits from a governmental program, all Options and all RSUs shall vest.  All references in the Agreement to Section 4(d), including without limitation the reference to Section 4(d) set forth in Section 6(c), shall be understood as referring to Section 4(d) as so amended.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The first two sentences of Section 14 are replaced in their entirety to read as follows&#58; &#8220;Depending on applicable tax rules, the Employee may recognize income for income tax purposes upon the grant, vesting, exercise or settlement of the awards covered by this Agreement, and the Employee shall be subject to tax and tax withholdings as appropriate.&#8221;  References in Section 14 to Federal income tax and Federal Insurance Contribution Act taxes shall be understood as references to the comparable taxes in the jurisdiction in which the Employee is employed.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Provisions applicable to individuals who are citizens or residents of Finland</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Definition of Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The definition of &#8220;Termination Date&#8221; in Section 4(c) is replaced in its entirety with the defined term &#8220;Expiry Date&#8221;, which shall mean the date of the Employee&#8217;s expiry of employment.  All references in the Agreement to Termination Date shall be understood as referring to Expiry Date.</font></div><div style="padding-left:108pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Leave of Absence and Transfer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Each use of the term &#8220;terminated&#8221; in Section 24 is replaced with the term &#8220;expired.&#8221;  Section 24 is amended to provide that, in addition to the enumerated permissible </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">leaves of absence, an Employee&#8217;s employment will not be deemed to have expired as a result of a </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">bona fide</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> leave of absence permitted pursuant to statute.  </font></div><div style="padding-left:36pt"><font><br></font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:27pt;text-decoration:underline">Definition of Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Section 23(d)(iii) is amended to provide that the events set forth in Sections 23(d)(iii)(A) through (D) shall provide grounds for a termination by the Employee with Good Reason if the Employee serves notice of Employee&#8217;s termination of employment within sixty (60) days of the occurrence of any such event and the employer fails to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">cure the event giving rise to Good Reason within thirty (30) days following receipt of such notice.</font></div><div style="padding-left:36pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">21</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Appendix C</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">RESTRICTIVE COVENANT AGREEMENT</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">22</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>dgx03312021ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib9b74b1bc07f47a7a296a437a0e51b98_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen H. Rusckowski, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;23, 2021 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:37.134%"><tr><td style="width:1.0%"></td><td style="width:11.892%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.908%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>dgx03312021ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="idb16b3621e9c4ec992c8621e7b26d06c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Mark J. Guinan, certify that&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Quest Diagnostics Incorporated&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:5pt;margin-top:5pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April&#160;23, 2021 </font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:31.140%"><tr><td style="width:1.0%"></td><td style="width:14.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.408%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>dgx03312021ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i441c74862d1b43698ab89b99b393424f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended March&#160;31, 2021 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:5.351%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.175%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.442%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 23, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen H. Rusckowski</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman, Chief Executive Officer and </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>dgx03312021ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i4fe701ec4d0c42e8bddeffd276950640_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. &#167; 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to 18 U.S.C. &#167; 1350, the undersigned certifies that, to the best of my knowledge, the Quarterly Report on Form 10-Q for the period ended March&#160;31, 2021 of Quest Diagnostics Incorporated, as being filed with the Securities and Exchange Commission concurrently herewith, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. &#167; 78m or 78o(d)) and that the information contained in the Quarterly Report fairly presents, in all material respects, the financial condition and results of operations of Quest Diagnostics Incorporated.</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.576%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.394%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 23, 2021</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark J. Guinan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>dgx-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7a2ec7e-72b2-4b96-9989-1413b2102795,g:ecef80b4-feab-4ac1-bfc2-6019ec2f6d37-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dgx="http://questdiagnostics.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://questdiagnostics.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dgx-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://questdiagnostics.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARE" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE">
        <link:definition>2104103 - Disclosure - EARNINGS PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHARETables" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables">
        <link:definition>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EARNINGSPERSHAREDetails" roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails">
        <link:definition>2406401 - Disclosure - EARNINGS PER SHARE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSACQUISITIONS" roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS">
        <link:definition>2107104 - Disclosure - BUSINESS ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTS" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS">
        <link:definition>2108105 - Disclosure - FAIR VALUE MEASUREMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSTables" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables">
        <link:definition>2309302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
        <link:definition>2410402 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FAIRVALUEMEASUREMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails">
        <link:definition>2411403 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETS" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS">
        <link:definition>2112106 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSTables" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables">
        <link:definition>2313303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSGoodwillDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails">
        <link:definition>2414404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSSchedulesDetails" roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
        <link:definition>2415405 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTS" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS">
        <link:definition>2116107 - Disclosure - FINANCIAL INSTRUMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSTables" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables">
        <link:definition>2317304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSNarrativeDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails">
        <link:definition>2418406 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSBalanceSheetsDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails">
        <link:definition>2419407 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FINANCIALINSTRUMENTSIncomeStatementDetails" roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails">
        <link:definition>2420408 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST">
        <link:definition>2121108 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
        <link:definition>2422409 - Disclosure - STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATA" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA">
        <link:definition>2123109 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATATables" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables">
        <link:definition>2324305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUPPLEMENTALCASHFLOWOTHERDATADetails" roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails">
        <link:definition>2425410 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2126110 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2427411 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATION" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION">
        <link:definition>2128111 - Disclosure - BUSINESS SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONTables" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables">
        <link:definition>2329306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTINFORMATIONDetails" roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails">
        <link:definition>2430412 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTIES" roleURI="http://questdiagnostics.com/role/RELATEDPARTIES">
        <link:definition>2131112 - Disclosure - RELATED PARTIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTIESDetails" roleURI="http://questdiagnostics.com/role/RELATEDPARTIESDetails">
        <link:definition>2432413 - Disclosure - RELATED PARTIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES">
        <link:definition>2133113 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables">
        <link:definition>2334307 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails" roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails">
        <link:definition>2435414 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENT" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENT">
        <link:definition>2136114 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTDetails" roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails">
        <link:definition>2437415 - Disclosure - SUBSEQUENT EVENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dgx_TotalAmortizingIntangibleAssetsMember" abstract="true" name="TotalAmortizingIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_AnatomicpathologytestingservicesMember" abstract="true" name="AnatomicpathologytestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_HealthcareInsurersMember" abstract="true" name="HealthcareInsurersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_AllotherservicesMember" abstract="true" name="AllotherservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_AccountsReceivableDisaggregationTableTextBlock" abstract="false" name="AccountsReceivableDisaggregationTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_RoutineclinicaltestingservicesMember" abstract="true" name="RoutineclinicaltestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_GovernmentPayersMember" abstract="true" name="GovernmentPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" abstract="false" name="EquityMethodInvestmentOwnershipPercentDisposedOf" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" abstract="true" name="MidAmericaClinicalLaboratoriesLLCMACLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" abstract="true" name="ExcludesgeneralandprofessionalliabilityclaimsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_PatientsMember" abstract="true" name="PatientsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_PercentageofNetAccountsReceivable" abstract="false" name="PercentageofNetAccountsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" abstract="false" name="TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dgx_COVID19TestingServicesMember" abstract="true" name="COVID19TestingServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" abstract="false" name="ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_GenebasedandesoterictestingservicesMember" abstract="true" name="GenebasedandesoterictestingservicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" abstract="false" name="NetIncomeLossExcludingRedeemableNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_OtherAccountsReceivableRelatedParties" abstract="false" name="OtherAccountsReceivableRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" abstract="true" name="FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_PercentageofNetRevenues" abstract="false" name="PercentageofNetRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="dgx_Q2SolutionsMember" abstract="true" name="Q2SolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" abstract="false" name="ScheduleOfRevenuesByMajorServiceTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="dgx_FairValueOfNetAssetsAcquired" abstract="false" name="FairValueOfNetAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_DescriptionOfBusinessAbstract" abstract="true" name="DescriptionOfBusinessAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dgx_UMassJointVentureMember" abstract="true" name="UMassJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_ClientPayersMember" abstract="true" name="ClientPayersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_SeniorunsecuredrevolvingcreditfacilityMember" abstract="true" name="SeniorunsecuredrevolvingcreditfacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_FeeforserviceMember" abstract="true" name="FeeforserviceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_DiagnosticInformationServicesBusinessMember" abstract="true" name="DiagnosticInformationServicesBusinessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_DSBusinessesMember" abstract="true" name="DSBusinessesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_CapitatedMember" abstract="true" name="CapitatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="dgx_StockRepurchaseProgramAdditionalAmountAuthorized" abstract="false" name="StockRepurchaseProgramAdditionalAmountAuthorized" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" abstract="true" name="ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>dgx-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7a2ec7e-72b2-4b96-9989-1413b2102795,g:ecef80b4-feab-4ac1-bfc2-6019ec2f6d37-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20210331.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1ca880ef-dd65-4e76-acdb-68ea643084c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_487d5208-a280-42e3-9945-4da2650ea641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1ca880ef-dd65-4e76-acdb-68ea643084c2" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_487d5208-a280-42e3-9945-4da2650ea641" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_63cfa647-4179-4f7a-8d7f-9178cc7e8ad5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_1ca880ef-dd65-4e76-acdb-68ea643084c2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_63cfa647-4179-4f7a-8d7f-9178cc7e8ad5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_07394ded-ebe1-40b5-bbd2-fc335f3188d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_65c1f75c-2773-4c6a-bb15-2f20582e6bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_07394ded-ebe1-40b5-bbd2-fc335f3188d6" xlink:to="loc_us-gaap_ProfitLoss_65c1f75c-2773-4c6a-bb15-2f20582e6bee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3868db90-5987-485f-bc00-314e86cef1b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_07394ded-ebe1-40b5-bbd2-fc335f3188d6" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_3868db90-5987-485f-bc00-314e86cef1b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_102c2f83-6b0b-41b5-8d48-ec67ce01c2db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_83c092da-f0e3-485c-9644-2018a35d9b6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_102c2f83-6b0b-41b5-8d48-ec67ce01c2db" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_83c092da-f0e3-485c-9644-2018a35d9b6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9ba958cb-0094-4a24-848e-15ef9ef8858e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_102c2f83-6b0b-41b5-8d48-ec67ce01c2db" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9ba958cb-0094-4a24-848e-15ef9ef8858e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_afcf73a6-27e3-4b7f-a9a9-5aac7312bc71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_102c2f83-6b0b-41b5-8d48-ec67ce01c2db" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_afcf73a6-27e3-4b7f-a9a9-5aac7312bc71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f75c62d0-57e9-4f8d-b8a7-2472147cea7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_6dc25982-54cc-4668-a8ea-009400b98f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f75c62d0-57e9-4f8d-b8a7-2472147cea7f" xlink:to="loc_us-gaap_CostsAndExpenses_6dc25982-54cc-4668-a8ea-009400b98f3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e63bdd5-c35c-464a-84b8-36ee6fb23e9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f75c62d0-57e9-4f8d-b8a7-2472147cea7f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1e63bdd5-c35c-464a-84b8-36ee6fb23e9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_a11d4f46-ff1a-435e-a87c-d7e68c444ccc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b72205fc-8dc9-4f74-b875-acf382dfd18c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a11d4f46-ff1a-435e-a87c-d7e68c444ccc" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b72205fc-8dc9-4f74-b875-acf382dfd18c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_88d7790f-8b57-4b90-a701-24d9ee5c1278" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a11d4f46-ff1a-435e-a87c-d7e68c444ccc" xlink:to="loc_us-gaap_CostOfRevenue_88d7790f-8b57-4b90-a701-24d9ee5c1278" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_ed3b4bbd-e559-4494-be84-b50a34ff6480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a11d4f46-ff1a-435e-a87c-d7e68c444ccc" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_ed3b4bbd-e559-4494-be84-b50a34ff6480" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f83ca233-f949-41ca-8900-21dfe38bed8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_a11d4f46-ff1a-435e-a87c-d7e68c444ccc" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_f83ca233-f949-41ca-8900-21dfe38bed8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_95a6993c-e7a0-445e-a6c2-5ca3ba3799cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_7aaf6e51-5bdc-4979-96f5-368193234963" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_95a6993c-e7a0-445e-a6c2-5ca3ba3799cf" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_7aaf6e51-5bdc-4979-96f5-368193234963" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_553a7d86-e711-4fba-a952-bfaac3464747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_95a6993c-e7a0-445e-a6c2-5ca3ba3799cf" xlink:to="loc_us-gaap_OperatingIncomeLoss_553a7d86-e711-4fba-a952-bfaac3464747" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5aefd3f-099f-4dd0-9116-523f117144b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_56e04dd8-690c-4160-b397-df3b486694b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5aefd3f-099f-4dd0-9116-523f117144b1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_56e04dd8-690c-4160-b397-df3b486694b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_c1cabae4-b599-4139-a5ca-ce9dd04c2974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_a5aefd3f-099f-4dd0-9116-523f117144b1" xlink:to="loc_us-gaap_ProfitLoss_c1cabae4-b599-4139-a5ca-ce9dd04c2974" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_96984727-a280-4ead-ad5e-1cf4d2b36fd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c482cc48-275e-4c86-a9ed-ee02a2d4a08f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_96984727-a280-4ead-ad5e-1cf4d2b36fd6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c482cc48-275e-4c86-a9ed-ee02a2d4a08f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8b193340-caa0-4de2-a9ea-61d29df4be4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_96984727-a280-4ead-ad5e-1cf4d2b36fd6" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_8b193340-caa0-4de2-a9ea-61d29df4be4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_05e9642a-1013-43c4-b4c0-f98d22ca73cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_28b62ec5-85dc-44a4-9538-7595cc7fa069" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_05e9642a-1013-43c4-b4c0-f98d22ca73cc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_28b62ec5-85dc-44a4-9538-7595cc7fa069" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e8e87cf0-8f01-4d0c-8745-36ee7a429a71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_05e9642a-1013-43c4-b4c0-f98d22ca73cc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_e8e87cf0-8f01-4d0c-8745-36ee7a429a71" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec3bd1e1-e494-4f26-8926-c8aa7febb7a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ac858f1c-e17c-4c23-9669-0bdce17d5f1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec3bd1e1-e494-4f26-8926-c8aa7febb7a8" xlink:to="loc_us-gaap_LiabilitiesCurrent_ac858f1c-e17c-4c23-9669-0bdce17d5f1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a6811702-2030-4428-a021-138b0b7e7011" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec3bd1e1-e494-4f26-8926-c8aa7febb7a8" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_a6811702-2030-4428-a021-138b0b7e7011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_d8e7ac37-1e5f-4404-89ac-86455b7bcb4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec3bd1e1-e494-4f26-8926-c8aa7febb7a8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_d8e7ac37-1e5f-4404-89ac-86455b7bcb4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6af6e99f-cd2a-4838-9938-6b8905a3c4a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec3bd1e1-e494-4f26-8926-c8aa7febb7a8" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6af6e99f-cd2a-4838-9938-6b8905a3c4a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3e5b61e3-ac63-4079-b4aa-871122cdde9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec3bd1e1-e494-4f26-8926-c8aa7febb7a8" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_3e5b61e3-ac63-4079-b4aa-871122cdde9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f87595fe-6bef-4567-bd93-4e832e9515da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec3bd1e1-e494-4f26-8926-c8aa7febb7a8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f87595fe-6bef-4567-bd93-4e832e9515da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b80d495c-db74-4529-9be9-453f75ae297b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ec3bd1e1-e494-4f26-8926-c8aa7febb7a8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b80d495c-db74-4529-9be9-453f75ae297b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fe28c29e-c8f4-4276-956a-6475241edb80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fd010d95-9d8f-40d9-bec7-fc701a0d394e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe28c29e-c8f4-4276-956a-6475241edb80" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_fd010d95-9d8f-40d9-bec7-fc701a0d394e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_5078ecc1-858b-41bb-a317-3b0792857175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe28c29e-c8f4-4276-956a-6475241edb80" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_5078ecc1-858b-41bb-a317-3b0792857175" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_8a9d9058-ebb2-40ab-8407-47e0b0736e88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe28c29e-c8f4-4276-956a-6475241edb80" xlink:to="loc_us-gaap_InventoryNet_8a9d9058-ebb2-40ab-8407-47e0b0736e88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_59f98ace-348d-4e44-a2a5-0d3f90cd2684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fe28c29e-c8f4-4276-956a-6475241edb80" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_59f98ace-348d-4e44-a2a5-0d3f90cd2684" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_477f0953-1c4c-44ba-a162-7642847c50be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9a5f203c-b10e-4a74-af24-657d87b4c97b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_477f0953-1c4c-44ba-a162-7642847c50be" xlink:to="loc_us-gaap_CommonStockValue_9a5f203c-b10e-4a74-af24-657d87b4c97b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7716c428-c1ae-4723-a841-6a20fd64f955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_477f0953-1c4c-44ba-a162-7642847c50be" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_7716c428-c1ae-4723-a841-6a20fd64f955" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5379620b-1770-41b3-930d-df86e6bd3976" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_477f0953-1c4c-44ba-a162-7642847c50be" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5379620b-1770-41b3-930d-df86e6bd3976" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26888173-c0b1-4343-bff0-65a5619bd27f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_477f0953-1c4c-44ba-a162-7642847c50be" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_26888173-c0b1-4343-bff0-65a5619bd27f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_9a961701-7bcd-4289-8581-08927af42487" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_477f0953-1c4c-44ba-a162-7642847c50be" xlink:to="loc_us-gaap_TreasuryStockValue_9a961701-7bcd-4289-8581-08927af42487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7a3001c9-e858-4c05-9683-547e4901ba4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5d1ec7c3-0260-41eb-aedb-9c4edb2baaf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7a3001c9-e858-4c05-9683-547e4901ba4f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_5d1ec7c3-0260-41eb-aedb-9c4edb2baaf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2209d980-2195-46ae-bf77-313a22680a06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7a3001c9-e858-4c05-9683-547e4901ba4f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2209d980-2195-46ae-bf77-313a22680a06" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ae7f78ce-91e5-4352-9c14-632ee58a4fe6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7a3001c9-e858-4c05-9683-547e4901ba4f" xlink:to="loc_us-gaap_LongTermDebtCurrent_ae7f78ce-91e5-4352-9c14-632ee58a4fe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_848c4291-7cd0-4785-82e4-0527720e9594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_db524fb4-4861-43c6-92ed-368549f6c7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_848c4291-7cd0-4785-82e4-0527720e9594" xlink:to="loc_us-gaap_StockholdersEquity_db524fb4-4861-43c6-92ed-368549f6c7fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_0716f21d-7534-43aa-be90-ea6df58c179a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_848c4291-7cd0-4785-82e4-0527720e9594" xlink:to="loc_us-gaap_MinorityInterest_0716f21d-7534-43aa-be90-ea6df58c179a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ddd6aad7-5cf2-45bf-89ec-300e3108ed23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cc93ec2c-7372-4693-b71c-dcbb56245c0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddd6aad7-5cf2-45bf-89ec-300e3108ed23" xlink:to="loc_us-gaap_AssetsCurrent_cc93ec2c-7372-4693-b71c-dcbb56245c0a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f1409ca6-5eef-4648-bab9-0a1b09465757" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddd6aad7-5cf2-45bf-89ec-300e3108ed23" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_f1409ca6-5eef-4648-bab9-0a1b09465757" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_40ddcf4c-57e5-45c7-996e-8912345a6819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddd6aad7-5cf2-45bf-89ec-300e3108ed23" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_40ddcf4c-57e5-45c7-996e-8912345a6819" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_399d735d-e381-49ce-b17c-2fb86b06b0c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddd6aad7-5cf2-45bf-89ec-300e3108ed23" xlink:to="loc_us-gaap_Goodwill_399d735d-e381-49ce-b17c-2fb86b06b0c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6e029716-bb46-420f-acb7-06026caa69ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddd6aad7-5cf2-45bf-89ec-300e3108ed23" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6e029716-bb46-420f-acb7-06026caa69ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_eb8bb650-b921-42ba-8a90-ba6d563a4273" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddd6aad7-5cf2-45bf-89ec-300e3108ed23" xlink:to="loc_us-gaap_EquityMethodInvestments_eb8bb650-b921-42ba-8a90-ba6d563a4273" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_353f62fe-f4ff-41ac-baf3-3a0daa557d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_ddd6aad7-5cf2-45bf-89ec-300e3108ed23" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_353f62fe-f4ff-41ac-baf3-3a0daa557d4a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7ee3437-29fd-4dcd-aafe-73d247d2a73c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c3799d4e-9880-493f-9217-10f6ebea0872" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7ee3437-29fd-4dcd-aafe-73d247d2a73c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c3799d4e-9880-493f-9217-10f6ebea0872" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_422b145b-1c5e-4002-8ac4-6f99471c6090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7ee3437-29fd-4dcd-aafe-73d247d2a73c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_422b145b-1c5e-4002-8ac4-6f99471c6090" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9b8e3eea-ec20-4bd4-8e29-6f1046dc0fd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a7ee3437-29fd-4dcd-aafe-73d247d2a73c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9b8e3eea-ec20-4bd4-8e29-6f1046dc0fd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22ea98b2-5e63-4ba0-8d3f-feb7aea1172e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_dc7a6e94-af2b-4f4e-a776-6cd264bfd6fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22ea98b2-5e63-4ba0-8d3f-feb7aea1172e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_dc7a6e94-af2b-4f4e-a776-6cd264bfd6fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb1cf257-6615-48f2-997b-c88bf569cf7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22ea98b2-5e63-4ba0-8d3f-feb7aea1172e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_eb1cf257-6615-48f2-997b-c88bf569cf7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6b5a097f-e6b3-45d3-9449-2679c96caedd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_22ea98b2-5e63-4ba0-8d3f-feb7aea1172e" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_6b5a097f-e6b3-45d3-9449-2679c96caedd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_95d461c2-b6dc-46a9-8d05-b38849f8ac5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_ProfitLoss_95d461c2-b6dc-46a9-8d05-b38849f8ac5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_06cbe4bb-ed20-48ea-aaa1-a3e1acf58b18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_06cbe4bb-ed20-48ea-aaa1-a3e1acf58b18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_019aa06a-aaba-4004-9887-2e175e5781f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_019aa06a-aaba-4004-9887-2e175e5781f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3f29eba6-a27d-4576-833c-eeda531445cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3f29eba6-a27d-4576-833c-eeda531445cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f06029a4-03c9-416d-a0a9-1a5412e49a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_ShareBasedCompensation_f06029a4-03c9-416d-a0a9-1a5412e49a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_53aac3ab-8036-44bc-8a90-492d59e1b380" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_53aac3ab-8036-44bc-8a90-492d59e1b380" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b94005b1-951e-4a6f-b225-4ff5cb7d8ea6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_b94005b1-951e-4a6f-b225-4ff5cb7d8ea6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b2f20eb3-6b32-41c6-86e4-972958959ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_b2f20eb3-6b32-41c6-86e4-972958959ae1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_38d9602b-5d52-454c-8089-d31a4d9b634d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_38d9602b-5d52-454c-8089-d31a4d9b634d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_28d5a665-ecdc-442a-ac41-0fc4408ab16e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f3107d19-576b-4424-86ab-6f7aa7e56bef" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_28d5a665-ecdc-442a-ac41-0fc4408ab16e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a312641a-ca2d-47f5-907d-7720a53982d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_70d0da3a-b7ed-4e72-8fdb-b1aff28c3af2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a312641a-ca2d-47f5-907d-7720a53982d3" xlink:to="loc_us-gaap_RepaymentsOfDebt_70d0da3a-b7ed-4e72-8fdb-b1aff28c3af2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_62b35811-12aa-4a27-88e2-0bea77d7bd90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a312641a-ca2d-47f5-907d-7720a53982d3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_62b35811-12aa-4a27-88e2-0bea77d7bd90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_c75e9d0f-bbfa-4f71-a9fa-2d177a191ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a312641a-ca2d-47f5-907d-7720a53982d3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_c75e9d0f-bbfa-4f71-a9fa-2d177a191ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8c4edb77-7f60-4d69-bba3-d636063974ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a312641a-ca2d-47f5-907d-7720a53982d3" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_8c4edb77-7f60-4d69-bba3-d636063974ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_5e547c19-9c66-4259-8f93-725c114d551b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a312641a-ca2d-47f5-907d-7720a53982d3" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_5e547c19-9c66-4259-8f93-725c114d551b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_50095d81-2910-4297-9e2f-8014ffc83813" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a312641a-ca2d-47f5-907d-7720a53982d3" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_50095d81-2910-4297-9e2f-8014ffc83813" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5dd35ab2-8748-4322-835c-2f1715897b6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_a312641a-ca2d-47f5-907d-7720a53982d3" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5dd35ab2-8748-4322-835c-2f1715897b6a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20210331.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHARE"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHARETables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHAREDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_030c0442-5b76-4eed-abe1-215052433d3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6935096d-14c3-40ba-b82f-9884d5cfcd5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_030c0442-5b76-4eed-abe1-215052433d3b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6935096d-14c3-40ba-b82f-9884d5cfcd5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c7732d08-ce9a-412b-9ec0-f35277fe7af9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_030c0442-5b76-4eed-abe1-215052433d3b" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_c7732d08-ce9a-412b-9ec0-f35277fe7af9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_797054a3-c06a-4cbc-b15c-c59a8dbe21f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6f31561c-e7e9-400c-a301-2995b5da302c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_797054a3-c06a-4cbc-b15c-c59a8dbe21f8" xlink:to="loc_us-gaap_NetIncomeLoss_6f31561c-e7e9-400c-a301-2995b5da302c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_7c8e9f81-30ab-4986-b07e-67209cd31cbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_797054a3-c06a-4cbc-b15c-c59a8dbe21f8" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_7c8e9f81-30ab-4986-b07e-67209cd31cbe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSACQUISITIONS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_e2c3f701-515d-4487-be7b-20e7f7656207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_68a9e3a0-0d98-45cd-bda6-2cd77114adfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_e2c3f701-515d-4487-be7b-20e7f7656207" xlink:to="loc_us-gaap_TradingSecurities_68a9e3a0-0d98-45cd-bda6-2cd77114adfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_6c74c0c2-78e1-4d0a-a1c2-d92c10e77fd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_e2c3f701-515d-4487-be7b-20e7f7656207" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_6c74c0c2-78e1-4d0a-a1c2-d92c10e77fd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2d4f85b2-90b8-4989-ab38-92cc5a1d6c48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_e2c3f701-515d-4487-be7b-20e7f7656207" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2d4f85b2-90b8-4989-ab38-92cc5a1d6c48" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bc5ab6e1-38d9-4ea1-81ff-8846da3af3a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_aba5e019-2797-4d93-ac7a-24ae7accaa2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bc5ab6e1-38d9-4ea1-81ff-8846da3af3a0" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_aba5e019-2797-4d93-ac7a-24ae7accaa2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e8029cb6-9c54-40f4-8005-6e44eef6d31e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bc5ab6e1-38d9-4ea1-81ff-8846da3af3a0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e8029cb6-9c54-40f4-8005-6e44eef6d31e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3f5c0f8-9d7a-4d63-b018-14abe75b1ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_cb81369c-c8e9-482f-b1d4-46e9499e45cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3f5c0f8-9d7a-4d63-b018-14abe75b1ba5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_cb81369c-c8e9-482f-b1d4-46e9499e45cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_16cbd470-f012-4a3e-b32f-272e4c6c937d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3f5c0f8-9d7a-4d63-b018-14abe75b1ba5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_16cbd470-f012-4a3e-b32f-272e4c6c937d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7adfc334-4f49-4524-a676-b51138359448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3f5c0f8-9d7a-4d63-b018-14abe75b1ba5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_7adfc334-4f49-4524-a676-b51138359448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_13e33513-2056-48fc-a10c-6e955c35fba0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3f5c0f8-9d7a-4d63-b018-14abe75b1ba5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_13e33513-2056-48fc-a10c-6e955c35fba0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2815e0de-9d2a-4acb-b1eb-6dded0ed3c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3f5c0f8-9d7a-4d63-b018-14abe75b1ba5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_2815e0de-9d2a-4acb-b1eb-6dded0ed3c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_eb605c2d-e812-462b-b58d-8375412b939d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3f5c0f8-9d7a-4d63-b018-14abe75b1ba5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_eb605c2d-e812-462b-b58d-8375412b939d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ca8973af-b852-4ccc-9d6c-84cd0042a171" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_c3f5c0f8-9d7a-4d63-b018-14abe75b1ba5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_ca8973af-b852-4ccc-9d6c-84cd0042a171" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTS"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20210331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATADetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_481b98dd-4f8a-4461-9c4e-3f5de64cc582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_3da2bfa1-03f3-4ca3-b8a0-4ac222f42e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_481b98dd-4f8a-4461-9c4e-3f5de64cc582" xlink:to="loc_us-gaap_Depreciation_3da2bfa1-03f3-4ca3-b8a0-4ac222f42e26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_43d190e9-25dd-499c-9b7c-9b3cc48271ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization_481b98dd-4f8a-4461-9c4e-3f5de64cc582" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_43d190e9-25dd-499c-9b7c-9b3cc48271ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_06938235-6c78-4a83-bfed-e8e8a8c2fe8b" xlink:href="dgx-20210331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_bf47fcaa-6498-4a7d-b7e8-77bba5811328" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_06938235-6c78-4a83-bfed-e8e8a8c2fe8b" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_bf47fcaa-6498-4a7d-b7e8-77bba5811328" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_ca05dca4-9c96-4f08-afc1-37e2bc2ed8da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired_06938235-6c78-4a83-bfed-e8e8a8c2fe8b" xlink:to="loc_us-gaap_LiabilitiesAssumed1_ca05dca4-9c96-4f08-afc1-37e2bc2ed8da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_fe12ed2e-9d72-49d5-b77c-32357a52636d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_3a46ae4d-1509-43f7-ad8f-27ffa139a345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_fe12ed2e-9d72-49d5-b77c-32357a52636d" xlink:to="loc_us-gaap_InterestExpense_3a46ae4d-1509-43f7-ad8f-27ffa139a345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_665576ad-1985-473f-aea8-d90444653283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNet_fe12ed2e-9d72-49d5-b77c-32357a52636d" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_665576ad-1985-473f-aea8-d90444653283" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#RELATEDPARTIES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#RELATEDPARTIESDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENT" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUBSEQUENTEVENT"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENT" xlink:type="extended"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUBSEQUENTEVENTDetails"/>
  <link:calculationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>dgx-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7a2ec7e-72b2-4b96-9989-1413b2102795,g:ecef80b4-feab-4ac1-bfc2-6019ec2f6d37-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20210331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended" id="ic2745cb30f9b4ce6972def05058d303a_CoverPage"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="ia012393a4e0b43cf8771df86c2976954_CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended" id="i54223d353ce84b33b274cf08db6c35e2_CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="i58ca2abbc9cf43c9a57655c2759999dd_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i5b037246011c421fb455d379a74d3fd7_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended" id="i8c2f8fcb9e7e450ebfeac60c2eb35efc_CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="ie3b43d2eb67a46cb9ca2728abd246367_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_010267d8-3e85-40c2-8b4b-b3bda8bd18e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_010267d8-3e85-40c2-8b4b-b3bda8bd18e8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_51975c24-98a3-470c-acce-5dbb1cc6e597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_51975c24-98a3-470c-acce-5dbb1cc6e597" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54e16aef-5e12-4f71-adf7-85a93ff3ed41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54e16aef-5e12-4f71-adf7-85a93ff3ed41" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_a7942e0e-b3d1-4bbd-90f1-0c98fda462b4" xlink:href="dgx-20210331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_a7942e0e-b3d1-4bbd-90f1-0c98fda462b4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4eb61cb3-8856-4602-8f9a-848640227964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4eb61cb3-8856-4602-8f9a-848640227964" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_2fafebfb-23f1-4c2c-9248-39ffa86b4cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_DividendsCommonStockCash_2fafebfb-23f1-4c2c-9248-39ffa86b4cce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f348b506-eed6-42ed-8de4-c8fb06a9d9fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f348b506-eed6-42ed-8de4-c8fb06a9d9fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_983f483f-d727-4ba2-88de-4ccf33e02875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_983f483f-d727-4ba2-88de-4ccf33e02875" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_04489f44-d582-494d-8ad0-ecd439e0f5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_04489f44-d582-494d-8ad0-ecd439e0f5c2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1a7c7fef-9e48-4760-a826-119bc2552f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1a7c7fef-9e48-4760-a826-119bc2552f8e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2d8a258e-e947-4ba0-892b-fc2e619c832f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2d8a258e-e947-4ba0-892b-fc2e619c832f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_916768e1-b022-4d01-b41d-a0843c7172dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_916768e1-b022-4d01-b41d-a0843c7172dc" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_0c762076-6df1-48c5-a116-008660db3dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_0c762076-6df1-48c5-a116-008660db3dc3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e219e85a-f4b6-4be1-bcda-af0899457f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e219e85a-f4b6-4be1-bcda-af0899457f83" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_67402038-e4ba-4a21-9c80-d1df6af8dd59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_788b4f09-54a5-4748-a2c1-37a36d3e9af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_010267d8-3e85-40c2-8b4b-b3bda8bd18e8" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6aa6dcd0-3b67-4374-832c-b1d75df2d9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6aa6dcd0-3b67-4374-832c-b1d75df2d9b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_47b5160c-a198-405e-aeb3-e9309392f637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_47b5160c-a198-405e-aeb3-e9309392f637" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_f5a6904c-3787-4589-a13c-c1db5c4000f9" xlink:href="dgx-20210331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_f5a6904c-3787-4589-a13c-c1db5c4000f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6b6baa4b-4759-4126-9008-8766c05be910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f9aa0ff7-300b-4dae-a74e-4a990b75387e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_010267d8-3e85-40c2-8b4b-b3bda8bd18e8" xlink:to="loc_us-gaap_StatementTable_f9aa0ff7-300b-4dae-a74e-4a990b75387e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_231055fb-cad3-48a7-b39b-146506deb0fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_f9aa0ff7-300b-4dae-a74e-4a990b75387e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_231055fb-cad3-48a7-b39b-146506deb0fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_231055fb-cad3-48a7-b39b-146506deb0fd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_231055fb-cad3-48a7-b39b-146506deb0fd" xlink:to="loc_us-gaap_EquityComponentDomain_231055fb-cad3-48a7-b39b-146506deb0fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_231055fb-cad3-48a7-b39b-146506deb0fd" xlink:to="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ced79fe1-f290-4bff-9401-5f6e61ffef90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_CommonStockMember_ced79fe1-f290-4bff-9401-5f6e61ffef90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_14f529e5-4401-4c4e-8da4-347a7c3f7944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_14f529e5-4401-4c4e-8da4-347a7c3f7944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_94900e22-d5ec-436a-9785-44cd97723c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_RetainedEarningsMember_94900e22-d5ec-436a-9785-44cd97723c2d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c09eb50d-6c52-4970-bcdb-88d1f111cc0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c09eb50d-6c52-4970-bcdb-88d1f111cc0e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e9ab6aeb-0c46-4c51-96e7-01801ce04310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_TreasuryStockMember_e9ab6aeb-0c46-4c51-96e7-01801ce04310" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_16da5bcc-7c25-4b5d-af4e-7da4569cf51a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_NoncontrollingInterestMember_16da5bcc-7c25-4b5d-af4e-7da4569cf51a" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20210331.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended" id="ib5773320d9394c55bf1e930e541d21c4_DESCRIPTIONOFBUSINESS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="i34335b3f09d541138e2e567dbb3d6ed3_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="ic6df6799f12b4027bda05539d0eead5a_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHARE"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended" id="i7ea4eda7f76149d58eee40e104a780fd_EARNINGSPERSHARE"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHARETables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="extended" id="iadcba7ee4e514836a91c7c5910c73133_EARNINGSPERSHARETables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHAREDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended" id="ic0503594117346bda7bb8e2e5dca8069_EARNINGSPERSHAREDetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSACQUISITIONS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended" id="i93bdb9561e144d8cb14d76a4aa2c1b7a_BUSINESSACQUISITIONS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended" id="i06128e304c5b4d66bf4a8e2fefeb5a9b_FAIRVALUEMEASUREMENTS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended" id="i8202e410b5cc4dd19fa9eed8900d1872_FAIRVALUEMEASUREMENTSTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended" id="i6fed30d221e947f6bdd33b4eb5eb79ff_FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e820f42f-0c3a-4796-b50f-e53b4824fbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_TradingSecurities_e820f42f-0c3a-4796-b50f-e53b4824fbc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_4d855222-5b84-4f6b-af40-b1d95c42f55a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_4d855222-5b84-4f6b-af40-b1d95c42f55a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4277505f-f8c6-4716-946f-7f0929f597d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4277505f-f8c6-4716-946f-7f0929f597d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_caac9816-62bd-447e-be20-5738ea82a632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_caac9816-62bd-447e-be20-5738ea82a632" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_a91e2617-68bd-4e13-a347-d8e51981f754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_a91e2617-68bd-4e13-a347-d8e51981f754" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_e6975fda-e304-415d-b6bc-21b7b5216996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_e6975fda-e304-415d-b6bc-21b7b5216996" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d8d9cd62-8789-40f8-8b87-c0d8d69eb350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d8d9cd62-8789-40f8-8b87-c0d8d69eb350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d8d9cd62-8789-40f8-8b87-c0d8d69eb350_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d8d9cd62-8789-40f8-8b87-c0d8d69eb350" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d8d9cd62-8789-40f8-8b87-c0d8d69eb350_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ca316b7f-3ab4-43e4-b84e-49aa5864d42b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d8d9cd62-8789-40f8-8b87-c0d8d69eb350" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ca316b7f-3ab4-43e4-b84e-49aa5864d42b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_16365fbc-0e7a-4548-b331-72bf006f94c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ca316b7f-3ab4-43e4-b84e-49aa5864d42b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_16365fbc-0e7a-4548-b331-72bf006f94c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0276abf7-9fd3-4a1b-b60a-cc506c753cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0276abf7-9fd3-4a1b-b60a-cc506c753cd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0276abf7-9fd3-4a1b-b60a-cc506c753cd8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0276abf7-9fd3-4a1b-b60a-cc506c753cd8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_0276abf7-9fd3-4a1b-b60a-cc506c753cd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0276abf7-9fd3-4a1b-b60a-cc506c753cd8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_82605114-95e3-47ec-8754-e6144af6813c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_82605114-95e3-47ec-8754-e6144af6813c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_385db861-04d3-4258-883a-feca4108d58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_385db861-04d3-4258-883a-feca4108d58a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ece6b0b3-21d2-4127-a67c-c35866ee5470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ece6b0b3-21d2-4127-a67c-c35866ee5470" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended" id="i70023356ad5c4efc87569dee79137115_FAIRVALUEMEASUREMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3598a770-f320-4fa6-9569-2ea4da89abd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_66c9b2d7-ac90-4990-8990-e136f85d5373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3598a770-f320-4fa6-9569-2ea4da89abd1" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_66c9b2d7-ac90-4990-8990-e136f85d5373" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_29077af1-9103-44f4-8c8d-8cacb9d1a818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3598a770-f320-4fa6-9569-2ea4da89abd1" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_29077af1-9103-44f4-8c8d-8cacb9d1a818" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3598a770-f320-4fa6-9569-2ea4da89abd1" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a9834c0a-d72c-4194-bd62-ce2d54481823" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:to="loc_srt_OwnershipAxis_a9834c0a-d72c-4194-bd62-ce2d54481823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a9834c0a-d72c-4194-bd62-ce2d54481823_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_a9834c0a-d72c-4194-bd62-ce2d54481823" xlink:to="loc_srt_OwnershipDomain_a9834c0a-d72c-4194-bd62-ce2d54481823_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a9a21808-4755-46eb-8eef-6cc5803aff87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_a9834c0a-d72c-4194-bd62-ce2d54481823" xlink:to="loc_srt_OwnershipDomain_a9a21808-4755-46eb-8eef-6cc5803aff87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_2e517dbd-87a7-4cd0-be7d-b9536c2c169b" xlink:href="dgx-20210331.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_a9a21808-4755-46eb-8eef-6cc5803aff87" xlink:to="loc_dgx_UMassJointVentureMember_2e517dbd-87a7-4cd0-be7d-b9536c2c169b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bae224b6-f210-422f-af20-c2fa2e695c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bae224b6-f210-422f-af20-c2fa2e695c1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1939bc16-703d-4942-92c3-9defd2c8958a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bae224b6-f210-422f-af20-c2fa2e695c1c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1939bc16-703d-4942-92c3-9defd2c8958a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended" id="ie77f96c37faf42c3a05edc2f929bb400_GOODWILLANDINTANGIBLEASSETS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended" id="i69d1f2e68e484ec1aa68d1163310accf_GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended" id="i43f9fa46816e47d59aa50e0e8d8e5253_GOODWILLANDINTANGIBLEASSETSGoodwillDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d86bdbc1-dbb2-4792-987e-38bdd5a9f85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_44a76be5-337e-4ba3-b6c7-99da4de8554b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d86bdbc1-dbb2-4792-987e-38bdd5a9f85d" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_44a76be5-337e-4ba3-b6c7-99da4de8554b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4ceb8619-2926-4099-a544-f8b19eab4160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d86bdbc1-dbb2-4792-987e-38bdd5a9f85d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4ceb8619-2926-4099-a544-f8b19eab4160" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bf4c055a-1ec0-490c-9f5f-1faac7e541b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4ceb8619-2926-4099-a544-f8b19eab4160" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bf4c055a-1ec0-490c-9f5f-1faac7e541b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bf4c055a-1ec0-490c-9f5f-1faac7e541b4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bf4c055a-1ec0-490c-9f5f-1faac7e541b4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_bf4c055a-1ec0-490c-9f5f-1faac7e541b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3baeb062-881c-44fd-82b8-dc11282d9c81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bf4c055a-1ec0-490c-9f5f-1faac7e541b4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3baeb062-881c-44fd-82b8-dc11282d9c81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_6c89deb7-12e5-4fce-93e7-437fd33fa975" xlink:href="dgx-20210331.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3baeb062-881c-44fd-82b8-dc11282d9c81" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_6c89deb7-12e5-4fce-93e7-437fd33fa975" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended" id="ifc708910fdc84b25974cd05711693478_GOODWILLANDINTANGIBLEASSETSSchedulesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:href="dgx-20210331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8af6c418-9ca4-4d7f-9cb7-a50dc9c8edf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8af6c418-9ca4-4d7f-9cb7-a50dc9c8edf5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d0450e77-9e70-4d57-bdca-ba1fb4ae6ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d0450e77-9e70-4d57-bdca-ba1fb4ae6ae1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f88638dc-41af-45b1-a1fe-403a4a9ce400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f88638dc-41af-45b1-a1fe-403a4a9ce400" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_00246ad8-fc7d-4879-84fe-c10031eb6e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_00246ad8-fc7d-4879-84fe-c10031eb6e11" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_cefcaa47-4467-44fc-a2a1-9c5cf2aaddf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_cefcaa47-4467-44fc-a2a1-9c5cf2aaddf8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_bbf73de7-50d3-4e80-93f3-c9bb217c8fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_bbf73de7-50d3-4e80-93f3-c9bb217c8fdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b3e0fb8f-9c94-4a6d-a302-eedf218e8866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b3e0fb8f-9c94-4a6d-a302-eedf218e8866" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_91ce7193-6e43-4c84-86c5-32c1147ab1c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_91ce7193-6e43-4c84-86c5-32c1147ab1c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dbcc862d-39af-447a-8c1d-a533ad671888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dbcc862d-39af-447a-8c1d-a533ad671888" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9503e0b0-25b6-4916-bdb6-a864fb4dd33c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9503e0b0-25b6-4916-bdb6-a864fb4dd33c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1e794d6c-68b2-4332-a456-3219f75c02e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1e794d6c-68b2-4332-a456-3219f75c02e0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f4c9569a-fedc-4a42-a562-71b3095547b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f4c9569a-fedc-4a42-a562-71b3095547b4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_14aa9996-e9ba-44bb-acfa-0e50740f396b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_14aa9996-e9ba-44bb-acfa-0e50740f396b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:href="dgx-20210331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ecd69bce-90c1-414a-8c7d-a81d45d88800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ecd69bce-90c1-414a-8c7d-a81d45d88800" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_04298765-f6bb-4164-b67c-5be6192a2923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_04298765-f6bb-4164-b67c-5be6192a2923" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_5a380561-d469-4d28-90c3-6f544b9750d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_5a380561-d469-4d28-90c3-6f544b9750d0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_3a59d609-476f-4174-b775-26bfca210a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_3a59d609-476f-4174-b775-26bfca210a2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_973ce848-8b13-47f1-947f-2ffcf0678481" xlink:href="dgx-20210331.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_973ce848-8b13-47f1-947f-2ffcf0678481" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c333e538-8f45-431a-8454-1dc5f89312fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c333e538-8f45-431a-8454-1dc5f89312fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c333e538-8f45-431a-8454-1dc5f89312fa_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c333e538-8f45-431a-8454-1dc5f89312fa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_c333e538-8f45-431a-8454-1dc5f89312fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e5ca883f-e4b0-4c60-83fd-01f70925c410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c333e538-8f45-431a-8454-1dc5f89312fa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e5ca883f-e4b0-4c60-83fd-01f70925c410" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b0feb7a7-28b6-486e-a5ab-f74f79c348a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e5ca883f-e4b0-4c60-83fd-01f70925c410" xlink:to="loc_us-gaap_TradeNamesMember_b0feb7a7-28b6-486e-a5ab-f74f79c348a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_7e1f674b-e0aa-43ee-ae3b-a81e3b1c01cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e5ca883f-e4b0-4c60-83fd-01f70925c410" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_7e1f674b-e0aa-43ee-ae3b-a81e3b1c01cb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTS"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended" id="i364a8f568b2c49bd92e2757e91b8b972_FINANCIALINSTRUMENTS"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended" id="i8373ca0a88534505b43844a34089d78d_FINANCIALINSTRUMENTSTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended" id="i7d1d8c62c3324a43a46f3ef3b3a66543_FINANCIALINSTRUMENTSNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3358c649-2d26-4352-bdac-4d646f5a3086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aad0689a-8931-4463-bccf-7330b064a85a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3358c649-2d26-4352-bdac-4d646f5a3086" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aad0689a-8931-4463-bccf-7330b064a85a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_73552950-06af-4bf8-8d30-f2b298e35638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_3358c649-2d26-4352-bdac-4d646f5a3086" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_73552950-06af-4bf8-8d30-f2b298e35638" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_3358c649-2d26-4352-bdac-4d646f5a3086" xlink:to="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b8eec63-669b-42ea-a7cd-bba449a77f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b8eec63-669b-42ea-a7cd-bba449a77f4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_5b8eec63-669b-42ea-a7cd-bba449a77f4e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b8eec63-669b-42ea-a7cd-bba449a77f4e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_5b8eec63-669b-42ea-a7cd-bba449a77f4e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d4eca7de-2256-4e48-85b5-f453b4ac2a03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b8eec63-669b-42ea-a7cd-bba449a77f4e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d4eca7de-2256-4e48-85b5-f453b4ac2a03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_542055f3-0fbb-448d-91bf-3707f0ffa8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d4eca7de-2256-4e48-85b5-f453b4ac2a03" xlink:to="loc_us-gaap_CashFlowHedgingMember_542055f3-0fbb-448d-91bf-3707f0ffa8ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_5538e87a-3b1b-44d0-8c19-43cc603b6619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d4eca7de-2256-4e48-85b5-f453b4ac2a03" xlink:to="loc_us-gaap_FairValueHedgingMember_5538e87a-3b1b-44d0-8c19-43cc603b6619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0ed8796f-2b96-4206-8bb3-4c0e84b86963" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:to="loc_srt_StatementScenarioAxis_0ed8796f-2b96-4206-8bb3-4c0e84b86963" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_0ed8796f-2b96-4206-8bb3-4c0e84b86963_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_0ed8796f-2b96-4206-8bb3-4c0e84b86963" xlink:to="loc_srt_ScenarioUnspecifiedDomain_0ed8796f-2b96-4206-8bb3-4c0e84b86963_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_dc174951-8326-4fef-8956-4d819d6c0b27" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_0ed8796f-2b96-4206-8bb3-4c0e84b86963" xlink:to="loc_srt_ScenarioUnspecifiedDomain_dc174951-8326-4fef-8956-4d819d6c0b27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_1e3509ec-5304-4fcf-b0dc-94f692c77242" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_dc174951-8326-4fef-8956-4d819d6c0b27" xlink:to="loc_srt_ScenarioForecastMember_1e3509ec-5304-4fcf-b0dc-94f692c77242" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d99b0a0e-41b0-4458-b4b4-7e7c737838a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:to="loc_srt_RangeAxis_d99b0a0e-41b0-4458-b4b4-7e7c737838a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d99b0a0e-41b0-4458-b4b4-7e7c737838a3_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_d99b0a0e-41b0-4458-b4b4-7e7c737838a3" xlink:to="loc_srt_RangeMember_d99b0a0e-41b0-4458-b4b4-7e7c737838a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d806f255-4058-4b92-af2f-8b1105a81e81" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_d99b0a0e-41b0-4458-b4b4-7e7c737838a3" xlink:to="loc_srt_RangeMember_d806f255-4058-4b92-af2f-8b1105a81e81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0385f93f-7f7d-4aca-b6a4-d93913d916ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_d806f255-4058-4b92-af2f-8b1105a81e81" xlink:to="loc_srt_MinimumMember_0385f93f-7f7d-4aca-b6a4-d93913d916ff" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended" id="id9cc9ce53f404fb7a0e6a72cd8c516cd_FINANCIALINSTRUMENTSBalanceSheetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1b4f6257-21bd-43b6-a5e3-0ff6cf762c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_0265615a-9092-439f-845a-cac3ff153a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1b4f6257-21bd-43b6-a5e3-0ff6cf762c13" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_0265615a-9092-439f-845a-cac3ff153a48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_1b4f6257-21bd-43b6-a5e3-0ff6cf762c13" xlink:to="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_41217ec0-d55e-43da-8a92-79aafd47bcc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_41217ec0-d55e-43da-8a92-79aafd47bcc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_41217ec0-d55e-43da-8a92-79aafd47bcc2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_41217ec0-d55e-43da-8a92-79aafd47bcc2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_41217ec0-d55e-43da-8a92-79aafd47bcc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b3582b01-7b9a-46af-9758-ca607188377b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_41217ec0-d55e-43da-8a92-79aafd47bcc2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b3582b01-7b9a-46af-9758-ca607188377b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_03b89a35-c22f-4b12-823f-9e344f11643d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b3582b01-7b9a-46af-9758-ca607188377b" xlink:to="loc_us-gaap_LongTermDebtMember_03b89a35-c22f-4b12-823f-9e344f11643d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e753ec4b-121b-4089-9646-4b3a296655ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e753ec4b-121b-4089-9646-4b3a296655ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_e753ec4b-121b-4089-9646-4b3a296655ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e753ec4b-121b-4089-9646-4b3a296655ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_e753ec4b-121b-4089-9646-4b3a296655ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_df968971-8097-46bd-9f08-d5a59d6f3a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e753ec4b-121b-4089-9646-4b3a296655ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_df968971-8097-46bd-9f08-d5a59d6f3a16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_b83a206c-9522-4516-a878-6d559894ee55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_df968971-8097-46bd-9f08-d5a59d6f3a16" xlink:to="loc_us-gaap_FairValueHedgingMember_b83a206c-9522-4516-a878-6d559894ee55" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended" id="i6a9e2f3c67bb4c4fbd61c10d1679bf82_FINANCIALINSTRUMENTSIncomeStatementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_367d33e2-6029-4191-9072-033b6d891bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_367d33e2-6029-4191-9072-033b6d891bf3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_6abf3403-dbb6-4e1b-99c8-b8ec6a5d3326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_6abf3403-dbb6-4e1b-99c8-b8ec6a5d3326" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_fd609d32-a39d-40eb-99be-52b2c9ee6437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_fd609d32-a39d-40eb-99be-52b2c9ee6437" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:to="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_72aa6b19-6550-4477-978f-469b7873d1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_72aa6b19-6550-4477-978f-469b7873d1f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_72aa6b19-6550-4477-978f-469b7873d1f4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_72aa6b19-6550-4477-978f-469b7873d1f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_72aa6b19-6550-4477-978f-469b7873d1f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2db8c557-3972-468a-9968-8c221ec145ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_72aa6b19-6550-4477-978f-469b7873d1f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2db8c557-3972-468a-9968-8c221ec145ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_890d293d-4461-483b-818b-8e608b9533d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2db8c557-3972-468a-9968-8c221ec145ad" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_890d293d-4461-483b-818b-8e608b9533d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3824f143-cfb4-440d-bddb-b355e3e8dfe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3824f143-cfb4-440d-bddb-b355e3e8dfe1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_3824f143-cfb4-440d-bddb-b355e3e8dfe1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3824f143-cfb4-440d-bddb-b355e3e8dfe1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_3824f143-cfb4-440d-bddb-b355e3e8dfe1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b77b2ec9-040c-4d26-9bea-f0c7a47165a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3824f143-cfb4-440d-bddb-b355e3e8dfe1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b77b2ec9-040c-4d26-9bea-f0c7a47165a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_3cc27854-00d0-4a6e-8aef-9719c12eed6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b77b2ec9-040c-4d26-9bea-f0c7a47165a3" xlink:to="loc_us-gaap_FairValueHedgingMember_3cc27854-00d0-4a6e-8aef-9719c12eed6c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20210331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended" id="i04296447d0774cb8abd7e98e2b3cefc8_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended" id="i13bbb82dc05e4f22a2bf5e8727aaaea9_STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:href="dgx-20210331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_3510cbed-4b61-4776-8fe8-b52d7a04144f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_3510cbed-4b61-4776-8fe8-b52d7a04144f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_6334b66c-461f-48b4-8c3d-6f0d664ee8e6" xlink:href="dgx-20210331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_6334b66c-461f-48b4-8c3d-6f0d664ee8e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_65baf59b-4ebb-4009-8b6f-4bd0e5844c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_65baf59b-4ebb-4009-8b6f-4bd0e5844c94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_dde78e87-7068-496f-b2d8-c24372b35110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_dde78e87-7068-496f-b2d8-c24372b35110" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_054b39ee-ef5b-4098-87fa-6a5e956d8fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_054b39ee-ef5b-4098-87fa-6a5e956d8fb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_a085605c-c412-4671-916a-59a8c58752c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_a085605c-c412-4671-916a-59a8c58752c0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_836a6ce2-c416-447e-82a1-5471386e5715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_836a6ce2-c416-447e-82a1-5471386e5715" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:href="dgx-20210331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d163ddc7-449f-41a7-8a1d-04008aaeba55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d163ddc7-449f-41a7-8a1d-04008aaeba55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d163ddc7-449f-41a7-8a1d-04008aaeba55_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d163ddc7-449f-41a7-8a1d-04008aaeba55" xlink:to="loc_us-gaap_EquityComponentDomain_d163ddc7-449f-41a7-8a1d-04008aaeba55_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_861e5444-bfe5-41d9-a083-1b009c6b6baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d163ddc7-449f-41a7-8a1d-04008aaeba55" xlink:to="loc_us-gaap_EquityComponentDomain_861e5444-bfe5-41d9-a083-1b009c6b6baa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_47af1ce1-b15b-41bc-83e7-30d9d2a5f01a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_861e5444-bfe5-41d9-a083-1b009c6b6baa" xlink:to="loc_us-gaap_TreasuryStockMember_47af1ce1-b15b-41bc-83e7-30d9d2a5f01a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:to="loc_srt_OwnershipAxis_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb" xlink:to="loc_srt_OwnershipDomain_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d09e7c42-8339-495e-b286-3e41ba957fa5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb" xlink:to="loc_srt_OwnershipDomain_d09e7c42-8339-495e-b286-3e41ba957fa5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_bf367a6f-cd9a-4c69-9db2-d63bb1ca98d2" xlink:href="dgx-20210331.xsd#dgx_UMassJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_d09e7c42-8339-495e-b286-3e41ba957fa5" xlink:to="loc_dgx_UMassJointVentureMember_bf367a6f-cd9a-4c69-9db2-d63bb1ca98d2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="extended" id="if5f08161fd6d481d9645bd5b91ab7fbd_SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="extended" id="ie02b7d3ba202496a80ca6fe4ea392311_SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATADetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="extended" id="i244675301a5641989cf04483a93b0fa8_SUPPLEMENTALCASHFLOWOTHERDATADetails"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended" id="i8bba9cbd4f2243e9bb7a30b8a5b61b50_COMMITMENTSANDCONTINGENCIES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="ic8bd8233ea4140298434ffd5861baf60_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f9688bdd-4d22-4ffc-bd57-32e114ec3e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_7ceb1578-bb0e-49e5-91a6-bbe2b02bbb07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9688bdd-4d22-4ffc-bd57-32e114ec3e23" xlink:to="loc_us-gaap_LitigationReserve_7ceb1578-bb0e-49e5-91a6-bbe2b02bbb07" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6420d613-823b-4f62-ba13-e835a75be105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9688bdd-4d22-4ffc-bd57-32e114ec3e23" xlink:to="loc_us-gaap_LossContingenciesTable_6420d613-823b-4f62-ba13-e835a75be105" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f8d4d017-6a4e-4512-86b4-638800238693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_6420d613-823b-4f62-ba13-e835a75be105" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f8d4d017-6a4e-4512-86b4-638800238693" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f8d4d017-6a4e-4512-86b4-638800238693_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f8d4d017-6a4e-4512-86b4-638800238693" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_f8d4d017-6a4e-4512-86b4-638800238693_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6bbe7426-37d0-4a24-9622-7485f7e72bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f8d4d017-6a4e-4512-86b4-638800238693" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6bbe7426-37d0-4a24-9622-7485f7e72bf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_b36d4b7c-1281-45fe-8302-d5ed3ba3f1ba" xlink:href="dgx-20210331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6bbe7426-37d0-4a24-9622-7485f7e72bf5" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_b36d4b7c-1281-45fe-8302-d5ed3ba3f1ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fbf9673b-3183-4335-81ec-d77c899828b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fbf9673b-3183-4335-81ec-d77c899828b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_df19a801-8963-4999-91df-c629b6cf3d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_df19a801-8963-4999-91df-c629b6cf3d7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_94fd9df7-2e09-434a-96ab-e61f5b930939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_94fd9df7-2e09-434a-96ab-e61f5b930939" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:to="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dd8270a1-def0-4b97-a641-6c791ab0676c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dd8270a1-def0-4b97-a641-6c791ab0676c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dd8270a1-def0-4b97-a641-6c791ab0676c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd8270a1-def0-4b97-a641-6c791ab0676c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dd8270a1-def0-4b97-a641-6c791ab0676c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd8270a1-def0-4b97-a641-6c791ab0676c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5e10c4a6-b083-413f-a9c2-d93ddfada382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:to="loc_us-gaap_SecuredDebtMember_5e10c4a6-b083-413f-a9c2-d93ddfada382" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_388d925c-f25d-4777-aed1-a46d2b2bc08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_388d925c-f25d-4777-aed1-a46d2b2bc08d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_6f612a9f-09dc-42be-9435-5c0fc13cab4a" xlink:href="dgx-20210331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_6f612a9f-09dc-42be-9435-5c0fc13cab4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d13533ab-d019-4e10-9998-310c61bce73f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:to="loc_us-gaap_CreditFacilityAxis_d13533ab-d019-4e10-9998-310c61bce73f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_d13533ab-d019-4e10-9998-310c61bce73f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_d13533ab-d019-4e10-9998-310c61bce73f" xlink:to="loc_us-gaap_CreditFacilityDomain_d13533ab-d019-4e10-9998-310c61bce73f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_18ed9a1a-9fc8-4264-9413-bc46adaf0ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_d13533ab-d019-4e10-9998-310c61bce73f" xlink:to="loc_us-gaap_CreditFacilityDomain_18ed9a1a-9fc8-4264-9413-bc46adaf0ef4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_0c2ed272-922b-4ebe-bdb5-dc76b834e389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_18ed9a1a-9fc8-4264-9413-bc46adaf0ef4" xlink:to="loc_us-gaap_LetterOfCreditMember_0c2ed272-922b-4ebe-bdb5-dc76b834e389" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c0376d30-d6ad-45e4-80f9-0a79f64d4403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c0376d30-d6ad-45e4-80f9-0a79f64d4403" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_26267df9-cbe2-4934-9911-2ff3237a4333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c0376d30-d6ad-45e4-80f9-0a79f64d4403" xlink:to="loc_us-gaap_SubsequentEventMember_26267df9-cbe2-4934-9911-2ff3237a4333" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended" id="iee85c89393644897b481a37aa63f0a53_BUSINESSSEGMENTINFORMATION"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended" id="iec9b32a18b824ff4be4359f2285b6c91_BUSINESSSEGMENTINFORMATIONTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended" id="i16fa788cc2b747a2bb713a786d0fcbe2_BUSINESSSEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_7f51ce0a-dbae-497c-a082-c1c2bb173ba7" xlink:href="dgx-20210331.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_dgx_PercentageofNetRevenues_7f51ce0a-dbae-497c-a082-c1c2bb173ba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fa6966f5-2b91-4e82-91e7-7d639a944b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fa6966f5-2b91-4e82-91e7-7d639a944b02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3d777e71-8363-42d4-a133-668b8b9cffaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_OperatingIncomeLoss_3d777e71-8363-42d4-a133-668b8b9cffaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_948d0111-97d6-469e-b8a3-a8b0269115f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_948d0111-97d6-469e-b8a3-a8b0269115f5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ee948520-8c12-4907-ac89-7477a6a33e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ee948520-8c12-4907-ac89-7477a6a33e28" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_20134633-3e41-442b-a3db-7c9d4f0084b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_20134633-3e41-442b-a3db-7c9d4f0084b6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_966ae3a1-23c4-455e-af41-7e1e90c32ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_966ae3a1-23c4-455e-af41-7e1e90c32ae6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3ccc3fde-aff7-477d-b17c-bc3a8681dcd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_ProfitLoss_3ccc3fde-aff7-477d-b17c-bc3a8681dcd8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_86c84faa-926f-49d6-a1e1-6a84ecd29c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_86c84faa-926f-49d6-a1e1-6a84ecd29c2f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2923ede-a338-4d3b-8d83-680a4245c27e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_NetIncomeLoss_c2923ede-a338-4d3b-8d83-680a4245c27e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b1f2e460-80a3-4cb3-b74d-a428f2dce648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b1f2e460-80a3-4cb3-b74d-a428f2dce648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b1f2e460-80a3-4cb3-b74d-a428f2dce648_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b1f2e460-80a3-4cb3-b74d-a428f2dce648" xlink:to="loc_us-gaap_SegmentDomain_b1f2e460-80a3-4cb3-b74d-a428f2dce648_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b1f2e460-80a3-4cb3-b74d-a428f2dce648" xlink:to="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_7f5bc5fb-defe-402e-955f-6d4bdf34e676" xlink:href="dgx-20210331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_7f5bc5fb-defe-402e-955f-6d4bdf34e676" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_726a22cd-0e17-4c20-bd22-ee7f6dfe1e9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:to="loc_us-gaap_AllOtherSegmentsMember_726a22cd-0e17-4c20-bd22-ee7f6dfe1e9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_2e05135d-06b0-44df-bb71-1f9f3d4520c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:to="loc_us-gaap_CorporateMember_2e05135d-06b0-44df-bb71-1f9f3d4520c2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:to="loc_srt_RangeAxis_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b" xlink:to="loc_srt_RangeMember_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad2ca952-ee65-4042-a2be-d02d396b32ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b" xlink:to="loc_srt_RangeMember_ad2ca952-ee65-4042-a2be-d02d396b32ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_16c4f26c-b97d-4c4b-9d7a-67a83eaa04c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ad2ca952-ee65-4042-a2be-d02d396b32ab" xlink:to="loc_srt_MinimumMember_16c4f26c-b97d-4c4b-9d7a-67a83eaa04c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1f514109-5071-45f6-a6ba-769dd94a129a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:to="loc_srt_ProductOrServiceAxis_1f514109-5071-45f6-a6ba-769dd94a129a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1f514109-5071-45f6-a6ba-769dd94a129a_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1f514109-5071-45f6-a6ba-769dd94a129a" xlink:to="loc_srt_ProductsAndServicesDomain_1f514109-5071-45f6-a6ba-769dd94a129a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1f514109-5071-45f6-a6ba-769dd94a129a" xlink:to="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_3e6f4bc8-95e0-4d7e-87fd-571633cd772a" xlink:href="dgx-20210331.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_3e6f4bc8-95e0-4d7e-87fd-571633cd772a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_0fb0abde-b794-4372-896d-d815b663a8f3" xlink:href="dgx-20210331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_COVID19TestingServicesMember_0fb0abde-b794-4372-896d-d815b663a8f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_a7e88d30-8895-4b34-883f-ce0c7d1fbf09" xlink:href="dgx-20210331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_a7e88d30-8895-4b34-883f-ce0c7d1fbf09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_2e7225b3-75ce-4a71-bf42-47364112e2bd" xlink:href="dgx-20210331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_2e7225b3-75ce-4a71-bf42-47364112e2bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_86068350-970c-460f-a618-a53374afd4ae" xlink:href="dgx-20210331.xsd#dgx_AllotherservicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_AllotherservicesMember_86068350-970c-460f-a618-a53374afd4ae" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#RELATEDPARTIES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="extended" id="i3f525d41e7984c3c8c0fc3cca46e27e1_RELATEDPARTIES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#RELATEDPARTIESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="extended" id="i7ebd73750e334f24943068c9dff636ad_RELATEDPARTIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_4de1aac6-78a8-45ca-bf99-c3f5fc7e21e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_RevenueFromRelatedParties_4de1aac6-78a8-45ca-bf99-c3f5fc7e21e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_c54a7df9-8119-46d8-b1d2-8683759f34f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_c54a7df9-8119-46d8-b1d2-8683759f34f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_12ce8125-0efb-4e67-8708-5ffdfed824db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_12ce8125-0efb-4e67-8708-5ffdfed824db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherAccountsReceivableRelatedParties_b3069603-cec3-4626-a7cb-c6fe0d7ed434" xlink:href="dgx-20210331.xsd#dgx_OtherAccountsReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_dgx_OtherAccountsReceivableRelatedParties_b3069603-cec3-4626-a7cb-c6fe0d7ed434" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_44a8e445-f33d-4c00-a7fb-d99211279d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_44a8e445-f33d-4c00-a7fb-d99211279d1d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_417550f7-1c24-4333-8757-e51fc39b6560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_417550f7-1c24-4333-8757-e51fc39b6560" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f9a3933c-b749-4b28-9875-05c630815ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f9a3933c-b749-4b28-9875-05c630815ab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_f9a3933c-b749-4b28-9875-05c630815ab8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f9a3933c-b749-4b28-9875-05c630815ab8" xlink:to="loc_us-gaap_RelatedPartyDomain_f9a3933c-b749-4b28-9875-05c630815ab8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4aa8ac5d-5d42-4c96-9b36-98c221bafc97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f9a3933c-b749-4b28-9875-05c630815ab8" xlink:to="loc_us-gaap_RelatedPartyDomain_4aa8ac5d-5d42-4c96-9b36-98c221bafc97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_887495c2-b841-4dbb-8973-4cd6d3515048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_4aa8ac5d-5d42-4c96-9b36-98c221bafc97" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_887495c2-b841-4dbb-8973-4cd6d3515048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7395a4f7-1fb4-4810-a3fd-818f2f048067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7395a4f7-1fb4-4810-a3fd-818f2f048067" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7395a4f7-1fb4-4810-a3fd-818f2f048067_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7395a4f7-1fb4-4810-a3fd-818f2f048067" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7395a4f7-1fb4-4810-a3fd-818f2f048067_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_13c6fd1c-255c-4823-8ee1-57ac957e8ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7395a4f7-1fb4-4810-a3fd-818f2f048067" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_13c6fd1c-255c-4823-8ee1-57ac957e8ab9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_350f24cc-2b82-41d8-96bc-a18f9f85bf86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_13c6fd1c-255c-4823-8ee1-57ac957e8ab9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_350f24cc-2b82-41d8-96bc-a18f9f85bf86" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_55b25610-7369-487d-9c6b-f5aa45e99aec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_55b25610-7369-487d-9c6b-f5aa45e99aec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_55b25610-7369-487d-9c6b-f5aa45e99aec_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_55b25610-7369-487d-9c6b-f5aa45e99aec" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_55b25610-7369-487d-9c6b-f5aa45e99aec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_794abca8-4fc5-4da8-b88b-9a01538c47e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_55b25610-7369-487d-9c6b-f5aa45e99aec" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_794abca8-4fc5-4da8-b88b-9a01538c47e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3e6d0c7b-ad50-4db6-874a-ec20cdda440c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_794abca8-4fc5-4da8-b88b-9a01538c47e1" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3e6d0c7b-ad50-4db6-874a-ec20cdda440c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES" xlink:type="extended" id="iae43f3abe57b4fffb50bd5ffda7d211e_REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables" xlink:type="extended" id="ie6f94df3458749a9817e3a7caeca74c1_REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails" xlink:type="extended" id="i9677975813bf4ed995e9f3029904f097_REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e15b4b8b-0a6a-4919-a782-48d5f4646906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_34cf375c-59a1-4087-b041-3c61a7f1359b" xlink:href="dgx-20210331.xsd#dgx_PercentageofNetRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e15b4b8b-0a6a-4919-a782-48d5f4646906" xlink:to="loc_dgx_PercentageofNetRevenues_34cf375c-59a1-4087-b041-3c61a7f1359b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_9e8036cb-5d43-460e-acd2-ea3a156f1e1a" xlink:href="dgx-20210331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e15b4b8b-0a6a-4919-a782-48d5f4646906" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_9e8036cb-5d43-460e-acd2-ea3a156f1e1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e15b4b8b-0a6a-4919-a782-48d5f4646906" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6169b963-b924-4a29-affc-51b99e36f567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6169b963-b924-4a29-affc-51b99e36f567" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_6169b963-b924-4a29-affc-51b99e36f567_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6169b963-b924-4a29-affc-51b99e36f567" xlink:to="loc_us-gaap_SegmentDomain_6169b963-b924-4a29-affc-51b99e36f567_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_460e0cee-7eda-4e03-8f48-eb4386536b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6169b963-b924-4a29-affc-51b99e36f567" xlink:to="loc_us-gaap_SegmentDomain_460e0cee-7eda-4e03-8f48-eb4386536b0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_867bdd94-7867-4d78-8535-6d91b9a4ad8f" xlink:href="dgx-20210331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_460e0cee-7eda-4e03-8f48-eb4386536b0e" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_867bdd94-7867-4d78-8535-6d91b9a4ad8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_0f6f8ea9-562c-41a1-8975-c6bf167bf023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_460e0cee-7eda-4e03-8f48-eb4386536b0e" xlink:to="loc_us-gaap_AllOtherSegmentsMember_0f6f8ea9-562c-41a1-8975-c6bf167bf023" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a042a770-1140-48fe-b616-da7fc414c974" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_srt_RangeAxis_a042a770-1140-48fe-b616-da7fc414c974" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a042a770-1140-48fe-b616-da7fc414c974_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a042a770-1140-48fe-b616-da7fc414c974" xlink:to="loc_srt_RangeMember_a042a770-1140-48fe-b616-da7fc414c974_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6d5b8d6-45cb-45c1-bb70-66888d2aa82c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a042a770-1140-48fe-b616-da7fc414c974" xlink:to="loc_srt_RangeMember_b6d5b8d6-45cb-45c1-bb70-66888d2aa82c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d0424685-da05-47fc-9fe3-f30e27a919dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b6d5b8d6-45cb-45c1-bb70-66888d2aa82c" xlink:to="loc_srt_MinimumMember_d0424685-da05-47fc-9fe3-f30e27a919dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_us-gaap_SubsegmentsAxis_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00" xlink:to="loc_us-gaap_SubsegmentsDomain_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00" xlink:to="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_c9f570df-a372-4712-afb1-179e58407715" xlink:href="dgx-20210331.xsd#dgx_HealthcareInsurersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_HealthcareInsurersMember_c9f570df-a372-4712-afb1-179e58407715" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_888ceef6-597b-4e30-a9b8-d58f88dbd483" xlink:href="dgx-20210331.xsd#dgx_GovernmentPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_GovernmentPayersMember_888ceef6-597b-4e30-a9b8-d58f88dbd483" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_96eef7ed-8767-478c-8305-5a9780b093e6" xlink:href="dgx-20210331.xsd#dgx_ClientPayersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_ClientPayersMember_96eef7ed-8767-478c-8305-5a9780b093e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_6f64b744-afe9-4ca5-826b-70c71efd86b8" xlink:href="dgx-20210331.xsd#dgx_PatientsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_PatientsMember_6f64b744-afe9-4ca5-826b-70c71efd86b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_98808f45-2ad6-48b0-85cd-929933b08f53" xlink:href="dgx-20210331.xsd#dgx_DSBusinessesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_DSBusinessesMember_98808f45-2ad6-48b0-85cd-929933b08f53" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_65f36cd6-8dbc-44ab-a31c-51bafb64df8d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_srt_ProductOrServiceAxis_65f36cd6-8dbc-44ab-a31c-51bafb64df8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_65f36cd6-8dbc-44ab-a31c-51bafb64df8d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_65f36cd6-8dbc-44ab-a31c-51bafb64df8d" xlink:to="loc_srt_ProductsAndServicesDomain_65f36cd6-8dbc-44ab-a31c-51bafb64df8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47bf4cf1-ead5-4175-9a81-a2528aafdfa6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_65f36cd6-8dbc-44ab-a31c-51bafb64df8d" xlink:to="loc_srt_ProductsAndServicesDomain_47bf4cf1-ead5-4175-9a81-a2528aafdfa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_caf58af3-a69d-4a68-a1bd-a3f7d1320bfc" xlink:href="dgx-20210331.xsd#dgx_FeeforserviceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47bf4cf1-ead5-4175-9a81-a2528aafdfa6" xlink:to="loc_dgx_FeeforserviceMember_caf58af3-a69d-4a68-a1bd-a3f7d1320bfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_38364392-f12b-4520-bcb1-cbe3e99ec133" xlink:href="dgx-20210331.xsd#dgx_CapitatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_47bf4cf1-ead5-4175-9a81-a2528aafdfa6" xlink:to="loc_dgx_CapitatedMember_38364392-f12b-4520-bcb1-cbe3e99ec133" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENT" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUBSEQUENTEVENT"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENT" xlink:type="extended" id="ia3e1bf0026804923beb1399bba66bf53_SUBSEQUENTEVENT"/>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUBSEQUENTEVENTDetails"/>
  <link:definitionLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended" id="i1a2ee6ee4f814b12bede103c01e71530_SUBSEQUENTEVENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_890fdc1a-4e44-4a94-87f2-ffd3851a3043" xlink:href="dgx-20210331.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_890fdc1a-4e44-4a94-87f2-ffd3851a3043" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f721384e-6bea-4546-a4c4-4d7971f54a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f721384e-6bea-4546-a4c4-4d7971f54a47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_599b2963-2046-41c1-aeb7-af1a11af2f70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_599b2963-2046-41c1-aeb7-af1a11af2f70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:to="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d2450279-530b-4a66-8426-513c09b76b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d2450279-530b-4a66-8426-513c09b76b14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d2450279-530b-4a66-8426-513c09b76b14_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d2450279-530b-4a66-8426-513c09b76b14" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d2450279-530b-4a66-8426-513c09b76b14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8117e862-cabe-40b2-be74-ee396997b097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d2450279-530b-4a66-8426-513c09b76b14" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8117e862-cabe-40b2-be74-ee396997b097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d986330a-b486-452f-961f-01d33dfd3c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8117e862-cabe-40b2-be74-ee396997b097" xlink:to="loc_us-gaap_SubsequentEventMember_d986330a-b486-452f-961f-01d33dfd3c79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2eb16545-4215-40b5-ac5a-c2a386ee0d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2eb16545-4215-40b5-ac5a-c2a386ee0d8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2eb16545-4215-40b5-ac5a-c2a386ee0d8e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2eb16545-4215-40b5-ac5a-c2a386ee0d8e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_2eb16545-4215-40b5-ac5a-c2a386ee0d8e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9ef0d69-425a-48dc-bc16-d99df7bd49ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2eb16545-4215-40b5-ac5a-c2a386ee0d8e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9ef0d69-425a-48dc-bc16-d99df7bd49ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_70c84bad-8e2c-4d8f-8644-166b754feb3f" xlink:href="dgx-20210331.xsd#dgx_Q2SolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9ef0d69-425a-48dc-bc16-d99df7bd49ff" xlink:to="loc_dgx_Q2SolutionsMember_70c84bad-8e2c-4d8f-8644-166b754feb3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_541d23d2-717b-4fbb-be16-2ce51179c1c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:to="loc_srt_StatementScenarioAxis_541d23d2-717b-4fbb-be16-2ce51179c1c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_541d23d2-717b-4fbb-be16-2ce51179c1c9_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementScenarioAxis_541d23d2-717b-4fbb-be16-2ce51179c1c9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_541d23d2-717b-4fbb-be16-2ce51179c1c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_63012b42-fe18-479b-a09d-39be993bfa8d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementScenarioAxis_541d23d2-717b-4fbb-be16-2ce51179c1c9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_63012b42-fe18-479b-a09d-39be993bfa8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b76a2054-0c69-475c-bbf7-b1adbd5a4574" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ScenarioUnspecifiedDomain_63012b42-fe18-479b-a09d-39be993bfa8d" xlink:to="loc_srt_ScenarioForecastMember_b76a2054-0c69-475c-bbf7-b1adbd5a4574" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>dgx-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7a2ec7e-72b2-4b96-9989-1413b2102795,g:ecef80b4-feab-4ac1-bfc2-6019ec2f6d37-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_d93f76d3-c307-4cb9-8dae-40e469387cd0_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_4e1f92d3-bdab-4bda-9e1d-5a40ea925a30_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reissuance of shares for employee benefit plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Treasury Stock Reissued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_96c83c5c-adea-47d4-8d1d-b1e485097443_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_c49e83fb-9607-44d7-ae30-2a42e8817d14_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_99d3089e-4242-414d-b208-dba4c8c935bd_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6425096c-22d3-42ad-bcd9-a164dde1c90b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_5e842d7f-f470-4e99-8ebd-57bf74004bf3_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, at Cost</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e7b655fe-aaad-41f3-bc6e-ca2646fc4b30_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_9a71a9d8-16da-408e-965a-03d77ab43d09_verboseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer-related intangibles</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_4bd40062-7897-42f6-a0a5-137b651106d2_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases:</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_063bae5b-1177-4d2e-8d39-40e09390bf5b_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_fbdb8785-dd44-4c67-9c85-dca6a81f45e6_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating costs and expenses, net</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_3d5f6b4f-1c48-4c77-9f0b-66193cbf0580_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_7e870f04-2de2-4cd0-8f3e-73bc22a3fca2_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_5a5a7144-2787-422a-8801-ea7381d89a76_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class action lawsuits</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_70812666-1ffc-436d-b1a2-4ca3f6a31716_terseLabel_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_label_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services [Member]</link:label>
    <link:label id="lab_dgx_RoutineclinicaltestingservicesMember_documentation_en-US" xlink:label="lab_dgx_RoutineclinicaltestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Routine clinical testing services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember" xlink:href="dgx-20210331.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_RoutineclinicaltestingservicesMember" xlink:to="lab_dgx_RoutineclinicaltestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_db4e7599-6b29-4f0c-aafc-78c7622573ca_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_a9bef105-c9d3-410f-86c1-8a87093bb622_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_331ab9ff-60fe-4b95-910a-8b5c39f020bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_3344ea69-aec5-40b2-9f14-a7738e10584b_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_86041c22-02e9-4b24-8e1e-022810e4c41a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of equity method investment</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Other than Temporary Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:to="lab_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_4a8555fc-fd82-4073-9c49-6456967040e6_terseLabel_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_label_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:label id="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_documentation_en-US" xlink:label="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excludes general and professional liability claims [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:href="dgx-20210331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:to="lab_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_6369adb2-ebac-4429-a711-86878a3f02c0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_95122e51-fa2f-4db5-b10a-1f5f6e408bd9_terseLabel_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_label_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:label id="lab_dgx_GenebasedandesoterictestingservicesMember_documentation_en-US" xlink:label="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gene-based and esoteric testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:href="dgx-20210331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GenebasedandesoterictestingservicesMember" xlink:to="lab_dgx_GenebasedandesoterictestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_620b5a1f-9c75-4f51-9385-9fff4d8e4be0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_a7f5f1ff-fff0-485d-a324-898fe9f1b8ab_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow and Other Data</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_432cfa6e-d95d-47ea-8707-1cbf9e346873_terseLabel_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self-insurance reserves</link:label>
    <link:label id="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_label_en-US" xlink:label="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Malpractice Loss Contingency, Accrual, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:to="lab_us-gaap_MalpracticeLossContingencyAccrualUndiscounted" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_b7b9a21a-2627-40c4-b328-7469024146c7_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bb24c187-5e3e-4aca-b99b-e94c1b8eb488_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_1dc5f6d9-9fa7-4d6b-ac67-012f04d4c494_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Net income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_7abec108-f9b6-4370-88d4-33bd0e8d182e_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_63526b47-c76d-4805-b5da-986f9979234c_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCIAL INSTRUMENTS</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_49cebc4c-835a-4ffb-9e0e-688812a7f4b0_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_3ad2e0a6-0431-4477-9262-8ac4247bb426_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0b2b2a4d-8eb9-4431-9b14-e1322467cc94_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_d907abfc-f38c-48b6-bea5-f7d38b156598_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE MEASUREMENTS</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_76f906c7-09b6-4ffa-8c6c-a578897b0945_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_8eb4a8a4-bfab-4686-9f31-2e4384631cc6_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_43c2559b-8a5b-4aa8-9348-865a758d087e_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total intangible assets, Net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_e2b0d221-2530-41d2-990c-e584466ea40f_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_d35f5d51-3283-4df3-b34c-9dfb4c366796_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_d3469ae6-8e0e-4d46-802d-7a78b33932ee_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_3f877a1d-bc2d-421d-afb0-55bd27e403f8_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_45701202-f3ba-4457-bdc8-148f05a11fed_terseLabel_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_label_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:label id="lab_dgx_TotalAmortizingIntangibleAssetsMember_documentation_en-US" xlink:label="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Amortizing Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:href="dgx-20210331.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TotalAmortizingIntangibleAssetsMember" xlink:to="lab_dgx_TotalAmortizingIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_a3bbb810-98b1-4a55-8e4d-4ab97ea72f3e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_edc74a0f-31a1-4774-bd0a-dcc4a10bb4a8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_cb96cf3d-bc0d-4293-96c8-ecb83117d08d_terseLabel_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash surrender value of life insurance policies</link:label>
    <link:label id="lab_us-gaap_CashSurrenderValueFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Surrender Value, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:to="lab_us-gaap_CashSurrenderValueFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_53c57b48-f766-4d54-878a-aee48ab9dbd7_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_d7c9ac69-0218-4273-8506-109927114f51_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_7ff05ba7-df6f-4b50-b6d0-b0332c533c37_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_ecd1aaec-2953-4aa8-90b2-6e1739f3596b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_20568a90-a053-49d5-8877-3720c550d27e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2049e2c6-de4b-44b7-976b-28ff57f6c82c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_UMassJointVentureMember_1eb22d88-c413-4cc0-b507-1c5672365265_terseLabel_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_label_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:label id="lab_dgx_UMassJointVentureMember_documentation_en-US" xlink:label="lab_dgx_UMassJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UMass Joint Venture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember" xlink:href="dgx-20210331.xsd#dgx_UMassJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_UMassJointVentureMember" xlink:to="lab_dgx_UMassJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_56da844f-6568-4a35-b60c-a71bba70840e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_22632d80-c5b6-4ffd-8b58-9902ed6679ad_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_a3b006c6-90fe-4788-b5c0-4eee7b55365f_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_b624a8f0-090e-47c1-bd5f-4d643f8439e0_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_3b74b406-91b3-418d-ba0e-6607a69dfeeb_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_22d4d15a-236d-4166-8d6b-151a451e0a6f_terseLabel_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_label_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:label id="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_documentation_en-US" xlink:label="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Excluding Redeemable Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:href="dgx-20210331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:to="lab_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_e95965d6-4445-4060-b67f-783c305ccf7f_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Cash acquired</link:label>
    <link:label id="lab_us-gaap_CashAcquiredFromAcquisition_label_en-US" xlink:label="lab_us-gaap_CashAcquiredFromAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired from Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAcquiredFromAcquisition" xlink:to="lab_us-gaap_CashAcquiredFromAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_96a15e7f-18d4-463c-97eb-32dccd8d8849_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_08c6b10c-eae2-4445-803d-e21509ac8455_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Cost</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_OtherAccountsReceivableRelatedParties_49572713-2098-49bd-8afd-5e2fe320a05f_terseLabel_en-US" xlink:label="lab_dgx_OtherAccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accounts receivable, related parties</link:label>
    <link:label id="lab_dgx_OtherAccountsReceivableRelatedParties_label_en-US" xlink:label="lab_dgx_OtherAccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Receivable, Related Parties</link:label>
    <link:label id="lab_dgx_OtherAccountsReceivableRelatedParties_documentation_en-US" xlink:label="lab_dgx_OtherAccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accounts Receivable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherAccountsReceivableRelatedParties" xlink:href="dgx-20210331.xsd#dgx_OtherAccountsReceivableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_OtherAccountsReceivableRelatedParties" xlink:to="lab_dgx_OtherAccountsReceivableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_f8185823-b912-4bfb-99f0-ca76676d0083_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under benefit plans</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_167a164f-6aea-4730-ba00-d7b93478e2bd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_b7a2b558-1651-40ba-8dda-a5cab4f4e9c7_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:to="lab_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_660356c6-38f8-4206-acde-957fdcc49540_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_722b43da-fc80-4bae-b85a-51b8945c6bf0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_fbb10af4-067c-4f24-86a3-dd25f94dbcb1_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c410b9db-8183-4a27-8162-e6bc19629028_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_fccb4ee4-9809-40e9-9f2e-38d4033c2e9e_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_fa9fbab0-ab1c-4f87-a42b-78001e8ec825_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for credit losses of $29 and $28 as of March 31, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_94cf6257-7e25-4c71-b170-3fa06595643a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_405dc8c9-16c7-4e36-a72b-90e17d620be1_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock- shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_be1e6cd6-7d56-4a6e-a5d4-a83ebd866753_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_ec6c34b3-15ce-4e11-9c11-da9a1902ebb0_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_44caff32-b0e8-4081-a1e3-7833318a63f6_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_91128266-697c-4b47-b962-ec5df79d0329_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetRevenues_7e099496-4570-4c8c-96e2-b00514752eb9_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of net revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_label_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:label id="lab_dgx_PercentageofNetRevenues_documentation_en-US" xlink:label="lab_dgx_PercentageofNetRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues" xlink:href="dgx-20210331.xsd#dgx_PercentageofNetRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetRevenues" xlink:to="lab_dgx_PercentageofNetRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_2282b0a3-d609-4270-bd5e-84341405742f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_0fd88f6c-a187-4001-9600-85ffcd17c265_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_29384ca9-14c9-47ac-b732-08e4cda4d233_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_1171518d-c57d-477d-80fd-18a95108f289_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Balance at end of period</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_79e26f2e-e224-4343-a817-1f17857b0ebd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_87326dc2-840a-48d9-b782-adad70a9369f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_82b45f8c-d360-4935-8edf-a83a87c30b70_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_24c58068-56ec-4674-8557-78b95b2d31b0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_770f9712-b3f2-43c7-91ce-05e9b6410e29_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in investments and other assets</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_ad21b03f-8124-417b-ae0b-2af091b14055_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating costs and expenses and other operating income:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_CapitatedMember_f6b890df-625e-4d00-b941-e3b064469e40_terseLabel_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated</link:label>
    <link:label id="lab_dgx_CapitatedMember_label_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:label id="lab_dgx_CapitatedMember_documentation_en-US" xlink:label="lab_dgx_CapitatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitated [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember" xlink:href="dgx-20210331.xsd#dgx_CapitatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_CapitatedMember" xlink:to="lab_dgx_CapitatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_0b295101-ed04-4980-85cb-1c19b9dcd1a2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Income Taxes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_490bfe4c-7348-45db-9759-af23667bcf46_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_afdc8839-c680-47ba-9c0e-55be82cf2b5a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of assets acquired</link:label>
    <link:label id="lab_us-gaap_FairValueOfAssetsAcquired_label_en-US" xlink:label="lab_us-gaap_FairValueOfAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfAssetsAcquired" xlink:to="lab_us-gaap_FairValueOfAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_6b9b8618-2a55-4d1a-afe6-67ad32a497fb_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_842dd426-8a0c-4445-815b-d9a2129e1b70_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends per common share</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_231cefe2-9150-461a-b7d0-f1267195bf9d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_b85c7b8e-ed1e-4900-ba7d-787690f3859c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_2f85143a-09a0-4fa2-973c-020e1ea1b9d8_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_df172ff7-a74d-4ea8-8a8a-675041e46733_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_3baa1e8c-f166-4b44-b3d5-5e18373682e1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_b76331db-8438-4ca3-a24b-2aa0727d53df_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Goodwill, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ad785888-21c8-4874-9c72-a62ac8f9cfa5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_81153831-3858-4a8d-8d87-839cc5968873_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total net revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_103651a9-41b5-4b58-8fbb-ff3f6c46937b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_0366d83f-1a7e-4b14-9fa0-bd872fc8d33d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableRelatedParties" xlink:to="lab_us-gaap_AccountsReceivableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_19a3f4cf-0abb-435d-b67d-6fb94573cfc0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_16243630-a397-4d6b-b133-e11aa27b390e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of liabilities assumed</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAssumed1_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAssumed1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAssumed1" xlink:to="lab_us-gaap_LiabilitiesAssumed1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_cbda9a11-8004-4bcb-a7c9-0025282e0c3c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_57d5aa26-df3a-483a-b359-9f10b7159a34_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_GovernmentPayersMember_e229c62e-859a-4eba-8ec9-bc16ceb40c45_terseLabel_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_label_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:label id="lab_dgx_GovernmentPayersMember_documentation_en-US" xlink:label="lab_dgx_GovernmentPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember" xlink:href="dgx-20210331.xsd#dgx_GovernmentPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_GovernmentPayersMember" xlink:to="lab_dgx_GovernmentPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6ba3ea34-e3dc-45a0-90e9-e42b37c1a420_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_0b718e42-bef4-4f51-a366-e515c4990328_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_fe28a900-e1aa-46f5-abc5-93686c6a1d89_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_e2ed601b-decd-4726-a44a-93778eabcaf5_terseLabel_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_label_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:label id="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_documentation_en-US" xlink:label="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Additional Amount Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:href="dgx-20210331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:to="lab_dgx_StockRepurchaseProgramAdditionalAmountAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c31c10e4-b96e-44f5-989f-b5a3dfb79e04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_51386b65-1c67-4019-a33d-a3436aa41aea_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2c7dd299-6a54-4d5e-9e7e-6799bc73279f_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_ae410475-3cef-4da0-91db-49ef8e4562b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_891f2a9c-6ced-4ce8-8bfa-33ca1e53f5eb_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioForecastMember_aa895c66-497d-4ccf-bb6f-0881376371bd_terseLabel_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario, Forecast</link:label>
    <link:label id="lab_srt_ScenarioForecastMember_label_en-US" xlink:label="lab_srt_ScenarioForecastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forecast [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioForecastMember" xlink:to="lab_srt_ScenarioForecastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a5fc076e-cefa-4e85-8c32-2a2b2ffd7def_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic(in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3da8affb-bc39-4045-bb8e-bcca6ceb054c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_d29b939b-43a4-4a10-b7b1-0faf4890eff9_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_867ee27b-67d7-4157-9cef-a31a9cfb4073_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_52295c72-1588-4d9e-8b9e-af13f9edcd98_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_9b390b65-4c3e-4f1a-912c-e1a4eb874226_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_045aa2cd-70eb-4f7b-bd39-1546028c76d0_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_9a9a48ba-1861-421b-a3bc-ef57693459bc_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_b23e5dc1-22ce-4464-bcdb-36fe47feda69_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_fa2ffe8e-4b6a-4731-8ce2-4adc61430ce2_terseLabel_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Unsecured Revolving Credit Facility</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_label_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:label id="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember_documentation_en-US" xlink:label="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior unsecured revolving credit facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:href="dgx-20210331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:to="lab_dgx_SeniorunsecuredrevolvingcreditfacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_bbe9fa29-9fcd-4c5b-8e8e-10bd9475f2c2_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_b08e083b-2c21-4719-8c47-b456e222938a_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:href="dgx-20210331.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:to="lab_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_29815efd-f223-4267-858c-6abbce613468_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_ec96c75d-9709-422e-9af8-d46a3a6d9e6b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2021 and December 31, 2020; 217 shares issued as of both March 31, 2021 and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMember_db029fe8-3f92-48fd-be8c-b8aac161700f_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMember_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMember" xlink:to="lab_us-gaap_LongTermDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b71f1271-ab93-4a5b-aacf-bc178d1add51_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_15b84387-922d-4718-ac9f-aa74908a4bb3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_48257c29-4b41-437c-bfba-627884673da0_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_51f52613-fcf2-40c1-a636-e568f9e47bf7_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_cd00a66e-43a2-401f-96b6-4b4ecadb12ba_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating expense, net</link:label>
    <link:label id="lab_us-gaap_OtherOperatingIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingIncomeExpenseNet" xlink:to="lab_us-gaap_OtherOperatingIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_59546302-a292-4391-bae8-056fcb9fb295_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_266942b7-42d9-483e-af96-7848ee9a5803_terseLabel_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of ownership interest sold</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_label_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:label id="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_documentation_en-US" xlink:label="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percent Disposed Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:href="dgx-20210331.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:to="lab_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_1ef23a1a-163e-4b5b-8fb3-5c0ddd452279_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_a1a47014-b9f6-48f5-8dbe-37b60ec783c9_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_f9bf1f31-03ec-45c2-b51e-fe24fdad2861_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_f9200eeb-49bb-48a1-9ecb-e03291032d4d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_69cfb8b4-b28f-49db-a1af-c7e6c5c6fd3f_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_2ec255a2-1ded-47c8-acd1-46e95784dac8_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_d23ae2a9-5ee2-4a5f-9f70-2a0bf9bda4c8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestAndDividendIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and Dividend Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestAndDividendIncomeOperating" xlink:to="lab_us-gaap_InterestAndDividendIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_54d52c04-e52a-4032-8c9b-ae67ce1b2e47_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillPeriodIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:to="lab_us-gaap_GoodwillPeriodIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_06c0cb51-837a-4700-bd4b-942aa1c27276_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ec3c2fd8-4d5d-4a2a-9540-d741021c3ee8_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_02ad275e-c8aa-4cdc-b3ae-7e99edcb3f4d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6737e0af-8fc6-45b3-b85a-e7abc9405f47_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_193df427-b7be-4351-b782-690aae676a2b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_20ef7ab0-ea15-4327-a1e2-99dd11786606_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_83295d21-2400-4219-b9ba-5a4104e139d9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_8bb9a6af-8180-4374-911f-3f3555425ec1_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_80e733bf-87a4-4d3e-88b1-583db3260c84_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_HealthcareInsurersMember_9d59ff5e-07ef-43d7-9919-46810666a154_terseLabel_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_label_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:label id="lab_dgx_HealthcareInsurersMember_documentation_en-US" xlink:label="lab_dgx_HealthcareInsurersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Insurers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember" xlink:href="dgx-20210331.xsd#dgx_HealthcareInsurersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_HealthcareInsurersMember" xlink:to="lab_dgx_HealthcareInsurersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_9cb11d18-0352-4f53-979e-0a2c73b78f12_terseLabel_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_label_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:label id="lab_dgx_AccountsReceivableDisaggregationTableTextBlock_documentation_en-US" xlink:label="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Disaggregation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:href="dgx-20210331.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:to="lab_dgx_AccountsReceivableDisaggregationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_5b0b063b-f429-42d1-bbb5-f6f8279e9a63_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</link:label>
    <link:label id="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Amounts Attributable to Parent, Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:to="lab_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0e8792fd-1abd-4009-8c11-57e3f7bfba2b_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_2303843d-5214-4502-88e4-a64b182926d4_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d9f2cba8-d651-482e-88ca-dd0be59213d3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_ff13b982-f4f4-4624-bb6e-af6c0c05cdfd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_72d86566-349e-4a34-a48c-761577c6fdef_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationReserve_2c69b0f0-23b2-4c28-bc68-855f5d3f1d8a_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation reserves</link:label>
    <link:label id="lab_us-gaap_LitigationReserve_label_en-US" xlink:label="lab_us-gaap_LitigationReserve" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Litigation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationReserve" xlink:to="lab_us-gaap_LitigationReserve" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_0f852ffd-66cb-4f67-b056-3637034eaf59_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_Q2SolutionsMember_6b0abbcc-d5d2-4165-8580-9778b855a61a_terseLabel_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_label_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions [Member]</link:label>
    <link:label id="lab_dgx_Q2SolutionsMember_documentation_en-US" xlink:label="lab_dgx_Q2SolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Q2 Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember" xlink:href="dgx-20210331.xsd#dgx_Q2SolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_Q2SolutionsMember" xlink:to="lab_dgx_Q2SolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_21c5baa3-36ee-4803-b223-b974fc1a78e5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_c300874f-2735-4737-a091-53a945102e2d_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsMinorityInterest_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:to="lab_us-gaap_PaymentsOfDividendsMinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_2cde0135-3263-40ab-9407-cb91e65629ae_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_99ca34e6-c32d-4111-9a15-326b263d14be_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_a76db9ad-8310-48c8-96ce-f37594f244dc_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_db2fbd0a-6183-404f-9512-83a8e65c7cd3_terseLabel_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Other</link:label>
    <link:label id="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unclassified Indefinite-lived Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:to="lab_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_127ad151-4af5-42d5-bd61-b0d32e8247ce_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_ecd9c0a9-b52b-4d68-a43c-fd179ccb15f4_terseLabel_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net accounts receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_label_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:label id="lab_dgx_PercentageofNetAccountsReceivable_documentation_en-US" xlink:label="lab_dgx_PercentageofNetAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Net Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable" xlink:href="dgx-20210331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PercentageofNetAccountsReceivable" xlink:to="lab_dgx_PercentageofNetAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_ef0ea293-20bb-4237-be8b-20f06e862dc7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_c9300156-689d-4362-a414-125e5c634706_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_7c0b889a-f950-4101-bf7a-1ab100f44039_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_3d268a45-99db-42d2-b2fa-9a8d0dcd6af8_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Quest Diagnostics stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_05825113-fc3d-42d8-adc5-83e935fec95b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f2acc447-a864-4503-8d88-88cb72104049_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_ed86fb42-ea2e-4f7a-9e41-85951c105fc0_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_c9605ea9-c363-4f21-bf2a-55a301d85db5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_a4def9c8-84e2-4c6c-80c1-a09f1595912c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AllotherservicesMember_5cda9c80-b537-40c4-b005-854c9b2048a0_terseLabel_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_label_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:label id="lab_dgx_AllotherservicesMember_documentation_en-US" xlink:label="lab_dgx_AllotherservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember" xlink:href="dgx-20210331.xsd#dgx_AllotherservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AllotherservicesMember" xlink:to="lab_dgx_AllotherservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_e5987bc0-bcc5-4410-abbf-9d98909aa373_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_908550c3-9f65-4d0c-b284-acadbc3d1ad4_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</link:label>
    <link:label id="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:to="lab_us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8e501357-3693-43c9-b538-ffa857980bba_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5f0cb9b5-93da-4a41-84ba-901045d3a0fe_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable associated with capital expenditures</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_45a2e57d-3da5-468a-8679-4f3b560b4ab4_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_426ee273-9090-4636-9898-6ee03f13fafe_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_d4aa244c-e551-4a35-98f4-5191cd0b4626_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENTS</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_PatientsMember_107a8a75-c39b-4ea7-82a1-fa83a1118633_terseLabel_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients</link:label>
    <link:label id="lab_dgx_PatientsMember_label_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:label id="lab_dgx_PatientsMember_documentation_en-US" xlink:label="lab_dgx_PatientsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patients [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember" xlink:href="dgx-20210331.xsd#dgx_PatientsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_PatientsMember" xlink:to="lab_dgx_PatientsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_4f1e455f-c104-4089-a73d-9a17e582e53c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_2d884e11-8cd2-4786-a74b-434f6e4b29a6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_7e405188-a50a-4b6e-add5-91fd191b4b67_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_b927eee1-f282-4d80-b04d-ae81880f2bce_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_e53256d2-8389-4d8a-9dcc-eac99b1c2380_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_f77ab661-bbd0-492c-8174-1faa61240c1e_negatedTerseLabel_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to noncontrolling interest partners</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_label_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:label id="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_documentation_en-US" xlink:label="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:href="dgx-20210331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:to="lab_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_b57185ac-1368-475c-b4fa-3d2130fa59e6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_9edcab56-8167-44ba-a46a-139e793afb39_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:href="dgx-20210331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_dd9c0da8-5d7c-4242-ad0c-65b1d8da16c2_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_519781dc-d89d-4986-a304-4997535d10df_terseLabel_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedge Accounting Basis Adjustment</link:label>
    <link:label id="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:to="lab_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_75607966-9366-4e64-b067-6650a539923e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7edcea8e-ab16-40cf-b18f-471082aef307_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b06b7591-a30d-43b1-8975-371e9bab51c9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_a92e0e7a-2f15-49b6-8164-6b8b09c9b767_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_0652e746-4f60-47e1-b679-300f84964638_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c16b673e-9699-437f-9739-4ae92bc84e2c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in available-for-sale debt securities, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7d96b930-8c19-4f10-85b2-2c301dd90e2b_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d11b896f-c752-4a78-8cb2-1548092e074f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d410ed7b-1030-4ea0-a8aa-ba5b28b03918_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c03e10e6-e688-4d3d-9441-ffff4c57d94a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a38c5168-884a-4b25-999c-78af8141fea5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_1ebad5d9-cff7-447d-beba-a0a637c98fcc_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_84bdac22-08a4-4d7d-b0c1-ce58e0cab616_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_720a97e3-825b-49ef-95cf-a41faea4a209_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred compensation liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Liability, Classified, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4e4f9f1a-7920-4197-ab3b-c826b070c4e4_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_4d0ff6cf-892f-42e5-876f-893d52fcf761_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5487545e-decb-4e14-8899-9456f39bac3c_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ac325dc2-af5a-413f-9852-df51285c85ca_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_02d10280-4c7d-443d-bf47-4da68f0a5e08_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_56f7a54f-d178-44fb-a753-f0161185080e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b20b2741-cd84-4600-a96f-7078e8368c76_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_af73ea1e-f59b-4fe3-a1fb-a8699c0850cb_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss, net of taxes</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DSBusinessesMember_02134236-3a9e-4112-9109-eaac51ca0e0f_terseLabel_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_label_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:label id="lab_dgx_DSBusinessesMember_documentation_en-US" xlink:label="lab_dgx_DSBusinessesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DS Businesses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember" xlink:href="dgx-20210331.xsd#dgx_DSBusinessesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DSBusinessesMember" xlink:to="lab_dgx_DSBusinessesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_ebb4a919-94f2-4e83-ba81-788933b23bee_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Not Subject to Amortization - Tradenames</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_1fe6c268-c807-41fe-b3dd-b74103c30951_terseLabel_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_label_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:label id="lab_dgx_DescriptionOfBusinessAbstract_documentation_en-US" xlink:label="lab_dgx_DescriptionOfBusinessAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of Business (Abstract)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract" xlink:href="dgx-20210331.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DescriptionOfBusinessAbstract" xlink:to="lab_dgx_DescriptionOfBusinessAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_cfaa2b3d-fd93-4a2a-9932-9f00815ac5ce_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_347c54eb-2a2c-485f-9d2f-5ddebe333954_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_06411093-4d18-46c4-b5cf-0061ff0a3912_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_8a2f07e1-6cca-43d7-b515-727c17f436b9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementScenarioAxis_ea4ea14d-8e7e-4625-b67d-8eda9b1d74ed_terseLabel_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:label id="lab_srt_StatementScenarioAxis_label_en-US" xlink:label="lab_srt_StatementScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementScenarioAxis" xlink:to="lab_srt_StatementScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_179c829c-7d2c-4022-a1bd-b3aac9ff14e0_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_97d2bac7-bdf2-4309-8554-0590727fa66f_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d3a2502d-b0cf-4c56-8a05-727d46885fb9_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Comprehensive income attributable to noncontrolling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_51fe8b6a-1516-475b-95db-eccce63d33cf_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_c90793ed-1b69-4333-9c73-a3f08c09ebae_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General corporate activities</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b5bc51ba-559b-44ee-a63d-fc7906f3c013_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_84d22ddb-cec0-4fa6-b74c-814233bd8610_terseLabel_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DIS business</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_label_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:label id="lab_dgx_DiagnosticInformationServicesBusinessMember_documentation_en-US" xlink:label="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostic Information Services Business [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:href="dgx-20210331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_DiagnosticInformationServicesBusinessMember" xlink:to="lab_dgx_DiagnosticInformationServicesBusinessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_86496d9f-584f-42c0-8095-b921b79a25a2_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_ddabccce-0092-40a4-b744-35967541e6a7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, related parties</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_75955be1-8f20-4069-ab5d-ae98e5ddab34_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_729c4693-4a32-448d-a00b-665cee0c7049_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_eac220a1-d0bb-405b-9925-f8c9e1b65449_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quest Diagnostics stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_fc4cd580-29f4-4c3e-a06d-130822c3e5b6_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_bfea1db5-4e08-4305-a049-7357470c1f97_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c626b977-5c73-4676-bb5b-b38bcdd1ccf8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_3c926eb0-3f64-4263-bccd-92f98ebf10c3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_08907d37-233d-40c9-b604-8841391ce459_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:href="dgx-20210331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_2645c369-4770-4e17-a305-c8587192d8b5_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_bbfc588c-55bd-4543-87fc-3cd60742d84c_totalLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_09caa179-8047-43aa-ac60-b2ab037d24b8_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage by noncontrolling owners</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_48c3585f-18bb-4399-9e3d-d549de2a98fc_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_6b435f93-6e53-4934-9c7d-d2dfe90d38b2_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_eb69e697-5dd3-4b83-9806-002e0e31e865_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_5f87dc7a-df4b-48ed-86ce-81634f8bc0ad_terseLabel_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:label id="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_documentation_en-US" xlink:label="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived and Indefinite-lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:href="dgx-20210331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FeeforserviceMember_926110c3-7dc2-4f08-a6ca-51da8bf13f22_terseLabel_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_label_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:label id="lab_dgx_FeeforserviceMember_documentation_en-US" xlink:label="lab_dgx_FeeforserviceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fee-for-service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember" xlink:href="dgx-20210331.xsd#dgx_FeeforserviceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FeeforserviceMember" xlink:to="lab_dgx_FeeforserviceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_f4dc98af-5daf-447c-acfa-d9ef59f243a9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_a3805cba-b6e6-4e81-95a4-5f524f6e97d0_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowElementsAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowElementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_1f3ed75d-a547-4fc5-b0e7-fee99b86cad6_terseLabel_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other operating segments</link:label>
    <link:label id="lab_us-gaap_AllOtherSegmentsMember_label_en-US" xlink:label="lab_us-gaap_AllOtherSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllOtherSegmentsMember" xlink:to="lab_us-gaap_AllOtherSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_214c909b-aac0-422a-aba7-5bde1fd9aef1_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_adb815d9-5156-454c-bb18-01b01409658a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_e6fe2646-1b71-482a-bd9a-720ff6d3e33f_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_07e459fb-1f4a-413d-9f02-fb02675c3f5b_terseLabel_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Technology</link:label>
    <link:label id="lab_us-gaap_UnpatentedTechnologyMember_label_en-US" xlink:label="lab_us-gaap_UnpatentedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpatented Technology [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnpatentedTechnologyMember" xlink:to="lab_us-gaap_UnpatentedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_27e84163-77ac-440e-8fe2-1e91ba8035de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ffbfa5eb-81de-4443-af6e-0bfbbe10e69a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ClientPayersMember_e432e5fd-8c73-434e-b822-8a8edcd17d92_terseLabel_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers</link:label>
    <link:label id="lab_dgx_ClientPayersMember_label_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:label id="lab_dgx_ClientPayersMember_documentation_en-US" xlink:label="lab_dgx_ClientPayersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Client Payers [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember" xlink:href="dgx-20210331.xsd#dgx_ClientPayersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ClientPayersMember" xlink:to="lab_dgx_ClientPayersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_b7781528-dbfa-49ae-a9fd-7aa2d43b9b18_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SecuredDebtMember_e6ff8cfc-01a4-41b0-89b7-217d54463a05_terseLabel_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Receivables Credit Facility</link:label>
    <link:label id="lab_us-gaap_SecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_SecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SecuredDebtMember" xlink:to="lab_us-gaap_SecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_17a6195c-4ea6-4343-a058-be594396b1db_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets and liabilities, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_1c82bc86-3f72-4868-9641-79cc027a3b01_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remaining borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_dce28e93-48f8-47c2-be7b-78d73942bda0_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_b19b1fcd-8f66-436f-afa8-c81b84e27f7c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_cdd89c16-a3f4-4f71-af69-8cc4a07c4245_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_068bb495-761f-4204-80eb-ddcb95c12e0b_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueHedgingMember_31d9b4de-9106-42df-a83c-c79d1585a85c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging</link:label>
    <link:label id="lab_us-gaap_FairValueHedgingMember_label_en-US" xlink:label="lab_us-gaap_FairValueHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueHedgingMember" xlink:to="lab_us-gaap_FairValueHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_bd7d388c-8647-4475-8d21-5d932d7bb3f2_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_81dd6c37-c67d-43a1-94c9-22c689fc84d7_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of treasury stock, value</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ce8c492e-80db-400a-b572-1c0084836bf4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options, shares</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_f955fd89-d52b-48dc-8e58-1bba8c834c4b_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4414fea8-5f3d-4044-aa93-96d6a4cd5ae6_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_667d9b86-161f-448a-8e70-95ea97a672bf_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_a7f51428-a7cd-4dfe-9023-3b6c5f979f3a_terseLabel_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_label_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service [Table Text Block]</link:label>
    <link:label id="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_documentation_en-US" xlink:label="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues by Major Service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:href="dgx-20210331.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:to="lab_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_8c971603-8a5a-4ed7-9303-3da24825d12d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_0b9513fa-d6ec-45d0-9700-46f549d1440c_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total non-operating expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_eb8ba941-e22c-4fd4-9746-d4957060d218_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-operating expense, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_a34c8bfe-5796-40ac-980c-ad9c495421e8_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_6a9ed29f-577b-4a6c-b3f4-567814fb10ef_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f86a769b-6c2d-4987-abe6-0d1d1916cfda_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, shares</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_27bc47a9-a62e-49a6-a40d-a964ab899d08_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity method investees</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_f27b5228-e8ad-42be-a468-7c0ad6db2dfd_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_ebeec02c-9709-4d52-a550-f8a479b9b12e_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedged items (Long-term debt)</link:label>
    <link:label id="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_label_en-US" xlink:label="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:to="lab_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_85dbcf8a-c78d-4313-b3d5-2073a742878d_verboseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9b100895-2f26-4de9-ad49-958642b506d8_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in Shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e65c8ef4-fa0f-45f1-8108-fa5eebbc760e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_84305a55-330f-4638-b92d-94caa09fcd8c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedge Accounting on the Statement of Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_d73f5594-997c-416c-8c85-ae18ab1c3c18_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_d51f2576-2ccf-41ea-8661-02cfa10a4dad_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_926ac41a-6c5c-431b-b44c-656213f3df1c_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_3bdd9e05-3b4c-4f38-9133-e7f27d8c08cb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_5b2178bd-ac03-497e-b786-251d4109a1a2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_8731061e-8691-478c-9fc8-5cec69e3e2e0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_8038cd3c-a4f7-46db-916c-e2a6d23f57d7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_3ab73ea5-5fae-48c6-9e56-07717ce0b6d4_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityNetIncome_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityNetIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Net Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityNetIncome" xlink:to="lab_us-gaap_TemporaryEquityNetIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_4032c7f9-ac40-4588-bfb9-923c143b7ef9_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_4132d33a-af16-4c63-bf9e-ceb6c6220499_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding, amount</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_b2ab214b-7053-46e3-ada4-b0ea89840b96_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_cd903918-4a21-4054-a088-bbc2193bcae7_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_c91b7a05-8eff-482d-8610-a327617c5abe_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_a74d8c22-8599-4624-a59b-0def25b85d1d_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_635f4ca2-4a07-4b68-b259-0a174c1658bd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_a8ab0610-6da5-4ec4-b4de-b227154f51e3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of interests acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b89b46f1-e662-4e8e-83c0-6cd51ac88615_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options and performance share units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_fe455851-c775-40ae-8dc7-0b13fd6cde77_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_005508b5-c523-48db-a9bc-741ab6300926_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE RECOGITION AND ALLOWANCE FOR CREDIT LOSSES</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_3550bcc8-e8a1-4c5f-926b-ceadd039969c_terseLabel_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends payable</link:label>
    <link:label id="lab_us-gaap_DividendsPayableCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:to="lab_us-gaap_DividendsPayableCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_2b03994d-ec81-4c19-887a-d2404bafaf1b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for credit losses</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:to="lab_us-gaap_ContractWithCustomerAssetCreditLossExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_4fb22c61-bbdb-4558-998e-a5fa88aa9f3f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Segment Reporting Information by Segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_cec6ba27-1610-4d78-9aca-5644a4fa1d2a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_afbc98c1-8136-4323-80ab-670b8c9088db_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8b09e941-6b9f-48b7-b617-2c2355dea6b4_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, value</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_8b38e78f-a710-4c9e-8d66-ee4996494acf_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leased assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d1e6d534-5e43-4ae5-9829-b5e5608f9895_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_184dc823-67cb-4759-b190-69dcbc1ab568_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_11f21315-fdd8-4fa6-8647-259265e1a41f_terseLabel_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Earnings allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_label_en-US" xlink:label="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:to="lab_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_6216d9a8-6624-4c54-96ce-f19413f0c27f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7bf45a17-7ca7-44cf-bf95-450ba9564af7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f9077695-0651-4c0d-8519-5a84e07562fe_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_d2e06e2d-6ea5-49a5-bda5-a2067bf9f3b5_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_f2ed1a52-28ae-4eec-8205-949594829e5e_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of investment, before tax</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Realized Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:to="lab_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_3f61a68c-a72e-4583-8880-d2a8273ed328_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_c565d724-0fca-48a8-b199-0535a63b68b2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0fbf7e87-4f7a-49b4-b17a-664a848f52b7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_6a48f045-a885-4497-a538-c24fa6706b1f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_7254b186-ee2e-4b3a-82ad-1f6695c71a5d_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_87ec37ae-b1c2-45d5-b0a0-c7b4ae24ecaf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_395aae42-4650-498f-9371-0ce5b77b8f30_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaid_2a448e6a-2ae1-4bf4-b0ff-ec80d6d5747e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaid_label_en-US" xlink:label="lab_us-gaap_InterestPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Including Capitalized Interest, Operating and Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaid" xlink:to="lab_us-gaap_InterestPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_c57fa3f5-1acb-4cee-8c40-cf2e434a69a9_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use Of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_f0623570-e224-4d25-b069-9ef82eda59a8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_10084c34-f932-40dc-9be3-394a49ddc861_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_e55f4aad-0891-4797-ba78-e405e909faa0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_5511c6d5-9942-4a6c-ba08-9243fbb5a347_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_befafab5-614f-45a3-b4f4-2da67c35bd14_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase authorization remaining available</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_632f0e05-c64c-4562-bc8b-034600353b97_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_bb90e9f8-3d40-4053-8dd3-f284784310e7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_95729979-ae3a-4cb3-a440-b39536cecd5e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bc0f51e0-5789-4d1a-b19b-cf00e7d735c2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income attributable to Quest Diagnostics</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_2c05c815-eb7e-45c2-8895-0e5f67e3a749_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax (benefit) provision</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_38a7b60c-5dd3-4d61-8f5f-09c990ffb7ad_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from related party recognized</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Other Revenues from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_453573fc-0b38-427d-a112-da289ea4eb07_totalLabel_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_label_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:label id="lab_dgx_FairValueOfNetAssetsAcquired_documentation_en-US" xlink:label="lab_dgx_FairValueOfNetAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of net assets acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired" xlink:href="dgx-20210331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_FairValueOfNetAssetsAcquired" xlink:to="lab_dgx_FairValueOfNetAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_009098c4-055f-44fa-a652-90dd83193512_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends received</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDividendsReceived_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDividendsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Dividends Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDividendsReceived" xlink:to="lab_us-gaap_ProceedsFromDividendsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a6bd5c7c-e83f-462b-bd59-843b37838da7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_5967eb50-4c45-4abc-962a-7d0aa6322968_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_f368f2a0-1d63-4503-bae6-a16d6f60169d_terseLabel_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:label id="lab_srt_ScenarioUnspecifiedDomain_label_en-US" xlink:label="lab_srt_ScenarioUnspecifiedDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioUnspecifiedDomain" xlink:to="lab_srt_ScenarioUnspecifiedDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_40e1118e-9499-4441-8ec0-f191bfd969c8_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_68b01c07-aa2b-4584-a463-cdb1e6ceebf2_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_9c63375b-aa7d-4413-8540-3c9f5a83ebbe_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_794ba297-af97-4ffc-93f9-4d4479ba80d6_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_15d1c07b-5bef-44d0-8765-815bf2455bc6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_27813de6-52aa-4c3f-8f4d-986837bd2003_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement Inputs</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_a53dddd5-0ac1-47e3-b0db-ab72596b3e84_negatedLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7a5cb3df-6905-4238-8a9f-1aca7b6e1cd2_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_d722af51-85a0-46b1-9cfd-22d665ca8766_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_6704a088-778c-479f-b6a6-08701db11c20_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_99696d36-bc10-4b6f-9a87-456105e5397c_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_ea4cea11-1b0c-44f7-8e49-c44e431975c2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity in earnings of equity method investees, net of taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_40f5127a-863e-49fa-91f6-8af74cb25318_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_591337ac-a5c4-483a-b815-1944f735433d_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_812f04e5-0400-4307-986c-0d6c79575958_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_7084bc72-519e-4bf8-a9ea-44c32b0628da_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes and equity in earnings of equity method investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_COVID19TestingServicesMember_6a433cb0-c529-41ea-9c87-10861da19198_terseLabel_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_label_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services [Member]</link:label>
    <link:label id="lab_dgx_COVID19TestingServicesMember_documentation_en-US" xlink:label="lab_dgx_COVID19TestingServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Testing Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember" xlink:href="dgx-20210331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_COVID19TestingServicesMember" xlink:to="lab_dgx_COVID19TestingServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_865f1574-2ecb-4733-a9b1-2e6c8294f899_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_0139f1e6-c91e-403d-afe9-00041e42441e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradingSecurities_b6d402d7-52de-469c-a16b-cf47d9087643_terseLabel_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading securities</link:label>
    <link:label id="lab_us-gaap_TradingSecurities_label_en-US" xlink:label="lab_us-gaap_TradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Trading, and Equity Securities, FV-NI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradingSecurities" xlink:to="lab_us-gaap_TradingSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_1f819a85-0687-46c2-9d20-aad12a6329c4_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_b92a465e-15cb-432f-90ab-1ecd460ff487_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_bb038d12-9346-48e7-ac50-38dd242eb35c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_87659f4e-2024-42be-ad30-2f17b4039cd7_terseLabel_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MACL</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_label_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL) [Member]</link:label>
    <link:label id="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_documentation_en-US" xlink:label="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mid America Clinical Laboratories, LLC (MACL)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:href="dgx-20210331.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:to="lab_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_23021b4b-2fea-472b-9089-2e0f2c9d04b0_negatedLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost; 86 and 84 shares as of March 31, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_22067798-28e4-4446-8887-c0c07dfe68c6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other financing activities, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_d4e04f99-2b20-4f44-91dc-cf1d7be4a044_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee payroll tax withholdings on stock issued under stock-based compensation plans</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_ab3ce9a3-7a8c-4122-8b79-404a1f87b09a_terseLabel_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_label_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</link:label>
    <link:label id="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_documentation_en-US" xlink:label="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:href="dgx-20210331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:to="lab_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d0d94645-8f08-4bc7-aa05-249a77d213c2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">EARNINGS (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_3c264b52-18cb-45ab-aabb-d0568be6c555_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_63710d97-48ad-40ea-a566-58cbf3737534_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill acquired during the period</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_b9054c16-f826-4cb7-bb92-743721ab6ef7_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_903af037-f86f-429d-ab1a-c39ec807110c_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_689e781e-b6f1-4787-9e0d-4189f6c8e3d5_terseLabel_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_label_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:label id="lab_dgx_AnatomicpathologytestingservicesMember_documentation_en-US" xlink:label="lab_dgx_AnatomicpathologytestingservicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Anatomic pathology testing services [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember" xlink:href="dgx-20210331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dgx_AnatomicpathologytestingservicesMember" xlink:to="lab_dgx_AnatomicpathologytestingservicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_702cd532-d690-44e5-af2e-a3dbc01d8e1f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_86d149c3-0c9b-4d93-bc6c-243e8d100af7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_867fa833-1dfd-43a7-a530-36780ea3b884_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvesteeMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvesteeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvesteeMember" xlink:to="lab_us-gaap_EquityMethodInvesteeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_6f022fa5-3e13-4a4b-8bd2-8928c330207f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Excluding Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_4443fafa-17ba-4c88-b711-64d804e01f0e_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Standards to be Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7ff5c25c-1758-499e-80b3-cc2026afbe52_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_7b34c1be-1b40-41ee-b89d-75cbb02e13ba_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>dgx-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:b7a2ec7e-72b2-4b96-9989-1413b2102795,g:ecef80b4-feab-4ac1-bfc2-6019ec2f6d37-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://questdiagnostics.com/role/CoverPage" xlink:type="simple" xlink:href="dgx-20210331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_61534cf3-1eaf-4b28-b9f2-01b4fedac005" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_DocumentType_61534cf3-1eaf-4b28-b9f2-01b4fedac005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a2e08df2-a052-413c-94aa-35ca1193db2a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_DocumentQuarterlyReport_a2e08df2-a052-413c-94aa-35ca1193db2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a28578a3-f009-4a0c-82c5-edadd84bb112" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_DocumentPeriodEndDate_a28578a3-f009-4a0c-82c5-edadd84bb112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_61d91ebc-fd68-48e6-9a74-c91514003044" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_DocumentTransitionReport_61d91ebc-fd68-48e6-9a74-c91514003044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_3c04d458-602c-48ff-8dcb-b5df241e7eb2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityFileNumber_3c04d458-602c-48ff-8dcb-b5df241e7eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_e0f40fec-c58a-4861-b78b-706b3240cfcd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityRegistrantName_e0f40fec-c58a-4861-b78b-706b3240cfcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_4ea1bafd-672a-4ddb-94eb-d979a0f969fd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityCentralIndexKey_4ea1bafd-672a-4ddb-94eb-d979a0f969fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_68ff36c7-2652-421a-9270-d590124ed8d7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_CurrentFiscalYearEndDate_68ff36c7-2652-421a-9270-d590124ed8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_43c92d69-623b-4293-a16f-015319b12199" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_DocumentFiscalYearFocus_43c92d69-623b-4293-a16f-015319b12199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8683a928-4cb0-4c1c-aa24-e4b7a47cf65b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8683a928-4cb0-4c1c-aa24-e4b7a47cf65b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_27944ead-fa3f-4548-a67b-a44f20c98c04" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_AmendmentFlag_27944ead-fa3f-4548-a67b-a44f20c98c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_eedcf54f-43f1-4dfc-9a74-3e80da792647" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityIncorporationStateCountryCode_eedcf54f-43f1-4dfc-9a74-3e80da792647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_f92033f5-1560-408c-940e-0ddb8a6b4285" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityTaxIdentificationNumber_f92033f5-1560-408c-940e-0ddb8a6b4285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b1c32e86-577e-4908-a331-9201f93e4511" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityAddressAddressLine1_b1c32e86-577e-4908-a331-9201f93e4511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_00613942-e28e-46ef-af19-72355c427085" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityAddressCityOrTown_00613942-e28e-46ef-af19-72355c427085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_cdf96bea-53b7-4e71-a01e-ef69f92bbe14" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityAddressStateOrProvince_cdf96bea-53b7-4e71-a01e-ef69f92bbe14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_1c858d6c-18db-4696-a581-3d72e643620c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityAddressPostalZipCode_1c858d6c-18db-4696-a581-3d72e643620c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_570a9b76-5a27-45be-bff5-7f97d22fc27f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_CityAreaCode_570a9b76-5a27-45be-bff5-7f97d22fc27f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_ae4082ea-963e-4a23-a0c8-fa35da28a173" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_LocalPhoneNumber_ae4082ea-963e-4a23-a0c8-fa35da28a173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e1848ca9-b28f-4b0a-bac6-a70470aeff37" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_Security12bTitle_e1848ca9-b28f-4b0a-bac6-a70470aeff37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_9d0c44c1-b70f-491f-8e35-5b3ee0c15b82" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_TradingSymbol_9d0c44c1-b70f-491f-8e35-5b3ee0c15b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_362676b6-bd75-4f9c-8471-87f9ceec6a6a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_SecurityExchangeName_362676b6-bd75-4f9c-8471-87f9ceec6a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_db903c14-6a17-4cb6-9a5b-86fe6e095e39" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityCurrentReportingStatus_db903c14-6a17-4cb6-9a5b-86fe6e095e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_82021da3-3f46-4b06-8590-44227d619b09" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityInteractiveDataCurrent_82021da3-3f46-4b06-8590-44227d619b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_69f5ad74-5ae4-4d1f-bfae-e3eb43d5e4c9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityFilerCategory_69f5ad74-5ae4-4d1f-bfae-e3eb43d5e4c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_cb9aa57a-e5be-42d0-b7ce-41c638bd457e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntitySmallBusiness_cb9aa57a-e5be-42d0-b7ce-41c638bd457e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_e87af4e1-8b67-418c-a29b-335f940d4c6c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityEmergingGrowthCompany_e87af4e1-8b67-418c-a29b-335f940d4c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b4b98613-0903-4472-99f5-7cd2ae418614" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityShellCompany_b4b98613-0903-4472-99f5-7cd2ae418614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_4941b019-272e-4560-b74a-88ca0a248298" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_912eca96-e760-40df-a579-b835093636fb" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_4941b019-272e-4560-b74a-88ca0a248298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b1ac0b2a-318d-4e9a-9fea-517bcb2cd23b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b1ac0b2a-318d-4e9a-9fea-517bcb2cd23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_425a148f-2b7b-4aac-8b0d-bb4414bf365f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_CostOfRevenueAbstract_425a148f-2b7b-4aac-8b0d-bb4414bf365f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f263bf2c-c6cf-47ad-b7f8-8c3862df4972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_425a148f-2b7b-4aac-8b0d-bb4414bf365f" xlink:to="loc_us-gaap_CostOfRevenue_f263bf2c-c6cf-47ad-b7f8-8c3862df4972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8a253afc-4631-4240-b059-2e2aec626d52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_425a148f-2b7b-4aac-8b0d-bb4414bf365f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_8a253afc-4631-4240-b059-2e2aec626d52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_85e17806-a4a4-4b3c-b722-0755c28853c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_425a148f-2b7b-4aac-8b0d-bb4414bf365f" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_85e17806-a4a4-4b3c-b722-0755c28853c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_2ad70b86-7b5a-4c29-9656-dc4201b91686" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_425a148f-2b7b-4aac-8b0d-bb4414bf365f" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_2ad70b86-7b5a-4c29-9656-dc4201b91686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_e1848443-3e78-450e-8279-3ed1c3a6ed00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_CostsAndExpenses_e1848443-3e78-450e-8279-3ed1c3a6ed00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ce83406d-c321-4cee-9d2c-46a462167d46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_OperatingIncomeLoss_ce83406d-c321-4cee-9d2c-46a462167d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e5d8ab22-8800-4855-9d8e-1d19975dfb52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e5d8ab22-8800-4855-9d8e-1d19975dfb52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_1e009fcc-a0b7-4e12-b156-83e5accea385" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e5d8ab22-8800-4855-9d8e-1d19975dfb52" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_1e009fcc-a0b7-4e12-b156-83e5accea385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_b13b8806-94fd-45cf-8acf-dda542d884e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e5d8ab22-8800-4855-9d8e-1d19975dfb52" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_b13b8806-94fd-45cf-8acf-dda542d884e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1c278456-6e9e-461e-a571-6aa184744043" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_e5d8ab22-8800-4855-9d8e-1d19975dfb52" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1c278456-6e9e-461e-a571-6aa184744043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a641bdd1-a8bf-4cac-a6b0-ff6fdb340304" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_a641bdd1-a8bf-4cac-a6b0-ff6fdb340304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fbce2829-3e18-4d0b-b40f-8b9b19832969" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fbce2829-3e18-4d0b-b40f-8b9b19832969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_23ba1636-887b-45ff-a846-f5388bd5b003" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_23ba1636-887b-45ff-a846-f5388bd5b003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_120f1e1d-30e2-4067-8943-793b5cf0076a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_ProfitLoss_120f1e1d-30e2-4067-8943-793b5cf0076a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_62aa515d-6b6e-4710-a8a4-be6ed0ffb128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_62aa515d-6b6e-4710-a8a4-be6ed0ffb128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ddc5e583-c5cb-4dd4-aacc-af327650fc0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_NetIncomeLoss_ddc5e583-c5cb-4dd4-aacc-af327650fc0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3454a318-51c6-4f2a-9d5a-36d298188e84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3454a318-51c6-4f2a-9d5a-36d298188e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b7742429-93bb-47aa-bb60-2d8225a45b31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3454a318-51c6-4f2a-9d5a-36d298188e84" xlink:to="loc_us-gaap_EarningsPerShareBasic_b7742429-93bb-47aa-bb60-2d8225a45b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_0c271625-abab-463c-a421-5b7878d142a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_3454a318-51c6-4f2a-9d5a-36d298188e84" xlink:to="loc_us-gaap_EarningsPerShareDiluted_0c271625-abab-463c-a421-5b7878d142a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_74fef903-3b6e-4008-a45d-729b1b1e1036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aef6b308-97ed-42b8-98fd-9151f045a419" xlink:to="loc_us-gaap_EarningsPerShareAbstract_74fef903-3b6e-4008-a45d-729b1b1e1036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_930a25ab-5986-4017-a446-1ae123e493fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_74fef903-3b6e-4008-a45d-729b1b1e1036" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_930a25ab-5986-4017-a446-1ae123e493fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c619f9e1-12bb-49f7-8c58-e2ad3fbd7cc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_74fef903-3b6e-4008-a45d-729b1b1e1036" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c619f9e1-12bb-49f7-8c58-e2ad3fbd7cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e645e979-0016-4a38-ac48-487995e15194" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_71084032-dbc3-493e-ac2b-ef33b2b4f495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e645e979-0016-4a38-ac48-487995e15194" xlink:to="loc_us-gaap_ProfitLoss_71084032-dbc3-493e-ac2b-ef33b2b4f495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_323bdd98-52bd-4927-9c3a-6a09961a3c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e645e979-0016-4a38-ac48-487995e15194" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_323bdd98-52bd-4927-9c3a-6a09961a3c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0cf71ad0-37e2-4c59-bce2-b0efb2dd1231" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_323bdd98-52bd-4927-9c3a-6a09961a3c7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_0cf71ad0-37e2-4c59-bce2-b0efb2dd1231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b640c7a2-e846-4713-8cc7-5327ea1fea73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_323bdd98-52bd-4927-9c3a-6a09961a3c7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_b640c7a2-e846-4713-8cc7-5327ea1fea73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f2a503d7-b300-4d78-a892-27ce65c018e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_323bdd98-52bd-4927-9c3a-6a09961a3c7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_f2a503d7-b300-4d78-a892-27ce65c018e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1cfb799f-2c2d-4d57-98d7-2a65110a66e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e645e979-0016-4a38-ac48-487995e15194" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1cfb799f-2c2d-4d57-98d7-2a65110a66e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_05fce135-0c17-479a-ba95-434cd5bad066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e645e979-0016-4a38-ac48-487995e15194" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_05fce135-0c17-479a-ba95-434cd5bad066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3fefecb9-0b1f-480d-b7c8-df40871b550f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e645e979-0016-4a38-ac48-487995e15194" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3fefecb9-0b1f-480d-b7c8-df40871b550f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_742a5dfb-b418-4546-8c72-e9a6413f21fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_742a5dfb-b418-4546-8c72-e9a6413f21fa" xlink:to="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1eda2691-ea8d-4526-86b4-446c9c36a618" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_1eda2691-ea8d-4526-86b4-446c9c36a618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_92b1ed1c-338a-491d-ae83-34a63759a913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_92b1ed1c-338a-491d-ae83-34a63759a913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_88919a2f-b11e-4cbd-ae7d-fc33c18dc9ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_InventoryNet_88919a2f-b11e-4cbd-ae7d-fc33c18dc9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_24faa8d2-7cb6-4cfb-bc98-bebdbce409a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_24faa8d2-7cb6-4cfb-bc98-bebdbce409a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_40963980-9a72-4c97-9991-1b751e0707e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_AssetsCurrent_40963980-9a72-4c97-9991-1b751e0707e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_966925b2-4b4a-437e-8f17-cffb07d3dcf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_966925b2-4b4a-437e-8f17-cffb07d3dcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_4d8252bb-152b-4580-a752-13905ec48d38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_4d8252bb-152b-4580-a752-13905ec48d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_0df95dd8-35f4-4eeb-9a71-eafc382197ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_Goodwill_0df95dd8-35f4-4eeb-9a71-eafc382197ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4df9ee76-af67-4e25-9341-c4598fb08e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4df9ee76-af67-4e25-9341-c4598fb08e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_c2e32cf1-6255-440b-909e-bd35c9dd9ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_EquityMethodInvestments_c2e32cf1-6255-440b-909e-bd35c9dd9ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f7ec109d-faeb-4870-9437-5dd5d657737c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f7ec109d-faeb-4870-9437-5dd5d657737c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_3c4953b4-0e29-4c1b-a1ab-9d0d1dd6bc8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0d77e904-63ab-4ff6-905a-634fc4149f39" xlink:to="loc_us-gaap_Assets_3c4953b4-0e29-4c1b-a1ab-9d0d1dd6bc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_742a5dfb-b418-4546-8c72-e9a6413f21fa" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_c631fe96-2354-4bdf-9f69-0f69c9ad5895" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_c631fe96-2354-4bdf-9f69-0f69c9ad5895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_aad6d376-3c12-4e06-935b-73b264a21cdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_LongTermDebtCurrent_aad6d376-3c12-4e06-935b-73b264a21cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_9e1946c0-10f6-42bc-aeb7-72a85ca62173" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_9e1946c0-10f6-42bc-aeb7-72a85ca62173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_44c5ea04-8189-451a-80ce-f98a54dc6d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_LiabilitiesCurrent_44c5ea04-8189-451a-80ce-f98a54dc6d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_58d44396-50a8-4d1f-a6a9-9454dbebf12c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_58d44396-50a8-4d1f-a6a9-9454dbebf12c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f4e4698e-ca30-442a-aee6-93101889aa9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f4e4698e-ca30-442a-aee6-93101889aa9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3a563d35-6c71-4dde-a203-5f69147a1816" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3a563d35-6c71-4dde-a203-5f69147a1816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_a9d55c1d-41c3-46bf-8aab-cd7268b4e809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_a9d55c1d-41c3-46bf-8aab-cd7268b4e809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_56a5c502-d5d2-4bae-b7e1-a1f96ec263a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount_56a5c502-d5d2-4bae-b7e1-a1f96ec263a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e7896932-497b-4a7d-a82e-c7e60c93e97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e7896932-497b-4a7d-a82e-c7e60c93e97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6f9d397f-8053-4311-a94b-6bb78287f0c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e7896932-497b-4a7d-a82e-c7e60c93e97c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_6f9d397f-8053-4311-a94b-6bb78287f0c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_f00dfeff-df6b-4236-8da9-21cc6967d50f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6f9d397f-8053-4311-a94b-6bb78287f0c4" xlink:to="loc_us-gaap_CommonStockValue_f00dfeff-df6b-4236-8da9-21cc6967d50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_18812a47-b084-40dc-aeef-3abdc05caa01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6f9d397f-8053-4311-a94b-6bb78287f0c4" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_18812a47-b084-40dc-aeef-3abdc05caa01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_606f4523-a70b-4f07-a987-f4232c736333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6f9d397f-8053-4311-a94b-6bb78287f0c4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_606f4523-a70b-4f07-a987-f4232c736333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b47bfa88-0aef-47d7-ba49-01efc321129c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6f9d397f-8053-4311-a94b-6bb78287f0c4" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b47bfa88-0aef-47d7-ba49-01efc321129c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ef650bcc-0880-454f-9d20-0d71db038af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6f9d397f-8053-4311-a94b-6bb78287f0c4" xlink:to="loc_us-gaap_TreasuryStockValue_ef650bcc-0880-454f-9d20-0d71db038af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7480265f-79ac-4c6d-b947-18db8b09aa6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6f9d397f-8053-4311-a94b-6bb78287f0c4" xlink:to="loc_us-gaap_StockholdersEquity_7480265f-79ac-4c6d-b947-18db8b09aa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_1fb9b002-bbbc-4d9c-8efe-bb30bc392f41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e7896932-497b-4a7d-a82e-c7e60c93e97c" xlink:to="loc_us-gaap_MinorityInterest_1fb9b002-bbbc-4d9c-8efe-bb30bc392f41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edcf53a2-7de5-4856-bfba-b47469dc0988" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e7896932-497b-4a7d-a82e-c7e60c93e97c" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_edcf53a2-7de5-4856-bfba-b47469dc0988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b60b1de2-75eb-475a-887f-ad02eef5d926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_9f782a12-c647-47ac-b39a-70f8e5c9937f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_b60b1de2-75eb-475a-887f-ad02eef5d926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1f47c214-0b61-475d-af54-65ea47d9a289" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e985c8cb-a029-42c1-b1d2-732c1af735cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1f47c214-0b61-475d-af54-65ea47d9a289" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e985c8cb-a029-42c1-b1d2-732c1af735cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_96311d4c-c52b-4d89-b72a-dc2206ead526" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1f47c214-0b61-475d-af54-65ea47d9a289" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_96311d4c-c52b-4d89-b72a-dc2206ead526" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_bbd05e88-6260-4f8a-9ee0-8fc572d65ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1f47c214-0b61-475d-af54-65ea47d9a289" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_bbd05e88-6260-4f8a-9ee0-8fc572d65ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_e533330a-dd3a-4b4d-9521-097cca5c5f17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1f47c214-0b61-475d-af54-65ea47d9a289" xlink:to="loc_us-gaap_CommonStockSharesIssued_e533330a-dd3a-4b4d-9521-097cca5c5f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_56ce151c-e711-4c7c-bbed-f0d86b6ac106" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1f47c214-0b61-475d-af54-65ea47d9a289" xlink:to="loc_us-gaap_TreasuryStockShares_56ce151c-e711-4c7c-bbed-f0d86b6ac106" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ec191033-bed6-467a-8f81-552d2c3bdb47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6dbaa5e3-9882-456f-b945-31c34fa8c48c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ec191033-bed6-467a-8f81-552d2c3bdb47" xlink:to="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6dbaa5e3-9882-456f-b945-31c34fa8c48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da8adda2-0a56-4b12-a855-59e53e3fa06c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6dbaa5e3-9882-456f-b945-31c34fa8c48c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da8adda2-0a56-4b12-a855-59e53e3fa06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_6209dda6-513d-475f-b9c1-7d9e1b740155" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da8adda2-0a56-4b12-a855-59e53e3fa06c" xlink:to="loc_us-gaap_ProfitLoss_6209dda6-513d-475f-b9c1-7d9e1b740155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51726c15-298b-4cbb-91d6-045aeeecdffc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da8adda2-0a56-4b12-a855-59e53e3fa06c" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51726c15-298b-4cbb-91d6-045aeeecdffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_51c98bcf-df4f-4050-affb-be8966114bc8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51726c15-298b-4cbb-91d6-045aeeecdffc" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_51c98bcf-df4f-4050-affb-be8966114bc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_03983de6-befa-4bb5-8c00-c17a333d3de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetCreditLossExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51726c15-298b-4cbb-91d6-045aeeecdffc" xlink:to="loc_us-gaap_ContractWithCustomerAssetCreditLossExpense_03983de6-befa-4bb5-8c00-c17a333d3de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b34cc6a7-a05d-473c-a97e-0353fcfb2832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51726c15-298b-4cbb-91d6-045aeeecdffc" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_b34cc6a7-a05d-473c-a97e-0353fcfb2832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4d4f229c-fde4-4c5b-aba7-7988cb4c1739" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51726c15-298b-4cbb-91d6-045aeeecdffc" xlink:to="loc_us-gaap_ShareBasedCompensation_4d4f229c-fde4-4c5b-aba7-7988cb4c1739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_49cc8c9c-2002-4d19-bd91-0061935401f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_51726c15-298b-4cbb-91d6-045aeeecdffc" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_49cc8c9c-2002-4d19-bd91-0061935401f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de05913b-edfa-4940-8aaa-b8e5acba978a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da8adda2-0a56-4b12-a855-59e53e3fa06c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de05913b-edfa-4940-8aaa-b8e5acba978a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_419fef21-c2e2-46a8-85d2-a88786c867b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de05913b-edfa-4940-8aaa-b8e5acba978a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_419fef21-c2e2-46a8-85d2-a88786c867b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ec92caa1-d4fa-49e9-98b0-b6675a3db5da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de05913b-edfa-4940-8aaa-b8e5acba978a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ec92caa1-d4fa-49e9-98b0-b6675a3db5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5989b91d-f0e3-4ad4-be4c-d9585117b553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de05913b-edfa-4940-8aaa-b8e5acba978a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable_5989b91d-f0e3-4ad4-be4c-d9585117b553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6dfcca82-e131-411b-a14d-44f143ecd931" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_de05913b-edfa-4940-8aaa-b8e5acba978a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet_6dfcca82-e131-411b-a14d-44f143ecd931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee51d035-a4d4-4b94-a7e5-7b2f18a72a36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_da8adda2-0a56-4b12-a855-59e53e3fa06c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ee51d035-a4d4-4b94-a7e5-7b2f18a72a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6ee14bbe-56d6-4980-b0d2-f756e1a0df8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6dbaa5e3-9882-456f-b945-31c34fa8c48c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6ee14bbe-56d6-4980-b0d2-f756e1a0df8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d053c3a8-6e17-4afc-899d-865819fe6427" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6ee14bbe-56d6-4980-b0d2-f756e1a0df8e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d053c3a8-6e17-4afc-899d-865819fe6427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9d29d3da-34b9-4fd1-8e81-271cccb6323f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6ee14bbe-56d6-4980-b0d2-f756e1a0df8e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9d29d3da-34b9-4fd1-8e81-271cccb6323f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bcacba70-7102-4ff2-aa79-5fe80070d8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6ee14bbe-56d6-4980-b0d2-f756e1a0df8e" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bcacba70-7102-4ff2-aa79-5fe80070d8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8e781520-a96f-4fc5-a000-c17a82e1d62f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_6ee14bbe-56d6-4980-b0d2-f756e1a0df8e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_8e781520-a96f-4fc5-a000-c17a82e1d62f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6dbaa5e3-9882-456f-b945-31c34fa8c48c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_781e93fc-fae9-4539-bb7d-45a890009f05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:to="loc_us-gaap_RepaymentsOfDebt_781e93fc-fae9-4539-bb7d-45a890009f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_13ff48c1-f3ed-4725-a37a-b2b2144cd773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_13ff48c1-f3ed-4725-a37a-b2b2144cd773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_05b73370-8f44-4181-857d-360246d33c54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_05b73370-8f44-4181-857d-360246d33c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_333a41e7-4bc2-47d8-a28c-369f3550ca93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_333a41e7-4bc2-47d8-a28c-369f3550ca93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_efa213d4-37eb-4414-aece-2c9e382bce4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_efa213d4-37eb-4414-aece-2c9e382bce4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0172f75c-4e57-483b-a0e4-b318e1e490bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividendsMinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:to="loc_us-gaap_PaymentsOfDividendsMinorityInterest_0172f75c-4e57-483b-a0e4-b318e1e490bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a7699190-31ce-47a7-847a-eae656260a3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_a7699190-31ce-47a7-847a-eae656260a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d6ef372d-122d-4bd8-b621-bf8d7fb231ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_03b07376-1302-4cc1-b46e-bc9cccc1aad3" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d6ef372d-122d-4bd8-b621-bf8d7fb231ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8e717359-3355-47da-a006-39737c586cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6dbaa5e3-9882-456f-b945-31c34fa8c48c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8e717359-3355-47da-a006-39737c586cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_526187eb-cd95-4153-936d-388ad60995bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6dbaa5e3-9882-456f-b945-31c34fa8c48c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_526187eb-cd95-4153-936d-388ad60995bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1c34f17d-2696-44fb-bb06-e67cea3f8729" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract_6dbaa5e3-9882-456f-b945-31c34fa8c48c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1c34f17d-2696-44fb-bb06-e67cea3f8729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="dgx-20210331.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_5355a0b7-03e8-4d26-b595-b2ecb7780be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_f9aa0ff7-300b-4dae-a74e-4a990b75387e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_5355a0b7-03e8-4d26-b595-b2ecb7780be3" xlink:to="loc_us-gaap_StatementTable_f9aa0ff7-300b-4dae-a74e-4a990b75387e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_231055fb-cad3-48a7-b39b-146506deb0fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f9aa0ff7-300b-4dae-a74e-4a990b75387e" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_231055fb-cad3-48a7-b39b-146506deb0fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_231055fb-cad3-48a7-b39b-146506deb0fd" xlink:to="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_ced79fe1-f290-4bff-9401-5f6e61ffef90" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_CommonStockMember_ced79fe1-f290-4bff-9401-5f6e61ffef90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_14f529e5-4401-4c4e-8da4-347a7c3f7944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_14f529e5-4401-4c4e-8da4-347a7c3f7944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_94900e22-d5ec-436a-9785-44cd97723c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_RetainedEarningsMember_94900e22-d5ec-436a-9785-44cd97723c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c09eb50d-6c52-4970-bcdb-88d1f111cc0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c09eb50d-6c52-4970-bcdb-88d1f111cc0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_e9ab6aeb-0c46-4c51-96e7-01801ce04310" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_TreasuryStockMember_e9ab6aeb-0c46-4c51-96e7-01801ce04310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_16da5bcc-7c25-4b5d-af4e-7da4569cf51a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2df38285-8ac3-4e32-aae6-a4a65870b609" xlink:to="loc_us-gaap_NoncontrollingInterestMember_16da5bcc-7c25-4b5d-af4e-7da4569cf51a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_010267d8-3e85-40c2-8b4b-b3bda8bd18e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_f9aa0ff7-300b-4dae-a74e-4a990b75387e" xlink:to="loc_us-gaap_StatementLineItems_010267d8-3e85-40c2-8b4b-b3bda8bd18e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_010267d8-3e85-40c2-8b4b-b3bda8bd18e8" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_51975c24-98a3-470c-acce-5dbb1cc6e597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_51975c24-98a3-470c-acce-5dbb1cc6e597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54e16aef-5e12-4f71-adf7-85a93ff3ed41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_54e16aef-5e12-4f71-adf7-85a93ff3ed41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_a7942e0e-b3d1-4bbd-90f1-0c98fda462b4" xlink:href="dgx-20210331.xsd#dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest_a7942e0e-b3d1-4bbd-90f1-0c98fda462b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4eb61cb3-8856-4602-8f9a-848640227964" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_4eb61cb3-8856-4602-8f9a-848640227964" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_2fafebfb-23f1-4c2c-9248-39ffa86b4cce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_DividendsCommonStockCash_2fafebfb-23f1-4c2c-9248-39ffa86b4cce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f348b506-eed6-42ed-8de4-c8fb06a9d9fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_f348b506-eed6-42ed-8de4-c8fb06a9d9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_983f483f-d727-4ba2-88de-4ccf33e02875" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_983f483f-d727-4ba2-88de-4ccf33e02875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_04489f44-d582-494d-8ad0-ecd439e0f5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_04489f44-d582-494d-8ad0-ecd439e0f5c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1a7c7fef-9e48-4760-a826-119bc2552f8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1a7c7fef-9e48-4760-a826-119bc2552f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2d8a258e-e947-4ba0-892b-fc2e619c832f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_2d8a258e-e947-4ba0-892b-fc2e619c832f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_916768e1-b022-4d01-b41d-a0843c7172dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_916768e1-b022-4d01-b41d-a0843c7172dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_0c762076-6df1-48c5-a116-008660db3dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_0c762076-6df1-48c5-a116-008660db3dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e219e85a-f4b6-4be1-bcda-af0899457f83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_e219e85a-f4b6-4be1-bcda-af0899457f83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_67402038-e4ba-4a21-9c80-d1df6af8dd59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_67402038-e4ba-4a21-9c80-d1df6af8dd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_788b4f09-54a5-4748-a2c1-37a36d3e9af0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_0b9d80b8-87db-428a-8106-d406096cc86a" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_788b4f09-54a5-4748-a2c1-37a36d3e9af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_010267d8-3e85-40c2-8b4b-b3bda8bd18e8" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6aa6dcd0-3b67-4374-832c-b1d75df2d9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6aa6dcd0-3b67-4374-832c-b1d75df2d9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityNetIncome_47b5160c-a198-405e-aeb3-e9309392f637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityNetIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:to="loc_us-gaap_TemporaryEquityNetIncome_47b5160c-a198-405e-aeb3-e9309392f637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_f5a6904c-3787-4589-a13c-c1db5c4000f9" xlink:href="dgx-20210331.xsd#dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:to="loc_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders_f5a6904c-3787-4589-a13c-c1db5c4000f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6b6baa4b-4759-4126-9008-8766c05be910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_ea5baf70-401d-495b-945a-e4d42ad24d6d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6b6baa4b-4759-4126-9008-8766c05be910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="dgx-20210331.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DescriptionOfBusinessAbstract_36aa3c67-51b1-4ac0-8ce3-c6f093047343" xlink:href="dgx-20210331.xsd#dgx_DescriptionOfBusinessAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_54931f02-b7c3-4675-89be-6b5e8703d005" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_DescriptionOfBusinessAbstract_36aa3c67-51b1-4ac0-8ce3-c6f093047343" xlink:to="loc_us-gaap_NatureOfOperations_54931f02-b7c3-4675-89be-6b5e8703d005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ffabca05-3652-4e45-bef3-36d79f7fa7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_778c5e92-8dfc-405e-b99b-726e0d631dec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ffabca05-3652-4e45-bef3-36d79f7fa7c7" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_778c5e92-8dfc-405e-b99b-726e0d631dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_a4f80e37-e47b-4b59-b8c6-562701f45636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4594ec5a-eb66-4eb2-9e1b-22455e6c47d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a4f80e37-e47b-4b59-b8c6-562701f45636" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4594ec5a-eb66-4eb2-9e1b-22455e6c47d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_c79b7d23-a357-4c7c-adcf-7b75d8d01b29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a4f80e37-e47b-4b59-b8c6-562701f45636" xlink:to="loc_us-gaap_UseOfEstimates_c79b7d23-a357-4c7c-adcf-7b75d8d01b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_dba1e6cf-6e46-4f14-9810-2d12c2bdd59a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a4f80e37-e47b-4b59-b8c6-562701f45636" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_dba1e6cf-6e46-4f14-9810-2d12c2bdd59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0c0db41f-06dd-44cd-8f63-c797397ccce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a4f80e37-e47b-4b59-b8c6-562701f45636" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0c0db41f-06dd-44cd-8f63-c797397ccce8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_7d0d8c4b-3d0c-4e63-aa1d-d2296ae6af4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_a4f80e37-e47b-4b59-b8c6-562701f45636" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_7d0d8c4b-3d0c-4e63-aa1d-d2296ae6af4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHARE"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_563819c3-cc3b-4d2e-b09e-92004db3c9db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_00b4b401-49fc-4f7d-ad3e-f521d4a914dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_563819c3-cc3b-4d2e-b09e-92004db3c9db" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_00b4b401-49fc-4f7d-ad3e-f521d4a914dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHARETables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e2864555-6f02-415f-aeca-a7f1c1410aa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a8aa5e33-be04-4db3-ab1d-09f956cb86fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e2864555-6f02-415f-aeca-a7f1c1410aa1" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a8aa5e33-be04-4db3-ab1d-09f956cb86fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_29829522-2294-4052-9645-3fa17a89eadc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_e2864555-6f02-415f-aeca-a7f1c1410aa1" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_29829522-2294-4052-9645-3fa17a89eadc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#EARNINGSPERSHAREDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/EARNINGSPERSHAREDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_04e3afed-bb37-4093-bd31-c21ee41c9ceb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_04e3afed-bb37-4093-bd31-c21ee41c9ceb" xlink:to="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_48facddd-f02d-41e3-8b85-689fed1cdd0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:to="loc_us-gaap_NetIncomeLoss_48facddd-f02d-41e3-8b85-689fed1cdd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_6bcbc4de-ea2d-4031-9f86-e763718cd731" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:to="loc_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted_6bcbc4de-ea2d-4031-9f86-e763718cd731" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_96dac9ad-b1c4-4bcb-964d-de19802d37f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_96dac9ad-b1c4-4bcb-964d-de19802d37f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dbab97f4-18e0-4fb4-a72f-b84ff77d1cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dbab97f4-18e0-4fb4-a72f-b84ff77d1cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_97089ca4-757d-41b0-9167-ea827d4aff9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_97089ca4-757d-41b0-9167-ea827d4aff9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_10b64550-854e-43e2-a076-7fdce947706d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_10b64550-854e-43e2-a076-7fdce947706d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c4a09dac-1332-4ae5-864f-fe9c3ae9979b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:to="loc_us-gaap_EarningsPerShareBasic_c4a09dac-1332-4ae5-864f-fe9c3ae9979b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_5655aaf5-a7d0-4cea-b6e0-97f4799223d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract_ff4bec2f-222f-4fdb-869a-f32b2b14ddbc" xlink:to="loc_us-gaap_EarningsPerShareDiluted_5655aaf5-a7d0-4cea-b6e0-97f4799223d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d9459295-7102-4549-91d1-591d8be59a83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_04e3afed-bb37-4093-bd31-c21ee41c9ceb" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d9459295-7102-4549-91d1-591d8be59a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSACQUISITIONS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5bde89f7-a275-405b-a505-22b05e98ba0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_513e0fd5-a1ff-4370-9e73-31d208fcdfd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5bde89f7-a275-405b-a505-22b05e98ba0d" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_513e0fd5-a1ff-4370-9e73-31d208fcdfd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3b04c073-192a-47d3-aadd-545f5e6947b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_e14122e5-fd7b-4882-a332-e835e278f1a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3b04c073-192a-47d3-aadd-545f5e6947b4" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_e14122e5-fd7b-4882-a332-e835e278f1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ca67e5b5-e51b-4834-b02f-66768d63e384" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_654eafa6-a56b-4f78-b9a9-34e1b6544378" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ca67e5b5-e51b-4834-b02f-66768d63e384" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_654eafa6-a56b-4f78-b9a9-34e1b6544378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_7a0bb998-f03e-4b02-91fe-f9850091c932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_7a0bb998-f03e-4b02-91fe-f9850091c932" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d8d9cd62-8789-40f8-8b87-c0d8d69eb350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d8d9cd62-8789-40f8-8b87-c0d8d69eb350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ca316b7f-3ab4-43e4-b84e-49aa5864d42b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d8d9cd62-8789-40f8-8b87-c0d8d69eb350" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ca316b7f-3ab4-43e4-b84e-49aa5864d42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_16365fbc-0e7a-4548-b331-72bf006f94c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_ca316b7f-3ab4-43e4-b84e-49aa5864d42b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_16365fbc-0e7a-4548-b331-72bf006f94c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0276abf7-9fd3-4a1b-b60a-cc506c753cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0276abf7-9fd3-4a1b-b60a-cc506c753cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_0276abf7-9fd3-4a1b-b60a-cc506c753cd8" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_82605114-95e3-47ec-8754-e6144af6813c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_82605114-95e3-47ec-8754-e6144af6813c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_385db861-04d3-4258-883a-feca4108d58a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_385db861-04d3-4258-883a-feca4108d58a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_ece6b0b3-21d2-4127-a67c-c35866ee5470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_886d6db8-6590-46da-8f33-30d19920b126" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_ece6b0b3-21d2-4127-a67c-c35866ee5470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_cd33e887-8c9e-4398-b3d3-38e697ee0c46" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradingSecurities_e820f42f-0c3a-4796-b50f-e53b4824fbc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradingSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_TradingSecurities_e820f42f-0c3a-4796-b50f-e53b4824fbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashSurrenderValueFairValueDisclosure_4d855222-5b84-4f6b-af40-b1d95c42f55a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashSurrenderValueFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_CashSurrenderValueFairValueDisclosure_4d855222-5b84-4f6b-af40-b1d95c42f55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4277505f-f8c6-4716-946f-7f0929f597d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_4277505f-f8c6-4716-946f-7f0929f597d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_caac9816-62bd-447e-be20-5738ea82a632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_caac9816-62bd-447e-be20-5738ea82a632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_a91e2617-68bd-4e13-a347-d8e51981f754" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent_a91e2617-68bd-4e13-a347-d8e51981f754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_e6975fda-e304-415d-b6bc-21b7b5216996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_db859b5a-f8fe-4223-b675-4703dcb0f2e8" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityFairValue_e6975fda-e304-415d-b6bc-21b7b5216996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FAIRVALUEMEASUREMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_ff659fce-930a-4dba-9ffe-487fff4eb004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ff659fce-930a-4dba-9ffe-487fff4eb004" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_a9834c0a-d72c-4194-bd62-ce2d54481823" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:to="loc_srt_OwnershipAxis_a9834c0a-d72c-4194-bd62-ce2d54481823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_a9a21808-4755-46eb-8eef-6cc5803aff87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_a9834c0a-d72c-4194-bd62-ce2d54481823" xlink:to="loc_srt_OwnershipDomain_a9a21808-4755-46eb-8eef-6cc5803aff87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_2e517dbd-87a7-4cd0-be7d-b9536c2c169b" xlink:href="dgx-20210331.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_a9a21808-4755-46eb-8eef-6cc5803aff87" xlink:to="loc_dgx_UMassJointVentureMember_2e517dbd-87a7-4cd0-be7d-b9536c2c169b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bae224b6-f210-422f-af20-c2fa2e695c1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a9fd710c-9050-4248-8ea5-9b0ca1f6fb8e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bae224b6-f210-422f-af20-c2fa2e695c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_1939bc16-703d-4942-92c3-9defd2c8958a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bae224b6-f210-422f-af20-c2fa2e695c1c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_1939bc16-703d-4942-92c3-9defd2c8958a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3598a770-f320-4fa6-9569-2ea4da89abd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_d483cf61-0de8-4009-b1fc-0c8882fc9886" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3598a770-f320-4fa6-9569-2ea4da89abd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_66c9b2d7-ac90-4990-8990-e136f85d5373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3598a770-f320-4fa6-9569-2ea4da89abd1" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_66c9b2d7-ac90-4990-8990-e136f85d5373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_29077af1-9103-44f4-8c8d-8cacb9d1a818" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_3598a770-f320-4fa6-9569-2ea4da89abd1" xlink:to="loc_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment_29077af1-9103-44f4-8c8d-8cacb9d1a818" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_1dea355d-caa9-4376-9395-fa258aa80637" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_ff659fce-930a-4dba-9ffe-487fff4eb004" xlink:to="loc_us-gaap_DebtInstrumentFairValue_1dea355d-caa9-4376-9395-fa258aa80637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1659e62e-1793-4ab2-82b9-7533016dba73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_090023fd-2bba-4150-a155-83e6ff0ae4e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1659e62e-1793-4ab2-82b9-7533016dba73" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_090023fd-2bba-4150-a155-83e6ff0ae4e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2fbda225-a7a1-4059-b5e4-6c2dd6254261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_497419c1-dd5e-44d1-8c1a-4f568c1c76a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2fbda225-a7a1-4059-b5e4-6c2dd6254261" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_497419c1-dd5e-44d1-8c1a-4f568c1c76a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_89b6ef41-5d7d-4454-8167-09aa0d1660db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2fbda225-a7a1-4059-b5e4-6c2dd6254261" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_89b6ef41-5d7d-4454-8167-09aa0d1660db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8ff6579f-2cb3-4251-aa70-e8619f16e9b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2fbda225-a7a1-4059-b5e4-6c2dd6254261" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_8ff6579f-2cb3-4251-aa70-e8619f16e9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSGoodwillDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9c2a023-5b52-4c0d-a0b8-14e9dee77847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_f3a4f4aa-b0c5-4f04-81b6-96adbb83cf30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9c2a023-5b52-4c0d-a0b8-14e9dee77847" xlink:to="loc_us-gaap_GoodwillRollForward_f3a4f4aa-b0c5-4f04-81b6-96adbb83cf30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ba1a96d1-5832-409c-92ed-e440d51b1987" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f3a4f4aa-b0c5-4f04-81b6-96adbb83cf30" xlink:to="loc_us-gaap_Goodwill_ba1a96d1-5832-409c-92ed-e440d51b1987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_9738bbb9-f4ff-4307-bf7c-3faf0ba8552e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f3a4f4aa-b0c5-4f04-81b6-96adbb83cf30" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_9738bbb9-f4ff-4307-bf7c-3faf0ba8552e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillPeriodIncreaseDecrease_9ce8e98d-354f-4aea-b33a-a8cd7545f14c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillPeriodIncreaseDecrease"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f3a4f4aa-b0c5-4f04-81b6-96adbb83cf30" xlink:to="loc_us-gaap_GoodwillPeriodIncreaseDecrease_9ce8e98d-354f-4aea-b33a-a8cd7545f14c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_09c8b325-4725-4336-adc0-c94480b2c264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_f3a4f4aa-b0c5-4f04-81b6-96adbb83cf30" xlink:to="loc_us-gaap_Goodwill_09c8b325-4725-4336-adc0-c94480b2c264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4ceb8619-2926-4099-a544-f8b19eab4160" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b9c2a023-5b52-4c0d-a0b8-14e9dee77847" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4ceb8619-2926-4099-a544-f8b19eab4160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_bf4c055a-1ec0-490c-9f5f-1faac7e541b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4ceb8619-2926-4099-a544-f8b19eab4160" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_bf4c055a-1ec0-490c-9f5f-1faac7e541b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3baeb062-881c-44fd-82b8-dc11282d9c81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_bf4c055a-1ec0-490c-9f5f-1faac7e541b4" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3baeb062-881c-44fd-82b8-dc11282d9c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_6c89deb7-12e5-4fce-93e7-437fd33fa975" xlink:href="dgx-20210331.xsd#dgx_MidAmericaClinicalLaboratoriesLLCMACLMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3baeb062-881c-44fd-82b8-dc11282d9c81" xlink:to="loc_dgx_MidAmericaClinicalLaboratoriesLLCMACLMember_6c89deb7-12e5-4fce-93e7-437fd33fa975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_d86bdbc1-dbb2-4792-987e-38bdd5a9f85d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_4ceb8619-2926-4099-a544-f8b19eab4160" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_d86bdbc1-dbb2-4792-987e-38bdd5a9f85d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_44a76be5-337e-4ba3-b6c7-99da4de8554b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_d86bdbc1-dbb2-4792-987e-38bdd5a9f85d" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_44a76be5-337e-4ba3-b6c7-99da4de8554b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#GOODWILLANDINTANGIBLEASSETSSchedulesDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba7762da-5fa1-47bd-9e0d-370ccc2c96d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:href="dgx-20210331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ba7762da-5fa1-47bd-9e0d-370ccc2c96d5" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_3f66086f-c60e-42a3-b1ca-a8e5bb1f0459" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_ecd69bce-90c1-414a-8c7d-a81d45d88800" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_us-gaap_CustomerRelationshipsMember_ecd69bce-90c1-414a-8c7d-a81d45d88800" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_04298765-f6bb-4164-b67c-5be6192a2923" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_04298765-f6bb-4164-b67c-5be6192a2923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnpatentedTechnologyMember_5a380561-d469-4d28-90c3-6f544b9750d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnpatentedTechnologyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_us-gaap_UnpatentedTechnologyMember_5a380561-d469-4d28-90c3-6f544b9750d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_3a59d609-476f-4174-b775-26bfca210a2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_3a59d609-476f-4174-b775-26bfca210a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_TotalAmortizingIntangibleAssetsMember_973ce848-8b13-47f1-947f-2ffcf0678481" xlink:href="dgx-20210331.xsd#dgx_TotalAmortizingIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4ff1cbce-cf7b-4ede-a70d-e9da4b728037" xlink:to="loc_dgx_TotalAmortizingIntangibleAssetsMember_973ce848-8b13-47f1-947f-2ffcf0678481" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c333e538-8f45-431a-8454-1dc5f89312fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c333e538-8f45-431a-8454-1dc5f89312fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e5ca883f-e4b0-4c60-83fd-01f70925c410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_c333e538-8f45-431a-8454-1dc5f89312fa" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e5ca883f-e4b0-4c60-83fd-01f70925c410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_b0feb7a7-28b6-486e-a5ab-f74f79c348a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e5ca883f-e4b0-4c60-83fd-01f70925c410" xlink:to="loc_us-gaap_TradeNamesMember_b0feb7a7-28b6-486e-a5ab-f74f79c348a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_7e1f674b-e0aa-43ee-ae3b-a81e3b1c01cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_e5ca883f-e4b0-4c60-83fd-01f70925c410" xlink:to="loc_us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember_7e1f674b-e0aa-43ee-ae3b-a81e3b1c01cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:href="dgx-20210331.xsd#dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable_f416a60c-c912-483f-a260-13552356dc71" xlink:to="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8af6c418-9ca4-4d7f-9cb7-a50dc9c8edf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_8af6c418-9ca4-4d7f-9cb7-a50dc9c8edf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d0450e77-9e70-4d57-bdca-ba1fb4ae6ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_d0450e77-9e70-4d57-bdca-ba1fb4ae6ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f88638dc-41af-45b1-a1fe-403a4a9ce400" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f88638dc-41af-45b1-a1fe-403a4a9ce400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_00246ad8-fc7d-4879-84fe-c10031eb6e11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_00246ad8-fc7d-4879-84fe-c10031eb6e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_cefcaa47-4467-44fc-a2a1-9c5cf2aaddf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_cefcaa47-4467-44fc-a2a1-9c5cf2aaddf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems_b016d372-9f07-4f13-b136-7815938a9057" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_bbf73de7-50d3-4e80-93f3-c9bb217c8fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_bbf73de7-50d3-4e80-93f3-c9bb217c8fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b3e0fb8f-9c94-4a6d-a302-eedf218e8866" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_b3e0fb8f-9c94-4a6d-a302-eedf218e8866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_91ce7193-6e43-4c84-86c5-32c1147ab1c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_91ce7193-6e43-4c84-86c5-32c1147ab1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dbcc862d-39af-447a-8c1d-a533ad671888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_dbcc862d-39af-447a-8c1d-a533ad671888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9503e0b0-25b6-4916-bdb6-a864fb4dd33c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_9503e0b0-25b6-4916-bdb6-a864fb4dd33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1e794d6c-68b2-4332-a456-3219f75c02e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_1e794d6c-68b2-4332-a456-3219f75c02e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f4c9569a-fedc-4a42-a562-71b3095547b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f4c9569a-fedc-4a42-a562-71b3095547b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_14aa9996-e9ba-44bb-acfa-0e50740f396b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract_779a677c-b6cd-484d-ae56-4c80cc80780e" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_14aa9996-e9ba-44bb-acfa-0e50740f396b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTS"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_daeaee4d-7331-496e-af4d-5fbfce01d733" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5d617080-2f29-4044-84df-4ec9fc897bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_daeaee4d-7331-496e-af4d-5fbfce01d733" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_5d617080-2f29-4044-84df-4ec9fc897bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5e65e582-566a-42d6-88fb-c056b798b25d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_564528e5-332e-41a2-8851-0b18792865ba" xlink:href="dgx-20210331.xsd#dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5e65e582-566a-42d6-88fb-c056b798b25d" xlink:to="loc_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock_564528e5-332e-41a2-8851-0b18792865ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_444109c6-7bfd-4602-b64d-2271a57e942e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_5e65e582-566a-42d6-88fb-c056b798b25d" xlink:to="loc_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_444109c6-7bfd-4602-b64d-2271a57e942e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_11845a7e-2b9c-46bf-9adb-0aa96eb236eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_11845a7e-2b9c-46bf-9adb-0aa96eb236eb" xlink:to="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b8eec63-669b-42ea-a7cd-bba449a77f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b8eec63-669b-42ea-a7cd-bba449a77f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_d4eca7de-2256-4e48-85b5-f453b4ac2a03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_5b8eec63-669b-42ea-a7cd-bba449a77f4e" xlink:to="loc_us-gaap_HedgingRelationshipDomain_d4eca7de-2256-4e48-85b5-f453b4ac2a03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_542055f3-0fbb-448d-91bf-3707f0ffa8ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d4eca7de-2256-4e48-85b5-f453b4ac2a03" xlink:to="loc_us-gaap_CashFlowHedgingMember_542055f3-0fbb-448d-91bf-3707f0ffa8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_5538e87a-3b1b-44d0-8c19-43cc603b6619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_d4eca7de-2256-4e48-85b5-f453b4ac2a03" xlink:to="loc_us-gaap_FairValueHedgingMember_5538e87a-3b1b-44d0-8c19-43cc603b6619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_0ed8796f-2b96-4206-8bb3-4c0e84b86963" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:to="loc_srt_StatementScenarioAxis_0ed8796f-2b96-4206-8bb3-4c0e84b86963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_dc174951-8326-4fef-8956-4d819d6c0b27" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_0ed8796f-2b96-4206-8bb3-4c0e84b86963" xlink:to="loc_srt_ScenarioUnspecifiedDomain_dc174951-8326-4fef-8956-4d819d6c0b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_1e3509ec-5304-4fcf-b0dc-94f692c77242" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_dc174951-8326-4fef-8956-4d819d6c0b27" xlink:to="loc_srt_ScenarioForecastMember_1e3509ec-5304-4fcf-b0dc-94f692c77242" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_d99b0a0e-41b0-4458-b4b4-7e7c737838a3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:to="loc_srt_RangeAxis_d99b0a0e-41b0-4458-b4b4-7e7c737838a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_d806f255-4058-4b92-af2f-8b1105a81e81" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_d99b0a0e-41b0-4458-b4b4-7e7c737838a3" xlink:to="loc_srt_RangeMember_d806f255-4058-4b92-af2f-8b1105a81e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0385f93f-7f7d-4aca-b6a4-d93913d916ff" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_d806f255-4058-4b92-af2f-8b1105a81e81" xlink:to="loc_srt_MinimumMember_0385f93f-7f7d-4aca-b6a4-d93913d916ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_3358c649-2d26-4352-bdac-4d646f5a3086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_ddaf3f20-c1a0-499e-a6a4-ecd87ca9560d" xlink:to="loc_us-gaap_DerivativeLineItems_3358c649-2d26-4352-bdac-4d646f5a3086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aad0689a-8931-4463-bccf-7330b064a85a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3358c649-2d26-4352-bdac-4d646f5a3086" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_aad0689a-8931-4463-bccf-7330b064a85a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_73552950-06af-4bf8-8d30-f2b298e35638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_3358c649-2d26-4352-bdac-4d646f5a3086" xlink:to="loc_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths_73552950-06af-4bf8-8d30-f2b298e35638" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSBalanceSheetsDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f60c56ad-8ebf-4e44-adc2-7fb56fc515a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f60c56ad-8ebf-4e44-adc2-7fb56fc515a8" xlink:to="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_41217ec0-d55e-43da-8a92-79aafd47bcc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_41217ec0-d55e-43da-8a92-79aafd47bcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b3582b01-7b9a-46af-9758-ca607188377b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_41217ec0-d55e-43da-8a92-79aafd47bcc2" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b3582b01-7b9a-46af-9758-ca607188377b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMember_03b89a35-c22f-4b12-823f-9e344f11643d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b3582b01-7b9a-46af-9758-ca607188377b" xlink:to="loc_us-gaap_LongTermDebtMember_03b89a35-c22f-4b12-823f-9e344f11643d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e753ec4b-121b-4089-9646-4b3a296655ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e753ec4b-121b-4089-9646-4b3a296655ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_df968971-8097-46bd-9f08-d5a59d6f3a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_e753ec4b-121b-4089-9646-4b3a296655ac" xlink:to="loc_us-gaap_HedgingRelationshipDomain_df968971-8097-46bd-9f08-d5a59d6f3a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_b83a206c-9522-4516-a878-6d559894ee55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_df968971-8097-46bd-9f08-d5a59d6f3a16" xlink:to="loc_us-gaap_FairValueHedgingMember_b83a206c-9522-4516-a878-6d559894ee55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1b4f6257-21bd-43b6-a5e3-0ff6cf762c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_4c3ebf5c-b460-4561-85e1-bf6ddfcd10f3" xlink:to="loc_us-gaap_DerivativeLineItems_1b4f6257-21bd-43b6-a5e3-0ff6cf762c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_0265615a-9092-439f-845a-cac3ff153a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1b4f6257-21bd-43b6-a5e3-0ff6cf762c13" xlink:to="loc_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease_0265615a-9092-439f-845a-cac3ff153a48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#FINANCIALINSTRUMENTSIncomeStatementDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e5118b1a-ca92-400d-9da9-0521ab85ebb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e5118b1a-ca92-400d-9da9-0521ab85ebb6" xlink:to="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_72aa6b19-6550-4477-978f-469b7873d1f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_72aa6b19-6550-4477-978f-469b7873d1f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_2db8c557-3972-468a-9968-8c221ec145ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_72aa6b19-6550-4477-978f-469b7873d1f4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_2db8c557-3972-468a-9968-8c221ec145ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_890d293d-4461-483b-818b-8e608b9533d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_2db8c557-3972-468a-9968-8c221ec145ad" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_890d293d-4461-483b-818b-8e608b9533d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3824f143-cfb4-440d-bddb-b355e3e8dfe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3824f143-cfb4-440d-bddb-b355e3e8dfe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_b77b2ec9-040c-4d26-9bea-f0c7a47165a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_3824f143-cfb4-440d-bddb-b355e3e8dfe1" xlink:to="loc_us-gaap_HedgingRelationshipDomain_b77b2ec9-040c-4d26-9bea-f0c7a47165a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueHedgingMember_3cc27854-00d0-4a6e-8aef-9719c12eed6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_b77b2ec9-040c-4d26-9bea-f0c7a47165a3" xlink:to="loc_us-gaap_FairValueHedgingMember_3cc27854-00d0-4a6e-8aef-9719c12eed6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_08368467-4598-4a65-857e-62b91be5b97c" xlink:to="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_367d33e2-6029-4191-9072-033b6d891bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_367d33e2-6029-4191-9072-033b6d891bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_6abf3403-dbb6-4e1b-99c8-b8ec6a5d3326" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:to="loc_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1_6abf3403-dbb6-4e1b-99c8-b8ec6a5d3326" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_fd609d32-a39d-40eb-99be-52b2c9ee6437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_6bee360f-d5e2-4bb5-b718-4fb8869be1a9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_fd609d32-a39d-40eb-99be-52b2c9ee6437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="simple" xlink:href="dgx-20210331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_aceea0bb-572a-420a-9475-eba4939aab80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_38e4d97c-bea4-4ade-8a1b-e031d6885fca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_aceea0bb-572a-420a-9475-eba4939aab80" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_38e4d97c-bea4-4ade-8a1b-e031d6885fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_6a55ad66-8535-4e9f-827b-d18561d88b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:href="dgx-20210331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_6a55ad66-8535-4e9f-827b-d18561d88b28" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_d163ddc7-449f-41a7-8a1d-04008aaeba55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_d163ddc7-449f-41a7-8a1d-04008aaeba55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_861e5444-bfe5-41d9-a083-1b009c6b6baa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_d163ddc7-449f-41a7-8a1d-04008aaeba55" xlink:to="loc_us-gaap_EquityComponentDomain_861e5444-bfe5-41d9-a083-1b009c6b6baa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_47af1ce1-b15b-41bc-83e7-30d9d2a5f01a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_861e5444-bfe5-41d9-a083-1b009c6b6baa" xlink:to="loc_us-gaap_TreasuryStockMember_47af1ce1-b15b-41bc-83e7-30d9d2a5f01a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:to="loc_srt_OwnershipAxis_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_d09e7c42-8339-495e-b286-3e41ba957fa5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_fdb2968a-8a3f-4af8-aa1a-4ebec98bc9cb" xlink:to="loc_srt_OwnershipDomain_d09e7c42-8339-495e-b286-3e41ba957fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_UMassJointVentureMember_bf367a6f-cd9a-4c69-9db2-d63bb1ca98d2" xlink:href="dgx-20210331.xsd#dgx_UMassJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_d09e7c42-8339-495e-b286-3e41ba957fa5" xlink:to="loc_dgx_UMassJointVentureMember_bf367a6f-cd9a-4c69-9db2-d63bb1ca98d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:href="dgx-20210331.xsd#dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable_fd58716e-4ecf-4a73-8800-1dd0c2c90d18" xlink:to="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_3510cbed-4b61-4776-8fe8-b52d7a04144f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_3510cbed-4b61-4776-8fe8-b52d7a04144f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_6334b66c-461f-48b4-8c3d-6f0d664ee8e6" xlink:href="dgx-20210331.xsd#dgx_StockRepurchaseProgramAdditionalAmountAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_dgx_StockRepurchaseProgramAdditionalAmountAuthorized_6334b66c-461f-48b4-8c3d-6f0d664ee8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_65baf59b-4ebb-4009-8b6f-4bd0e5844c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_65baf59b-4ebb-4009-8b6f-4bd0e5844c94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_dde78e87-7068-496f-b2d8-c24372b35110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_dde78e87-7068-496f-b2d8-c24372b35110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_054b39ee-ef5b-4098-87fa-6a5e956d8fb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_054b39ee-ef5b-4098-87fa-6a5e956d8fb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_a085605c-c412-4671-916a-59a8c58752c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued_a085605c-c412-4671-916a-59a8c58752c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_836a6ce2-c416-447e-82a1-5471386e5715" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems_f7330c2f-6546-499a-82dd-23aa4b4bb95e" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_836a6ce2-c416-447e-82a1-5471386e5715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATA"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_0bd7dce4-ef4d-457d-98d9-a12cfbd1e3bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_8fbe37af-a57b-4930-b67b-8e49bb9985e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_0bd7dce4-ef4d-457d-98d9-a12cfbd1e3bc" xlink:to="loc_us-gaap_CashFlowSupplementalDisclosuresTextBlock_8fbe37af-a57b-4930-b67b-8e49bb9985e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATATables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_20bc04b6-f9f9-40af-a9e2-9efbf455ea26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_4c189ecf-2f29-46a0-abce-62a3e7788874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_20bc04b6-f9f9-40af-a9e2-9efbf455ea26" xlink:to="loc_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock_4c189ecf-2f29-46a0-abce-62a3e7788874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUPPLEMENTALCASHFLOWOTHERDATADetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_de87a92b-138e-4912-8dd8-525831bfe4cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_Depreciation_de87a92b-138e-4912-8dd8-525831bfe4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_abfe381f-d749-4634-afe5-f6fb3f9a7588" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_abfe381f-d749-4634-afe5-f6fb3f9a7588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c4b68de8-2468-4440-96dc-cc3d68195a92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c4b68de8-2468-4440-96dc-cc3d68195a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_ac385e02-b3ef-4869-a1cd-73f3b8887c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_InterestExpense_ac385e02-b3ef-4869-a1cd-73f3b8887c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestAndDividendIncomeOperating_b74f2325-0722-4765-9ff2-25e75754fe4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestAndDividendIncomeOperating"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_InterestAndDividendIncomeOperating_b74f2325-0722-4765-9ff2-25e75754fe4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_0572cafd-0dda-40f1-8ff8-4e720610c67d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_0572cafd-0dda-40f1-8ff8-4e720610c67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaid_a6f0c526-cbf4-494d-919c-4c6a636f9621" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaid"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_InterestPaid_a6f0c526-cbf4-494d-919c-4c6a636f9621" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_7709ae5e-7a1f-42c9-8c0a-0f11f4232a9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_IncomeTaxesPaid_7709ae5e-7a1f-42c9-8c0a-0f11f4232a9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_27470ad9-488a-4ba5-809d-ac7d13fcc631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_27470ad9-488a-4ba5-809d-ac7d13fcc631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_f647690f-5755-4921-b031-e0d4a1061261" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DividendsPayableCurrentAndNoncurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_DividendsPayableCurrentAndNoncurrent_f647690f-5755-4921-b031-e0d4a1061261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfAssetsAcquired_84021aa7-6582-43c2-861a-ebbb4325ef10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfAssetsAcquired"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_FairValueOfAssetsAcquired_84021aa7-6582-43c2-861a-ebbb4325ef10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAssumed1_bc852851-4389-4047-9649-6ce78c566fcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAssumed1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_LiabilitiesAssumed1_bc852851-4389-4047-9649-6ce78c566fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FairValueOfNetAssetsAcquired_dfc75f4c-4527-4ad5-aaaf-1dd7ef7ef5be" xlink:href="dgx-20210331.xsd#dgx_FairValueOfNetAssetsAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_dgx_FairValueOfNetAssetsAcquired_dfc75f4c-4527-4ad5-aaaf-1dd7ef7ef5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_753eabbf-b9cd-4a41-8585-48423459c1ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_753eabbf-b9cd-4a41-8585-48423459c1ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3bd8e7ee-55f7-46f1-97f1-31799c165b71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_3bd8e7ee-55f7-46f1-97f1-31799c165b71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_93aa9b54-5357-41f6-8a9e-22c488bd21f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowElementsAbstract_27e0aff2-eb92-4b44-a41a-2ec694f0d335" xlink:to="loc_us-gaap_LeaseCostAbstract_93aa9b54-5357-41f6-8a9e-22c488bd21f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9f92e984-bf48-4c03-a787-756fea3e7982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_93aa9b54-5357-41f6-8a9e-22c488bd21f0" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9f92e984-bf48-4c03-a787-756fea3e7982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6b6cb5ed-8bda-4476-8ef4-7a98a5158133" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_af300bd0-14a2-4781-80d9-fab906702574" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_6b6cb5ed-8bda-4476-8ef4-7a98a5158133" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_af300bd0-14a2-4781-80d9-fab906702574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_caf1875b-973b-460e-a9f0-0691665a83f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_6420d613-823b-4f62-ba13-e835a75be105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_caf1875b-973b-460e-a9f0-0691665a83f9" xlink:to="loc_us-gaap_LossContingenciesTable_6420d613-823b-4f62-ba13-e835a75be105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_f8d4d017-6a4e-4512-86b4-638800238693" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6420d613-823b-4f62-ba13-e835a75be105" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_f8d4d017-6a4e-4512-86b4-638800238693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6bbe7426-37d0-4a24-9622-7485f7e72bf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_f8d4d017-6a4e-4512-86b4-638800238693" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6bbe7426-37d0-4a24-9622-7485f7e72bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_b36d4b7c-1281-45fe-8302-d5ed3ba3f1ba" xlink:href="dgx-20210331.xsd#dgx_ExcludesgeneralandprofessionalliabilityclaimsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_6bbe7426-37d0-4a24-9622-7485f7e72bf5" xlink:to="loc_dgx_ExcludesgeneralandprofessionalliabilityclaimsMember_b36d4b7c-1281-45fe-8302-d5ed3ba3f1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_f9688bdd-4d22-4ffc-bd57-32e114ec3e23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_6420d613-823b-4f62-ba13-e835a75be105" xlink:to="loc_us-gaap_LossContingenciesLineItems_f9688bdd-4d22-4ffc-bd57-32e114ec3e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationReserve_7ceb1578-bb0e-49e5-91a6-bbe2b02bbb07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LitigationReserve"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_f9688bdd-4d22-4ffc-bd57-32e114ec3e23" xlink:to="loc_us-gaap_LitigationReserve_7ceb1578-bb0e-49e5-91a6-bbe2b02bbb07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_caf1875b-973b-460e-a9f0-0691665a83f9" xlink:to="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dd8270a1-def0-4b97-a641-6c791ab0676c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dd8270a1-def0-4b97-a641-6c791ab0676c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dd8270a1-def0-4b97-a641-6c791ab0676c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredDebtMember_5e10c4a6-b083-413f-a9c2-d93ddfada382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SecuredDebtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:to="loc_us-gaap_SecuredDebtMember_5e10c4a6-b083-413f-a9c2-d93ddfada382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_388d925c-f25d-4777-aed1-a46d2b2bc08d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_388d925c-f25d-4777-aed1-a46d2b2bc08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_6f612a9f-09dc-42be-9435-5c0fc13cab4a" xlink:href="dgx-20210331.xsd#dgx_SeniorunsecuredrevolvingcreditfacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_add293f2-1e4c-49f9-97ab-4b8679416e4a" xlink:to="loc_dgx_SeniorunsecuredrevolvingcreditfacilityMember_6f612a9f-09dc-42be-9435-5c0fc13cab4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_d13533ab-d019-4e10-9998-310c61bce73f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:to="loc_us-gaap_CreditFacilityAxis_d13533ab-d019-4e10-9998-310c61bce73f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_18ed9a1a-9fc8-4264-9413-bc46adaf0ef4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_d13533ab-d019-4e10-9998-310c61bce73f" xlink:to="loc_us-gaap_CreditFacilityDomain_18ed9a1a-9fc8-4264-9413-bc46adaf0ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_0c2ed272-922b-4ebe-bdb5-dc76b834e389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_18ed9a1a-9fc8-4264-9413-bc46adaf0ef4" xlink:to="loc_us-gaap_LetterOfCreditMember_0c2ed272-922b-4ebe-bdb5-dc76b834e389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c0376d30-d6ad-45e4-80f9-0a79f64d4403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1d8901f6-b91f-4bbb-aca7-9b4d3e8a5df6" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c0376d30-d6ad-45e4-80f9-0a79f64d4403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_26267df9-cbe2-4934-9911-2ff3237a4333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_c0376d30-d6ad-45e4-80f9-0a79f64d4403" xlink:to="loc_us-gaap_SubsequentEventMember_26267df9-cbe2-4934-9911-2ff3237a4333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_97ffbcbf-4b84-424b-afe8-971bd0f5dc72" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fbf9673b-3183-4335-81ec-d77c899828b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_fbf9673b-3183-4335-81ec-d77c899828b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_df19a801-8963-4999-91df-c629b6cf3d7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_df19a801-8963-4999-91df-c629b6cf3d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_94fd9df7-2e09-434a-96ab-e61f5b930939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2961e799-690e-48bb-ac47-2ad92231eec1" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_94fd9df7-2e09-434a-96ab-e61f5b930939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_ca9a0423-ae5c-44bf-bfc7-6f79950d68e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MalpracticeLossContingencyAccrualUndiscounted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_caf1875b-973b-460e-a9f0-0691665a83f9" xlink:to="loc_us-gaap_MalpracticeLossContingencyAccrualUndiscounted_ca9a0423-ae5c-44bf-bfc7-6f79950d68e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_c02c73ca-52de-4b3f-9aaf-5b9201cb67b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_caf1875b-973b-460e-a9f0-0691665a83f9" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_c02c73ca-52de-4b3f-9aaf-5b9201cb67b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_fbaa0513-6791-47c3-b872-1f45168f40b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_6339acab-7d9f-46e7-a385-0234897be734" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_fbaa0513-6791-47c3-b872-1f45168f40b2" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_6339acab-7d9f-46e7-a385-0234897be734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_74547dde-5a14-4344-b0eb-c27bc7f06703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_15bcf4de-74f3-470b-b649-3bb018160cfd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_74547dde-5a14-4344-b0eb-c27bc7f06703" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_15bcf4de-74f3-470b-b649-3bb018160cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_d0cf7a42-fcce-42b4-b3b8-0ec54c65ffa1" xlink:href="dgx-20210331.xsd#dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_74547dde-5a14-4344-b0eb-c27bc7f06703" xlink:to="loc_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock_d0cf7a42-fcce-42b4-b3b8-0ec54c65ffa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#BUSINESSSEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_bcc5c887-fe92-4162-b0ba-9f1cc9848f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_bcc5c887-fe92-4162-b0ba-9f1cc9848f99" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b1f2e460-80a3-4cb3-b74d-a428f2dce648" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b1f2e460-80a3-4cb3-b74d-a428f2dce648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b1f2e460-80a3-4cb3-b74d-a428f2dce648" xlink:to="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_7f5bc5fb-defe-402e-955f-6d4bdf34e676" xlink:href="dgx-20210331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_7f5bc5fb-defe-402e-955f-6d4bdf34e676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_726a22cd-0e17-4c20-bd22-ee7f6dfe1e9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:to="loc_us-gaap_AllOtherSegmentsMember_726a22cd-0e17-4c20-bd22-ee7f6dfe1e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_2e05135d-06b0-44df-bb71-1f9f3d4520c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_58811011-0693-4c96-a377-a1cb5e30e9e9" xlink:to="loc_us-gaap_CorporateMember_2e05135d-06b0-44df-bb71-1f9f3d4520c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:to="loc_srt_RangeAxis_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ad2ca952-ee65-4042-a2be-d02d396b32ab" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7b47b1c6-1769-49ca-8ca4-1c9c1f298b9b" xlink:to="loc_srt_RangeMember_ad2ca952-ee65-4042-a2be-d02d396b32ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_16c4f26c-b97d-4c4b-9d7a-67a83eaa04c5" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ad2ca952-ee65-4042-a2be-d02d396b32ab" xlink:to="loc_srt_MinimumMember_16c4f26c-b97d-4c4b-9d7a-67a83eaa04c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1f514109-5071-45f6-a6ba-769dd94a129a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:to="loc_srt_ProductOrServiceAxis_1f514109-5071-45f6-a6ba-769dd94a129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1f514109-5071-45f6-a6ba-769dd94a129a" xlink:to="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_RoutineclinicaltestingservicesMember_3e6f4bc8-95e0-4d7e-87fd-571633cd772a" xlink:href="dgx-20210331.xsd#dgx_RoutineclinicaltestingservicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_RoutineclinicaltestingservicesMember_3e6f4bc8-95e0-4d7e-87fd-571633cd772a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_COVID19TestingServicesMember_0fb0abde-b794-4372-896d-d815b663a8f3" xlink:href="dgx-20210331.xsd#dgx_COVID19TestingServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_COVID19TestingServicesMember_0fb0abde-b794-4372-896d-d815b663a8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GenebasedandesoterictestingservicesMember_a7e88d30-8895-4b34-883f-ce0c7d1fbf09" xlink:href="dgx-20210331.xsd#dgx_GenebasedandesoterictestingservicesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_GenebasedandesoterictestingservicesMember_a7e88d30-8895-4b34-883f-ce0c7d1fbf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AnatomicpathologytestingservicesMember_2e7225b3-75ce-4a71-bf42-47364112e2bd" xlink:href="dgx-20210331.xsd#dgx_AnatomicpathologytestingservicesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_AnatomicpathologytestingservicesMember_2e7225b3-75ce-4a71-bf42-47364112e2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AllotherservicesMember_86068350-970c-460f-a618-a53374afd4ae" xlink:href="dgx-20210331.xsd#dgx_AllotherservicesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2a54f529-69af-4999-b71f-c17d58b7e70c" xlink:to="loc_dgx_AllotherservicesMember_86068350-970c-460f-a618-a53374afd4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4097d581-8f00-4d36-8e74-de479e47acb2" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_7f51ce0a-dbae-497c-a082-c1c2bb173ba7" xlink:href="dgx-20210331.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_dgx_PercentageofNetRevenues_7f51ce0a-dbae-497c-a082-c1c2bb173ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fa6966f5-2b91-4e82-91e7-7d639a944b02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fa6966f5-2b91-4e82-91e7-7d639a944b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3d777e71-8363-42d4-a133-668b8b9cffaf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_OperatingIncomeLoss_3d777e71-8363-42d4-a133-668b8b9cffaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_948d0111-97d6-469e-b8a3-a8b0269115f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_948d0111-97d6-469e-b8a3-a8b0269115f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ee948520-8c12-4907-ac89-7477a6a33e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ee948520-8c12-4907-ac89-7477a6a33e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_20134633-3e41-442b-a3db-7c9d4f0084b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_20134633-3e41-442b-a3db-7c9d4f0084b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_966ae3a1-23c4-455e-af41-7e1e90c32ae6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_966ae3a1-23c4-455e-af41-7e1e90c32ae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3ccc3fde-aff7-477d-b17c-bc3a8681dcd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_ProfitLoss_3ccc3fde-aff7-477d-b17c-bc3a8681dcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_86c84faa-926f-49d6-a1e1-6a84ecd29c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_86c84faa-926f-49d6-a1e1-6a84ecd29c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2923ede-a338-4d3b-8d83-680a4245c27e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_b3d91035-0689-4990-b9fa-cbac0f24382b" xlink:to="loc_us-gaap_NetIncomeLoss_c2923ede-a338-4d3b-8d83-680a4245c27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="dgx-20210331.xsd#RELATEDPARTIES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_dea3c2c3-b5e2-4db1-b7eb-7aa0d773d086" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4257d5d1-e845-4ea6-9ead-58f962d44282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_dea3c2c3-b5e2-4db1-b7eb-7aa0d773d086" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_4257d5d1-e845-4ea6-9ead-58f962d44282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#RELATEDPARTIESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/RELATEDPARTIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_b2f10213-681a-4233-957b-17772e669291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_b2f10213-681a-4233-957b-17772e669291" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f9a3933c-b749-4b28-9875-05c630815ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f9a3933c-b749-4b28-9875-05c630815ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4aa8ac5d-5d42-4c96-9b36-98c221bafc97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f9a3933c-b749-4b28-9875-05c630815ab8" xlink:to="loc_us-gaap_RelatedPartyDomain_4aa8ac5d-5d42-4c96-9b36-98c221bafc97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvesteeMember_887495c2-b841-4dbb-8973-4cd6d3515048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvesteeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_4aa8ac5d-5d42-4c96-9b36-98c221bafc97" xlink:to="loc_us-gaap_EquityMethodInvesteeMember_887495c2-b841-4dbb-8973-4cd6d3515048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7395a4f7-1fb4-4810-a3fd-818f2f048067" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7395a4f7-1fb4-4810-a3fd-818f2f048067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_13c6fd1c-255c-4823-8ee1-57ac957e8ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7395a4f7-1fb4-4810-a3fd-818f2f048067" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_13c6fd1c-255c-4823-8ee1-57ac957e8ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_350f24cc-2b82-41d8-96bc-a18f9f85bf86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_13c6fd1c-255c-4823-8ee1-57ac957e8ab9" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_350f24cc-2b82-41d8-96bc-a18f9f85bf86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_55b25610-7369-487d-9c6b-f5aa45e99aec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_55b25610-7369-487d-9c6b-f5aa45e99aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_794abca8-4fc5-4da8-b88b-9a01538c47e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_55b25610-7369-487d-9c6b-f5aa45e99aec" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_794abca8-4fc5-4da8-b88b-9a01538c47e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3e6d0c7b-ad50-4db6-874a-ec20cdda440c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_794abca8-4fc5-4da8-b88b-9a01538c47e1" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_3e6d0c7b-ad50-4db6-874a-ec20cdda440c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_16623aee-bf16-4503-82cd-e6c3d2575a02" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_4de1aac6-78a8-45ca-bf99-c3f5fc7e21e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_RevenueFromRelatedParties_4de1aac6-78a8-45ca-bf99-c3f5fc7e21e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_c54a7df9-8119-46d8-b1d2-8683759f34f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_c54a7df9-8119-46d8-b1d2-8683759f34f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_12ce8125-0efb-4e67-8708-5ffdfed824db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_12ce8125-0efb-4e67-8708-5ffdfed824db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_OtherAccountsReceivableRelatedParties_b3069603-cec3-4626-a7cb-c6fe0d7ed434" xlink:href="dgx-20210331.xsd#dgx_OtherAccountsReceivableRelatedParties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_dgx_OtherAccountsReceivableRelatedParties_b3069603-cec3-4626-a7cb-c6fe0d7ed434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_44a8e445-f33d-4c00-a7fb-d99211279d1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_44a8e445-f33d-4c00-a7fb-d99211279d1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDividendsReceived_417550f7-1c24-4333-8757-e51fc39b6560" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDividendsReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_d1fe4633-5d90-4fc1-8876-aafe344253f1" xlink:to="loc_us-gaap_ProceedsFromDividendsReceived_417550f7-1c24-4333-8757-e51fc39b6560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d9b0877e-0d8d-45aa-974b-325c001618fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_67acd895-332f-4c2c-b3fc-1d32e0a14f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d9b0877e-0d8d-45aa-974b-325c001618fc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_67acd895-332f-4c2c-b3fc-1d32e0a14f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c485544b-1c33-4620-ad65-0288f67b92d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_cc27d56f-d5bd-4550-affb-8443f9e9b15c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c485544b-1c33-4620-ad65-0288f67b92d2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_cc27d56f-d5bd-4550-affb-8443f9e9b15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_b5d673f2-4b38-4258-9b95-05361b6886a6" xlink:href="dgx-20210331.xsd#dgx_AccountsReceivableDisaggregationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c485544b-1c33-4620-ad65-0288f67b92d2" xlink:to="loc_dgx_AccountsReceivableDisaggregationTableTextBlock_b5d673f2-4b38-4258-9b95-05361b6886a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d30a4f46-2639-4875-80b1-d8d020aecb34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d30a4f46-2639-4875-80b1-d8d020aecb34" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_6169b963-b924-4a29-affc-51b99e36f567" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_6169b963-b924-4a29-affc-51b99e36f567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_460e0cee-7eda-4e03-8f48-eb4386536b0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_6169b963-b924-4a29-affc-51b99e36f567" xlink:to="loc_us-gaap_SegmentDomain_460e0cee-7eda-4e03-8f48-eb4386536b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DiagnosticInformationServicesBusinessMember_867bdd94-7867-4d78-8535-6d91b9a4ad8f" xlink:href="dgx-20210331.xsd#dgx_DiagnosticInformationServicesBusinessMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_460e0cee-7eda-4e03-8f48-eb4386536b0e" xlink:to="loc_dgx_DiagnosticInformationServicesBusinessMember_867bdd94-7867-4d78-8535-6d91b9a4ad8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllOtherSegmentsMember_0f6f8ea9-562c-41a1-8975-c6bf167bf023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllOtherSegmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_460e0cee-7eda-4e03-8f48-eb4386536b0e" xlink:to="loc_us-gaap_AllOtherSegmentsMember_0f6f8ea9-562c-41a1-8975-c6bf167bf023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a042a770-1140-48fe-b616-da7fc414c974" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_srt_RangeAxis_a042a770-1140-48fe-b616-da7fc414c974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b6d5b8d6-45cb-45c1-bb70-66888d2aa82c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a042a770-1140-48fe-b616-da7fc414c974" xlink:to="loc_srt_RangeMember_b6d5b8d6-45cb-45c1-bb70-66888d2aa82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d0424685-da05-47fc-9fe3-f30e27a919dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b6d5b8d6-45cb-45c1-bb70-66888d2aa82c" xlink:to="loc_srt_MinimumMember_d0424685-da05-47fc-9fe3-f30e27a919dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_us-gaap_SubsegmentsAxis_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_605e57a1-8f5d-44bf-9d6e-00a8a21f3d00" xlink:to="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_HealthcareInsurersMember_c9f570df-a372-4712-afb1-179e58407715" xlink:href="dgx-20210331.xsd#dgx_HealthcareInsurersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_HealthcareInsurersMember_c9f570df-a372-4712-afb1-179e58407715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_GovernmentPayersMember_888ceef6-597b-4e30-a9b8-d58f88dbd483" xlink:href="dgx-20210331.xsd#dgx_GovernmentPayersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_GovernmentPayersMember_888ceef6-597b-4e30-a9b8-d58f88dbd483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_ClientPayersMember_96eef7ed-8767-478c-8305-5a9780b093e6" xlink:href="dgx-20210331.xsd#dgx_ClientPayersMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_ClientPayersMember_96eef7ed-8767-478c-8305-5a9780b093e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PatientsMember_6f64b744-afe9-4ca5-826b-70c71efd86b8" xlink:href="dgx-20210331.xsd#dgx_PatientsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_PatientsMember_6f64b744-afe9-4ca5-826b-70c71efd86b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_DSBusinessesMember_98808f45-2ad6-48b0-85cd-929933b08f53" xlink:href="dgx-20210331.xsd#dgx_DSBusinessesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_798b5162-6a2d-44c0-846f-f84fa12a895f" xlink:to="loc_dgx_DSBusinessesMember_98808f45-2ad6-48b0-85cd-929933b08f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_65f36cd6-8dbc-44ab-a31c-51bafb64df8d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_srt_ProductOrServiceAxis_65f36cd6-8dbc-44ab-a31c-51bafb64df8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_47bf4cf1-ead5-4175-9a81-a2528aafdfa6" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_65f36cd6-8dbc-44ab-a31c-51bafb64df8d" xlink:to="loc_srt_ProductsAndServicesDomain_47bf4cf1-ead5-4175-9a81-a2528aafdfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_FeeforserviceMember_caf58af3-a69d-4a68-a1bd-a3f7d1320bfc" xlink:href="dgx-20210331.xsd#dgx_FeeforserviceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47bf4cf1-ead5-4175-9a81-a2528aafdfa6" xlink:to="loc_dgx_FeeforserviceMember_caf58af3-a69d-4a68-a1bd-a3f7d1320bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_CapitatedMember_38364392-f12b-4520-bcb1-cbe3e99ec133" xlink:href="dgx-20210331.xsd#dgx_CapitatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_47bf4cf1-ead5-4175-9a81-a2528aafdfa6" xlink:to="loc_dgx_CapitatedMember_38364392-f12b-4520-bcb1-cbe3e99ec133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_e15b4b8b-0a6a-4919-a782-48d5f4646906" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a7335925-75d8-4046-8034-de3ab3ff216b" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_e15b4b8b-0a6a-4919-a782-48d5f4646906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetRevenues_34cf375c-59a1-4087-b041-3c61a7f1359b" xlink:href="dgx-20210331.xsd#dgx_PercentageofNetRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e15b4b8b-0a6a-4919-a782-48d5f4646906" xlink:to="loc_dgx_PercentageofNetRevenues_34cf375c-59a1-4087-b041-3c61a7f1359b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_PercentageofNetAccountsReceivable_9e8036cb-5d43-460e-acd2-ea3a156f1e1a" xlink:href="dgx-20210331.xsd#dgx_PercentageofNetAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_e15b4b8b-0a6a-4919-a782-48d5f4646906" xlink:to="loc_dgx_PercentageofNetAccountsReceivable_9e8036cb-5d43-460e-acd2-ea3a156f1e1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENT" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUBSEQUENTEVENT"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_d2f8704b-4cb1-4756-b476-06272a7f1c21" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_4772f7eb-12ba-4082-853e-1c10f8af6787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_d2f8704b-4cb1-4756-b476-06272a7f1c21" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_4772f7eb-12ba-4082-853e-1c10f8af6787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="dgx-20210331.xsd#SUBSEQUENTEVENTDetails"/>
  <link:presentationLink xlink:role="http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_72f7e487-abac-43cc-902b-591ecd56e7e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_72f7e487-abac-43cc-902b-591ecd56e7e0" xlink:to="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d2450279-530b-4a66-8426-513c09b76b14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d2450279-530b-4a66-8426-513c09b76b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8117e862-cabe-40b2-be74-ee396997b097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d2450279-530b-4a66-8426-513c09b76b14" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8117e862-cabe-40b2-be74-ee396997b097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d986330a-b486-452f-961f-01d33dfd3c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_8117e862-cabe-40b2-be74-ee396997b097" xlink:to="loc_us-gaap_SubsequentEventMember_d986330a-b486-452f-961f-01d33dfd3c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2eb16545-4215-40b5-ac5a-c2a386ee0d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2eb16545-4215-40b5-ac5a-c2a386ee0d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9ef0d69-425a-48dc-bc16-d99df7bd49ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_2eb16545-4215-40b5-ac5a-c2a386ee0d8e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9ef0d69-425a-48dc-bc16-d99df7bd49ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_Q2SolutionsMember_70c84bad-8e2c-4d8f-8644-166b754feb3f" xlink:href="dgx-20210331.xsd#dgx_Q2SolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b9ef0d69-425a-48dc-bc16-d99df7bd49ff" xlink:to="loc_dgx_Q2SolutionsMember_70c84bad-8e2c-4d8f-8644-166b754feb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementScenarioAxis_541d23d2-717b-4fbb-be16-2ce51179c1c9" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementScenarioAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:to="loc_srt_StatementScenarioAxis_541d23d2-717b-4fbb-be16-2ce51179c1c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioUnspecifiedDomain_63012b42-fe18-479b-a09d-39be993bfa8d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioUnspecifiedDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementScenarioAxis_541d23d2-717b-4fbb-be16-2ce51179c1c9" xlink:to="loc_srt_ScenarioUnspecifiedDomain_63012b42-fe18-479b-a09d-39be993bfa8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioForecastMember_b76a2054-0c69-475c-bbf7-b1adbd5a4574" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ScenarioForecastMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScenarioUnspecifiedDomain_63012b42-fe18-479b-a09d-39be993bfa8d" xlink:to="loc_srt_ScenarioForecastMember_b76a2054-0c69-475c-bbf7-b1adbd5a4574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a1b18286-65f5-49d9-a28f-f2872dce6474" xlink:to="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_890fdc1a-4e44-4a94-87f2-ffd3851a3043" xlink:href="dgx-20210331.xsd#dgx_EquityMethodInvestmentOwnershipPercentDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:to="loc_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf_890fdc1a-4e44-4a94-87f2-ffd3851a3043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f721384e-6bea-4546-a4c4-4d7971f54a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_f721384e-6bea-4546-a4c4-4d7971f54a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_599b2963-2046-41c1-aeb7-af1a11af2f70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_10772406-5bd1-466c-9522-850cc92f33fd" xlink:to="loc_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal_599b2963-2046-41c1-aeb7-af1a11af2f70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>dgx-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:dgx="http://questdiagnostics.com/20210331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dgx-20210331.xsd" xlink:type="simple"/>
    <context id="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i94087c0a58c24d71ac0e67f043afc91a_I20210415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-04-15</instant>
        </period>
    </context>
    <context id="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie648c1d0f7124826ab1f231505fef1e4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i71eadae108864617a48c288ee03da704_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3a5f406ec8444737afc188d6eaf5b3df_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ie646d19d5cf7459186c0619c49ea5b00_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad2c3ee49929469181f46b8451771c2e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i30e7f83270134cbba57989f6c87ee5dc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6763b3092130441aa4d3e7b62a500f77_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4383ddd8bce04187905a84f784749ae5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie8041207d92044f2b46db9b98a65cc49_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1c968630629445fe8e4c6a11b499ae19_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9847f3acf448409280792183ebb09888_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i19684d6afbf34103a049012a6f48ef9c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idd48c006babc44508fba201daabd149f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1229f5eae1bb44628fb91b7979affa6f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia93fe46925ac4e9bb7935ca7294c9f15_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0837bdde940d4fec8198129389d20b30_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i31fe7b51e3304a36906e002676eabb34_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6f7944d31d44461c81787b9b98e14b57_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id66c8836535840cab79f0efa55d1cee1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie4f49c664e464e75a6577f2c5dbd5d00_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i44d7060969104f55af57e24f5142babe_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic2353c85dd054cf1943d3a8d511c4959_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i795ed9a1abc545c88b550e1eedd5d75c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i207c605753d646cb94bcf01101b0bf97_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ieb90cf4bc9e9485d83bb0be21e4bf3ca_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i2c99680609bd4fb4ac289f25c8f9e0b6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic022103456b94e4f920519555dc899e2_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i41ab8be1210042b6bb81b9c60bf8605a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifae32d3d791f4367832627f55e477d07_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie15d552706e0430088071b5ee01807cd_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2a26f2f8c8934f1b93702b137ab17309_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i72931c6b70d14f8e8c1d97620ad67fbe_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iec9454bd4f9d47f3b5eee627c27ab502_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i4f0cdcdd19e149f58288a99e479bfc5d_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="if402423ae2b24c479ced9a86251c3483_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i20b63065eb04432ba75178f3f9ab8895_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic67cad7792d740b5a02d32b5524496e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i219be6c936d3415ca28de30c5ecdd725_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i94d5c3ec8c294ad2b02b16745af5b212_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i68ce47c4dd1146df8e572f0c839b6589_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iee79e433c95e49c9a0a5609e33cf096b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14aa0040139a42d3b7c0bff4113965f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic8b7e170774c4e2f95ec5ebd85bba23b_I20150701">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">dgx:UMassJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2015-07-01</instant>
        </period>
    </context>
    <context id="ib735db70e8754b31974b71ba0360f16f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="idcc7342da57f4a33aff95cad60d1c936_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0d63d7e9761b4274807931de4482a38c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">dgx:MidAmericaClinicalLaboratoriesLLCMACLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic90470dc4f4e496caf705d77fa10f616_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibb591aeff91e492ea542a000f524e7ba_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iedd67844f6da45dea182ccba35b463fa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iadbedddfbeb44bccac35bc1968c7198f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i57106d7badad475d94a3fdc00692bdf1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if045c9990da04355aabfd81d38c5e41d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i604ee99bfe964292aabcd6f1b7a316d6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8dd08a56a99d48b4a6ee1e2a7e24fcbe_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i246eef5102584ee28b17a57e7f0313fe_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnpatentedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i329a30ceb1f446f2b7a379a3a3609fdd_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2340158a38984ae194d149a5c95c9e3c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if8a7848040184bc9a44a3890de687919_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id151570e96bf47e2b5807c317f3da3d2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibb6b341327284acb8967c7a25afd49bf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4da6e7d6898a41e2a321057961de0c2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dgx:TotalAmortizingIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5fedf49ea624406aa29fd6ba884c32c8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i878a393788d6403c92b8b90fb49da518_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i90898918a80f45fcb9a06e317a5665ff_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7627047194654fc7b1f1cb6056491ceb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:UnclassifiedIndefinitelivedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i901bac352fa04938b24046e76fcd794f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i09a88d5cf6634758a4963ee5f06aa537_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i823a17c2df114f629409d133576bca9e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i814f0c2b21984f29aeb4ef63fc8777f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LongTermDebtMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4276aed117b24b4684c477c58a926e2f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i510d256807de405f9d7a30a62b33c0d3_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i063340d2e658481d80d2f35fd862966a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic92ff83c2e994ef6b59823da5190e3e9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:FairValueHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic1d5d10bdab3470c9d09e9af10bb66bb_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i6978a3b581d84bdba38eca5a17dc6a46_D20200701-20200930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-07-01</startDate>
            <endDate>2020-09-30</endDate>
        </period>
    </context>
    <context id="i2f8703a530294e5daab49bce5e5794c1_D20201001-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5dc9a03ecce042689d1a37deafd8f119_D20210301-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if1694b157a7e4e05adbfb726d63a9dfb_D20210201-20210228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <startDate>2021-02-01</startDate>
            <endDate>2021-02-28</endDate>
        </period>
    </context>
    <context id="ifaee625cde9f46a19f40eb5a77955d58_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ice8c8a53b7e44301b5d027627be99368_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id9b169a1c4be4f32aab0d0b964a44035_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3abb6c012f5f45fabdd35c0f3a5e994d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">dgx:SeniorunsecuredrevolvingcreditfacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibdcc6647a3314cfe8c8e1a11819788f2_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i4a8b8a1360eb45169025ce2e3ff740e3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9dba11073b29434b8978baa1dd517320_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">dgx:ExcludesgeneralandprofessionalliabilityclaimsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2be09d01fcd644908d4f7bcba929237f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i80fa10a73f264102b635c6298c5c5763_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iace971bbe9244cfb88051e717b4dc21b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i36f5b862a2f64309ae325f1bd8812f84_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8f4d95d055c34010ae22105b313a4c19_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic899b274b3de44a4a751b3c0cf303ca1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3a6fda505e7a4e16ad43273771a429c6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i758562ef5a3244ce83bd69c73f546e0e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie9e62f1f9ce94456b1cd2a528dd83efc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i25a98fa306ed41b296725d35a192e146_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:RoutineclinicaltestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i28f9959f287848bf8d465e16d1d746ff_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i03c3744a2bab43538ebec4cd3b356cf1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:COVID19TestingServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0bdf51bbf7f242a3be5bed92c72c57cb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic4d4da36106e49a4a2dc103517d9f28a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:GenebasedandesoterictestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i61fa9a0d6266465f843c0dcd281594b4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib9e55ffc9602438bb96b19f2de74ce1b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AnatomicpathologytestingservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i170cc44a7d484de4b0e68d788f39ca90_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0e7fdb8aa0b74dcd8f92d2bf7a45989c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:AllotherservicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i5cdb593684214c31b69e5e0f14a1dd79_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="iac11f459e1d042178af5545dbcf89c00_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3447dfba2db4452db6c128cbd3d017fb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifde7a741912648d2a3710f6aba0b6239_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idf44f85037c240d487111d5bb5558877_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0e5b35b7ea4e4d4894444db26f102438_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1719a6433f8e402a8040ef12f6efed91_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibb28805c772d49adaf22a67346afc2ec_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:EquityMethodInvesteeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i452e2b67663443a9b36290cf5a2aa1e6_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icd123d8c628f46e5aba2e460d5deafe6_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:FeeforserviceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iebb5fe74da844f1f961e8e1d2bb794b5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i42e148eb5e0e4659b907643c8a63fc0c_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dgx:CapitatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6a2808ee150047299c3ed09ef79ab8b5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i06001aa5c1104e2e9732e941f42c3fcf_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ide5defc240be4dcab0b768c6f15899ab_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibc9de92a860e40a589282211d1647b6f_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic87438c858c24f95bcf9ba166ab81b0e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie8459599fb5c4db59c067f7d2b4152d5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6810771a2a1c4d05944123a1bf5e1b52_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i46815f8f6c1c4752a37528dcfe600782_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i30bb0b3b6fb2412594595890e5f1e61e_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id0b6faefc1d44456895da76547e73051_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3e2f380500494c60add6976b3bc32aa1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4f9466da8f9f4a6aa123bbced054fed3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:HealthcareInsurersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2c126b415f014916be2b95fa29f24224_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i69898b4810d540df8211bce4cdd5525d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:GovernmentPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i127c3faa32b7427d9b99ea5587e176d7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8413c530df5c4dbfb070686c9de5c5e3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:ClientPayersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i964abdb4332b41dd9081bba6b23cb70a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iadb31c200e50479698a170bd1aa2fdd4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:PatientsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic08defe16103451e81c2c39229b0890c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0bc155227aa9447ea638f9b050fb14fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">dgx:DiagnosticInformationServicesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i12272fb69d15405f9bdaf2b4151db72f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i59a13ec4490e4a7b8c12492922d70b63_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:AllOtherSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">dgx:DSBusinessesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i39c87593f7934842babf6575faeb22bb_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ic411e7e9465f4d0ca07e2fc70dfc9403_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001022079</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementScenarioAxis">srt:ScenarioForecastMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">dgx:Q2SolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="claim">
        <measure>dgx:claim</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY18xLTEtMS0xLTA_434c7b8b-bcd1-4278-bfe5-228236c9417a">0001022079</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY18yLTEtMS0xLTA_e88428b5-a221-4472-9a94-f5a23e673ccb">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY18zLTEtMS0xLTA_8fe24a13-b7ac-4ab8-ad51-cd33ef15c7cb">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY180LTEtMS0xLTA_4191a0de-806b-4a2e-baf8-1268f1e83e47">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80L2ZyYWc6ODRiMjdiNGE3MjJlNDExNmEwY2U4NmQ2YWE5NDFhZTYvdGFibGU6MDBiN2ExNmJiNTk0NDY2MWE4ZDVlNWZmY2JkZmM3M2MvdGFibGVyYW5nZTowMGI3YTE2YmI1OTQ0NjYxYThkNWU1ZmZjYmRmYzczY181LTEtMS0xLTA_c832ca62-3759-481e-b205-3e9c47d0d0f6">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTI2_0ca903ed-70cb-4beb-bba4-f56c1966fa16">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTI3_6867ba36-6aca-4697-b724-a62aa8751728">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV83Njk2NTgxMzk2Mzg5_86bf81b1-5f18-49e0-bd99-25af7b32f572">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTI4_2f0d70de-282f-465b-b585-f4f9e299e130">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTI5_fe223b7b-7d7b-440d-ae34-aff75ac2ef5c">001-12215</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTMw_e597d1e3-bfca-4918-8800-cbbf4eba0aa5">Quest Diagnostics Inc</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8wLTAtMS0xLTA_4e9538b3-7ae6-4f7f-84c6-dd3c56d80439">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8wLTUtMS0xLTA_6b23e0aa-1ed3-4e23-9a50-02a995bbd3cc">16-1387862</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8yLTAtMS0xLTA_7372df66-6dd5-4c27-8aba-4786cdcefdb1">500 Plaza Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8zLTAtMS0xLTA_685500c0-0415-4e7f-85f5-8b4f6cd90cb6">Secaucus,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8zLTEtMS0xLTA_6454ff2e-8fae-460d-a064-c5c490390b44">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl8zLTItMS0xLTA_7db4732e-f73a-4655-aa83-c1afaa840254">07094</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl80LTAtMS0xLTA_659c2194-30b3-44cc-94ea-30cf529f6ba5">(973)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6YTNmMWI2MmY3NDhmNDM3Y2FjODUwYzY3MzM5ZDYwZTIvdGFibGVyYW5nZTphM2YxYjYyZjc0OGY0MzdjYWM4NTBjNjczMzlkNjBlMl80LTEtMS0xLTA_53f81089-f208-4aef-a19f-c3c75ac5a030">520-2700</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6NWZhYzA2NjRlZTZkNDM2NDlkMWM2NGJlNjZkMDVjNTQvdGFibGVyYW5nZTo1ZmFjMDY2NGVlNmQ0MzY0OWQxYzY0YmU2NmQwNWM1NF8xLTAtMS0xLTA_67cc5aaf-fff4-4f52-acff-242abde8b8a7">Common Stock, $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6NWZhYzA2NjRlZTZkNDM2NDlkMWM2NGJlNjZkMDVjNTQvdGFibGVyYW5nZTo1ZmFjMDY2NGVlNmQ0MzY0OWQxYzY0YmU2NmQwNWM1NF8xLTEtMS0xLTA_f7dd2a8b-d1d7-47a7-898c-8f558fabf493">DGX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6NWZhYzA2NjRlZTZkNDM2NDlkMWM2NGJlNjZkMDVjNTQvdGFibGVyYW5nZTo1ZmFjMDY2NGVlNmQ0MzY0OWQxYzY0YmU2NmQwNWM1NF8xLTItMS0xLTA_09c2c383-0cfb-4f85-8e7a-bc321641248e">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTMx_4293d888-994a-4fef-ae99-7ec3521cc238">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTMy_087339fd-b385-4294-813d-baf0a749a04b">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6OGM5MjlmNzcwZjI5NDRiZmFiMzgyZGJmM2U5MzZiZTgvdGFibGVyYW5nZTo4YzkyOWY3NzBmMjk0NGJmYWIzODJkYmYzZTkzNmJlOF8wLTAtMS0xLTA_7bca3067-d068-4b1e-aa1e-23500a672aee">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6OGM5MjlmNzcwZjI5NDRiZmFiMzgyZGJmM2U5MzZiZTgvdGFibGVyYW5nZTo4YzkyOWY3NzBmMjk0NGJmYWIzODJkYmYzZTkzNmJlOF8xLTMtMS0xLTA_0c3495d4-43b8-4c3f-8796-dbf7edfc8936">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGFibGU6OGM5MjlmNzcwZjI5NDRiZmFiMzgyZGJmM2U5MzZiZTgvdGFibGVyYW5nZTo4YzkyOWY3NzBmMjk0NGJmYWIzODJkYmYzZTkzNmJlOF8yLTMtMS0xLTA_e157c184-eae9-4f53-8dbf-c46591900cc5">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xOTMz_b31d7e92-b0bd-4d12-90f5-511ae09c9acd">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i94087c0a58c24d71ac0e67f043afc91a_I20210415"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xL2ZyYWc6ZmFjNTNkZmQxNjM2NGFiY2FjMmIwNzA1OWVjMThkZWUvdGV4dHJlZ2lvbjpmYWM1M2RmZDE2MzY0YWJjYWMyYjA3MDU5ZWMxOGRlZV8xODY3_5ea9be1d-0e27-420a-a23c-7996f7370c86"
      unitRef="shares">130638109</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMi0xLTEtMS0w_5707f964-3952-4bb0-8285-66a2db635202"
      unitRef="usd">2720000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMi0zLTEtMS0w_debf5b4b-12fb-4aa4-b032-5e3257ccef82"
      unitRef="usd">1822000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNS0xLTEtMS0w_b5ef0c5e-c981-44c2-8fc4-d2a53e28e9a9"
      unitRef="usd">1626000000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNS0zLTEtMS0w_74fec4c8-959c-41ea-96d5-75d23e1a3532"
      unitRef="usd">1270000000</us-gaap:CostOfRevenue>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNi0xLTEtMS0w_93b0f91d-daa0-4159-9972-8bdb9d4ee174"
      unitRef="usd">407000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNi0zLTEtMS0w_a8f6a88d-44e5-4294-bff3-4f9b306bbc3b"
      unitRef="usd">347000000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNy0xLTEtMS0w_5db0d9c8-984b-4210-bb28-34cf97c0427f"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNy0zLTEtMS0w_43dced7e-0d56-4ee3-b2b5-707b1b07bd39"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfOS0xLTEtMS0w_30568554-a2ce-4e56-bfbb-26ca466fc8a4"
      unitRef="usd">0</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:OtherOperatingIncomeExpenseNet
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfOS0zLTEtMS0w_6ea4f46f-6645-4ec9-af6b-23b9b9761d8d"
      unitRef="usd">-5000000</us-gaap:OtherOperatingIncomeExpenseNet>
    <us-gaap:CostsAndExpenses
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTAtMS0xLTEtMA_0492bf03-bbc9-4a59-b9a7-5f289d54b881"
      unitRef="usd">2060000000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTAtMy0xLTEtMA_dbc5c5d0-46d4-408b-8b53-2cb2657b20ba"
      unitRef="usd">1647000000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTItMS0xLTEtMA_ae0ca3b2-6c40-4783-b097-6649caf28ea1"
      unitRef="usd">660000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTItMy0xLTEtMA_2b0bd0a5-11b1-4ede-a418-0ba3c409dca4"
      unitRef="usd">175000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTUtMS0xLTEtMA_ba6d3cb2-2445-4165-9c3c-541e14e2e542"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTUtMy0xLTEtMA_50b8e56c-0a4f-424d-b7a6-0175f77f5ca0"
      unitRef="usd">-41000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTYtMS0xLTEtMA_fa2bdb44-3fda-4ed2-bbd7-68a8f8f07d24"
      unitRef="usd">4000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTYtMy0xLTEtMA_4ac5444e-e45c-44ce-89c3-a4d778f4f75b"
      unitRef="usd">-16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTctMS0xLTEtMA_12781090-ba32-430b-a9b2-c8d81b2423f0"
      unitRef="usd">-34000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTctMy0xLTEtMA_6e7663bc-0e1b-4199-8b93-a70860045cbd"
      unitRef="usd">-57000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTktMS0xLTEtMA_68cb98f2-e8a4-4e7f-a37a-dffc54e3baab"
      unitRef="usd">626000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMTktMy0xLTEtMA_56a0f168-10ff-464c-885a-deefed235790"
      unitRef="usd">118000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjAtMS0xLTEtMA_d6a57dc7-2c36-464a-8f00-4a4deb7c1ef0"
      unitRef="usd">153000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjAtMy0xLTEtMA_8774bc60-fe5a-4214-ad6b-e2c1e9415800"
      unitRef="usd">26000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjEtMS0xLTEtMA_321c0498-38e1-400e-8546-de39b1d23a11"
      unitRef="usd">17000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjEtMy0xLTEtMA_58d180f9-620c-4cbb-9fad-24ea8c20e1b9"
      unitRef="usd">14000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjQtMS0xLTEtMA_cf26cf12-7b31-4614-a0dc-66d6bc1e79e5"
      unitRef="usd">490000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjQtMy0xLTEtMA_92fb979a-3ee2-4ccf-9da5-4d41db66e87e"
      unitRef="usd">106000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjUtMS0xLTEtMA_2c163f96-eea6-4760-91dd-5a40b6ee1602"
      unitRef="usd">21000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjUtMy0xLTEtMA_2389759b-1580-4484-bf9c-ca58f6dda3cb"
      unitRef="usd">7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjYtMS0xLTEtMA_386ae93c-11e0-4aed-abff-6f830872463e"
      unitRef="usd">469000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMjYtMy0xLTEtMA_a7dd1758-f5b6-469e-b844-988d3671d4fa"
      unitRef="usd">99000000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMzYtMS0xLTEtMA_8e74c989-c715-4eed-a5f6-a8c23aaf3692"
      unitRef="usdPerShare">3.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfMzYtMy0xLTEtMA_0190fd9c-9880-4b1e-bdbf-05e8688871ef"
      unitRef="usdPerShare">0.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDEtMS0xLTEtMA_6ce60b1a-cc8a-43f0-87ec-37e18f72afad"
      unitRef="usdPerShare">3.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDEtMy0xLTEtMA_c1257c6d-b585-45a2-9bd4-078f86fbe761"
      unitRef="usdPerShare">0.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDQtMS0xLTEtMA_85bbaea0-8dab-460b-8378-fa9e9f39fe66"
      unitRef="shares">133000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDQtMy0xLTEtMA_ac1f508b-9c68-4a36-b1e0-2ae9d59140cd"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDYtMS0xLTEtMA_79e6cda0-590e-4bcd-bd44-56cc14707083"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xMy9mcmFnOjA5ZDA0NjkyZjc1MzRiOWJiNGRhZDA1OTliMjdjZDc5L3RhYmxlOjliZWVmMTBmMDVjNTRiMDI5NTBjZWZlN2NiMGNmNTMyL3RhYmxlcmFuZ2U6OWJlZWYxMGYwNWM1NGIwMjk1MGNlZmU3Y2IwY2Y1MzJfNDYtMy0xLTEtMA_7e230a04-db07-44b2-9301-8024829b4802"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMi0xLTEtMS0w_cf26cf12-7b31-4614-a0dc-66d6bc1e79e5"
      unitRef="usd">490000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMi0zLTEtMS0w_92fb979a-3ee2-4ccf-9da5-4d41db66e87e"
      unitRef="usd">106000000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfNS0xLTEtMS0w_3b207e93-ef81-4f58-b957-ad3b992cc239"
      unitRef="usd">-3000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfNS0zLTEtMS0w_78b22e5e-32ec-4ad4-888f-cf651d8f71f6"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfNi0xLTEtMS0w_f53a1662-8dfc-4a88-89e4-a2f548a0fa9c"
      unitRef="usd">-7000000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfNi0zLTEtMS0w_f507eab5-4ffc-4c2f-97a9-fb6db80f6a97"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfOS0xLTEtMS0w_0aeafba9-7346-410b-8c8d-fe3ac36c1b40"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfOS0zLTEtMS0w_e699c32a-9ccc-45ca-8e4a-991c88664d1d"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTEtMS0xLTEtMA_f8f7207b-cc28-45bd-b93e-c6dfb817ee20"
      unitRef="usd">480000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTEtMy0xLTEtMA_4bcb9a7c-ae0f-4182-ad78-e7b08f697d53"
      unitRef="usd">87000000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTItMS0xLTEtMA_9b88933a-5879-4eec-b0aa-f464726b242a"
      unitRef="usd">21000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTItMy0xLTEtMA_d5074173-d3e1-475d-8fdf-760110e2fc61"
      unitRef="usd">7000000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTMtMS0xLTEtMA_e768f93b-513b-47ab-96ad-608fd239dacf"
      unitRef="usd">459000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xNi9mcmFnOjBhNjhiOTBmNDc0ZTRhY2RiOTYzMjNjMzcwYjdkYmNmL3RhYmxlOmVjNDAzNDkyMzQ2NDQwMThhYjE3NmQ5NDVjYjNhYTYwL3RhYmxlcmFuZ2U6ZWM0MDM0OTIzNDY0NDAxOGFiMTc2ZDk0NWNiM2FhNjBfMTMtMy0xLTEtMA_22fdb77e-ef5b-4a7d-af47-1a81fcd9ac60"
      unitRef="usd">80000000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMy0xLTEtMS0w_6a6e8f5e-0ac0-40f0-ac7e-f12c59d1117c"
      unitRef="usd">1230000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMy0zLTEtMS0w_b8bbd80a-1ad8-4109-9094-db6ae92a2879"
      unitRef="usd">1158000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNC0wLTEtMS0wL3RleHRyZWdpb246OGZhNzI1MWQ3OGUyNDE1NmJkNDAzZmIzZDE3NTE3MDBfNjQ_9de05a7e-70a7-4723-9f88-4ca1efa3bfee"
      unitRef="usd">29000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNC0wLTEtMS0wL3RleHRyZWdpb246OGZhNzI1MWQ3OGUyNDE1NmJkNDAzZmIzZDE3NTE3MDBfNzE_d1ddf0ca-8203-4f87-857d-fa537289930d"
      unitRef="usd">28000000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNC0xLTEtMS0w_7c43beae-4e73-42cc-816f-9726cbdb18c8"
      unitRef="usd">1382000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNC0zLTEtMS0w_634aa8d7-5f1f-4c35-b9e7-125e7f6b1fc7"
      unitRef="usd">1520000000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNS0xLTEtMS0w_b29f90d2-beaa-42cf-ad6c-d3dc75955643"
      unitRef="usd">223000000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNS0zLTEtMS0w_85b120dc-4d16-440f-82cd-2617fbea8b7c"
      unitRef="usd">223000000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNi0xLTEtMS0w_067de7c3-9f62-4692-8734-967c08de86fe"
      unitRef="usd">164000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNi0zLTEtMS0w_47d62a38-4c24-4fb1-be5c-fb7b7d4cc8a7"
      unitRef="usd">157000000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfOC0xLTEtMS0w_d125f7c5-4023-4d60-a3d2-3f01f36603e4"
      unitRef="usd">2999000000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfOC0zLTEtMS0w_60499e01-04a8-4b91-91b8-6b8622ef559b"
      unitRef="usd">3058000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfOS0xLTEtMS0w_f3f4c917-2e6a-4104-a75d-a62df36653f3"
      unitRef="usd">1624000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfOS0zLTEtMS0w_5baa2b43-dca3-4aac-b5bc-83457a2a2e1b"
      unitRef="usd">1627000000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTAtMS0xLTEtMA_d247b8c9-0dc7-4371-a692-d07703bfc8b8"
      unitRef="usd">600000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTAtMy0xLTEtMA_dc2ec8e0-ebcb-4c0b-a0cf-1bb103a6b8fb"
      unitRef="usd">604000000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTEtMS0xLTEtMA_94e3584d-69d9-4eb6-9a4a-6e85c3151b8b"
      unitRef="usd">6870000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTEtMy0xLTEtMA_d06e06f3-3d9d-4770-bfee-c769d8ce9013"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTItMS0xLTEtMA_a359896b-55d1-4d67-992a-14ab05d2796f"
      unitRef="usd">1141000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTItMy0xLTEtMA_180bd8a5-bc11-4f1f-847e-c51318b24afe"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:EquityMethodInvestments
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTMtMS0xLTEtMA_f5b6c4ab-2959-45c5-a857-d1722868d691"
      unitRef="usd">527000000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTMtMy0xLTEtMA_cb658489-164c-4163-9e37-cd508f424393"
      unitRef="usd">521000000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTQtMS0xLTEtMA_43ba50fc-e426-4281-aae4-b83121ca573f"
      unitRef="usd">170000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTQtMy0xLTEtMA_3117c819-4de5-422b-a8ba-c7020c08bf2c"
      unitRef="usd">176000000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTYtMS0xLTEtMA_a1772381-fe4c-4e96-8199-9bde95cc9f85"
      unitRef="usd">13931000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMTYtMy0xLTEtMA_45de1891-1f1a-406d-874e-b63a4f2d4f00"
      unitRef="usd">14026000000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjAtMS0xLTEtMA_d34af5ce-5c07-4c8a-b01c-186b5638d882"
      unitRef="usd">1559000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjAtMy0xLTEtMA_c38bc4ce-ad81-4684-8404-488717a69ba5"
      unitRef="usd">1633000000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjEtMS0xLTEtMA_3005a542-0006-46e1-8df4-718b955db48b"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjEtMy0xLTEtMA_d49c7265-f744-4250-9efe-b4ecc8afff74"
      unitRef="usd">2000000</us-gaap:LongTermDebtCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjItMS0xLTEtMA_dde5f975-96ae-44c8-9671-493613d5b46e"
      unitRef="usd">146000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjItMy0xLTEtMA_7f08c990-a6e2-4370-8b6b-fd71dbddf4df"
      unitRef="usd">141000000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjQtMS0xLTEtMA_ee4c59a8-5a76-4577-9fff-a52233a6d36e"
      unitRef="usd">1707000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjQtMy0xLTEtMA_d89fa6cb-9d82-4d20-b2c8-44d6b1207bd2"
      unitRef="usd">1776000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjUtMS0xLTEtMA_4b479cf0-8f23-4d36-a01b-66a2ea678695"
      unitRef="usd">4010000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjUtMy0xLTEtMA_c218b14c-e9b1-4726-9c89-0544ee11d905"
      unitRef="usd">4013000000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjYtMS0xLTEtMA_8fef11a7-ccd7-465b-be04-d463d47a2498"
      unitRef="usd">503000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjYtMy0xLTEtMA_7231bcec-90ee-45a8-ab06-ed2631f58ddd"
      unitRef="usd">499000000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjctMS0xLTEtMA_655960b1-d90e-4fe7-8e88-ce3a7586ee83"
      unitRef="usd">842000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjctMy0xLTEtMA_26484c68-b1cd-4d9e-a89d-6deaa48e940c"
      unitRef="usd">847000000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjktMS0xLTEtMA_4372c80d-ff34-4a53-a0b5-ce541aff3345"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMjktMy0xLTEtMA_732f2695-9bac-412e-b0dd-97a3ae2b693f"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzAtMS0xLTEtMA_00a49017-0bc8-4717-9a4c-de35736075e7"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzAtMy0xLTEtMA_a2d0b6c8-f057-4a56-abb8-a3f44769646d"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityCarryingAmount>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzI5_47b6e572-7818-4291-95ff-6ed4666686de"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzI5_76d34712-247b-4ade-80b8-3452ef9a9738"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzQz_7249b571-9ce8-4863-9df5-ec4537fa54f1"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzQz_a2b2d6bc-560a-49af-8148-3dfa172a883b"
      unitRef="shares">600000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzExNw_cb3f9339-e72c-482e-b8bd-f4e00a4a1571"
      unitRef="shares">217000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMC0xLTEtMC90ZXh0cmVnaW9uOjAyMWI1OTAyNGI3NjQ0YmY4NmRlMmY1NGZhMzEyM2RlXzExNw_fe5823bb-6336-4cde-997c-29cc36c56b79"
      unitRef="shares">217000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMS0xLTEtMA_838ffb60-72a4-4500-8bed-4a1406908656"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzMtMy0xLTEtMA_cd6e02cd-9b55-47fc-8de4-52fa2f6ee84d"
      unitRef="usd">2000000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzQtMS0xLTEtMA_efbbce10-cc26-46a1-82c9-4111b9c5b24d"
      unitRef="usd">2824000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzQtMy0xLTEtMA_51611063-096c-400c-a7e7-c0c2ad6381cb"
      unitRef="usd">2841000000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzUtMS0xLTEtMA_764701fe-f731-4e06-a165-f231abfadd3e"
      unitRef="usd">9690000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzUtMy0xLTEtMA_9942c173-2dfd-4bc5-98e4-dac7a8ffd5cd"
      unitRef="usd">9303000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzYtMS0xLTEtMA_06c15a31-d55c-4bc5-a689-6476535f476d"
      unitRef="usd">-31000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzYtMy0xLTEtMA_b0f0e77a-b7d4-4702-9ab1-33c7cc6a57fb"
      unitRef="usd">-21000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockShares
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjhmMTRlMWIyOGIzNjQ0ZTVhMzBhMjA5NjgyNWFhMDU3XzMw_0856f18a-1579-4224-a330-3acdc61412b0"
      unitRef="shares">86000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzctMC0xLTEtMC90ZXh0cmVnaW9uOjhmMTRlMWIyOGIzNjQ0ZTVhMzBhMjA5NjgyNWFhMDU3XzM3_b0ead229-b621-4520-a3c9-58cc920ede03"
      unitRef="shares">84000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzctMS0xLTEtMA_4334f9c2-c06e-49d0-8345-e213ab323d8a"
      unitRef="usd">5740000000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzctMy0xLTEtMA_e854b5f9-201b-4d43-8fff-00a91e72dcf5"
      unitRef="usd">5366000000</us-gaap:TreasuryStockValue>
    <us-gaap:StockholdersEquity
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzgtMS0xLTEtMA_a912c1c3-8248-49f8-8152-55c58072260f"
      unitRef="usd">6745000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzgtMy0xLTEtMA_aca5335a-7443-4e54-98f1-f126817c3c69"
      unitRef="usd">6759000000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzktMS0xLTEtMA_c1332f0f-9b4d-40c6-b271-fdc08fa052c4"
      unitRef="usd">45000000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfMzktMy0xLTEtMA_bc901a75-1741-42aa-87d4-de1c96c97ad7"
      unitRef="usd">50000000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNDAtMS0xLTEtMA_aa4e92c7-1e20-4644-a22f-49621afcec12"
      unitRef="usd">6790000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNDAtMy0xLTEtMA_268109a3-3a3b-4a58-bdfb-c02573c32043"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNDEtMS0xLTEtMA_aca3faed-db38-4073-8fa0-52f25066adce"
      unitRef="usd">13931000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8xOS9mcmFnOmQyYjY4NjA2Y2Y3NTQ5YWZiMmJjN2VjMGJhODQ1OTEwL3RhYmxlOmRmYWVhZWMyZGE0NjQ1NWM5ZjdiODExMDNmNTU2M2UxL3RhYmxlcmFuZ2U6ZGZhZWFlYzJkYTQ2NDU1YzlmN2I4MTEwM2Y1NTYzZTFfNDEtMy0xLTEtMA_2d0b2b44-e906-4cf0-a846-9819c9067639"
      unitRef="usd">14026000000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMy0xLTEtMS0w_2e2e568e-62e0-4408-92f0-4c711c655599"
      unitRef="usd">490000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMy0zLTEtMS0w_6dbbcbe7-c49e-450f-a5c3-995a6c50161d"
      unitRef="usd">106000000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNS0xLTEtMS0w_96ec49f5-2a16-421e-8a04-d0ca6fee93be"
      unitRef="usd">101000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNS0zLTEtMS0w_59871bb6-bc9f-4f95-acc5-186379b8f0e9"
      unitRef="usd">85000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNi0xLTEtMS0w_844f5787-769d-4c42-b59a-f9170be2c607"
      unitRef="usd">2000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:ContractWithCustomerAssetCreditLossExpense
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNi0zLTEtMS0w_4aef03e8-8daf-41fe-a49b-ca59ee4458fe"
      unitRef="usd">7000000</us-gaap:ContractWithCustomerAssetCreditLossExpense>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNy0xLTEtMS0w_f091924d-803f-4091-b545-593d40dedbea"
      unitRef="usd">-17000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNy0zLTEtMS0w_d27c31c4-538b-401b-b2b4-97391ef02fbd"
      unitRef="usd">14000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfOC0xLTEtMS0w_cea0ca3f-fe75-4827-a5a2-14218542a061"
      unitRef="usd">18000000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfOC0zLTEtMS0w_49e9c39e-3c6a-4ee3-97be-971768857e50"
      unitRef="usd">14000000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTEtMS0xLTEtMA_061e92f9-a213-4051-9c06-22c1154c704b"
      unitRef="usd">2000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTEtMy0xLTEtMA_6db21f24-a625-4af3-b463-9d059cef20a0"
      unitRef="usd">2000000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTMtMS0xLTEtMA_156c735b-65c8-4dad-9afb-b321d260883e"
      unitRef="usd">-138000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTMtMy0xLTEtMA_1d64c84e-a847-4ec8-8ff6-50072fddde8c"
      unitRef="usd">-85000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTQtMS0xLTEtMA_478a1000-fa25-4adf-9ce1-6d4dedfee83e"
      unitRef="usd">-164000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTQtMy0xLTEtMA_c8ecb88a-7a13-4d5a-af7f-83c126d6e3ae"
      unitRef="usd">-47000000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTUtMS0xLTEtMA_1672c161-881c-41ca-bb40-344344af4b10"
      unitRef="usd">163000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTUtMy0xLTEtMA_89ecc4c0-93f6-450f-9963-9dd375c19504"
      unitRef="usd">-3000000</us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTctMS0xLTEtMA_fd4702dd-efeb-4001-a7fa-61f989bbab57"
      unitRef="usd">-2000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTctMy0xLTEtMA_5769b5d6-39b6-4fab-999f-70367f2cc7bf"
      unitRef="usd">12000000</us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTgtMS0xLTEtMA_5ce069d0-c01b-40f5-af94-f4163853b9f1"
      unitRef="usd">731000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMTgtMy0xLTEtMA_709a4e6e-bea9-4133-bc80-174fc976c5e6"
      unitRef="usd">247000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjEtMS0xLTEtMA_b4dc1bef-ba29-4960-af22-8aae29f4e7f8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjEtMy0xLTEtMA_25599550-a190-447d-be46-8eeb3fc9029e"
      unitRef="usd">108000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjQtMS0xLTEtMA_b790a204-af14-4793-944f-7d01592c5267"
      unitRef="usd">86000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjQtMy0xLTEtMA_42b95910-9ee9-43bf-ab2a-9115ba16362f"
      unitRef="usd">83000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjYtMS0xLTEtMA_c83c225f-c976-4fdb-9d8a-b006e98337b5"
      unitRef="usd">7000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjYtMy0xLTEtMA_49ea78bb-eff5-442e-9bc5-899397146a93"
      unitRef="usd">15000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjctMS0xLTEtMA_56d1f7e6-8f0b-4e50-b435-73c09a2a2cfa"
      unitRef="usd">-93000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMjctMy0xLTEtMA_a95366d5-88d7-4011-aed6-14c6c0f9bedc"
      unitRef="usd">-206000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfDebt
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzEtMS0xLTEtMA_c6a8e00b-fe35-4109-ab68-f6636b01514e"
      unitRef="usd">1000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzEtMy0xLTEtMA_f34b7b78-851f-41fb-ba0c-929415964ae9"
      unitRef="usd">801000000</us-gaap:RepaymentsOfDebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzItMS0xLTEtMA_9af1dfda-660d-4c64-9156-d06b83b8bcc5"
      unitRef="usd">410000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzItMy0xLTEtMA_ae304e71-2d51-4804-8349-deaa9a90daf8"
      unitRef="usd">75000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzMtMS0xLTEtMA_a9dad0b2-4eed-42f8-820e-d13a450a22cb"
      unitRef="usd">17000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzMtMy0xLTEtMA_676f2207-cf89-4553-878f-27211003825f"
      unitRef="usd">80000000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzQtMS0xLTEtMA_59037235-2c0c-4ff6-8e22-b1284a357b4c"
      unitRef="usd">21000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzQtMy0xLTEtMA_e47b08ae-9cc0-4c4b-907e-94731749afab"
      unitRef="usd">13000000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzUtMS0xLTEtMA_ad6359af-33e1-48ae-9e80-5cee3a8ff433"
      unitRef="usd">75000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzUtMy0xLTEtMA_c6c26fa3-83d5-4fc1-87a4-efc217311269"
      unitRef="usd">71000000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzYtMS0xLTEtMA_0818706c-4b42-4cd6-b729-e8ac12eda689"
      unitRef="usd">29000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:PaymentsOfDividendsMinorityInterest
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzYtMy0xLTEtMA_cba4fbe0-cccf-467c-a235-39412cd3edb8"
      unitRef="usd">7000000</us-gaap:PaymentsOfDividendsMinorityInterest>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzktMS0xLTEtMA_ed44a252-7c90-442d-8c63-47bbe4c8db2f"
      unitRef="usd">-47000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfMzktMy0xLTEtMA_c406ef61-625a-49d9-9ebf-dd9be7e9bcc6"
      unitRef="usd">-4000000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDAtMS0xLTEtMA_7331ef35-caa1-4931-a9bd-a7a4b48859d9"
      unitRef="usd">-566000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDAtMy0xLTEtMA_1d72bf46-98ab-4900-ac82-4d930ab82db0"
      unitRef="usd">-891000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDItMS0xLTEtMA_fb1a3f4f-67a7-4caa-8ae7-b372d95790ed"
      unitRef="usd">72000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDItMy0xLTEtMA_a79e0f86-a0eb-489a-b8aa-5e70c3bff3c5"
      unitRef="usd">-850000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDQtMS0xLTEtMA_d9ab02df-cdda-4445-a7eb-a9c03bb8ffba"
      unitRef="usd">1158000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDQtMy0xLTEtMA_6d8114cb-e234-4790-ae7b-e10dcff8471d"
      unitRef="usd">1192000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDUtMS0xLTEtMA_c1830a1b-23ae-4800-aa0d-e069bd91556c"
      unitRef="usd">1230000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i3a5f406ec8444737afc188d6eaf5b3df_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yMi9mcmFnOjI3MmI1ZWUwYjFkNzQ0NDg4ZWU1YmUwMjAyMzU1YjgzL3RhYmxlOjcwZmI3NWUxMDNhZTRkMDBiNDYwZDNhOWUzNDM3MTE2L3RhYmxlcmFuZ2U6NzBmYjc1ZTEwM2FlNGQwMGI0NjBkM2E5ZTM0MzcxMTZfNDUtMy0xLTEtMA_a62019e5-9c60-4b56-8146-ba2746a00cf0"
      unitRef="usd">342000000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie646d19d5cf7459186c0619c49ea5b00_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xLTEtMS0w_48423f68-8431-4caa-9b04-c6adf942ff54"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie646d19d5cf7459186c0619c49ea5b00_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0zLTEtMS0w_d438301d-d4b9-4518-92db-7d3a3e9b3f53"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iad2c3ee49929469181f46b8451771c2e_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi01LTEtMS0w_fa9107f5-22b6-4a29-805d-4cefc6f584f9"
      unitRef="usd">2841000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i30e7f83270134cbba57989f6c87ee5dc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi03LTEtMS0w_f24d0d63-c4db-4c2d-b591-661b511737c3"
      unitRef="usd">9303000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6763b3092130441aa4d3e7b62a500f77_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi05LTEtMS0w_296c5132-25d0-4ae5-a6bf-c897c6b53fba"
      unitRef="usd">-21000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4383ddd8bce04187905a84f784749ae5_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xMS0xLTEtMA_8586f4b2-23e6-45c0-a908-d894e9d29faf"
      unitRef="usd">-5366000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie8041207d92044f2b46db9b98a65cc49_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xMy0xLTEtMA_22744437-73ad-4997-8b79-40010f0b5b28"
      unitRef="usd">50000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xNS0xLTEtMA_6c11ed90-f475-4f9a-88c1-885c6b2fbd13"
      unitRef="usd">6809000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMi0xOC0xLTEtMA_06b12df7-7bc0-4214-9120-e54c154ce155"
      unitRef="usd">82000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i1c968630629445fe8e4c6a11b499ae19_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMy03LTEtMS0w_364ea3d4-4eb5-4c8d-a901-00855a168593"
      unitRef="usd">469000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i9847f3acf448409280792183ebb09888_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMy0xMy0xLTEtMA_dda61b59-07c9-4885-bd43-ee56d465cb20"
      unitRef="usd">17000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMy0xNS0xLTEtMA_a8febb34-2736-415e-a573-92027d3aac05"
      unitRef="usd">486000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMy0xOC0xLTEtMA_df610d6a-36a8-44b7-9299-837045903377"
      unitRef="usd">4000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i19684d6afbf34103a049012a6f48ef9c_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNC05LTEtMS0w_256858b9-fce1-4b7b-9e66-2dbc47c9a844"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNC0xNS0xLTEtMA_37e2b2cc-db76-41eb-b579-200aa2e8f266"
      unitRef="usd">-10000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i1c968630629445fe8e4c6a11b499ae19_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNS03LTEtMS0w_511ef1f7-b9c0-4e09-994d-fb859955cad4"
      unitRef="usd">82000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNS0xNS0xLTEtMA_fec064e5-6909-4fb4-9995-9e64f02cc043"
      unitRef="usd">82000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i9847f3acf448409280792183ebb09888_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNi0xMy0xLTEtMA_311502e0-d374-4863-bbfa-61aba5e23dd7"
      unitRef="usd">22000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNi0xNS0xLTEtMA_41892c71-8735-458e-889d-8802c56df539"
      unitRef="usd">22000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNi0xOC0xLTEtMA_a990b05d-ada0-4666-9090-c6f27aa289de"
      unitRef="usd">7000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNy01LTEtMS0w_096ed111-89a0-41ff-a744-84b90546eb9e"
      unitRef="usd">-29000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNy0xMS0xLTEtMA_335394d7-3df5-4cd0-8858-fda1bf2263cd"
      unitRef="usd">34000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfNy0xNS0xLTEtMA_fc3b1865-2b47-435c-9db7-0573ea3c6b32"
      unitRef="usd">5000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOC01LTEtMS0w_e5e55173-0bea-4d65-9bda-fa64de0a2a84"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOC0xNS0xLTEtMA_aef527e0-cbe0-4cef-a03a-b855a954f87c"
      unitRef="usd">18000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="idd48c006babc44508fba201daabd149f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOS0xLTEtMS00NDA1_c44c7353-b8e9-4cd4-8820-2458bb5f35d8"
      unitRef="shares">1000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOS01LTEtMS0w_dcc95819-114b-4960-a4d8-e6c50dbeb995"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOS0xMS0xLTEtMA_bf54ebe0-a85b-45cc-bb32-60082d663d82"
      unitRef="usd">14000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfOS0xNS0xLTEtMA_ceea0962-cd7f-43e5-8ffd-718f50c571e7"
      unitRef="usd">17000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1afcc23c616a43418f2f41ff83fd9485_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTAtNS0xLTEtMA_e8e88885-1f76-486b-b770-8516edc6b010"
      unitRef="usd">9000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTAtMTEtMS0xLTM0NDg_5dc30c86-126f-46d2-b19b-dcad34032564"
      unitRef="usd">12000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTAtMTUtMS0xLTM1NTc_3ae96e4b-9e43-4b76-9098-31fd68ef36e4"
      unitRef="usd">21000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="idd48c006babc44508fba201daabd149f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTEtMS0xLTEtMA_2779294b-531a-40b2-8896-9cbb3b6632a8"
      unitRef="shares">3000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTEtMTEtMS0xLTA_784a5646-9bed-433e-a340-8bad068c8f6a"
      unitRef="usd">410000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTEtMTUtMS0xLTM1NTc_63c23c81-be2a-4446-8029-ab0d3328d50c"
      unitRef="usd">410000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1229f5eae1bb44628fb91b7979affa6f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMS0xLTEtMA_c9abb91b-1d42-4efb-b2d6-ac06845f4de8"
      unitRef="shares">131000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1229f5eae1bb44628fb91b7979affa6f_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMy0xLTEtMA_87afbb4e-9671-4003-a85e-1d3ee42b829b"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia93fe46925ac4e9bb7935ca7294c9f15_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItNS0xLTEtMA_8d37b922-5551-4490-9279-2c7b7454096c"
      unitRef="usd">2824000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i0837bdde940d4fec8198129389d20b30_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItNy0xLTEtMA_eaf960cd-4341-40a3-95fa-b9fe8edd62b6"
      unitRef="usd">9690000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i31fe7b51e3304a36906e002676eabb34_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItOS0xLTEtMA_aee6692e-05eb-4011-bc30-90a99805c823"
      unitRef="usd">-31000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6f7944d31d44461c81787b9b98e14b57_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMTEtMS0xLTA_47fad0e6-8ae2-4148-948a-4a5800a9e80f"
      unitRef="usd">-5740000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id66c8836535840cab79f0efa55d1cee1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMTMtMS0xLTA_bd283c53-6f0f-4e82-9662-d1909b28ed96"
      unitRef="usd">45000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMTUtMS0xLTA_ef02dd6f-9576-49f9-b0b9-01de73f421a2"
      unitRef="usd">6790000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjZhZTg3ZWQ0ZjYxODQ1YWU5NzM5YTYzOThhZTFlZGY0L3RhYmxlcmFuZ2U6NmFlODdlZDRmNjE4NDVhZTk3MzlhNjM5OGFlMWVkZjRfMTItMTgtMS0xLTA_a338dd1e-fc87-4c96-8b11-1ef2577faca4"
      unitRef="usd">79000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie4f49c664e464e75a6577f2c5dbd5d00_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xLTEtMS0w_070f796a-b766-4e8b-bad4-719e0a2da260"
      unitRef="shares">133000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4f49c664e464e75a6577f2c5dbd5d00_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0zLTEtMS0w_e2ce89bb-38a7-4b5c-a8c9-a7344a003c37"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i44d7060969104f55af57e24f5142babe_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi01LTEtMS0w_5e110915-84f5-4720-8858-b81a913a2685"
      unitRef="usd">2722000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic2353c85dd054cf1943d3a8d511c4959_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi03LTEtMS0w_83b3a658-253a-451d-bdd2-131a19a4a7ad"
      unitRef="usd">8174000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i795ed9a1abc545c88b550e1eedd5d75c_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi05LTEtMS0w_709c0607-7dde-455f-b7f3-bebd3570fd6a"
      unitRef="usd">-39000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i207c605753d646cb94bcf01101b0bf97_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xMS0xLTEtMA_29123c95-be23-4c6b-b313-2636871d2cbf"
      unitRef="usd">-5218000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ieb90cf4bc9e9485d83bb0be21e4bf3ca_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xMy0xLTEtMA_956f238b-a2f0-4d26-875f-31db47b1b98f"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xNS0xLTEtMA_faee0673-dbc1-48bc-a73d-ba11f8f69210"
      unitRef="usd">5687000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMi0xOC0xLTEtMA_81d80ef7-68dc-4fdb-988c-ebc5f27dea33"
      unitRef="usd">76000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="i2c99680609bd4fb4ac289f25c8f9e0b6_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMy03LTEtMS0w_567cbb6b-5fb3-4422-89ec-c2e524f1e617"
      unitRef="usd">99000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="ic022103456b94e4f920519555dc899e2_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMy0xMy0xLTEtMA_bd485d86-ff27-47e5-bcaa-8ea40b42becd"
      unitRef="usd">6000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMy0xNS0xLTEtMA_70cef85f-8732-42ba-a04c-d15dfc34dece"
      unitRef="usd">105000000</dgx:NetIncomeLossExcludingRedeemableNoncontrollingInterest>
    <us-gaap:TemporaryEquityNetIncome
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMy0xOC0xLTEtMA_880fd432-f7c2-4424-87f6-557bd67fd799"
      unitRef="usd">1000000</us-gaap:TemporaryEquityNetIncome>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i41ab8be1210042b6bb81b9c60bf8605a_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNC05LTEtMS0w_5c81baf1-dc8f-483d-9d00-82eefcee9afd"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNC0xNS0xLTEtMA_3d667edb-fccb-417d-8d81-c816fa8d5b83"
      unitRef="usd">-19000000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:DividendsCommonStockCash
      contextRef="i2c99680609bd4fb4ac289f25c8f9e0b6_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNS03LTEtMS0w_07940e07-a8a7-46de-8dab-c1b8913422e2"
      unitRef="usd">76000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNS0xNS0xLTEtMA_23ae8751-3a42-40de-9fff-8a8bcfa61feb"
      unitRef="usd">76000000</us-gaap:DividendsCommonStockCash>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="ic022103456b94e4f920519555dc899e2_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNi0xMy0xLTEtMA_08fefaa7-1bf3-4672-a7d8-ea1f2babb0f2"
      unitRef="usd">6000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNi0xNS0xLTEtMA_681fc313-1a04-45aa-9c7c-eab4ab7cb092"
      unitRef="usd">6000000</us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders>
    <dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNi0xOC0xLTEtMA_91737315-1fb4-4020-a2e2-5ab94c888e22"
      unitRef="usd">1000000</dgx:TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNy01LTEtMS0w_29809666-76ee-404a-88a0-921b53fc8b27"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNy0xMS0xLTEtMA_8f8f36cb-99db-4e90-b073-c7f614cedb3c"
      unitRef="usd">3000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfNy0xNS0xLTEtMA_30a7131c-35a0-443e-98f3-1a57f5ba2d5b"
      unitRef="usd">6000000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOC01LTEtMS0w_fc9cdae6-c33e-452d-a405-3b36d5f40e7c"
      unitRef="usd">14000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOC0xNS0xLTEtMA_f623fb6c-1545-47e6-9d24-325e276535d4"
      unitRef="usd">14000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie15d552706e0430088071b5ee01807cd_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOS0xLTEtMS0w_8e8280af-c174-4237-9722-f4b042643dea"
      unitRef="shares">2000000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOS01LTEtMS0w_55b668f7-b184-46c7-a42f-73176b064f81"
      unitRef="usd">12000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOS0xMS0xLTEtMA_3f47836e-003c-4921-8882-e747ecfa4db5"
      unitRef="usd">68000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfOS0xNS0xLTEtMA_e7abe80b-1692-46d2-bd30-de4de4530f49"
      unitRef="usd">80000000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iab6dd78a4c2749b7b4d7901c3c959328_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTAtNS0xLTEtMA_890c2221-ad11-484b-ad1c-c8a95eada8e3"
      unitRef="usd">13000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTAtMTUtMS0xLTA_bbb1811b-a5d3-453c-81c0-3195869d9262"
      unitRef="usd">13000000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ie15d552706e0430088071b5ee01807cd_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTEtMS0xLTEtMA_50f09dea-4361-4056-9a4c-0b9b2983e36f"
      unitRef="shares">1000000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTEtMTEtMS0xLTA_cbe12ede-4c74-46a6-a31e-a16100ada5d7"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTEtMTUtMS0xLTA_2cd62f29-8602-4b45-99eb-2d39c148c1f2"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i2a26f2f8c8934f1b93702b137ab17309_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMS0xLTEtMA_256d5624-2e99-43d2-8cda-781c13ca3279"
      unitRef="shares">134000000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2a26f2f8c8934f1b93702b137ab17309_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMy0xLTEtMA_10e8bb84-9192-41c7-a452-de4f7fd7f7c8"
      unitRef="usd">2000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i72931c6b70d14f8e8c1d97620ad67fbe_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItNS0xLTEtMA_5229e38d-35d6-4303-ac9d-a5e1f49def44"
      unitRef="usd">2738000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iec9454bd4f9d47f3b5eee627c27ab502_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItNy0xLTEtMA_d7c1ec62-5c26-4e57-bb60-d7d2dd45d9e9"
      unitRef="usd">8197000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4f0cdcdd19e149f58288a99e479bfc5d_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItOS0xLTEtMA_3e7002b7-d10f-41db-af72-0db6725ee201"
      unitRef="usd">-58000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if402423ae2b24c479ced9a86251c3483_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMTEtMS0xLTA_9e4e5778-ab4b-4a29-80e1-3bb3e997067f"
      unitRef="usd">-5222000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i20b63065eb04432ba75178f3f9ab8895_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMTMtMS0xLTA_ce95fbe9-d4d7-4542-b2e6-db73ba08d738"
      unitRef="usd">46000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3a5f406ec8444737afc188d6eaf5b3df_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMTUtMS0xLTA_84ab7ff6-76be-4cbf-93ee-6edd65852c71"
      unitRef="usd">5703000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests
      contextRef="i3a5f406ec8444737afc188d6eaf5b3df_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8yNS9mcmFnOjhkNDdhZjQwMWVmMzQ1M2M4ZjAzMjE5OGQ1MzFmMWIzL3RhYmxlOjNkMzFjMzZkOWRlOTRiOGRiYmU0YjM3ZjM5ZDZiY2I0L3RhYmxlcmFuZ2U6M2QzMWMzNmQ5ZGU5NGI4ZGJiZTRiMzdmMzlkNmJjYjRfMTItMTgtMS0xLTA_68c26016-6690-486b-b3b4-65c1f4349e69"
      unitRef="usd">76000000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:NatureOfOperations
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zMS9mcmFnOjM4ZDlmYjJkNjc1MzRkZjRiYWQwN2JiNWJhNDU1YmU3L3RleHRyZWdpb246MzhkOWZiMmQ2NzUzNGRmNGJhZDA3YmI1YmE0NTViZTdfMTc1NA_deca462a-0725-4023-9485-e349759f4a7d">DESCRIPTION OF BUSINESS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIzMA_119d2eb0-8b18-436b-ad82-7783536affac">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#x201c;COVID-19&#x201d;) continues to spread and severely impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three months ended March&#160;31, 2021 may not be indicative of the results that may be expected for the full year.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Earnings Per Share&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIwMw_76c316e6-068f-4e04-a3cc-68653d6b523f">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#x2019;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;).</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIyMQ_e5dff932-010d-4f8f-83e7-dd156f1f008b">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.</us-gaap:UseOfEstimates>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIxNw_6eab7cec-bd95-4e2c-a796-53d6cc8fc2e1">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNC9mcmFnOmYwNGYyYjRlZThkMTRlMmM5M2FiOWYzZWJjMTZjNjlkL3RleHRyZWdpb246ZjA0ZjJiNGVlOGQxNGUyYzkzYWI5ZjNlYmMxNmM2OWRfNjIxOA_c072650a-b040-4b11-accf-3c6e13407be8">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#x2019;s consolidated results of operations, financial position or cash flows.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RleHRyZWdpb246ZGU0ZjhiMjg4YWM2NDEyNmJlMTgyZmNmN2FlNzE1NjlfODEy_4e77e20e-88f0-4a85-b499-ac4abd3902a4">EARNINGS PER SHARE&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RleHRyZWdpb246ZGU0ZjhiMjg4YWM2NDEyNmJlMTgyZmNmN2FlNzE1NjlfODI5_a0d1ecd7-3582-432c-b96e-6344b4a330da">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amounts attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Earnings allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Earnings available to Quest Diagnostics&#x2019; common stockholders &#x2013; basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;468&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of dilutive securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings per share attributable to Quest Diagnostics&#x2019; common stockholders:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.73&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfNy0xLTEtMS0w_f8e73ff7-bcb6-4db7-a590-c2bc92fa7dfe"
      unitRef="usd">469000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfNy0zLTEtMS0w_d9a2ba6f-d750-42e6-8a2c-f3e95d65d54d"
      unitRef="usd">99000000</us-gaap:NetIncomeLoss>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfOC0xLTEtMS0w_5862d104-3d28-4000-adc2-46620c0a593d"
      unitRef="usd">1000000</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfOC0zLTEtMS0w_a1d709b2-98c7-4757-951b-d6546d7bd2b2"
      unitRef="usd">0</us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfOS0xLTEtMS0w_ca3efba3-7fdc-45a1-98d9-c4597bf7544e"
      unitRef="usd">468000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfOS0zLTEtMS0w_51273225-72d8-4457-b5ad-f3ae7c72d331"
      unitRef="usd">99000000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTEtMS0xLTEtMA_85bbaea0-8dab-460b-8378-fa9e9f39fe66"
      unitRef="shares">133000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTEtMy0xLTEtMA_ac1f508b-9c68-4a36-b1e0-2ae9d59140cd"
      unitRef="shares">134000000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTMtMS0xLTEtMA_d3c10217-8047-481c-bdcc-d1fde4e60cac"
      unitRef="shares">2000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTMtMy0xLTEtMA_fcbb0606-2443-498c-9d31-cfdf0ab2352c"
      unitRef="shares">1000000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTQtMS0xLTEtMA_79e6cda0-590e-4bcd-bd44-56cc14707083"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTQtMy0xLTEtMA_7e230a04-db07-44b2-9301-8024829b4802"
      unitRef="shares">135000000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTctMS0xLTEtMA_dd758091-3dc3-47f1-8910-2e816564e6aa"
      unitRef="usdPerShare">3.52</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMTctMy0xLTEtMA_335d14ea-df46-43a4-bc5f-4fc91eaa23a3"
      unitRef="usdPerShare">0.74</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMjItMS0xLTEtMA_e07c591a-3a64-4f4a-a203-1efc5291f69d"
      unitRef="usdPerShare">3.46</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjg0NTI5MmVmNGI2NjRlNTA5OWZhY2U4OTJiM2M2MTYyL3RhYmxlcmFuZ2U6ODQ1MjkyZWY0YjY2NGU1MDk5ZmFjZTg5MmIzYzYxNjJfMjItMy0xLTEtMA_d90ab3be-e8df-44a6-a53c-cbbf484a5b0d"
      unitRef="usdPerShare">0.73</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RleHRyZWdpb246ZGU0ZjhiMjg4YWM2NDEyNmJlMTgyZmNmN2FlNzE1NjlfODMx_3d916cd8-6826-4a9b-9364-459769bac47b">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options and performance share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjdjOGNmOWMyODVhMDRkMGZhZmI0MjliZmNhNzkwZjM0L3RhYmxlcmFuZ2U6N2M4Y2Y5YzI4NWEwNGQwZmFmYjQyOWJmY2E3OTBmMzRfMi0xLTEtMS0w_803f6ef3-c69b-48ca-9400-7938c8fe7b96"
      unitRef="shares">1000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV8zNy9mcmFnOmRlNGY4YjI4OGFjNjQxMjZiZTE4MmZjZjdhZTcxNTY5L3RhYmxlOjdjOGNmOWMyODVhMDRkMGZhZmI0MjliZmNhNzkwZjM0L3RhYmxlcmFuZ2U6N2M4Y2Y5YzI4NWEwNGQwZmFmYjQyOWJmY2E3OTBmMzRfMi0zLTEtMS0w_df219823-019d-40b1-b55c-11f13f9241df"
      unitRef="shares">2000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80My9mcmFnOmVhYzdjNjRlZDdmZDQ3ZjY5YWJjODk0MDc0YjJiZGRjL3RleHRyZWdpb246ZWFjN2M2NGVkN2ZkNDdmNjlhYmM4OTQwNzRiMmJkZGNfNDIzNA_eef97a46-92b5-42a5-ae6b-2d5a8eb1fece">BUSINESS ACQUISITIONS&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 6, 2021, the Company entered into a definitive agreement to acquire the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma.  The transaction, which is expected to close in mid-2021, remains subject to customary closing conditions.&lt;/span&gt;&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNzY5NjU4MTQwMzcyNw_022b0c4c-25ca-4d3f-b6d3-783188cb38cd">FAIR VALUE MEASUREMENTS  &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-right:72pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#x201c;invested&#x201d; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended March 31, 2021, the Company recorded an $8&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of March&#160;31, 2021 and December&#160;31, 2020, the fair value of the Company&#x2019;s debt was estimated at $4.4&#160;billion and $4.6 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNzY5NjU4MTQwMzcyNA_0535a13d-8642-4689-9172-1adf6dbf818c">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.260%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Quoted Prices in Active Markets for Identical Assets/Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Other Observable Inputs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Inputs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.191%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.345%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.198%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basis of Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trading securities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash surrender value of life insurance policies&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Available-for-sale debt securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;129&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred compensation liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Redeemable noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:TradingSecurities
      contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNi0xLTEtMS0w_bf96e31c-8512-418f-8151-1bce6c1b15f4"
      unitRef="usd">71000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNi0zLTEtMS0w_90adb924-8a8a-4266-9fda-6ef80cad7d67"
      unitRef="usd">71000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNi01LTEtMS0w_de975a7b-3c90-4893-83ac-0a4e64d1aeb3"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNi03LTEtMS0w_8ff89d53-340d-4169-9c0c-434940b60293"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNy0xLTEtMS0w_821cf0f6-c1e2-4ffe-a954-f6d055877651"
      unitRef="usd">52000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNy0zLTEtMS0w_526d1dc9-bd91-4493-bc3c-5bbcca366a2f"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNy01LTEtMS0w_7db94472-b41f-4dd9-a980-5133cea2a27d"
      unitRef="usd">52000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfNy03LTEtMS0w_9919c5a3-5d4e-4983-92d7-fa1a76b7e7be"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfOS0xLTEtMS0w_e1782092-bcd2-4277-a899-c5901d66c0fb"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfOS0zLTEtMS0w_9af744d9-31ee-4230-af9d-a2f0fa2883b3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfOS01LTEtMS0w_c28add00-8c94-49cc-832f-5c4fff609c6e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfOS03LTEtMS0w_ebbf6f4f-fc06-4662-8167-49dff4785cc3"
      unitRef="usd">2000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTItMS0xLTEtMA_e85c6d70-3edb-47f8-be4a-903c4e9d7b76"
      unitRef="usd">125000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTItMy0xLTEtMA_ea42e5c2-e3bc-4d74-a5a2-19b1ec6fd9a8"
      unitRef="usd">71000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTItNS0xLTEtMA_2e0fac3d-4061-4edd-b798-3877f40855dd"
      unitRef="usd">52000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTItNy0xLTEtMA_8552c1b4-fdf9-421a-8638-d5457c6c1252"
      unitRef="usd">2000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTUtMS0xLTEtMA_5fa6c93f-db32-44f3-80b1-aeb5b8b6f472"
      unitRef="usd">132000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTUtMy0xLTEtMA_89471c9d-cd58-4941-bfb9-f78e46819a14"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i219be6c936d3415ca28de30c5ecdd725_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTUtNS0xLTEtMA_2038ab6a-2390-419e-9f19-964ed07c515c"
      unitRef="usd">132000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMTUtNy0xLTEtMA_66f3e79c-cf84-46de-9917-0b48bbda5be5"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i0ed43c43b5ff493e9231f461d2f7f59b_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMjItMS0xLTEtMA_65e9762d-8241-44ef-acae-e175b6219d3b"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="ic67cad7792d740b5a02d32b5524496e1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMjItMy0xLTEtMA_2a74f5a3-f4e5-4077-99a9-971b8db585ec"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i94d5c3ec8c294ad2b02b16745af5b212_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOjg2NGQzOGMwYmVkZTQ2M2VhMWI2N2M0MjViNWQ4OTI0L3RhYmxlcmFuZ2U6ODY0ZDM4YzBiZWRlNDYzZWExYjY3YzQyNWI1ZDg5MjRfMjItNy0xLTEtMA_957f43d3-62a3-489e-8ca7-8f06c1e3f710"
      unitRef="usd">79000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:TradingSecurities
      contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMy0xLTEtMS0w_f2884811-c6cd-4e6e-9d4a-8121c60912de"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMy0zLTEtMS0w_58d07d69-8f71-4a75-8ddb-5684b7398941"
      unitRef="usd">67000000</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMy01LTEtMS0w_5a92a490-6e9d-4cec-9f30-235e6d5b5b14"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:TradingSecurities
      contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMy03LTEtMS0w_0bd9f252-8e4f-4856-bf15-477e30aeaa9a"
      unitRef="usd">0</us-gaap:TradingSecurities>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNC0xLTEtMS0w_ba912736-9588-4d32-848c-f76fc3f48237"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNC0zLTEtMS0w_468888c8-aa05-47c2-8a85-30cd538cb7d1"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNC01LTEtMS0w_6cee07dc-9652-4b83-8a64-13a8408a9173"
      unitRef="usd">50000000</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:CashSurrenderValueFairValueDisclosure
      contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNC03LTEtMS0w_98ff8245-b0eb-4660-b90a-91fe5304c311"
      unitRef="usd">0</us-gaap:CashSurrenderValueFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNS0xLTEtMS0w_f910be8f-a367-456a-80f5-5189d165f7c9"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNS0zLTEtMS0w_ccfca975-16df-496a-b7bf-016096a6c35d"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNS01LTEtMS0w_7b6c16e5-d19b-4588-9ae8-d9727fc1fe84"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfNS03LTEtMS0w_cd8ef568-a31d-4638-b05b-a846b11b8972"
      unitRef="usd">12000000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTAtMS0xLTEtMA_ffabd768-23cd-46db-839c-f9fd872ce8a8"
      unitRef="usd">129000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTAtMy0xLTEtMA_f6a0d95d-67cf-4503-b76a-1019b635b789"
      unitRef="usd">67000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTAtNS0xLTEtMA_7d595b21-0742-4f82-b192-5fe049f037ca"
      unitRef="usd">50000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTAtNy0xLTEtMA_7de0e0d9-0c8c-4692-abd9-1154c08e5eff"
      unitRef="usd">12000000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTMtMS0xLTEtMA_2dc4585d-7847-4106-aee3-98024d783b8b"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTMtMy0xLTEtMA_316a2ffe-e36d-4506-8ba4-3d1dd12b5788"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i3c8d9aa6fdec429aa7c92b71fd0637cc_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTMtNS0xLTEtMA_c1a9a0d2-2e3d-48ef-a8f6-ee4e5796fe76"
      unitRef="usd">126000000</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent
      contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMTMtNy0xLTEtMA_0fa19664-ea99-4d01-b95d-589771e17396"
      unitRef="usd">0</us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i68ce47c4dd1146df8e572f0c839b6589_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMjEtMS0xLTEtMA_fa0fc8d1-4b8a-4ced-b2bb-88f792691b07"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="iee79e433c95e49c9a0a5609e33cf096b_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMjEtMy0xLTEtMA_861cf3fe-cc07-44b3-920e-a1fa467a4226"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:RedeemableNoncontrollingInterestEquityFairValue
      contextRef="i14aa0040139a42d3b7c0bff4113965f2_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RhYmxlOmRlNTBiNzg3ZTM3NzQ0ZGZhZWM0ZjY5MjA1NWM4YWIzL3RhYmxlcmFuZ2U6ZGU1MGI3ODdlMzc3NDRkZmFlYzRmNjkyMDU1YzhhYjNfMjEtNy0xLTEtMA_33889dba-0779-4cf9-bffc-04e6314b416c"
      unitRef="usd">82000000</us-gaap:RedeemableNoncontrollingInterestEquityFairValue>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ic8b7e170774c4e2f95ec5ebd85bba23b_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNDc3OA_3cd40039-b3e9-4dc5-a071-3b56daa9b5b3"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment
      contextRef="ib735db70e8754b31974b71ba0360f16f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNDM5ODA0NjUxOTY0NA_1f6059bf-827b-4ab7-9670-ff67bcf07dd2"
      unitRef="usd">8000000</us-gaap:EquityMethodInvestmentOtherThanTemporaryImpairment>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNDM5ODA0NjUyMDM4Mw_0f3c9fb3-6186-4711-83c4-725450c33574"
      unitRef="usd">4400000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80Ni9mcmFnOmFiZDYwMWNhMzgwMTQ2MzVhN2E2NzVkMWE2YWY2ZjdlL3RleHRyZWdpb246YWJkNjAxY2EzODAxNDYzNWE3YTY3NWQxYTZhZjZmN2VfNTc0Ng_8a52e85a-118b-43e6-b0b8-9ff8768c5262"
      unitRef="usd">4600000000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfMTI1MQ_92770fa0-9abe-4340-961e-4dfa685fc425">GOODWILL AND INTANGIBLE ASSETS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The changes in goodwill for the three months ended March&#160;31, 2021 and for the year ended December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Principally all of the Company&#x2019;s goodwill as of March&#160;31, 2021 and December&#160;31, 2020 was associated with its DIS business.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy, Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining 56% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Intangible assets as of March&#160;31, 2021 and December&#160;31, 2020 consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(659)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(827)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(827)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfMTI0NA_eba8550a-03ea-4113-bee9-3ec6e74282fe">The changes in goodwill for the three months ended March&#160;31, 2021 and for the year ended December&#160;31, 2020 were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.906%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.589%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.562%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.175%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill acquired during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMS0xLTEtMS0w_19f0e71c-8dad-4dae-bd91-82baf5d5ecc9"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i9adbe4d9a49f4d73b4e4e499c1602647_I20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMS0zLTEtMS0w_c247d3ba-30d4-4e57-8855-1692e80321fc"
      unitRef="usd">6619000000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMi0xLTEtMS0w_82f86c6b-8679-479f-96da-9c2c3b0055ba"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idcc7342da57f4a33aff95cad60d1c936_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMi0zLTEtMS0w_f03fee8b-0fd2-4364-821f-60a7c8e70baf"
      unitRef="usd">247000000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMy0xLTEtMS0w_5f91a53f-2979-4b54-9c9e-d7b68875b60e"
      unitRef="usd">-3000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:GoodwillPeriodIncreaseDecrease
      contextRef="idcc7342da57f4a33aff95cad60d1c936_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfMy0zLTEtMS0w_e72f1f5c-153d-4a22-8b15-afa72db51379"
      unitRef="usd">7000000</us-gaap:GoodwillPeriodIncreaseDecrease>
    <us-gaap:Goodwill
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfNy0xLTEtMS0w_a1ddedb2-53c8-42b6-813f-a53861ae4dcf"
      unitRef="usd">6870000000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOmYzNGQ5ZDI0NTg4NzRlOTY4NDQ3OWQ4MmMwY2ZjZjJlL3RhYmxlcmFuZ2U6ZjM0ZDlkMjQ1ODg3NGU5Njg0NDc5ZDgyYzBjZmNmMmVfNy0zLTEtMS0w_230cbaa0-b109-42b6-b564-6782392c1996"
      unitRef="usd">6873000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i0d63d7e9761b4274807931de4482a38c_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfNzY5NjU4MTM5NzIyMg_9cbef2c7-dd3b-4fd5-ac13-54e2e0b6d2a7"
      unitRef="number">0.56</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfMTI0OA_e2a64112-09e2-4460-a619-332198039f85">Intangible assets as of March&#160;31, 2021 and December&#160;31, 2020 consisted of the following:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.017%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.724%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.727%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Amortization&lt;br/&gt;Period &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:24pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amortizing intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer-related&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(659)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(638)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(68)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(65)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(95)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,732&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(827)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;931&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Intangible assets not subject to amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(827)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(800)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic90470dc4f4e496caf705d77fa10f616_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy0xLTEtMS0w_fd36e39e-8b58-4580-9990-ba7eee87cd4c">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibb591aeff91e492ea542a000f524e7ba_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy0zLTEtMS0w_fa9260e2-c901-41a5-931c-e946e209d228"
      unitRef="usd">1481000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibb591aeff91e492ea542a000f524e7ba_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy01LTEtMS0w_bd10a2c1-9243-4188-8be5-8193855cbc69"
      unitRef="usd">659000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibb591aeff91e492ea542a000f524e7ba_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy03LTEtMS0w_e5d74e27-a683-46f0-b194-3999a70e20c1"
      unitRef="usd">822000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="iedd67844f6da45dea182ccba35b463fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy05LTEtMS0w_f091906b-22a7-4e32-957d-d1056aeb4a6c"
      unitRef="usd">1479000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iedd67844f6da45dea182ccba35b463fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy0xMS0xLTEtMA_436a726e-b92f-4d0b-8a4f-3491f3212084"
      unitRef="usd">638000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="iedd67844f6da45dea182ccba35b463fa_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMy0xMy0xLTEtMA_e0bc2c30-3766-4c0b-a5d4-8229cbef0cb8"
      unitRef="usd">841000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="iadbedddfbeb44bccac35bc1968c7198f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC0xLTEtMS0w_925a9b68-25c3-4c80-abfb-2fd71dbcb143">P9Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i57106d7badad475d94a3fdc00692bdf1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC0zLTEtMS0w_11e26a3b-6d70-453f-b96a-3af03151b52b"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i57106d7badad475d94a3fdc00692bdf1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC01LTEtMS0w_efad2f67-a604-40c7-b443-c33042521b49"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i57106d7badad475d94a3fdc00692bdf1_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC03LTEtMS0w_9c254d64-aae4-44ab-b687-0c7157a057a9"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if045c9990da04355aabfd81d38c5e41d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC05LTEtMS0w_faeec7cc-3770-4d6b-8a02-1fb7189dcbe2"
      unitRef="usd">3000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if045c9990da04355aabfd81d38c5e41d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC0xMS0xLTEtMA_8cc85106-0f10-42b8-ab80-78a30cf17eb0"
      unitRef="usd">2000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if045c9990da04355aabfd81d38c5e41d_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNC0xMy0xLTEtMA_19c3efc8-4109-43fd-b340-f423febb527c"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i604ee99bfe964292aabcd6f1b7a316d6_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS0xLTEtMS0w_c4724351-1bb3-4b3a-83da-85d2c1330da5">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i8dd08a56a99d48b4a6ee1e2a7e24fcbe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS0zLTEtMS0w_98a08fea-7573-448e-b9ad-6cb1edafb0de"
      unitRef="usd">140000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8dd08a56a99d48b4a6ee1e2a7e24fcbe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS01LTEtMS0w_7319f6f9-03e0-4a3d-af49-b623d2d0cf01"
      unitRef="usd">68000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i8dd08a56a99d48b4a6ee1e2a7e24fcbe_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS03LTEtMS0w_ff64d55c-bf57-428f-9bf0-b5f858e939b5"
      unitRef="usd">72000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i246eef5102584ee28b17a57e7f0313fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS05LTEtMS0w_60462fc4-6e3b-4416-80f6-3b212b716572"
      unitRef="usd">141000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i246eef5102584ee28b17a57e7f0313fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS0xMS0xLTEtMA_87ef9c2a-5e10-4b38-891b-71b442c0e969"
      unitRef="usd">65000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i246eef5102584ee28b17a57e7f0313fe_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNS0xMy0xLTEtMA_5599d677-9591-4a34-a9d0-ae3bc82bdbb4"
      unitRef="usd">76000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i329a30ceb1f446f2b7a379a3a3609fdd_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi0xLTEtMS0w_e7ebaecf-050d-4494-b99a-948ae26a3789">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i2340158a38984ae194d149a5c95c9e3c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi0zLTEtMS0w_4583ca33-82c1-49e1-b6d5-5ed0d4639117"
      unitRef="usd">108000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2340158a38984ae194d149a5c95c9e3c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi01LTEtMS0w_8342312a-b251-4686-81ca-df404298c8d1"
      unitRef="usd">98000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2340158a38984ae194d149a5c95c9e3c_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi03LTEtMS0w_414c9043-e3ae-41e1-8eda-2c2e9cce5a66"
      unitRef="usd">10000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="if8a7848040184bc9a44a3890de687919_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi05LTEtMS0w_5a101fd4-ee4d-41a2-98ba-6a235d705a7d"
      unitRef="usd">108000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if8a7848040184bc9a44a3890de687919_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi0xMS0xLTEtMA_09cc4927-af20-4602-bd7f-6e829be83d08"
      unitRef="usd">95000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="if8a7848040184bc9a44a3890de687919_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNi0xMy0xLTEtMA_51e11ddf-f27b-4e38-af10-9365a09c3ac8"
      unitRef="usd">13000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id151570e96bf47e2b5807c317f3da3d2_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy0xLTEtMS0w_33d89fef-244c-4480-adee-c872e12eca52">P17Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ibb6b341327284acb8967c7a25afd49bf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy0zLTEtMS0w_7ed52b02-1b1e-421d-a453-ca16a7c1598a"
      unitRef="usd">1732000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibb6b341327284acb8967c7a25afd49bf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy01LTEtMS0w_f005acc1-9c34-43b7-9d6c-f684373de200"
      unitRef="usd">827000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ibb6b341327284acb8967c7a25afd49bf_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy03LTEtMS0w_82daf21d-4288-4f74-a4e4-bfe149467085"
      unitRef="usd">905000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i4da6e7d6898a41e2a321057961de0c2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy05LTEtMS0w_1888bb23-759f-4467-b113-de78ea32d273"
      unitRef="usd">1731000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4da6e7d6898a41e2a321057961de0c2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy0xMS0xLTEtMA_0b906697-ae02-4121-b73f-3f5f89231be8"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i4da6e7d6898a41e2a321057961de0c2c_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfNy0xMy0xLTEtMA_43fdf8ef-f2f7-407d-afc4-700af8ff4585"
      unitRef="usd">931000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i5fedf49ea624406aa29fd6ba884c32c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTAtMy0xLTEtMA_3d6ac24e-6c00-4014-8bed-b6ac4ee19244"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i5fedf49ea624406aa29fd6ba884c32c8_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTAtNy0xLTEtMA_2f1ca6ef-8ad2-4a6c-8c42-e990be34689f"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i878a393788d6403c92b8b90fb49da518_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTAtOS0xLTEtMA_65150016-5472-4cc1-a1be-bbc7d8abdce8"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i878a393788d6403c92b8b90fb49da518_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTAtMTMtMS0xLTA_dec88ef3-a17c-4e60-bf4a-ddff6e45efd5"
      unitRef="usd">235000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i90898918a80f45fcb9a06e317a5665ff_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTItMy0xLTEtMA_70cf4899-f5a9-406f-821b-5c35a9435d6e"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i90898918a80f45fcb9a06e317a5665ff_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTItNy0xLTEtMA_9f9b5bb0-60e1-4b42-888a-78ccfa53eb10"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i7627047194654fc7b1f1cb6056491ceb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTItOS0xLTEtMA_c095e92a-d4ea-4ddb-b79b-59d7589b538a"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i7627047194654fc7b1f1cb6056491ceb_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTItMTMtMS0xLTA_78750499-371d-4ca9-ba06-094d752833eb"
      unitRef="usd">1000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtMy0xLTEtMA_96e711a5-a786-4df1-b29a-6182ae80aba0"
      unitRef="usd">1968000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtNS0xLTEtMA_395c230a-8183-4819-9a50-16f3c3f76fe6"
      unitRef="usd">827000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtNy0xLTEtMA_ded0dcbe-a091-4acf-8295-ceb4da514595"
      unitRef="usd">1141000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtOS0xLTEtMA_9c7bfbcc-01ff-43d0-b9ee-17bccce84db7"
      unitRef="usd">1967000000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtMTEtMS0xLTA_e9ea6567-3517-4f81-995f-e585844c0ac9"
      unitRef="usd">800000000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjdhOTM5MWFkODQxYTQ2YTBhMzY1ZTVhYzQzOWNmNDAxL3RhYmxlcmFuZ2U6N2E5MzkxYWQ4NDFhNDZhMGEzNjVlNWFjNDM5Y2Y0MDFfMTMtMTMtMS0xLTA_252eab75-83a5-40e8-808e-89235a8d0749"
      unitRef="usd">1167000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RleHRyZWdpb246ZTZlMzE4ZGZiNjM1NDBkNWE3MGI4NTY2NTBkYTg0MWNfMTIyNg_28348343-f35a-4163-b4b0-a829d3c5f098">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2021 is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.935%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.972%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfMS0xLTEtMS0w_2615b268-3d2f-4087-8c86-d0f2d44046ce"
      unitRef="usd">74000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfMi0xLTEtMS0w_7e57062c-5adf-4d05-9e8c-e9d6c321e77f"
      unitRef="usd">98000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfMy0xLTEtMS0w_9500047f-3376-45dc-8ca8-ead0132bb18e"
      unitRef="usd">96000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfNC0xLTEtMS0w_19147456-5209-4562-8ef4-fbe664437044"
      unitRef="usd">93000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfNS0xLTEtMS0w_cbf09f26-c80e-48e2-a95e-0e9e96c50e75"
      unitRef="usd">92000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfNi0xLTEtMS0w_31d3a9c7-29c4-46f5-ac18-938753712be4"
      unitRef="usd">86000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfNy0xLTEtMS0w_b2051300-413d-4264-b257-de202bcf441c"
      unitRef="usd">366000000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV80OS9mcmFnOmU2ZTMxOGRmYjYzNTQwZDVhNzBiODU2NjUwZGE4NDFjL3RhYmxlOjE0ZTZkNTI3OTNlMzRhMDNhOWNhM2UwMWMxZGFkMGRjL3RhYmxlcmFuZ2U6MTRlNmQ1Mjc5M2UzNGEwM2E5Y2EzZTAxYzFkYWQwZGNfOC0xLTEtMS0w_22751cb1-94a0-4169-afb0-af4128d7de3b"
      unitRef="usd">905000000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNTAxNg_948fc7f4-1cfa-4d65-a2dc-6b2a47718344">FINANCIAL INSTRUMENTS &#160;&#160;&#160;&#160;The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Cash Flow Hedges&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $1&#160;million as of both March&#160;31, 2021 and December&#160;31, 2020.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Derivatives &#x2013; Fair Value Hedges &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of March&#160;31, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both March&#160;31, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three months ended March&#160;31, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:DerivativesPolicyTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNTAzNg_a44941fb-c654-461c-9418-78d2209cd39d">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. &lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i901bac352fa04938b24046e76fcd794f_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfMzM0Ng_24ba9574-203b-403d-9a2e-22752f7f3a94"
      unitRef="usd">1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i09a88d5cf6634758a4963ee5f06aa537_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfMzM0Ng_f594e093-ba33-47a6-ad5e-8ddd52a952fc"
      unitRef="usd">1000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNDM5ODA0NjUxOTI0Ng_e3fae644-7887-4e0a-9174-2e23039337c4"
      unitRef="usd">1000000</us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths>
    <dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNTAxMA_46bcfd2d-feb2-40d6-bc68-a08813d4ba65">As of March&#160;31, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.810%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.313%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.315%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hedge Accounting Basis Adjustment (a)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Balance Sheet Classification&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a) As of both March&#160;31, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.&lt;/span&gt;&lt;/div&gt;</dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i823a17c2df114f629409d133576bca9e_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOmQyNDc2YTllZjZiYTRkNTBhNGYxMmIzMTQ3MzdlNjQyL3RhYmxlcmFuZ2U6ZDI0NzZhOWVmNmJhNGQ1MGE0ZjEyYjMxNDczN2U2NDJfMi01LTEtMS0w_ba75a788-b165-48ce-a581-7f46cdc40d43"
      unitRef="usd">48000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
      contextRef="i814f0c2b21984f29aeb4ef63fc8777f0_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOmQyNDc2YTllZjZiYTRkNTBhNGYxMmIzMTQ3MzdlNjQyL3RhYmxlcmFuZ2U6ZDI0NzZhOWVmNmJhNGQ1MGE0ZjEyYjMxNDczN2U2NDJfMi05LTEtMS0w_4233101f-30ff-4522-891a-271ab3830576"
      unitRef="usd">51000000</us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease>
    <us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RleHRyZWdpb246ZGUzMGM5YTk0ZTYzNGFiY2JkNDQ0Nzc5YTI3MjczYTBfNTAxOA_9d37c5aa-500a-4673-afd1-987661a68290">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three months ended March&#160;31, 2021 and 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.742%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.746%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total for line item in which the effects of fair value hedges are recorded&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Gain (loss) on fair value hedging relationships:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Hedged items (Long-term debt)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(69)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfMy0zLTEtMS0w_fa2bdb44-3fda-4ed2-bbd7-68a8f8f07d24"
      unitRef="usd">4000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfMy01LTEtMS0w_4ac5444e-e45c-44ce-89c3-a4d778f4f75b"
      unitRef="usd">-16000000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i4276aed117b24b4684c477c58a926e2f_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfNi0zLTEtMS0w_d71491fb-622d-4adb-918f-f46f317fb93a"
      unitRef="usd">0</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1
      contextRef="i510d256807de405f9d7a30a62b33c0d3_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfNi01LTEtMS0w_29b5f776-9f39-4ae2-a2f8-f839554cb5d7"
      unitRef="usd">-69000000</us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i063340d2e658481d80d2f35fd862966a_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfNy0zLTEtMS0w_5740d96d-f0d6-4bd1-8bce-081769ca2533"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ic92ff83c2e994ef6b59823da5190e3e9_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81NS9mcmFnOmRlMzBjOWE5NGU2MzRhYmNiZDQ0NDc3OWEyNzI3M2EwL3RhYmxlOjgwMmQyOThkMjY0MDRkNDg5NDkwZDEwNTFlMTgwOGM4L3RhYmxlcmFuZ2U6ODAyZDI5OGQyNjQwNGQ0ODk0OTBkMTA1MWUxODA4YzhfNy01LTEtMS0w_49accbfa-d1a6-469b-bfc7-9d7f4d73aa89"
      unitRef="usd">69000000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMjk5Mg_bf5429d8-4d04-48db-8ff1-37f03525382b">STOCKHOLDERS&#x2019; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Stockholders' Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Changes in Accumulated Other Comprehensive Loss by Component&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income (loss) includes: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Foreign currency translation adjustments;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 7); and&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dividend Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the first quarter of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In each of February and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of March&#160;31, 2021, $2.5 billion remained available under the Company&#x2019;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share Repurchases&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, the Company repurchased 3.4 million shares of its common stock for $410 million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2020, the Company repurchased 0.7 million shares of its common stock for $75 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Shares Reissued from Treasury Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the three months ended March&#160;31, 2021 and 2020, the Company reissued 0.6 million shares and 1.1 million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:-36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 5.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTA5MQ_fcdb4e2d-aaed-494a-a365-53e75717f172"
      unitRef="usdPerShare">0.62</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="ic1d5d10bdab3470c9d09e9af10bb66bb_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTIyNA_26a2bb23-3a42-41b0-9c60-495601aeaca7"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i6978a3b581d84bdba38eca5a17dc6a46_D20200701-20200930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTIyNA_3c13c964-b4af-4b65-8444-f7b13b42b210"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="i2f8703a530294e5daab49bce5e5794c1_D20201001-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTIyNA_9204c008-1849-4b5f-b98a-173e850e6849"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTIyNA_b30ae346-7132-49b8-add0-3cb3e6d9bb0a"
      unitRef="usdPerShare">0.56</us-gaap:CommonStockDividendsPerShareDeclared>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="i5dc9a03ecce042689d1a37deafd8f119_D20210301-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTA5OTUxMTYzMzMyOA_59acab79-8a76-4845-ada8-4318eeb09022"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <dgx:StockRepurchaseProgramAdditionalAmountAuthorized
      contextRef="if1694b157a7e4e05adbfb726d63a9dfb_D20210201-20210228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTA5OTUxMTYzMzMyOA_8b5056b1-47cd-4488-8d60-700fb09057ed"
      unitRef="usd">1000000000</dgx:StockRepurchaseProgramAdditionalAmountAuthorized>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTY0OTI2NzQ0NDY4NQ_79c7e70a-a30a-4c86-9e01-a5edea4dbae3"
      unitRef="usd">2500000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTY0OTI2NzQ0NDY5NA_bf388df8-cc97-4181-b303-55e83f928dd3"
      unitRef="shares">3400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="i1fd3e5c346f44c14a42611bff0ecca28_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTY0OTI2NzQ0NDY4MQ_17a0c67b-6194-4e16-9dc7-b8989e68fbf6"
      unitRef="usd">410000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTcyOQ_62316c00-0796-4c9a-bad1-a2e51b3fc5c9"
      unitRef="shares">700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod
      contextRef="ifae32d3d791f4367832627f55e477d07_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTc2Mw_53de591b-52cf-4465-af8c-c6864aab7869"
      unitRef="usd">75000000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTg2Mg_22223ae2-1c2b-4639-87f4-b71e275b0ce3"
      unitRef="shares">600000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMTg3Ng_7cebdf9a-3654-4017-87d9-b51aafddec5b"
      unitRef="shares">1100000</us-gaap:StockIssuedDuringPeriodSharesTreasuryStockReissued>
    <us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners
      contextRef="ic8b7e170774c4e2f95ec5ebd85bba23b_I20150701"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV81OC9mcmFnOmQ2MjY5NjRkM2RmYTRmZjg4NjEzYTVjOGZiZmNkZjNlL3RleHRyZWdpb246ZDYyNjk2NGQzZGZhNGZmODg2MTNhNWM4ZmJmY2RmM2VfMjI2Mg_3cd40039-b3e9-4dc5-a071-3b56daa9b5b3"
      unitRef="number">0.189</us-gaap:MinorityInterestOwnershipPercentageByNoncontrollingOwners>
    <us-gaap:CashFlowSupplementalDisclosuresTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RleHRyZWdpb246MzMwYTNhNzA4NTYwNDAwMzg3ZjQ5NDc1ZDU3NjkzM2NfMjc1OQ_1b57094d-60ba-4129-8f37-fd438f735d3e">SUPPLEMENTAL CASH FLOW AND OTHER DATA&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three months ended March&#160;31, 2021 and 2020 was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
    <us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RleHRyZWdpb246MzMwYTNhNzA4NTYwNDAwMzg3ZjQ5NDc1ZDU3NjkzM2NfMjc1NQ_e1c23604-fdd4-4a0d-a2c1-dfa72ce0b5a4">Supplemental cash flow and other data for the three months ended March&#160;31, 2021 and 2020 was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense, net&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(41)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income taxes paid&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable associated with capital expenditures&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Businesses acquired:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value of net assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business acquisitions, net of cash acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Leases:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leased assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock>
    <us-gaap:Depreciation
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMi0xLTEtMS0w_698d104f-3a2a-4b87-a251-80dce7a89cf4"
      unitRef="usd">74000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMi0zLTEtMS0w_224fac26-2fb8-4a4b-b4f6-4e80a654d93c"
      unitRef="usd">60000000</us-gaap:Depreciation>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMy0xLTEtMS0w_5db0d9c8-984b-4210-bb28-34cf97c0427f"
      unitRef="usd">27000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMy0zLTEtMS0w_58857add-56d8-46e5-9996-8234414a7c68"
      unitRef="usd">25000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNC0xLTEtMS0w_f6681f7f-1a5c-4d3a-9489-c4240e02c5a5"
      unitRef="usd">101000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNC0zLTEtMS0w_0027a07a-a3e4-4e0b-808a-4a27f83659b2"
      unitRef="usd">85000000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:InterestExpense
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNi0xLTEtMS0w_a29d5885-40ce-40cc-b717-b13571000d10"
      unitRef="usd">38000000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNi0zLTEtMS0w_44d6cc8d-2351-43b5-bc50-8128256c81f9"
      unitRef="usd">42000000</us-gaap:InterestExpense>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNy0xLTEtMS0w_7adc689e-ce1a-4a45-9f73-faafc3b4affd"
      unitRef="usd">0</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestAndDividendIncomeOperating
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfNy0zLTEtMS0w_8aa85aca-48a4-49eb-9484-2d837fcc8422"
      unitRef="usd">1000000</us-gaap:InterestAndDividendIncomeOperating>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfOC0xLTEtMS0w_3a31329f-df84-43e7-adac-421ac63c0a42"
      unitRef="usd">-38000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfOC0zLTEtMS0w_f32fc28e-70f0-4e9d-b838-c87eb3db3d80"
      unitRef="usd">-41000000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestPaid
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTAtMS0xLTEtMA_1ddba5e0-d531-4eb4-8590-0c48c998f1c5"
      unitRef="usd">32000000</us-gaap:InterestPaid>
    <us-gaap:InterestPaid
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTAtMy0xLTEtMA_7c7f0f02-e005-42e0-b998-360c09d3901a"
      unitRef="usd">48000000</us-gaap:InterestPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTEtMS0xLTEtMA_4fcfa64f-51fd-4057-a68b-089158f01463"
      unitRef="usd">7000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTEtMy0xLTEtMA_5b416b9c-296d-431f-a949-51efd4a93c98"
      unitRef="usd">18000000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTMtMS0xLTEtMA_86cff41f-3a0c-4e16-b6d2-b4fbe8ea6d4f"
      unitRef="usd">30000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTMtMy0xLTEtMA_0d929cb3-ea87-41bf-8e44-70f716659368"
      unitRef="usd">11000000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTUtMS0xLTEtMA_5c971e67-f4d1-4667-9a45-a258a2546447"
      unitRef="usd">82000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:DividendsPayableCurrentAndNoncurrent
      contextRef="i3a5f406ec8444737afc188d6eaf5b3df_I20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTUtMy0xLTEtMA_55f121f0-a700-4314-8920-8dfb532351cb"
      unitRef="usd">75000000</us-gaap:DividendsPayableCurrentAndNoncurrent>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTgtMS0xLTEtMA_d2b7deb8-fd23-4889-be6d-55f96e389d7a"
      unitRef="usd">0</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:FairValueOfAssetsAcquired
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTgtMy0xLTEtMA_c2fbf2bc-34d8-4eaa-ad13-aca0d33265cd"
      unitRef="usd">131000000</us-gaap:FairValueOfAssetsAcquired>
    <us-gaap:LiabilitiesAssumed1
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTktMS0xLTEtMA_69b7c7dc-7fd8-45fc-8bd4-f57fa5d446a9"
      unitRef="usd">0</us-gaap:LiabilitiesAssumed1>
    <us-gaap:LiabilitiesAssumed1
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMTktMy0xLTEtMA_0ffbf919-a698-4a9e-9927-5e140246561b"
      unitRef="usd">20000000</us-gaap:LiabilitiesAssumed1>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjAtMS0xLTEtMA_173881a2-57d7-406a-ad0d-2b99dc56e356"
      unitRef="usd">0</dgx:FairValueOfNetAssetsAcquired>
    <dgx:FairValueOfNetAssetsAcquired
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjAtMy0xLTEtMA_7f96d9b4-3be7-451a-9c63-499a60d33973"
      unitRef="usd">111000000</dgx:FairValueOfNetAssetsAcquired>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjMtMS0xLTEtMA_d61f144b-4984-4ee8-8abf-a50512fdb979"
      unitRef="usd">0</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:CashAcquiredFromAcquisition
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjMtMy0xLTEtMA_1afd35ef-cfd3-4889-9cdf-e3fc94b09ef3"
      unitRef="usd">3000000</us-gaap:CashAcquiredFromAcquisition>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjQtMS0xLTEtMA_49decafa-f3a9-43f3-a7ac-5a87a7f11b93"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMjQtMy0xLTEtMA_54e8314b-e233-4802-80c0-5a75ed91fbd1"
      unitRef="usd">108000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMzEtMS0xLTEtMA_b49faf81-8bba-49dd-920f-4da60d61a587"
      unitRef="usd">36000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82MS9mcmFnOjMzMGEzYTcwODU2MDQwMDM4N2Y0OTQ3NWQ1NzY5MzNjL3RhYmxlOjAwOWI1ZWFhZmEzZjQ1NTZhOWM5MDhhODA0ODNiYjAxL3RhYmxlcmFuZ2U6MDA5YjVlYWFmYTNmNDU1NmE5YzkwOGE4MDQ4M2JiMDFfMzEtMy0xLTEtMA_a2d0caec-f6fe-45c2-8dbd-a4b97dfacf73"
      unitRef="usd">32000000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfOTIwMg_a99c7940-8d11-44f2-aba1-aac78a73d427">COMMITMENTS AND CONTINGENCIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Letters of Credit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In support of its risk management program, to ensure the Company&#x2019;s performance or payment to third parties, $70 million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2021.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#x2019; compensation loss payments.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Lease Obligations&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  No liability has been recorded for any of these potential contingent obligations.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#x2019;s 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Certain Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;401(k) Plan Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#x2019;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;In re: Quest Diagnostics ERISA Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; and plaintiffs filed a consolidated amended complaint.  The Company plans to vigorously defend this matter and has filed a motion to dismiss the complaint.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;AMCA Data Security Incident&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#x201c;AMCA&#x201d;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#x2019;s system between August 1, 2018 and March 30, 2019 (the &#x201c;AMCA Data Security Incident&#x201d;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#x2019;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#x2019;s nor the Company&#x2019;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#x2019; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; qui tam&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2021, the Company does not believe that material losses related to legal matters are probable.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Reserves for legal matters totaled $2 million and $1 million as of March&#160;31, 2021 and December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reserves for General and Professional Liability Claims&lt;/span&gt;&lt;/div&gt;&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $142 million and $138 million as of March&#160;31, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifaee625cde9f46a19f40eb5a77955d58_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTEx_8d7c72fc-935d-40ae-a18d-57e5cf0d6ed7"
      unitRef="usd">100000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ice8c8a53b7e44301b5d027627be99368_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfNDM5ODA0NjUyNjgxNw_18522b79-a313-469b-815a-00123ad5885f"
      unitRef="usd">600000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="id9b169a1c4be4f32aab0d0b964a44035_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTY0_01568ae5-8ceb-44ee-bfe4-dd702a99ca68"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i3abb6c012f5f45fabdd35c0f3a5e994d_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfNDM5ODA0NjUyNjg0NA_a45b9195-0272-4679-b55d-ff15b08d9302"
      unitRef="usd">750000000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ice8c8a53b7e44301b5d027627be99368_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfNjQ0_612a0a04-9929-42e0-b62a-03901ea9514f"
      unitRef="usd">70000000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTY0OTI2NzQ1NzI2Ng_5a5eed12-71be-45ac-9c41-92ce9fc2de3c"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="ibdcc6647a3314cfe8c8e1a11819788f2_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTY0OTI2NzQ1NzI3MQ_6ee08e81-f493-49fb-a4aa-1881f9b7d9c7"
      unitRef="claim">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationReserve
      contextRef="i4a8b8a1360eb45169025ce2e3ff740e3_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfNzkwOQ_f678f8ff-d445-4edf-909c-507bb59b770f"
      unitRef="usd">2000000</us-gaap:LitigationReserve>
    <us-gaap:LitigationReserve
      contextRef="i9dba11073b29434b8978baa1dd517320_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfMTY0OTI2NzQ1NzQxOA_ba59b839-5466-4426-943e-39a666f40f78"
      unitRef="usd">1000000</us-gaap:LitigationReserve>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfOTAyMg_266c634c-cd81-4567-b64b-e84117da7e54"
      unitRef="usd">142000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:MalpracticeLossContingencyAccrualUndiscounted
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82NC9mcmFnOmM4YjE5MDFiYjZkMTQ1YTI4MWViNDc0MjNhNTk4NTY0L3RleHRyZWdpb246YzhiMTkwMWJiNmQxNDVhMjgxZWI0NzQyM2E1OTg1NjRfOTAyOQ_4003271d-fc9f-4611-a2af-db7a243c5021"
      unitRef="usd">138000000</us-gaap:MalpracticeLossContingencyAccrualUndiscounted>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfMjM1MQ_83bbe453-1a8d-4774-9233-d7c76c217b87">BUSINESS SEGMENT INFORMATION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;As of March&#160;31, 2021, substantially all of the Company&#x2019;s services were provided within the United States, and substantially all of the Company&#x2019;s assets were located within the United States.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:29.25pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three months ended March&#160;31, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues by major service were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i2be09d01fcd644908d4f7bcba929237f_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfODAx_513a9c56-569d-4d7c-8703-3c624cf2a359"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i80fa10a73f264102b635c6298c5c5763_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfODAx_af395924-3ce5-4d6c-aa81-03ce00b03bb7"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfMjM1NQ_6c1e1a2c-43b5-4a12-a6e3-370d2ea9c360">The following table is a summary of segment information for the three months ended March&#160;31, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#x2019;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Operating earnings (loss):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DIS business&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;712&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other operating segments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General corporate activities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(61)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Non-operating expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income before income taxes and equity in earnings of equity method investees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Equity in earnings of equity method investees, net of taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Less: Net income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Net income attributable to Quest Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iace971bbe9244cfb88051e717b4dc21b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMy0xLTEtMS0w_12b5497c-7d85-4e93-9e76-bbafd0b1199c"
      unitRef="usd">2643000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36f5b862a2f64309ae325f1bd8812f84_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMy0zLTEtMS0w_2b5a7187-2528-442e-aced-615c112a2055"
      unitRef="usd">1744000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f4d95d055c34010ae22105b313a4c19_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfNC0xLTEtMS0w_612949e9-6741-4340-903d-f4f0202266ed"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic899b274b3de44a4a751b3c0cf303ca1_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfNC0zLTEtMS0w_269d051b-656c-4bb3-8726-221859248fa1"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfNS0xLTEtMS0w_83c44d01-1399-4be6-865c-3c645e2d93d0"
      unitRef="usd">2720000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfNS0zLTEtMS0w_26a180c2-6e42-4b03-9572-54552f38422e"
      unitRef="usd">1822000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:OperatingIncomeLoss
      contextRef="iace971bbe9244cfb88051e717b4dc21b_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfOC0xLTEtMS0w_04e6d49a-dae4-464a-aa42-1cc22cc155a4"
      unitRef="usd">712000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i36f5b862a2f64309ae325f1bd8812f84_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfOC0zLTEtMS0w_8c40bb33-8e86-405e-84fb-0808f28b4c15"
      unitRef="usd">205000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8f4d95d055c34010ae22105b313a4c19_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfOS0xLTEtMS0w_6349f2a7-13e7-4071-a89b-d20772e713b4"
      unitRef="usd">9000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic899b274b3de44a4a751b3c0cf303ca1_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfOS0zLTEtMS0w_ebfa1d3b-3517-4ef1-a39a-07a889c2c5eb"
      unitRef="usd">9000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3a6fda505e7a4e16ad43273771a429c6_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTAtMS0xLTEtMA_1e28a356-bd88-4850-91b8-6c5d6aa77112"
      unitRef="usd">-61000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i758562ef5a3244ce83bd69c73f546e0e_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTAtMy0xLTEtMA_9c2617f9-c5c2-44ff-82c9-42ff6c6ca80b"
      unitRef="usd">-39000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTEtMS0xLTEtMA_ed850ac4-550a-4f56-8bf7-02cf55f8c6aa"
      unitRef="usd">660000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTEtMy0xLTEtMA_f43ad472-bcd6-4f30-a287-8411eb8e9adc"
      unitRef="usd">175000000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTItMS0xLTEtMA_12781090-ba32-430b-a9b2-c8d81b2423f0"
      unitRef="usd">-34000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTItMy0xLTEtMA_6e7663bc-0e1b-4199-8b93-a70860045cbd"
      unitRef="usd">-57000000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTMtMS0xLTEtMA_68cb98f2-e8a4-4e7f-a37a-dffc54e3baab"
      unitRef="usd">626000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTMtMy0xLTEtMA_56a0f168-10ff-464c-885a-deefed235790"
      unitRef="usd">118000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTQtMS0xLTEtMA_d6a57dc7-2c36-464a-8f00-4a4deb7c1ef0"
      unitRef="usd">153000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTQtMy0xLTEtMA_8774bc60-fe5a-4214-ad6b-e2c1e9415800"
      unitRef="usd">26000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTUtMS0xLTEtMA_321c0498-38e1-400e-8546-de39b1d23a11"
      unitRef="usd">17000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTUtMy0xLTEtMA_58d180f9-620c-4cbb-9fad-24ea8c20e1b9"
      unitRef="usd">14000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ProfitLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTgtMS0xLTEtMA_cf26cf12-7b31-4614-a0dc-66d6bc1e79e5"
      unitRef="usd">490000000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTgtMy0xLTEtMA_92fb979a-3ee2-4ccf-9da5-4d41db66e87e"
      unitRef="usd">106000000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTktMS0xLTEtMA_2c163f96-eea6-4760-91dd-5a40b6ee1602"
      unitRef="usd">21000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMTktMy0xLTEtMA_2389759b-1580-4484-bf9c-ca58f6dda3cb"
      unitRef="usd">7000000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMjAtMS0xLTEtMA_386ae93c-11e0-4aed-abff-6f830872463e"
      unitRef="usd">469000000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmQ0MDg0ZjUyM2EyYzRmOTJiYmIxMmRiOWFkMzllNDQzL3RhYmxlcmFuZ2U6ZDQwODRmNTIzYTJjNGY5MmJiYjEyZGI5YWQzOWU0NDNfMjAtMy0xLTEtMA_a7dd1758-f5b6-469e-b844-988d3671d4fa"
      unitRef="usd">99000000</us-gaap:NetIncomeLoss>
    <dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RleHRyZWdpb246ZjljOGM4NGU0MzBlNDNhMjk5MjVhMjQwNGU2MDY2YmJfNzY5NjU4MTM5NzUzOA_303bc134-a792-4254-9d8f-0536023cea6f">Net revenues by major service were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.285%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Routine clinical testing services&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,032&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gene-based and esoteric (including advanced diagnostics) testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Anatomic pathology testing services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;All other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total net revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:ScheduleOfRevenuesByMajorServiceTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie9e62f1f9ce94456b1cd2a528dd83efc_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfMy0xLTEtMS0zOTk4_3920a611-97b0-4b31-937a-31c2cd9f81ab"
      unitRef="usd">1032000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i25a98fa306ed41b296725d35a192e146_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfMy0zLTEtMS0zOTk4_b02d4ebb-ff17-454d-bbd9-8c8df53266e7"
      unitRef="usd">945000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28f9959f287848bf8d465e16d1d746ff_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNC0xLTEtMS0zOTk4_0c5b3141-c75c-4322-88f6-057ec8dbc274"
      unitRef="usd">828000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03c3744a2bab43538ebec4cd3b356cf1_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNC0zLTEtMS0zOTk4_a1da4838-b101-47f6-9d41-c5a5d6a2cd46"
      unitRef="usd">24000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0bdf51bbf7f242a3be5bed92c72c57cb_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNS0xLTEtMS0zOTk4_c94941d1-fba9-4858-a149-ef4155c843e7"
      unitRef="usd">653000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic4d4da36106e49a4a2dc103517d9f28a_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNS0zLTEtMS0zOTk4_0c8ba84a-7f35-4f1e-a572-357675dfca76"
      unitRef="usd">641000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i61fa9a0d6266465f843c0dcd281594b4_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNi0xLTEtMS0zOTk4_cf16daa8-9010-4909-bb24-6a7d7e4d0f0c"
      unitRef="usd">130000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib9e55ffc9602438bb96b19f2de74ce1b_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNi0zLTEtMS0zOTk4_003762ad-8c8d-40fb-923e-9eaa027fd8c7"
      unitRef="usd">134000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i170cc44a7d484de4b0e68d788f39ca90_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNy0xLTEtMS0zOTk4_05495a4d-9ae7-49b7-b93c-0d7daeb3b083"
      unitRef="usd">77000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e7fdb8aa0b74dcd8f92d2bf7a45989c_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfNy0zLTEtMS0zOTk4_7cefde4f-d7dd-4700-adf2-2ef00ac21dd0"
      unitRef="usd">78000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfOC0xLTEtMS00NTg4_a814217d-19d0-46a9-a7d6-28ae9dd7c194"
      unitRef="usd">2720000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV82Ny9mcmFnOmY5YzhjODRlNDMwZTQzYTI5OTI1YTI0MDRlNjA2NmJiL3RhYmxlOmIwNzY4YzZlODk5ODQ1YzE4NTJhMzkxMmY4ZmMzYzgxL3RhYmxlcmFuZ2U6YjA3NjhjNmU4OTk4NDVjMTg1MmEzOTEyZjhmYzNjODFfOC0zLTEtMS00NTg4_7613795b-3f47-44fe-8649-d4f5fc10fd78"
      unitRef="usd">1822000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMjM3OA_abc31f52-cc98-4950-a8b3-c7953acd9774">RELATED PARTIES&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company's equity method investees primarily consist of its clinical trials central laboratory services joint venture (see Note 14), a diagnostic information services joint venture, and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  During the three months ended March&#160;31, 2021 and 2020, the Company recognized net revenues of $5 million and $9 million, respectively, associated with diagnostic information services provided to its equity method investees.  As of March&#160;31, 2021 and December&#160;31, 2020, there was $5 million and $3 million, respectively, of accounts receivable from equity method investees related to such services.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2021 and 2020, the Company recognized income of $3 million and $4 million, respectively, associated with the performance of certain corporate services, including transition services, for its equity method investees, classified within selling, general and administrative expenses.  As of March&#160;31, 2021 and December&#160;31, 2020, there was $1 million and $3 million, respectively, of other receivables from equity method investees included in prepaid expenses and other current assets related to these service agreements and other transition related items.  In addition, accounts payable and accrued expenses as of both March&#160;31, 2021 and December&#160;31, 2020 included $1 million due to equity method investees.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2021 and 2020, the Company received dividends from its equity method investees of $16 million and $5 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i5cdb593684214c31b69e5e0f14a1dd79_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMzQ1_9e57c950-85fc-4db7-a070-f135f5dd88e1"
      unitRef="usd">5000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="iac11f459e1d042178af5545dbcf89c00_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMzUy_99cae39b-6b9c-4df6-b388-87d26d683e39"
      unitRef="usd">9000000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="i3447dfba2db4452db6c128cbd3d017fb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfNjg0_b2044353-4aa6-45db-bfbf-673c9ee6243a"
      unitRef="usd">5000000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="ifde7a741912648d2a3710f6aba0b6239_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTY0OTI2NzQ0NDI0MQ_443ac32d-467f-401b-9a19-a71a2175cffd"
      unitRef="usd">3000000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="idf44f85037c240d487111d5bb5558877_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTQxNQ_63f43565-d426-4e6e-9c9a-04452be12199"
      unitRef="usd">3000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty
      contextRef="i0e5b35b7ea4e4d4894444db26f102438_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTY0OTI2NzQ0NDY3NQ_b44bdba5-0f30-4462-a352-9d4c74668493"
      unitRef="usd">4000000</us-gaap:RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty>
    <dgx:OtherAccountsReceivableRelatedParties
      contextRef="i1719a6433f8e402a8040ef12f6efed91_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTkwOA_26cbdc33-1485-4e54-b969-db5ba9a7b64b"
      unitRef="usd">1000000</dgx:OtherAccountsReceivableRelatedParties>
    <dgx:OtherAccountsReceivableRelatedParties
      contextRef="ibb28805c772d49adaf22a67346afc2ec_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTkxNQ_91687cf8-5c3d-4a9a-979c-8ab460169771"
      unitRef="usd">3000000</dgx:OtherAccountsReceivableRelatedParties>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i3447dfba2db4452db6c128cbd3d017fb_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMjE4Ng_ab62aef9-8d25-4bc5-9f81-d90a8112042b"
      unitRef="usd">1000000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="ifde7a741912648d2a3710f6aba0b6239_I20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMjE4Ng_ff5d4a29-8c1b-4191-9ae5-b4005cc95878"
      unitRef="usd">1000000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="i5cdb593684214c31b69e5e0f14a1dd79_D20210101-20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTY0OTI2NzQ0NDk3NA_49e9b4a4-39a1-4b4e-864d-5cdc0a159518"
      unitRef="usd">16000000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:ProceedsFromDividendsReceived
      contextRef="iac11f459e1d042178af5545dbcf89c00_D20200101-20200331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83MC9mcmFnOmFmOGNlN2VmMWMwNzRkNjk4NDBkMDYyMzRlOWFlMDQ3L3RleHRyZWdpb246YWY4Y2U3ZWYxYzA3NGQ2OTg0MGQwNjIzNGU5YWUwNDdfMTY0OTI2NzQ0NDk2OQ_f81efa5f-77c6-4e74-911f-77b48e3fc9ab"
      unitRef="usd">5000000</us-gaap:ProceedsFromDividendsReceived>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMzYwOA_ad960876-050e-47de-99b5-2de02879e702">REVENUE RECOGNITION&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DIS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Net revenues in the Company&#x2019;s DIS business accounted for over 95% of the Company&#x2019;s total net revenues for the three months ended March&#160;31, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;DS&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The Company&#x2019;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i80fa10a73f264102b635c6298c5c5763_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMTMx_a1648dee-7370-427a-aca4-765b11fb480c"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i2be09d01fcd644908d4f7bcba929237f_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMTMx_f35f6e15-7d93-40e1-81f8-260761ffd21b"
      unitRef="number">0.95</dgx:PercentageofNetRevenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMzYwNA_3e1e7ccf-2e67-4e79-8eb1-1081a3619b30">The approximate percentage of net revenue by type of customer was as follows:&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare insurers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fee-for-service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitated&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total healthcare insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenues&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <dgx:PercentageofNetRevenues
      contextRef="i452e2b67663443a9b36290cf5a2aa1e6_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMy0xLTEtMS0w_361b0d56-120d-4066-8e87-957beef688b9"
      unitRef="number">0.38</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="icd123d8c628f46e5aba2e460d5deafe6_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMy0zLTEtMS0w_97695a61-9203-4c56-a7cf-6a9bbb6eb275"
      unitRef="number">0.34</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iebb5fe74da844f1f961e8e1d2bb794b5_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNC0xLTEtMS0w_b8ad52e4-98bd-4d1c-9c82-18c5d4957f99"
      unitRef="number">0.02</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i42e148eb5e0e4659b907643c8a63fc0c_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNC0zLTEtMS0w_3edb8493-eda5-42d4-adc8-d6598b7b4dd0"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i6a2808ee150047299c3ed09ef79ab8b5_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNS0xLTEtMS0w_1d321a09-aac7-4047-8f2f-2035cc198be2"
      unitRef="number">0.40</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i06001aa5c1104e2e9732e941f42c3fcf_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNS0zLTEtMS0w_663c90fc-10f8-48c9-9af0-85d9325e9f23"
      unitRef="number">0.37</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ide5defc240be4dcab0b768c6f15899ab_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNi0xLTEtMS0w_36b6800e-1858-422e-a7c6-29a01c023d62"
      unitRef="number">0.10</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ibc9de92a860e40a589282211d1647b6f_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNi0zLTEtMS0w_f84bfc34-ea33-47aa-8d00-f05a42add8d2"
      unitRef="number">0.14</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ic87438c858c24f95bcf9ba166ab81b0e_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNy0xLTEtMS0w_eadff93d-cae4-47f7-8abc-988bb1929e7e"
      unitRef="number">0.35</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="ie8459599fb5c4db59c067f7d2b4152d5_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfNy0zLTEtMS0w_fc53813a-feac-47bd-ba86-567a180cb127"
      unitRef="number">0.33</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i6810771a2a1c4d05944123a1bf5e1b52_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfOC0xLTEtMS0w_ce39c51a-265c-42a3-a2b5-2535ee940c5a"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i46815f8f6c1c4752a37528dcfe600782_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfOC0zLTEtMS0w_15f6507e-92af-440e-877d-9234ccc7fdc5"
      unitRef="number">0.12</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="iace971bbe9244cfb88051e717b4dc21b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfOS0xLTEtMS0w_f7122d46-9fa5-4cc6-bfb3-b04e5c9da576"
      unitRef="number">0.97</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i36f5b862a2f64309ae325f1bd8812f84_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfOS0zLTEtMS0w_ec4cac17-9692-48ed-9e2e-be95eb805e97"
      unitRef="number">0.96</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i30bb0b3b6fb2412594595890e5f1e61e_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMTAtMS0xLTEtMA_6482b0cc-dfe3-4b68-9971-92eee3a8eb52"
      unitRef="number">0.03</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="id0b6faefc1d44456895da76547e73051_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMTAtMy0xLTEtMA_fc700faa-b4b3-4fb2-b137-bcfc38580c3e"
      unitRef="number">0.04</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMTEtMS0xLTEtMA_a73f1c76-116a-4884-b566-7bfc6dd6badd"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:PercentageofNetRevenues
      contextRef="if5089cfcd7604a2fbc30eb4a37cef047_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjJmMzg4NDc5ZGE3MjQwODliNjQwY2FiZDIzYjJlNjQ5L3RhYmxlcmFuZ2U6MmYzODg0NzlkYTcyNDA4OWI2NDBjYWJkMjNiMmU2NDlfMTEtMy0xLTEtMA_ecb21d14-c8cb-472f-9202-62b69b24410c"
      unitRef="number">1</dgx:PercentageofNetRevenues>
    <dgx:AccountsReceivableDisaggregationTableTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RleHRyZWdpb246NjIyOGQ1M2Y0MmQ3NGU0OGJjYTNkNjIyMTQyZTM4YjZfMzYwMg_ca7c94e4-b886-4949-a430-fd00843c6a7e">The approximate percentage of net accounts receivable by type of customer was as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Healthcare Insurers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Client Payers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patients (including coinsurance and deductible responsibilities)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total DIS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dgx:AccountsReceivableDisaggregationTableTextBlock>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i3e2f380500494c60add6976b3bc32aa1_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfMi0xLTEtMS0w_59f34879-6a25-45a0-938c-d8cfa1d63df9"
      unitRef="number">0.33</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i4f9466da8f9f4a6aa123bbced054fed3_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfMi0zLTEtMS0w_3cb0de1d-0998-40ed-b995-8eb574ccf23b"
      unitRef="number">0.34</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i2c126b415f014916be2b95fa29f24224_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfMy0xLTEtMS0w_bcee0a12-cd66-47e2-b085-397978cd65ff"
      unitRef="number">0.07</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i69898b4810d540df8211bce4cdd5525d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfMy0zLTEtMS0w_24216279-75c9-4308-8b38-a8d12d17e081"
      unitRef="number">0.06</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i127c3faa32b7427d9b99ea5587e176d7_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNC0xLTEtMS0w_d8518f2c-ab97-452a-ae6c-8e8fdea18272"
      unitRef="number">0.43</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i8413c530df5c4dbfb070686c9de5c5e3_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNC0zLTEtMS0w_f7a625a6-06e4-4e08-9658-8d4f51a1e0bd"
      unitRef="number">0.46</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i964abdb4332b41dd9081bba6b23cb70a_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNS0xLTEtMS0w_2d72228a-a605-4417-934e-24083fff4516"
      unitRef="number">0.13</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="iadb31c200e50479698a170bd1aa2fdd4_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNS0zLTEtMS0w_009ef276-80bd-4fe0-8fe6-3f5cb588bfa4"
      unitRef="number">0.11</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ic08defe16103451e81c2c39229b0890c_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNi0xLTEtMS0w_059b6466-7064-4db0-ac53-2c48cef802d0"
      unitRef="number">0.96</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i0bc155227aa9447ea638f9b050fb14fb_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNi0zLTEtMS0w_22bfa81c-596f-4f02-8c91-cf940350e31d"
      unitRef="number">0.97</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i12272fb69d15405f9bdaf2b4151db72f_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNy0xLTEtMS0w_64227398-2533-4373-a2d5-2002411b450b"
      unitRef="number">0.04</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i59a13ec4490e4a7b8c12492922d70b63_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfNy0zLTEtMS0w_b3044a4f-fdf0-4001-bba7-6810d931474e"
      unitRef="number">0.03</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="ie648c1d0f7124826ab1f231505fef1e4_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfOC0xLTEtMS0w_8b5b57ef-727e-4f3c-a2a0-17d026c4ee27"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <dgx:PercentageofNetAccountsReceivable
      contextRef="i71eadae108864617a48c288ee03da704_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV83My9mcmFnOjYyMjhkNTNmNDJkNzRlNDhiY2EzZDYyMjE0MmUzOGI2L3RhYmxlOjRmMDc3MDRmY2M0MzQ5MDVhYzEyMjVjNmI5ZGZjMjRjL3RhYmxlcmFuZ2U6NGYwNzcwNGZjYzQzNDkwNWFjMTIyNWM2YjlkZmMyNGNfOC0zLTEtMS0w_8e3a9bb8-d46b-40d4-b995-e6e2b29d6478"
      unitRef="number">1</dgx:PercentageofNetAccountsReceivable>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i8dbed4e81ed14963b472f052115ee891_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV84Mi9mcmFnOmUyYTk1ODIwNzBhYjQwNWJiN2NjMTYyOGU4ODY1YjRkL3RleHRyZWdpb246ZTJhOTU4MjA3MGFiNDA1YmI3Y2MxNjI4ZTg4NjViNGRfMTI0OA_6f1b40b4-7da4-4e04-8ad4-ae557ad7cdda">SUBSEQUENT EVENTS&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; ("Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner for $760&#160;million in an all-cash transaction.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, the Company expects to record a pre-tax gain during the second quarter of 2021 of approximately $310&#160;million.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Solutions' clients, providing a range of complementary lab testing capabilities to augment Q&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Solutions' core offerings and extend its industry leading suite of services.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <dgx:EquityMethodInvestmentOwnershipPercentDisposedOf
      contextRef="i39c87593f7934842babf6575faeb22bb_I20210401"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV84Mi9mcmFnOmUyYTk1ODIwNzBhYjQwNWJiN2NjMTYyOGU4ODY1YjRkL3RleHRyZWdpb246ZTJhOTU4MjA3MGFiNDA1YmI3Y2MxNjI4ZTg4NjViNGRfNzY5NjU4MTM5OTY4NA_b57fdcc2-983b-4c5e-b355-8753620da8e2"
      unitRef="number">0.40</dgx:EquityMethodInvestmentOwnershipPercentDisposedOf>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="i39c87593f7934842babf6575faeb22bb_I20210401"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV84Mi9mcmFnOmUyYTk1ODIwNzBhYjQwNWJiN2NjMTYyOGU4ODY1YjRkL3RleHRyZWdpb246ZTJhOTU4MjA3MGFiNDA1YmI3Y2MxNjI4ZTg4NjViNGRfMTY0OTI2NzQ0NTU4OQ_f390a4e1-0e45-4b75-a5f9-e7a5c08c7c66"
      unitRef="usd">760000000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal
      contextRef="ic411e7e9465f4d0ca07e2fc70dfc9403_D20210401-20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjQ4YTRjNTFmN2U2OTQ3YTFiM2QyMGY0MmExNTI4MGM1L3NlYzo0OGE0YzUxZjdlNjk0N2ExYjNkMjBmNDJhMTUyODBjNV84Mi9mcmFnOmUyYTk1ODIwNzBhYjQwNWJiN2NjMTYyOGU4ODY1YjRkL3RleHRyZWdpb246ZTJhOTU4MjA3MGFiNDA1YmI3Y2MxNjI4ZTg4NjViNGRfNDM5ODA0NjUxNjM3NA_872b50c3-deb1-47f3-9241-2e2c948fa3ba"
      unitRef="usd">310000000</us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656449489560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 15, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-12215<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Quest Diagnostics Inc<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001022079<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">16-1387862<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 Plaza Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Secaucus,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(973)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-2700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DGX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130,638,109<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656524349064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenues</a></td>
<td class="nump">$ 2,720<span></span>
</td>
<td class="nump">$ 1,822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Operating costs and expenses and other operating income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of services</a></td>
<td class="nump">1,626<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingIncomeExpenseNet', window );">Other operating expense, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total operating costs and expenses, net</a></td>
<td class="nump">2,060<span></span>
</td>
<td class="nump">1,647<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">4<span></span>
</td>
<td class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total non-operating expense, net</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">626<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 469<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic(in dollars per share)</a></td>
<td class="nump">$ 3.52<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 3.46<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in Shares)</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in Shares)</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656442539432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 490<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive loss:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign currency translation adjustment</a></td>
<td class="num">(3)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Net change in available-for-sale debt securities, net of taxes</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss</a></td>
<td class="num">(10)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income</a></td>
<td class="nump">480<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: Comprehensive income attributable to noncontrolling interests</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 459<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656524041336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 1,230<span></span>
</td>
<td class="nump">$ 1,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for credit losses of $29 and $28 as of March 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">1,382<span></span>
</td>
<td class="nump">1,520<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">223<span></span>
</td>
<td class="nump">223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">164<span></span>
</td>
<td class="nump">157<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,999<span></span>
</td>
<td class="nump">3,058<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">1,624<span></span>
</td>
<td class="nump">1,627<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">604<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">6,870<span></span>
</td>
<td class="nump">6,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity method investees</a></td>
<td class="nump">527<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,931<span></span>
</td>
<td class="nump">14,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities and Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">1,559<span></span>
</td>
<td class="nump">1,633<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of long-term operating lease liabilities</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,707<span></span>
</td>
<td class="nump">1,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Long-term debt</a></td>
<td class="nump">4,010<span></span>
</td>
<td class="nump">4,013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">503<span></span>
</td>
<td class="nump">499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">842<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Quest Diagnostics stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2021 and December 31, 2020; 217 shares issued as of both March 31, 2021 and December 31, 2020</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,824<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">9,690<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(31)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost; 86 and 84 shares as of March 31, 2021 and December 31, 2020, respectively</a></td>
<td class="num">(5,740)<span></span>
</td>
<td class="num">(5,366)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Quest Diagnostics stockholders' equity</a></td>
<td class="nump">6,745<span></span>
</td>
<td class="nump">6,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interests</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders' equity</a></td>
<td class="nump">6,790<span></span>
</td>
<td class="nump">6,809<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 13,931<span></span>
</td>
<td class="nump">$ 14,026<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656593522056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 29<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">600<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">217<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656450227496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 490<span></span>
</td>
<td class="nump">$ 106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetCreditLossExpense', window );">Provision for credit losses</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income tax (benefit) provision</a></td>
<td class="num">(17)<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">18<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="num">(2)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">138<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(164)<span></span>
</td>
<td class="num">(47)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable', window );">Income taxes payable</a></td>
<td class="nump">163<span></span>
</td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet', window );">Other assets and liabilities, net</a></td>
<td class="nump">2<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">731<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(86)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Increase in investments and other assets</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(93)<span></span>
</td>
<td class="num">(206)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of debt</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(410)<span></span>
</td>
<td class="num">(75)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(21)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(75)<span></span>
</td>
<td class="num">(71)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsMinorityInterest', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities, net</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(566)<span></span>
</td>
<td class="num">(891)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents and restricted cash</a></td>
<td class="nump">72<span></span>
</td>
<td class="num">(850)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">1,158<span></span>
</td>
<td class="nump">1,192<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents and restricted cash, end of period</a></td>
<td class="nump">$ 1,230<span></span>
</td>
<td class="nump">$ 342<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetCreditLossExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetCreditLossExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsMinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsMinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656524921608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Treasury Stock, at Cost</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2019</a></td>
<td class="nump">$ 5,687<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,722<span></span>
</td>
<td class="nump">$ 8,174<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
<td class="num">$ (5,218)<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of taxes</a></td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (75)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Mar. 31, 2020</a></td>
<td class="nump">5,703<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,738<span></span>
</td>
<td class="nump">8,197<span></span>
</td>
<td class="num">(58)<span></span>
</td>
<td class="num">(5,222)<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2019</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Mar. 31, 2020</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">133.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Dec. 31, 2020</a></td>
<td class="nump">6,809<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">2,841<span></span>
</td>
<td class="nump">9,303<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="num">(5,366)<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest', window );">Net income</a></td>
<td class="nump">486<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive loss, net of taxes</a></td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends declared</a></td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(82)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Issuance of common stock under benefit plans</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (12)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock</a></td>
<td class="num">(410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (410)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, shares at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">131.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Balance, value at Mar. 31, 2021</a></td>
<td class="nump">6,790<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2,824<span></span>
</td>
<td class="nump">$ 9,690<span></span>
</td>
<td class="num">$ (31)<span></span>
</td>
<td class="num">$ (5,740)<span></span>
</td>
<td class="nump">$ 45<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Dec. 31, 2020</a></td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityNetIncome', window );">Net income</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders', window );">Distributions to noncontrolling interest partners</a></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Balance, Value at Mar. 31, 2021</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss), Excluding Redeemable Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityNetIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of net income or loss attributable to temporary equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityNetIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656448310056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_DescriptionOfBusinessAbstract', window );"><strong>Description of Business (Abstract)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Background</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;Quest Diagnostics Incorporated and its subsidiaries ("Quest Diagnostics" or the "Company") empower people to take action to improve health outcomes.&#160; The Company uses its extensive database of clinical lab results to derive diagnostic insights that reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management.&#160; The Company's diagnostic information services business ("DIS") provides information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The Company provides services to a broad range of customers, including patients, clinicians, hospitals, independent delivery networks ("IDNs"), health plans, employers, accountable care organizations ("ACOs"), and direct contract entities ("DCEs").  The Company offers the broadest access in the United States to diagnostic information services through its nationwide network of laboratories, patient service centers and phlebotomists in physician offices and the Company's connectivity resources, including call centers and mobile paramedics, nurses and other health and wellness professionals.  The Company is the world's leading provider of diagnostic information services.  The Company provides interpretive consultation with one of the largest medical and scientific staffs in the industry. The Company's Diagnostic Solutions businesses ("DS") are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_DescriptionOfBusinessAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of Business (Abstract)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_DescriptionOfBusinessAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656443861096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The accounting policies of the Company are the same as those set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A novel strain of coronavirus (&#8220;COVID-19&#8221;) continues to spread and severely impact the economy of the United States and other countries around the world.  The Company's testing volume and revenues have been materially impacted by the COVID-19 pandemic, including periods of decline in testing volume in the Company's base business (which excludes COVID-19 testing) compared to historical 2019 levels and periods of significant demand for COVID-19 testing.  As a result, operating results for the three months ended March&#160;31, 2021 may not be indicative of the results that may be expected for the full year.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Earnings Per Share</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;New Accounting Standards to be Adopted</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656442791304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">EARNINGS (LOSS) PER SHARE</a></td>
<td class="text">EARNINGS PER SHARE<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.46&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656443846504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">BUSINESS ACQUISITIONS</a></td>
<td class="text">BUSINESS ACQUISITIONS<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 6, 2021, the Company entered into a definitive agreement to acquire the outreach laboratory services business of Mercy Health, which serves providers and patients in Arkansas, Kansas, Missouri and Oklahoma.  The transaction, which is expected to close in mid-2021, remains subject to customary closing conditions.</span>&#160;&#160;&#160;&#160;For details regarding the Company's 2020 acquisitions, see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656444016552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">FAIR VALUE MEASUREMENTS</a></td>
<td class="text">FAIR VALUE MEASUREMENTS  <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;A detailed description regarding the Company's fair value measurements is contained in Note 7 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified supplemental deferred compensation plan.  A participant's deferrals, together with Company matching credits, are invested in a variety of participant-directed stock and bond mutual funds that are classified as trading securities.  The trading securities are classified within Level 1 of the fair value hierarchy because the changes in the fair value of these securities are measured using quoted prices in active markets based on the market price per unit multiplied by the number of units held, exclusive of any transaction costs.  A corresponding adjustment for changes in fair value of the trading securities is also reflected in the changes in fair value of the deferred compensation obligation.  The deferred compensation liabilities are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the trading securities.</span></div><div style="padding-right:72pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company offers certain employees the opportunity to participate in a non-qualified deferred compensation program.  A participant's deferrals, together with Company matching credits, are &#8220;invested&#8221; at the direction of the employee in a hypothetical portfolio of investments which are tracked by an administrator.  The Company purchases life insurance policies, with the Company named as beneficiary of the policies, for the purpose of funding the program's liability.  Changes in the cash surrender value of the life insurance policies are based upon earnings and changes in the value of the underlying investments.  Changes in the fair value of the deferred compensation obligation are derived using quoted prices in active markets based on the market price per unit multiplied by the number of units.  The cash surrender value and the deferred compensation obligation are classified within Level 2 of the fair value hierarchy because their inputs are derived principally from observable market data by correlation to the hypothetical investments. Deferrals under the plan currently may only be made by participants who made deferrals under the plan in 2017. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's available-for-sale debt securities are measured at fair value based on estimated future cash flows.  These fair value measurements are classified within Level 3 of the fair value hierarchy as the fair value is based on significant inputs that are not observable, including cash flow projections. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass Memorial Medical Center ("UMass") on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  As of March&#160;31, 2021, the redeemable noncontrolling interest was presented at its fair value.  The fair value measurement of the redeemable noncontrolling interest is classified within Level 3 of the fair value hierarchy because the fair value is based on a discounted cash flow analysis that takes into account, among other items, the joint venture's expected future cash flows, long term growth rates, and a discount rate commensurate with economic risk.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March 31, 2021, the Company recorded an $8&#160;million impairment charge, which is included in equity in earnings of equity method investees, net of taxes, in order to adjust to fair value an investment that is accounted for under the equity method of accounting.  Following the impairment charge, the carrying value of the investment is not material.  The fair value measurement was classified within Level 3 of the fair value hierarchy as it was based on significant inputs that are not observable, including cash flow projections.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The carrying amounts of cash and cash equivalents, accounts receivable, and accounts payable and accrued expenses approximate fair value based on the short maturities of these instruments.  As of March&#160;31, 2021 and December&#160;31, 2020, the fair value of the Company&#8217;s debt was estimated at $4.4&#160;billion and $4.6 billion, respectively.  Principally all of the Company's debt is classified within Level 1 of the fair value hierarchy because the fair value of the debt is estimated based on rates currently offered to the Company with identical terms and maturities, using quoted active market prices and yields, taking into account the underlying terms of the debt instruments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656448112904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The changes in goodwill for the three months ended March&#160;31, 2021 and for the year ended December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,870&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Principally all of the Company&#8217;s goodwill as of March&#160;31, 2021 and December&#160;31, 2020 was associated with its DIS business.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, adjustments to goodwill primarily related to foreign currency translation.  For the year ended December&#160;31, 2020, goodwill acquired was principally associated with the acquisitions of Blueprint Genetics Oy, Memorial Hermann Diagnostic Laboratories, the outreach laboratory division of Memorial Hermann Health System; and the remaining 56% interest in Mid America Clinical Laboratories, LLC (see Note 6 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K).  For the year ended December&#160;31, 2020, adjustments to goodwill primarily related to foreign currency translation.  &#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Intangible assets as of March&#160;31, 2021 and December&#160;31, 2020 consisted of the following:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(659)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,732&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(827)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,968&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(827)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2021 is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656444016552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">FINANCIAL INSTRUMENTS</a></td>
<td class="text">FINANCIAL INSTRUMENTS &#160;&#160;&#160;&#160;The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Cash Flow Hedges</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;From time to time, the Company has entered into various interest rate lock agreements and forward-starting interest rate swap agreements to hedge part of the Company's interest rate exposure associated with the variability in future cash flows attributable to changes in interest rates. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The total net loss, net of taxes, recognized in accumulated other comprehensive loss, related to the Company's cash flow hedges was $1&#160;million as of both March&#160;31, 2021 and December&#160;31, 2020.  The net amount of deferred losses on cash flow hedges that is expected to be reclassified from accumulated other comprehensive loss into interest expense, net within the next twelve months is $1&#160;million.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Derivatives &#8211; Fair Value Hedges </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Historically, the Company has entered into various fixed-to-variable interest rate swap agreements in order to convert a portion of the Company's long-term debt into variable interest rate debt.  All such fixed-to-variable interest rate swap agreements have been terminated and proceeds from the terminations have been reflected as basis adjustments to the hedged debt instruments and are being amortized as a reduction of interest expense, net over the remaining terms of such debt instruments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three months ended March&#160;31, 2021 and 2020:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div>&#160;&#160;&#160;&#160;A detailed description regarding the Company's use of derivative financial instruments is contained in Note 15 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656443847064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity Attributable to Parent [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</a></td>
<td class="text">STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST<div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Stockholders' Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Accumulated Other Comprehensive Loss by Component</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income (loss) includes: </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Foreign currency translation adjustments;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net deferred gains (losses) on cash flow hedges, which represent deferred gains (losses), net of tax, on interest rate-related derivative financial instruments designated as cash flow hedges, net of amounts reclassified to interest expense (see Note 7); and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Net changes in available-for-sale debt securities, which represent unrealized holding gains (losses), net of tax on available-for-sale debt securities.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021 and 2020, the tax effects related to the deferred gains (losses) on cash flow hedges and net changes in available-for-sale debt securities were not material.  Foreign currency translation adjustments related to indefinite investments in non-U.S. subsidiaries are not adjusted for income taxes.  </span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the first quarter of 2021, the Company's Board of Directors declared a quarterly cash dividend of $0.62 per common share.  During each of the four quarters of 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.56 per common share. </span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In each of February and March 2021, the Company's Board of Directors increased the size of its share repurchase program by $1&#160;billion. As of March&#160;31, 2021, $2.5 billion remained available under the Company&#8217;s share repurchase authorization.  The share repurchase authorization has no set expiration or termination date.</span></div><div style="text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchases</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2021, the Company repurchased 3.4 million shares of its common stock for $410 million.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For the three months ended March&#160;31, 2020, the Company repurchased 0.7 million shares of its common stock for $75 million.</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Shares Reissued from Treasury Stock</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's practice has been to issue shares related to its Employee Stock Purchase Plan ("ESPP") and its stock-based compensation program from shares of its common stock held in treasury or by issuing new shares of its common stock.  In January 2021, the Company began to issue shares related to its ESPP and stock-based compensation program solely from common stock held in treasury.  For the three months ended March&#160;31, 2021 and 2020, the Company reissued 0.6 million shares and 1.1 million shares, respectively from treasury stock.  For details regarding the Company's stock ownership and compensation plans, see Note 17 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Redeemable Noncontrolling Interest</span></div><div style="text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the sale of an 18.9% noncontrolling interest in a subsidiary to UMass on July 1, 2015, the Company granted UMass the right to require the Company to purchase all of its interest in the subsidiary at fair value commencing July 1, 2020.  The subsidiary performs diagnostic information services in a defined territory within the state of Massachusetts.  Since the redemption of the noncontrolling interest is outside of the Company's control, it has been presented outside of stockholders' equity at the greater of its carrying amount or its fair value.  As of March&#160;31, 2021 and December&#160;31, 2020, the redeemable noncontrolling interest was presented at its fair value.  For further information regarding the fair value of the redeemable noncontrolling interest, see Note 5.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656444016552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock', window );">SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</a></td>
<td class="text">SUPPLEMENTAL CASH FLOW AND OTHER DATA<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Supplemental cash flow and other data for the three months ended March&#160;31, 2021 and 2020 was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowSupplementalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -URI http://asc.fasb.org/topic&amp;trid=2134446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowSupplementalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656443908920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Letters of Credit</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company can issue letters of credit totaling $100&#160;million under its $600&#160;million secured receivables credit facility and $150&#160;million under its $750&#160;million senior unsecured revolving credit facility.  For further discussion regarding the Company's secured receivables credit facility and senior unsecured revolving credit facility, see Note 13 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In support of its risk management program, to ensure the Company&#8217;s performance or payment to third parties, $70 million in letters of credit under the secured receivables credit facility were outstanding as of March&#160;31, 2021.  The letters of credit primarily represent collateral for current and future automobile liability and workers&#8217; compensation loss payments.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Lease Obligations</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company remains subject to contingent obligations under certain real estate leases, including leases that were entered into by certain predecessor companies of a subsidiary prior to the Company's acquisition of the subsidiary.  No liability has been recorded for any of these potential contingent obligations.  For further details, see Note 18 to the audited consolidated financial statements in the Company&#8217;s 2020 Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company may incur losses associated with these proceedings and investigations, but it is not possible to estimate the amount of loss or range of loss, if any, that might result from adverse judgments, settlements, fines, penalties, or other resolution of these proceedings and investigations based on the stage of these proceedings and investigations, the absence of specific allegations as to alleged damages, the uncertainty as to the certification of a class or classes and the size of any certified class, if applicable, and/or the lack of resolution of significant factual and legal issues.  The Company has insurance coverage rights in place (limited in amount; subject to deductible) for certain potential costs and liabilities related to these proceedings and investigations.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">401(k) Plan Lawsuit</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;In 2020, two putative class action lawsuits were filed in the U.S. District Court for New Jersey against the Company and other defendants with respect to the Company&#8217;s 401(k) plan. The complaint alleges, among other things, that the fiduciaries of the 401(k) plan breached their duties by failing to disclose the expenses and risks of plan investment options, allowing unreasonable administration expenses to be charged to plan participants, and selecting and retaining high cost and poor performing investments.  In October 2020, the court consolidated the two lawsuits under the caption </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">In re: Quest Diagnostics ERISA Litigation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> and plaintiffs filed a consolidated amended complaint.  The Company plans to vigorously defend this matter and has filed a motion to dismiss the complaint.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">AMCA Data Security Incident</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;&#160;&#160;&#160;On June 3, 2019, the Company reported that Retrieval-Masters Creditors Bureau, Inc./American Medical Collection Agency (&#8220;AMCA&#8221;) had informed the Company and Optum360 LLC that an unauthorized user had access to AMCA&#8217;s system between August 1, 2018 and March 30, 2019 (the &#8220;AMCA Data Security Incident&#8221;).  Optum360 provides revenue management services to the Company, and AMCA provided debt collection services to Optum360.  AMCA first informed the Company of the AMCA Data Security Incident on May 14, 2019.  AMCA&#8217;s affected system included financial information (e.g., credit card numbers and bank account information), medical information and other personal information (e.g., social security numbers). Test results were not included.  Neither Optum360&#8217;s nor the Company&#8217;s systems or databases were involved in the incident. AMCA also informed the Company that information pertaining to other laboratories&#8217; customers was also affected.  Following announcement of the AMCA Data Security Incident, AMCA sought protection under the U.S. bankruptcy laws.  The bankruptcy proceeding has been dismissed.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Numerous putative class action lawsuits were filed against the Company related to the AMCA Data Security Incident.  The U.S. Judicial Panel on Multidistrict Litigation transferred the cases still pending to, and consolidated them for pre-trial proceedings in, the U.S. District Court for New Jersey.  In November 2019, the plaintiffs in the multidistrict proceeding filed a consolidated putative class action complaint against the Company and Optum360 that named additional individuals as plaintiffs and that asserted a variety of common law and statutory claims in connection with the AMCA Data Security Incident.  In January 2020, the Company moved to dismiss the consolidated complaint; the motion to dismiss is pending.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In addition, certain federal and state governmental authorities are investigating, or otherwise seeking information and/or documents from the Company related to the AMCA Data Security Incident and related matters, including the Office for Civil Rights of the U.S. Department of Health and Human Services, Attorneys General offices from numerous states and the District of Columbia, and certain U.S. senators.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Legal Matters</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the normal course of business, the Company has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with the Company's activities as a provider of diagnostic testing, information and services.  These actions could involve claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages, and could have an adverse impact on the Company's client base and reputation.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is also involved, from time to time, in other reviews, investigations and proceedings by governmental agencies regarding the Company's business which may result in adverse judgments, settlements, fines, penalties, injunctions or other relief. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The federal or state governments may bring claims based on the Company's current practices, which it believes are lawful.  In addition, certain federal and state statutes, including the</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> qui tam</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> provisions of the federal False Claims Act, allow private individuals to bring lawsuits against healthcare companies on behalf of government or private payers.  The Company is aware of lawsuits, and from time to time has received subpoenas, related to billing practices based on the qui tam provisions of the Civil False Claims Act or other federal and state statutes, regulations or other laws.  The Company understands that there may be other pending qui tam claims brought by former employees or other "whistle blowers" as to which the Company cannot determine the extent of any potential liability.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Management cannot predict the outcome of such matters.  Although management does not anticipate that the ultimate outcome of such matters will have a material adverse effect on the Company's financial condition, given the high degree of judgment involved in establishing loss estimates related to these types of matters, the outcome of such matters may be material to the Company's consolidated results of operations or cash flows in the period in which the impact of such matters is determined or paid.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;These matters are in different stages.  Some of these matters are in their early stages.  Matters may involve responding to and cooperating with various government investigations and related subpoenas.  As of March&#160;31, 2021, the Company does not believe that material losses related to legal matters are probable.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Reserves for legal matters totaled $2 million and $1 million as of March&#160;31, 2021 and December&#160;31, 2020, respectively.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reserves for General and Professional Liability Claims</span></div>&#160;&#160;&#160;&#160;As a general matter, providers of clinical testing services may be subject to lawsuits alleging negligence or other similar legal claims.  These suits could involve claims for substantial damages.  Any professional liability litigation could also have an adverse impact on the Company's client base and reputation.  The Company maintains various liability insurance coverages for, among other things, claims that could result from providing, or failing to provide, clinical testing services, including inaccurate testing results, and other exposures.  The Company's insurance coverage limits its maximum exposure on individual claims; however, the Company is essentially self-insured for a significant portion of these claims.  Reserves for such matters, including those associated with both asserted and incurred but not reported claims, are established on an undiscounted basis by considering actuarially determined losses based upon the Company's historical and projected loss experience.  Such reserves totaled $142 million and $138 million as of March&#160;31, 2021 and December&#160;31, 2020, respectively.  Management believes that established reserves and present insurance coverage are sufficient to cover currently estimated exposures.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656448310056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENT INFORMATION</a></td>
<td class="text">BUSINESS SEGMENT INFORMATION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's DIS business is the only reportable segment based on the manner in which the Chief Executive Officer, who is the Company's chief operating decision maker ("CODM"), assesses performance and allocates resources across the organization.  The DIS business provides diagnostic information services to a broad range of customers, including patients, clinicians, hospitals, IDNs, health plans, employers, ACOs and DCEs.  The Company is the world's leading provider of diagnostic information services, which includes providing information and insights based on the industry-leading menu of routine, non-routine and advanced clinical testing and anatomic pathology testing, and other diagnostic information services.  The DIS business accounted for greater than 95% of net revenues in 2021 and 2020.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All other operating segments include the Company's DS businesses, which consist of its risk assessment services and healthcare information technology businesses.  The Company's DS businesses are the leading provider of risk assessment services for the life insurance industry and offer healthcare organizations and clinicians robust information technology solutions. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As of March&#160;31, 2021, substantially all of the Company&#8217;s services were provided within the United States, and substantially all of the Company&#8217;s assets were located within the United States.</span></div><div style="text-indent:29.25pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following table is a summary of segment information for the three months ended March&#160;31, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues by major service were as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656443908920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">RELATED PARTIES<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company's equity method investees primarily consist of its clinical trials central laboratory services joint venture (see Note 14), a diagnostic information services joint venture, and an investment in a fund that purchases strategic holdings in private companies in the healthcare industry.  During the three months ended March&#160;31, 2021 and 2020, the Company recognized net revenues of $5 million and $9 million, respectively, associated with diagnostic information services provided to its equity method investees.  As of March&#160;31, 2021 and December&#160;31, 2020, there was $5 million and $3 million, respectively, of accounts receivable from equity method investees related to such services.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2021 and 2020, the Company recognized income of $3 million and $4 million, respectively, associated with the performance of certain corporate services, including transition services, for its equity method investees, classified within selling, general and administrative expenses.  As of March&#160;31, 2021 and December&#160;31, 2020, there was $1 million and $3 million, respectively, of other receivables from equity method investees included in prepaid expenses and other current assets related to these service agreements and other transition related items.  In addition, accounts payable and accrued expenses as of both March&#160;31, 2021 and December&#160;31, 2020 included $1 million due to equity method investees.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;During the three months ended March&#160;31, 2021 and 2020, the Company received dividends from its equity method investees of $16 million and $5 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656448257224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">REVENUE RECOGITION AND ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="text">REVENUE RECOGNITION<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DIS</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Net revenues in the Company&#8217;s DIS business accounted for over 95% of the Company&#8217;s total net revenues for the three months ended March&#160;31, 2021 and 2020 and are primarily comprised of a high volume of relatively low-dollar transactions. The DIS business, which provides clinical testing services and other services, satisfies its performance obligations and recognizes revenues primarily upon completion of the testing process (when results are reported) or when services have been rendered.  The Company estimates the amount of consideration it expects to be entitled to receive from customer groups in exchange for providing services using the portfolio approach. These estimates include the impact of contractual allowances (including payer denials), and patient price concessions. The portfolios determined using the portfolio approach consist of the following groups of customers: healthcare insurers, government payers (Medicare and Medicaid programs), client payers and patients.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;For further details regarding revenue recognition in the Company's DIS business, see Note 3 to the audited consolidated financial statements in the Company's 2020 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company&#8217;s DS businesses primarily satisfy their performance obligations and recognize revenues when delivery has occurred or services have been rendered. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net revenue by type of customer was as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The approximate percentage of net accounts receivable by type of customer was as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656448112904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENTS</a></td>
<td class="text">SUBSEQUENT EVENTS<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;On April 1, 2021, the Company sold its 40% ownership interest in Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ("Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Solutions"), its clinical trials central laboratory services joint venture, to IQVIA Holdings, Inc. ("IQVIA"), its joint venture partner for $760&#160;million in an all-cash transaction.  Prior to the transaction, the Company accounted for its minority interest as an equity method investment.  As a result of the transaction, the Company expects to record a pre-tax gain during the second quarter of 2021 of approximately $310&#160;million.  </span></div><div style="text-indent:36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Under a multi-year agreement, the Company will remain the strategic preferred laboratory provider for Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' clients, providing a range of complementary lab testing capabilities to augment Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Solutions' core offerings and extend its industry leading suite of services.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656441916088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">The interim unaudited consolidated financial statements reflect all adjustments which in the opinion of management are necessary for a fair statement of results of operations, comprehensive income, financial condition, cash flows and stockholders' equity for the periods presented.  Except as otherwise disclosed, all such adjustments are of a normal recurring nature.  Operating results for the interim periods are not necessarily indicative of the results that may be expected for the full year.  These interim unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company&#8217;s 2020 Annual Report on Form 10-K.  The year-end balance sheet data was derived from the audited consolidated financial statements as of December&#160;31, 2020, but does not include all the disclosures required by accounting principles generally accepted in the United States (&#8220;GAAP&#8221;).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use Of Estimates</a></td>
<td class="text">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text">The Company's unvested restricted stock units that contain non-forfeitable rights to dividends are participating securities and, therefore, are included in the earnings allocation in computing earnings per share using the two-class method.  Basic earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding.  Diluted earnings per common share is calculated by dividing net income attributable to Quest Diagnostics, adjusted for earnings allocated to participating securities, by the weighted average number of common shares outstanding after giving effect to all potentially dilutive common shares outstanding during the period.  Potentially dilutive common shares include the dilutive effect of outstanding stock options and performance share units granted under the Company's Amended and Restated Employee Long-Term Incentive Plan and its Amended and Restated Non-Employee Director Long-Term Incentive Plan.  Earnings allocable to participating securities include the portion of dividends declared as well as the portion of undistributed earnings during the period allocable to participating securities.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Standards to be Adopted</a></td>
<td class="text">In March 2020, the Financial Accounting Standards Board issued a new accounting standard which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform due to the risk of cessation of the London Interbank Offered Rate ("LIBOR").  The amendments apply only to contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform.  The pronouncement is effective immediately and can be applied through December 31, 2022.  The adoption of this standard is not expected to have a material impact on the Company&#8217;s consolidated results of operations, financial position or cash flows.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">The Company uses derivative financial instruments to manage its exposure to market risks for changes in interest rates and, from time to time, foreign currencies.  This strategy includes the use of interest rate swap agreements, forward-starting interest rate swap agreements, interest rate lock agreements and foreign currency forward contracts to manage its exposure to movements in interest and currency rates.  The Company has established policies and procedures for risk assessment and the approval, reporting and monitoring of derivative financial instrument activities.  These policies prohibit holding or issuing derivative financial instruments for speculative purposes.  The Company does not enter into derivative financial instruments that contain credit-risk-related contingent features or requirements to post collateral. <div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Company is exposed to interest rate risk on its cash and cash equivalents and its debt obligations.  Interest income earned on cash and cash equivalents may fluctuate as interest rates change; however, due to their relatively short maturities, the Company does not hedge these assets or their investment cash flows and the impact of interest rate risk is not material.  The Company's debt obligations consist of fixed-rate and variable-rate debt instruments.  The Company's primary objective is to achieve the lowest overall cost of funding while managing the variability in cash outflows within an acceptable range.  In order to achieve this objective, the Company has historically entered into interest rate swap agreements.  </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Interest rate swaps involve the periodic exchange of payments without the exchange of underlying principal or notional amounts.  Net settlements between the counterparties are recognized as an adjustment to interest expense, net.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41620-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41675-113959<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(n))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579240-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656447999352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share, Basic and Diluted [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text">The computation of basic and diluted earnings per common share was as follows (in millions, except per share data):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amounts attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Earnings allocated to participating securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</span></div></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">468&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of dilutive securities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings per share attributable to Quest Diagnostics&#8217; common stockholders:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.46&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.73&#160;</span></td><td style="border-bottom:2pt solid #000;border-top:2pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text">The following securities were not included in the calculation of diluted earnings per share due to their antidilutive effect:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options and performance share units</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656443642536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value, Measurement Inputs</a></td>
<td class="text">The following table provides a summary of the recognized assets and liabilities that are measured at fair value on a recurring basis:<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:46.260%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Quoted Prices in Active Markets for Identical Assets/Liabilities</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Other Observable Inputs</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Inputs</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">March 31, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:46.191%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.345%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.372%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basis of Fair Value Measurements</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">December 31, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Level 3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading securities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash surrender value of life insurance policies</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Available-for-sale debt securities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Redeemable noncontrolling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656448309224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Changes in Goodwill, Net</a></td>
<td class="text">The changes in goodwill for the three months ended March&#160;31, 2021 and for the year ended December&#160;31, 2020 were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.906%"><tr><td style="width:1.0%"/><td style="width:57.589%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.562%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.175%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,619&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill acquired during the period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Balance, end of period</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,870&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873&#160;</span></td><td style="border-bottom:1.5pt solid #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets Excluding Goodwill</a></td>
<td class="text">Intangible assets as of March&#160;31, 2021 and December&#160;31, 2020 consisted of the following:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:21.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.017%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.724%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.776%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.727%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Amortization<br/>Period <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amortizing intangible assets:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer-related</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(659)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(638)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">841&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Technology</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(65)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(95)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,732&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(827)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,731&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">931&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Intangible assets not subject to amortization:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,968&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(827)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,141&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(800)</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,167&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense Intangible Assets</a></td>
<td class="text">The estimated amortization expense related to amortizable intangible assets for each of the five succeeding fiscal years and thereafter as of March&#160;31, 2021 is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:40.935%"><tr><td style="width:1.0%"/><td style="width:72.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.972%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2021</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">366&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">905&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656448169080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock', window );">Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt</a></td>
<td class="text">As of March&#160;31, 2021 and December&#160;31, 2020, the following amounts were recorded on the consolidated balance sheets related to cumulative basis adjustments for fair value hedges included in the carrying amount of long-term debt:<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.660%"><tr><td style="width:1.0%"/><td style="width:18.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.313%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.315%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hedge Accounting Basis Adjustment (a)</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Balance Sheet Classification</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) As of both March&#160;31, 2021 and December&#160;31, 2020, the entire balance is associated with remaining unamortized hedging adjustments on discontinued relationships.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Fair Value Hedge Accounting on the Statement of Operations</a></td>
<td class="text">The following table presents the effect of fair value hedge accounting on the consolidated statements of operations for the three months ended March&#160;31, 2021 and 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.742%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.746%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (expense), net</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total for line item in which the effects of fair value hedges are recorded</span></td><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gain (loss) on fair value hedging relationships:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hedged items (Long-term debt)</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656447999352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock', window );">Supplemental Cash Flow and Other Data</a></td>
<td class="text">Supplemental cash flow and other data for the three months ended March&#160;31, 2021 and 2020 was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable associated with capital expenditures</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Businesses acquired:</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of liabilities assumed</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of net assets acquired</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Cash acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business acquisitions, net of cash acquired</span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Leases:</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leased assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of supplemental cash flow information for the periods presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656443908088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Summary of Segment Reporting Information by Segment</a></td>
<td class="text">The following table is a summary of segment information for the three months ended March&#160;31, 2021 and 2020.  Segment asset information is not presented since it is not used by the CODM at the operating segment level.  Operating earnings (loss) of each segment represents net revenues less directly identifiable expenses to arrive at operating income (loss) for the segment.  General corporate activities included in the table below are comprised of general management and administrative corporate expenses, amortization and impairment of intangible assets and other operating income and expenses, net of certain general corporate activity costs that are allocated to the DIS and DS businesses.  The accounting policies of the segments are the same as those of the Company as set forth in Note 2 to the audited consolidated financial statements contained in the Company&#8217;s 2020 Annual Report on Form 10-K and Note 2 to the interim unaudited consolidated financial statements.<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenues:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,744&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues </span></td><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating earnings (loss):</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DIS business</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other operating segments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General corporate activities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(61)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">660&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-operating expense, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income before income taxes and equity in earnings of equity method investees</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">626&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Income tax expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity in earnings of equity method investees, net of taxes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Less: Net income attributable to noncontrolling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income attributable to Quest Diagnostics</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock', window );">Schedule of Revenues by Major Service</a></td>
<td class="text">Net revenues by major service were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:78.285%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.841%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Routine clinical testing services</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">945&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">828&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gene-based and esoteric (including advanced diagnostics) testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">653&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Anatomic pathology testing services</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total net revenues</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,720&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,822&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Revenues by Major Service</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656444015432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The approximate percentage of net revenue by type of customer was as follows:<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare insurers:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee-for-service</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitated</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total healthcare insurers</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenues</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_AccountsReceivableDisaggregationTableTextBlock', window );">Accounts Receivable Disaggregation</a></td>
<td class="text">The approximate percentage of net accounts receivable by type of customer was as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Healthcare Insurers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Client Payers</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patients (including coinsurance and deductible responsibilities)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total DIS</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DS</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net accounts receivable</span></td><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_AccountsReceivableDisaggregationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable Disaggregation [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_AccountsReceivableDisaggregationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656451055752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>EARNINGS PER SHARE (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract', window );"><strong>Amounts attributable to Quest Diagnostics&#8217; common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">$ 469<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted', window );">Less: Earnings allocated to participating securities</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Earnings available to Quest Diagnostics&#8217; common stockholders &#8211; basic and diluted</a></td>
<td class="nump">$ 468<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Stock options and performance share units</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted</a></td>
<td class="nump">135<span></span>
</td>
<td class="nump">135<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic(in dollars per share)</a></td>
<td class="nump">$ 3.52<span></span>
</td>
<td class="nump">$ 0.74<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 3.46<span></span>
</td>
<td class="nump">$ 0.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Stock options and performance share units</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656450113128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details) - Recurring Basis - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">$ 71<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">125<span></span>
</td>
<td class="nump">129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">79<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">71<span></span>
</td>
<td class="nump">67<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Other Observable Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">50<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">132<span></span>
</td>
<td class="nump">126<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Significant Unobservable Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradingSecurities', window );">Trading securities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashSurrenderValueFairValueDisclosure', window );">Cash surrender value of life insurance policies</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Available-for-sale debt securities</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">12<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent', window );">Deferred compensation liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue', window );">Redeemable noncontrolling interest</a></td>
<td class="nump">$ 79<span></span>
</td>
<td class="nump">$ 82<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558606&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121553693&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=121645371&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashSurrenderValueFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashSurrenderValueFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradingSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradingSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656530425688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FAIR VALUE MEASUREMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt</a></td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="nump">$ 4,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment', window );">Impairment of equity method investment</a></td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems', window );"><strong>Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 35<br> -Paragraph 32<br> -URI http://asc.fasb.org/extlink&amp;oid=121548190&amp;loc=d3e32787-111569<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656530433688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at beginning of period</a></td>
<td class="nump">$ 6,873<span></span>
</td>
<td class="nump">$ 6,619<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Goodwill acquired during the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">247<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillPeriodIncreaseDecrease', window );">Adjustments to goodwill</a></td>
<td class="num">(3)<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, Balance at end of period</a></td>
<td class="nump">$ 6,870<span></span>
</td>
<td class="nump">$ 6,873<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember', window );">MACL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=dgx_MidAmericaClinicalLaboratoriesLLCMACLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656524321576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 1,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,967<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(827)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract', window );"><strong>Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of 2021</a></td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">92<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2026</a></td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Total</a></td>
<td class="nump">905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Intangible Assets Not Subject to Amortization - Tradenames</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">235<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember', window );">Intangible Assets Not Subject to Amortization - Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer-related intangibles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 1,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(638)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 822<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember', window );">Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(68)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(98)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(95)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember', window );">Total Amortizing Intangible Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Amortization Period</a></td>
<td class="text">17 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Intangible assets, Cost</a></td>
<td class="nump">$ 1,732<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Intangible assets, Accumulated Amortization</a></td>
<td class="num">(827)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(800)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Total intangible assets, Net</a></td>
<td class="nump">$ 905<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 931<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite-Lived and Indefinite-lived Intangible Assets [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UnpatentedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dgx_TotalAmortizingIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656441829096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Narrative) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">$ (31)<span></span>
</td>
<td class="num">$ (21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths', window );">Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember', window );">Cash Flow Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121549185&amp;loc=d3e80748-113994<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656443646056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Balance Sheets) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember', window );">Long-term Debt | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease', window );">Hedge Accounting Basis Adjustment</a></td>
<td class="nump">$ 48<span></span>
</td>
<td class="nump">$ 51<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4EE<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109999712-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LongTermDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656450030216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>FINANCIAL INSTRUMENTS (Income Statement) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">$ 4<span></span>
</td>
<td class="num">$ (16)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1', window );">Hedged items (Long-term debt)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(69)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember', window );">Other Nonoperating Income (Expense) | Fair Value Hedging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivatives designated as hedging instruments</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 25<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121577467&amp;loc=d3e76258-113986<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_FairValueHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656450311112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS&#8217; EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details) - USD ($)<br> $ / shares in Units, shares in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Feb. 28, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jul. 01, 2015</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends per common share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized', window );">Additional amount authorized</a></td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="nump">$ 1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Share repurchase authorization remaining available</a></td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued', window );">Reissuance of shares for employee benefit plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=dgx_UMassJointVentureMember', window );">UMass Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners', window );">Ownership percentage by noncontrolling owners</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember', window );">Treasury Stock, at Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems', window );"><strong>Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock- shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 410,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_StockRepurchaseProgramAdditionalAmountAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Additional Amount Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_StockRepurchaseProgramAdditionalAmountAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=dgx_UMassJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=dgx_UMassJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_TreasuryStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656449225928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental Cash Flow Elements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 74<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">27<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization expense</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">85<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(42)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndDividendIncomeOperating', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest expense, net</a></td>
<td class="num">(38)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaid', window );">Interest paid</a></td>
<td class="nump">32<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">18<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Accounts payable associated with capital expenditures</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsPayableCurrentAndNoncurrent', window );">Dividends payable</a></td>
<td class="nump">82<span></span>
</td>
<td class="nump">75<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfAssetsAcquired', window );">Fair value of assets acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAssumed1', window );">Fair value of liabilities assumed</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(20)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_FairValueOfNetAssetsAcquired', window );">Fair value of net assets acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAcquiredFromAcquisition', window );">Less: Cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Business acquisitions, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Leases:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Leased assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 36<span></span>
</td>
<td class="nump">$ 32<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_FairValueOfNetAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of net assets acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_FairValueOfNetAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAcquiredFromAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAcquiredFromAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsPayableCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsPayableCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of assets acquired in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndDividendIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.1-5)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndDividendIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAssumed1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of liabilities assumed in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAssumed1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656450171896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>claim</div>
</th>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>claim</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted', window );">Self-insurance reserves</a></td>
<td class="nump">$ 142,000,000<span></span>
</td>
<td class="nump">$ 138,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Class action lawsuits | claim</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding, amount</a></td>
<td class="nump">70,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember', window );">Secured Receivables Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility capacity</a></td>
<td class="nump">150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember', window );">Senior Unsecured Revolving Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Remaining borrowing capacity</a></td>
<td class="nump">750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember', window );">Excludes general and professional liability claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationReserve', window );">Litigation reserves</a></td>
<td class="nump">$ 2,000,000<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MalpracticeLossContingencyAccrualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MalpracticeLossContingencyAccrualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=dgx_SeniorunsecuredrevolvingcreditfacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=dgx_ExcludesgeneralandprofessionalliabilityclaimsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656546148600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENT INFORMATION (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,720<span></span>
</td>
<td class="nump">$ 1,822<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">660<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Non-operating expense, net</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes and equity in earnings of equity method investees</a></td>
<td class="nump">626<span></span>
</td>
<td class="nump">118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="num">(153)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity in earnings of equity method investees, net of taxes</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">490<span></span>
</td>
<td class="nump">106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: Net income attributable to noncontrolling interests</a></td>
<td class="nump">21<span></span>
</td>
<td class="nump">7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to Quest Diagnostics</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember', window );">Routine clinical testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">1,032<span></span>
</td>
<td class="nump">945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember', window );">COVID-19 Testing Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">828<span></span>
</td>
<td class="nump">24<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember', window );">Gene-based and esoteric testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">653<span></span>
</td>
<td class="nump">641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember', window );">Anatomic pathology testing services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">130<span></span>
</td>
<td class="nump">134<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember', window );">All other services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 2,643<span></span>
</td>
<td class="nump">$ 1,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">$ 712<span></span>
</td>
<td class="nump">$ 205<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total net revenues</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">General corporate activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Total operating income</a></td>
<td class="num">$ (61)<span></span>
</td>
<td class="num">$ (39)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 14: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3000-108585<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_RoutineclinicaltestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_COVID19TestingServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_GenebasedandesoterictestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AnatomicpathologytestingservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_AllotherservicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_AllotherservicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656449498680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES (Details) - Equity Method Investee - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenues</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Receivables</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable, related parties</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDividendsReceived', window );">Dividends received</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_OtherAccountsReceivableRelatedParties', window );">Other accounts receivable, related parties</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty', window );">Income from related party recognized</a></td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_OtherAccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Accounts Receivable, Related Parties</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_OtherAccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables arising from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends received on equity and other investments during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3337-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_EquityMethodInvesteeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656524865624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">97.00%<span></span>
</td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">96.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">97.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Fee-for-service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">38.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Healthcare Insurers | Capitated</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Government Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Client Payers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Patients</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember', window );">DIS business | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">95.00%<span></span>
</td>
<td class="nump">95.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember', window );">All other operating segments | DS Businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetRevenues', window );">Percentage of net revenues</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_PercentageofNetAccountsReceivable', window );">Net accounts receivable</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Accounts Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_PercentageofNetRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of Net Revenues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_PercentageofNetRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=dgx_DiagnosticInformationServicesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_HealthcareInsurersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_FeeforserviceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_FeeforserviceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dgx_CapitatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dgx_CapitatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_GovernmentPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_ClientPayersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_ClientPayersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_PatientsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_PatientsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=dgx_DSBusinessesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm139656530421448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT (Details) - Q2 Solutions - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Apr. 01, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember', window );">Scenario, Forecast</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal', window );">Gain on sale of investment, before tax</a></td>
<td class="nump">$ 310<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf', window );">Percent of ownership interest sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 760<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dgx_EquityMethodInvestmentOwnershipPercentDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investment, Ownership Percent Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dgx_EquityMethodInvestmentOwnershipPercentDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dgx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of an equity method investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=dgx_Q2SolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementScenarioAxis=srt_ScenarioForecastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementScenarioAxis=srt_ScenarioForecastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>57
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $J EU('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " !*@)=2/\:'Y>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M:L,P#(=?9?B>R'%&#B;-96.G%@8K;.QF;+4UB_]@:R1]^R59FS*V!]C1TL^?
M/H%:':4."9]3B)C(8KX;7>^SU''#3D11 F1]0J=R.27\U#R$Y!1-SW2$J/2'
M.B((SAMP2,HH4C #B[@26=<:+75"12%=\$:O^/B9^@5F-&"/#CUEJ,H*6#=/
MC.>Q;^$&F&&$R>7O IJ5N%3_Q"X=8)?DF.V:&H:A'.HE-^U0P=MN^[*L6UB?
M27F-TZ]L)9TC;MAU\FO]\+A_8IW@HBKX?2'J?=5(+B1OWF?7'WXW81>,/=A_
M;'P5[%KX=1?=%U!+ P04    " !*@)=2F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M $J EU+9[1EA+04  %<5   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME9C;<MLV$(:OTZ? :'J1S%@6 .KDC*T96;83MXXC6VY:M],+B(0D3DA"!4#+
MZM-W04JDG*&6[(W-T_[ZN%C\"^)\H_1WLY+2DM<X2LQ%:V7M^F.G8_R5C(4Y
M56N9P)V%TK&P<*J7';/64@194!QU.*7]3BS"I#4ZSZY-]>A<I38*$SG5Q*1Q
M+/3V4D9J<]%BK?V%QW"YLNY"9W2^%DLYD_:W]53#6:=0"<)8)B94"=%R<=$:
MLX\3C[N [(EOH=R8@V/B7F6NU'=W<AM<M*@CDI'TK9,0\.]%3F04.27@^&<G
MVBI^TP4>'N_5;[*7AY>9"R,G*OH]#.SJHC5LD4 N1!K91[7Y+'<OU'-ZOHI,
M]I=L\F>[W1;Q4V-5O L&@CA,\O_B=9>(@P"/'@G@NP#^0P []@O>+L#+7C0G
MRU[K2E@Q.M=J0[1[&M3<09:;+!K>)DS<,,ZLAKLAQ-G11+U(3:8P8J1-S$IH
M:<X[%H3=[8Z_$[G,1?@1$8]\48E=&7*=!#)X&]\!H(**[ZDN.2KX1>A3XK$3
MPBEG%3P3/'R\AG#6JPI_@^,52?(R/0]-TE_CN;$:ZNYO1+);2'8SR>X1R2OE
MIS ;+'G:KF55QO%P1ML/"$6OH.@UHWA(A;921UOR*-=*VRHB7,KJ5")$_8*H
MWXQH*G6H E=1! J[,D6XTKZ&?GKWKJ8,!@7;H.&8:0$^EMG0\73A6@L1&2Q?
MPX)IB.I<)S:T6W(31I+<I_%<ZBH67(-2UF:<LQ["<U;PG#7A>93+T$T62-:]
MB"M'#]=Y2*6QY"H4RT09&_J&W"8^PL=H:7BT">$$!E*+"&0#^4I^E=M*V\.E
M*&2.<DX'9QC9@14S5&Z2:NW*ZR8T/I ]2Z'1^J^1:\.@MCVL\!DOT7BSTC]D
MNX&+U=T"%ZN9CJRT9>;]+ZJ=9QSGPN4>4*K2V1GNS6- "G*L2"PK.7"!.F]@
MI;TSW)1WM0Y31VGP*>$LZX3,+!0449I,5 J3 .:""JH+K*9[7&.0I>,SW*AW
MD$_BE=P&D+9P$?H9*6)H-9*LWV;><##L<XRP]'V&F_6.<!P$L#PR)_L#<@?/
MD:])=>YPR1ZE9!J)?P6YTK".Q3#+5L :]8("<^+.8)B?U":I1,3E9M(7*<RD
M$PRN[ NL46,HX(HBG&KU$B9^=1)QS?M?L+5FV1%XHXY0H$VAXX";_!FNC\Z,
M&D4ZH&==C*WL";RF)V1D\(%V' 47>'\V\#Y@*&4/X+AMWZG,8U<JP98:-2(]
M3MM\0"E&5/H_QPW[*;2P[%$+POC[^0<"!9MJR%<E%JXT47$,AC.SRO]^0GZF
MIY3!1Y$FWT2$+FMYV14X;NJP9@S"9$EFVWBNHDK$FB^&3W]@(&5/X+AK[[-$
MKE_]E4C@P^_8"JU&Z/YYAC4 7C8 WJ@![)<_^9(ZRQ5X1'4GKU%\_O$K]BU9
M:?R\D?'?)O!ME&\XN,68V*-6DN&*-62EU_/&ZW[HXV"E2Z6K"Q_7N1,:*F#L
M^Q*$0";()3'&TO)Y(\N?Q2**R&5JX+:I'DU<IVX]Y)5.[S5R^NM8ZJ4KL$^@
M8%=@K?%:))7IJQ&L12N-WL-]>I^LE81D84"X3"U0:?<>[M3[6?G&&6?9#A'Y
MFEIHD8DSM*K=F9UR+U-V&XDO(^;1OC=D%+Z47@ZQ.@=;5VY4LAT]0WRW,LUW
ML8JKQ:[A.-LKZY2/YUN.\,$/@VI()!<02D\'\/LZW\7+3ZQ:9QMA<V6MBK/#
ME12!U.X!N+]0RNY/W \4>ZFC_P!02P,$%     @ 2H"74G_^3]LX!0  VA,
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M%@#/GZ0T^X%]076<-_T?4$L#!!0    ( $J EU(AU<&J7 ,  ,0)   8
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M:_<2\P.EF"VN(H_N +Z:?[)7%'?._H3)[S=T7&R%-"R%#4$&]QW*J<ZO#/D
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M!.*LI0)YXG"K -F:U@)RF81FF7S[@ L5FF-;8NZ807W27'+@KCERGR$7*L;
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MN(&)MQ)49H!X0-P2#].C%&?8'MB:^4:(5'-M(GZ% 3EZ,$N)?$&HA#-E"LT
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M;A3D60"_KQS*O'W@ _K7I6?_ E!+ P04    " !*@)=2L<B1_G #  !C"
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MVGJE5CJG9'LVI#,UXIWP P4O*_OHN<< II5JI"5\:S5?$\&U0+ */C1H+ 6
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MA. U9WH";$\QA: 92:)7BV)/;MUK5L_<%NVZ:X3"IB:!X*.*>-6U?HJYP\O
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M_)FQ0MAD ]Y/+7#6#V)@]0WI] ]02P,$%     @ 2H"74MF8H<!] P  [@<
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M96D^^,^2!C)JIT#RM5)VOW &NA$__0-02P,$%     @ 2H"74O)R)"Q:#0
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M16HG>X<S3B_/3@5-8N*&&B.JFN<H6!5%\]J(][U1XH0:GJ._SG:@[;A"L:<
MN8\*F:'6LOGF4GHN2[&5M_CK#?H;V<]([OSPM%6.F$=<XNL2*8_Q-$^\IS36
M;,5CRH+CQ0M2C?\\>O$$1E$N4DA3<*8I=MV%OCWY=B$N+LZB/I):=_14*^O
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M:2@G%05EZ@Q6)<ZYR^M/T_O'N^F43>]^?KA[_,CN'W]Z>GZX^GC_]'C>=9!
M^[I)B78=T.(]:'WVH)5;6G:G4I'NGN]"LUJ]N%+O.CX(^,!-A_6C-HM[<70
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M.+TS=E$ ^VN+"Z:=1 /=BW3Q#U!+ P04    " !*@)=2YZT;E6 %  !Y#
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MFLK>;E,:*5&:!W2_%$)O#T9 ,Z1._@=02P,$%     @ 2H"74I_&2.4!!
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M\] .CP5_):$3 ][/K?6;%TG0?G=-_@-02P,$%     @ 2H"74C"@AHJ% P
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MD..&U<+>J]TU[M<S<'R9$L8_8=?X]@<!9+6QJMR#*8*2R^;-GO9Y. ",HC<
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M;GM$J3?AGAT^G-[XN^U".W+3OZ[IIPD:%J#]I>8(A@\V4/_8F?X+4$L#!!0
M   ( $J EU)I2&=&40,  )L'   9    >&PO=V]R:W-H965T<R]S:&5E=#(Y
M+GAM;(U578_:.A#]*Z-(E5JIW7RQ['8%2"RP+=(6$-#VX:H/)AD2JXF=V@9V
M_WW'3LBR]Q9ZI2BQ)S-GCN?8X]Y!JI\Z1S3P5!9"][W<F.K.]W628\GTE:Q0
MT)^M5"4S-%69KRN%+'5!9>%'0=#U2\:%-^@YVT(->G)G"BYPH4#ORI*IYWLL
MY*'OA=[1L.19;JS!'_0JEN$*S==JH6CFMR@I+U%H+@4HW/:]87AW?VW]G<,W
MC@=],@:[DHV4/^UDFO:]P!+" A-C$1A]]CC"HK! 1.-7@^FU*6W@Z?B(_N#6
M3FO9,(TC67SGJ<G[WJT'*6[9KC!+>?B,S7H<P406VKWA4/MV*6.RTT:633#-
M2R[J+WMJZG 2<!N<"8B:@,CQKA,YEF-FV*"GY &4]28T.W!+==%$C@LKRLHH
M^LLIS@R6DV^3V=<)+">C^:?9=#V=SV X&\/P\7'^?3@;3>!AOH31<C*>KN%Q
MOEI-5O!VS38%ZG<]WQ #B^,G3;;[.EMT)EL,7Z0PN8:)2#%]'>\3\Y9^=*1_
M'UT$_,+4%<3A>XB"*+R %[?EB!U>?*X<N$>Q0]@J6<*(N"K:-B2)R6'DQ$ %
M_PPWVME_7$C8:1-V7,+.F81CKEF6*<R8VZ1R"PV%/Q7W,M0Z1V!5I>03I]V*
M4*%*4!@Z6A96T %7S>HVSV">*V=.CJLZ, WT;&5!YU3?P3I7B*_D BIVDK?5
MMJ\ /B,K3)XPA<"%WBE4%/N ^('ZQ0>-:L\3A/@6WD#<H=>(5=P0N10BB&$M
M#2L@_R\$= *(;^"3W*,2U (,5.S9VL, P@Z,"GYBBZ\ACF%!!20CN43VJ:''
MTQ5\O(&/71BO*%\'9B]5L& !47+O"TI>MTI>7RS_,$GDSA)88H)\;X\(O%;W
M3Y)>QOR[I.R85;UD_3_R_DO+,467&_)K+*^$G1Y5H3(W.IXHLZA5N('N49?&
MTJ&"=U]T><M%4NQ2+C)(I!.:"=H;3*341=,==6?+7:&N)+7\#2\X!>IW$,80
MAJ=Z=JVDI&>'%)V=*<%?I/5/&B95)W/7@@:'4_?.UMK>/,.ZX;ZXU]<6%3*C
MU4"!6PH-KFY(455?!?7$R,JUWXTT)(4;THY/45D'^K^5TAPG-D%['P]^ U!+
M P04    " !*@)=25L&MW8X#  !)"P  &0   'AL+W=O<FMS:&5E=',O<VAE
M970S,"YX;6RUEFUOVS80Q[\*H05# K31DQ]3VX =>VN!)DAMI'U-2[1%A"(U
MDK*[;[\CI<B*+&MKT;VQ1?+N]/L?*=Y-CD*^J(00C;ZGC*NIDVB=W;FNBA*2
M8G4K,L)A92=DBC4,Y=Y5F20XMDXI<P//&[@IIMR93>S<DYQ-1*X9Y>1)(I6G
M*99_+P@3QZGC.Z\3:[I/M)EP9Y,,[\F&Z.?L2<+(K:+$-"5<4<&1)+NI,_?O
M[OW .%B+KY0<5>T9&2E;(5[,X%,\=3Q#1!B)M F!X>] [@EC)A)P_%4&=:IW
M&L?Z\VOT/ZQX$+/%BMP+]HW&.IDZ(P?%9(=SIM?B^)&4@OHF7B28LK_H6-IZ
M#HIRI45:.@-!2GGQC[^7B:@Y0)QVAZ!T")H.O0L.8>D06J$%F96UQ!K/)E(<
MD336$,T\V-Q8;U!#N=G&C9:P2L%/SU;S]>.GQS\WZ&FU1IN/\_4*72^)QI2I
M&_0>/6^6Z/KJ!ETA%ZD$2Z(0Y>B94ZW>U28>*&.P*3!W51].7 V(YD5N5.(L
M"IS@ DZ('@37B4(K'I/XK;\+TBI]P:N^1= 9\ '+6Q3Z[U#@!7X+S_U_=_<Z
M<,(JW:&-%UZ(-T]%SK5"6&M)M[G&6T:0%NA+3I1&2XKW7"A-(_7[;Z/ 'WY
MD4A3..UP#J*71+"82'77P=&K.'J6HW>!XQ$N",HA./EWE+9=+*(/;'1S4QQF
MO<%XXA[JF3VW&9],WE#W*^I^)_5GHM0=6F')*=]#$AD3$=8D-M@9E@!+,ZQA
M#2D2Y9)J2EKIB[?T:V1^@_W<PFM''U3H@T[T$_0!OJV?V79DU_P/YM:B$<(\
M1C%EN6Y^)H7$0<L&C1HBSVTN;="P4CGL5/G-WIJP(?A )%2!2D=Q4T 941K
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M_G&4B 2V&QP.M3.DREKZ1>#VB^,^G/)&*WLRATO)FAAK+>GM[02FV["P*%S
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M&])#?:R0H39<AOIP(8-1PXA1*$>M4=[F,0?IY.[VW5%=NZD5;E@A8@5X_+J
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M_\,FM[4KX,92\3"'M8*0LNP3?\TG8@?0?LH!)P><4X%:#M1.!>HY4'\-U(\
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M/KP3D1CH[Y><JY>;Y '%SP'=?P%02P,$%     @ 2H"74M9\.IP^!   5 \
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M889?%"CK@.M+*<W.L!O4G][P#U!+ P04    " !*@)=2!(_@.PT#  !G$
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M^A' _ KB&$/@:<013 %HP) XMN?@T7D4=>=4M/MK8?X;4$L#!!0    ( $J
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MXP"''D%L14C*-, I #B]&" :Q5R#O (@KRXWU)BM-,AK /+Z8I LC3P-\AT
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M@D+6!(6L"0I9$Q2R)O])UG>M5W_]=Z5=XUJ5S=&?=;^PYI]02P$"% ,4
M" !*@)=2!T%-8H$   "Q    $               @ $     9&]C4')O<',O
M87!P+GAM;%!+ 0(4 Q0    ( $J EU(_QH?E[@   "L"   1
M  "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $J EU*97)PC
M$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL
M4$L! A0#%     @ 2H"74MGM&6$M!0  5Q4  !@              ("!#0@
M 'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $J EU)__D_;
M. 4  -H3   8              " @7 -  !X;"]W;W)K<VAE971S+W-H965T
M,BYX;6Q02P$"% ,4    " !*@)=2(=7!JEP#  #$"0  &
M@('>$@  >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 2H"7
M4KD!_$!B!@  $AH  !@              ("!<!8  'AL+W=O<FMS:&5E=',O
M<VAE970T+GAM;%!+ 0(4 Q0    ( $J EU+]>151P (  %\'   8
M      " @0@=  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"% ,4
M" !*@)=2QOR7&A &  !#&   &               @('^'P  >&PO=V]R:W-H
M965T<R]S:&5E=#8N>&UL4$L! A0#%     @ 2H"74J>SM+=0!P  TB,  !@
M             ("!1"8  'AL+W=O<FMS:&5E=',O<VAE970W+GAM;%!+ 0(4
M Q0    ( $J EU(5:!I$! (  (D$   8              " @<HM  !X;"]W
M;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " !*@)=2:F]!V48(   Z
M%0  &               @($$,   >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL
M4$L! A0#%     @ 2H"74K'(D?YP P  8P@  !D              ("!@#@
M 'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " !*@)=2DU[J
MLZ4"  "B!0  &0              @($G/   >&PO=V]R:W-H965T<R]S:&5E
M=#$Q+GAM;%!+ 0(4 Q0    ( $J EU*L@W%E$@D  #X;   9
M  " @0,_  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @
M2H"74I\T94]/!0  >0P  !D              ("!3$@  'AL+W=O<FMS:&5E
M=',O<VAE970Q,RYX;6Q02P$"% ,4    " !*@)=2*5'W%-L'  "G%   &0
M            @('230  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4
M Q0    ( $J EU*)L/,']@8  $\2   9              " @>15  !X;"]W
M;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ 2H"74MF8H<!] P
M[@<  !D              ("!$5T  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX
M;6Q02P$"% ,4    " !*@)=2\G(D+%H-   1(P  &0              @('%
M8   >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    ( $J EU+*
M[V$8% <  *$1   9              " @59N  !X;"]W;W)K<VAE971S+W-H
M965T,3@N>&UL4$L! A0#%     @ 2H"74BBC,Q(,!   G0H  !D
M     ("!H74  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( $J EU( 9;0CEP,  .((   9              "
M@7&1  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ 2H"7
M4FMWYCYP!   L H  !D              ("!/Y4  'AL+W=O<FMS:&5E=',O
M<VAE970R-2YX;6Q02P$"% ,4    " !*@)=2G\9(Y0$$  "#"0  &0
M        @('FF0  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0
M   ( $J EU(PH(:*A0,  ,\'   9              " @1Z>  !X;"]W;W)K
M<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ 2H"74FRP^IUN!0  ^ P
M !D              ("!VJ$  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q0
M2P$"% ,4    " !*@)=2:4AG1E$#  ";!P  &0              @(%_IP
M>&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( $J EU)6P:W=
MC@,  $D+   9              " @0>K  !X;"]W;W)K<VAE971S+W-H965T
M,S N>&UL4$L! A0#%     @ 2H"74N9!_=?3!   :Q8  !D
M ("!S*X  'AL+W=O<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !*
M@)=2S0T()0X#  "H"   &0              @('6LP  >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    ( $J EU+?]K0?" ,  )@(   9
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M970S-RYX;6Q02P$"% ,4    " !*@)=2(&FDLG,$   :$   &0
M    @(%NR0  >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    (
M $J EU+6?#J</@0  %0/   9              " @1C.  !X;"]W;W)K<VAE
M971S+W-H965T,SDN>&UL4$L! A0#%     @ 2H"74FD6DQ&@ P  !@T  !D
M             ("!C=(  'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"
M% ,4    " !*@)=23[JM)*0%  "]&@  &0              @(%DU@  >&PO
M=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( $J EU)R&F+N3 ,
M &0*   9              " @3_<  !X;"]W;W)K<VAE971S+W-H965T-#(N
M>&UL4$L! A0#%     @ 2H"74MZ#CH&(!   &1H  !D              ("!
MPM\  'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !*@)=2
M;[1K[Z\"    !P  &0              @(&!Y   >&PO=V]R:W-H965T<R]S
M:&5E=#0T+GAM;%!+ 0(4 Q0    ( $J EU($C^ [#0,  &<0   -
M      "  6?G  !X;"]S='EL97,N>&UL4$L! A0#%     @ 2H"74I>*NQS
M    $P(   L              ( !G^H  %]R96QS+RYR96QS4$L! A0#%
M  @ 2H"74G]IVQ4H!   PQT   \              ( !B.L  'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( $J EU)''&"YI $  )L:   :
M  "  =WO  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M $J EU(NTOC K@$  ,H:   3              "  ;GQ  !;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@     T #0 (PX  )CS      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>148</ContextCount>
  <ElementCount>291</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>50</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>5</UnitCount>
  <MyReports>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2104103 - Disclosure - EARNINGS PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARE</Role>
      <ShortName>EARNINGS PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2107104 - Disclosure - BUSINESS ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSACQUISITIONS</Role>
      <ShortName>BUSINESS ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2108105 - Disclosure - FAIR VALUE MEASUREMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</Role>
      <ShortName>FAIR VALUE MEASUREMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2112106 - Disclosure - GOODWILL AND INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2116107 - Disclosure - FINANCIAL INSTRUMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</Role>
      <ShortName>FINANCIAL INSTRUMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2121108 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2123109 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2126110 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2128111 - Disclosure - BUSINESS SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2131112 - Disclosure - RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RELATEDPARTIES</Role>
      <ShortName>RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2133113 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES</Role>
      <ShortName>REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2136114 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENT</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - EARNINGS PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHARETables</Role>
      <ShortName>EARNINGS PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARE</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2317304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTS</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2324305 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2334307 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables</Role>
      <ShortName>REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2406401 - Disclosure - EARNINGS PER SHARE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/EARNINGSPERSHAREDetails</Role>
      <ShortName>EARNINGS PER SHARE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/EARNINGSPERSHARETables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2410402 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2411403 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails</Role>
      <ShortName>FAIR VALUE MEASUREMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2414404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2415405 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2418406 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Narrative) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2419407 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Balance Sheets) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2420408 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails</Role>
      <ShortName>FINANCIAL INSTRUMENTS (Income Statement) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2422409 - Disclosure - STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails</Role>
      <ShortName>STOCKHOLDERS??? EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2425410 - Disclosure - SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails</Role>
      <ShortName>SUPPLEMENTAL CASH FLOW &amp; OTHER DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2427411 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2430412 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails</Role>
      <ShortName>BUSINESS SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2432413 - Disclosure - RELATED PARTIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/RELATEDPARTIESDetails</Role>
      <ShortName>RELATED PARTIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/RELATEDPARTIES</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2435414 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails</Role>
      <ShortName>REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="dgx-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2437415 - Disclosure - SUBSEQUENT EVENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails</Role>
      <ShortName>SUBSEQUENT EVENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://questdiagnostics.com/role/SUBSEQUENTEVENT</ParentRole>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="dgx-20210331.htm">dgx-20210331.htm</File>
    <File>dgx-20210331.xsd</File>
    <File>dgx-20210331_cal.xml</File>
    <File>dgx-20210331_def.xml</File>
    <File>dgx-20210331_lab.xml</File>
    <File>dgx-20210331_pre.xml</File>
    <File>dgx03312021ex101.htm</File>
    <File>dgx03312021ex311.htm</File>
    <File>dgx03312021ex312.htm</File>
    <File>dgx03312021ex321.htm</File>
    <File>dgx03312021ex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>62
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "dgx-20210331.htm": {
   "axisCustom": 0,
   "axisStandard": 21,
   "contextCount": 148,
   "dts": {
    "calculationLink": {
     "local": [
      "dgx-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dgx-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "dgx-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "dgx-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dgx-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "dgx-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 377,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 5
   },
   "keyCustom": 11,
   "keyStandard": 280,
   "memberCustom": 19,
   "memberStandard": 31,
   "nsprefix": "dgx",
   "nsuri": "http://questdiagnostics.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://questdiagnostics.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104103 - Disclosure - EARNINGS PER SHARE",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARE",
     "shortName": "EARNINGS PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107104 - Disclosure - BUSINESS ACQUISITIONS",
     "role": "http://questdiagnostics.com/role/BUSINESSACQUISITIONS",
     "shortName": "BUSINESS ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108105 - Disclosure - FAIR VALUE MEASUREMENTS",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS",
     "shortName": "FAIR VALUE MEASUREMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112106 - Disclosure - GOODWILL AND INTANGIBLE ASSETS",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116107 - Disclosure - FINANCIAL INSTRUMENTS",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS",
     "shortName": "FINANCIAL INSTRUMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121108 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2123109 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126110 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128111 - Disclosure - BUSINESS SEGMENT INFORMATION",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION",
     "shortName": "BUSINESS SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131112 - Disclosure - RELATED PARTIES",
     "role": "http://questdiagnostics.com/role/RELATEDPARTIES",
     "shortName": "RELATED PARTIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2133113 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES",
     "shortName": "REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136114 - Disclosure - SUBSEQUENT EVENT",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENT",
     "shortName": "SUBSEQUENT EVENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2203201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - EARNINGS PER SHARE (Tables)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHARETables",
     "shortName": "EARNINGS PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - FAIR VALUE MEASUREMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables",
     "shortName": "FAIR VALUE MEASUREMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317304 - Disclosure - FINANCIAL INSTRUMENTS (Tables)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables",
     "shortName": "FINANCIAL INSTRUMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dgx:ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2324305 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - BUSINESS SEGMENT INFORMATION (Tables)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables",
     "shortName": "BUSINESS SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2334307 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Tables)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables",
     "shortName": "REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406401 - Disclosure - EARNINGS PER SHARE (Details)",
     "role": "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails",
     "shortName": "EARNINGS PER SHARE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i0ed43c43b5ff493e9231f461d2f7f59b_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410402 - Disclosure - FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Recognized Assets and Liabilities at Fair Value) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i0ed43c43b5ff493e9231f461d2f7f59b_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TradingSecurities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411403 - Disclosure - FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
     "shortName": "FAIR VALUE MEASUREMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-8",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i71eadae108864617a48c288ee03da704_I20201231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414404 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Goodwill) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i9adbe4d9a49f4d73b4e4e499c1602647_I20191231",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415405 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "role": "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS (Schedules) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418406 - Disclosure - FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Narrative) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i823a17c2df114f629409d133576bca9e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419407 - Disclosure - FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Balance Sheets) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i823a17c2df114f629409d133576bca9e_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherNonoperatingIncomeExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420408 - Disclosure - FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "role": "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
     "shortName": "FINANCIAL INSTRUMENTS (Income Statement) (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i4276aed117b24b4684c477c58a926e2f_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422409 - Disclosure - STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "role": "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails",
     "shortName": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockDividendsPerShareDeclared",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425410 - Disclosure - SUPPLEMENTAL CASH FLOW & OTHER DATA (Details)",
     "role": "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails",
     "shortName": "SUPPLEMENTAL CASH FLOW & OTHER DATA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427411 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MalpracticeLossContingencyAccrualUndiscounted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430412 - Disclosure - BUSINESS SEGMENT INFORMATION (Details)",
     "role": "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
     "shortName": "BUSINESS SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie9e62f1f9ce94456b1cd2a528dd83efc_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i5cdb593684214c31b69e5e0f14a1dd79_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432413 - Disclosure - RELATED PARTIES (Details)",
     "role": "http://questdiagnostics.com/role/RELATEDPARTIESDetails",
     "shortName": "RELATED PARTIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i5cdb593684214c31b69e5e0f14a1dd79_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "dgx:PercentageofNetRevenues",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435414 - Disclosure - REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Details)",
     "role": "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails",
     "shortName": "REVENUE RECOGNITION AND ALLOWANCE FOR CREDIT LOSSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "dgx:PercentageofNetAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ic411e7e9465f4d0ca07e2fc70dfc9403_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437415 - Disclosure - SUBSEQUENT EVENT (Details)",
     "role": "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails",
     "shortName": "SUBSEQUENT EVENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ic411e7e9465f4d0ca07e2fc70dfc9403_D20210401-20210630",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentRealizedGainLossOnDisposal",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie648c1d0f7124826ab1f231505fef1e4_I20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": "-6",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerAssetCreditLossExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie4f49c664e464e75a6577f2c5dbd5d00_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "role": "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "ie4f49c664e464e75a6577f2c5dbd5d00_I20191231",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2102102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "dgx-20210331.htm",
      "contextRef": "i8dbed4e81ed14963b472f052115ee891_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 50,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dgx_AccountsReceivableDisaggregationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Disaggregation [Table Text Block]",
        "label": "Accounts Receivable Disaggregation [Table Text Block]",
        "terseLabel": "Accounts Receivable Disaggregation"
       }
      }
     },
     "localname": "AccountsReceivableDisaggregationTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_AllotherservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other services [Member]",
        "label": "All other services [Member]",
        "terseLabel": "All other services"
       }
      }
     },
     "localname": "AllotherservicesMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_AnatomicpathologytestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Anatomic pathology testing services [Member]",
        "label": "Anatomic pathology testing services [Member]",
        "terseLabel": "Anatomic pathology testing services"
       }
      }
     },
     "localname": "AnatomicpathologytestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_COVID19TestingServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "COVID-19 Testing Services",
        "label": "COVID-19 Testing Services [Member]",
        "terseLabel": "COVID-19 Testing Services"
       }
      }
     },
     "localname": "COVID19TestingServicesMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_CapitatedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitated [Member]",
        "label": "Capitated [Member]",
        "terseLabel": "Capitated"
       }
      }
     },
     "localname": "CapitatedMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ClientPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Client Payers [Member]",
        "label": "Client Payers [Member]",
        "terseLabel": "Client Payers"
       }
      }
     },
     "localname": "ClientPayersMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DSBusinessesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "DS Businesses [Member]",
        "label": "DS Businesses [Member]",
        "terseLabel": "DS Businesses"
       }
      }
     },
     "localname": "DSBusinessesMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_DescriptionOfBusinessAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of Business (Abstract)",
        "label": "Description of Business (Abstract)",
        "terseLabel": "Description of Business (Abstract)"
       }
      }
     },
     "localname": "DescriptionOfBusinessAbstract",
     "nsuri": "http://questdiagnostics.com/20210331",
     "xbrltype": "stringItemType"
    },
    "dgx_DiagnosticInformationServicesBusinessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostic Information Services Business [Member]",
        "label": "Diagnostic Information Services Business [Member]",
        "terseLabel": "DIS business"
       }
      }
     },
     "localname": "DiagnosticInformationServicesBusinessMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_EquityMethodInvestmentOwnershipPercentDisposedOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Method Investment, Ownership Percent Disposed Of",
        "label": "Equity Method Investment, Ownership Percent Disposed Of",
        "terseLabel": "Percent of ownership interest sold"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentDisposedOf",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_ExcludesgeneralandprofessionalliabilityclaimsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excludes general and professional liability claims [Member]",
        "label": "Excludes general and professional liability claims [Member]",
        "terseLabel": "Excludes general and professional liability claims"
       }
      }
     },
     "localname": "ExcludesgeneralandprofessionalliabilityclaimsMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FairValueOfNetAssetsAcquired": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of net assets acquired",
        "label": "Fair value of net assets acquired",
        "totalLabel": "Fair value of net assets acquired"
       }
      }
     },
     "localname": "FairValueOfNetAssetsAcquired",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_FeeforserviceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fee-for-service [Member]",
        "label": "Fee-for-service [Member]",
        "terseLabel": "Fee-for-service"
       }
      }
     },
     "localname": "FeeforserviceMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_FiniteLivedAndIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "label": "Finite-Lived and Indefinite-lived Intangible Assets [Table]",
        "terseLabel": "Finite-Lived and Indefinite-lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_GenebasedandesoterictestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gene-based and esoteric testing services [Member]",
        "label": "Gene-based and esoteric testing services [Member]",
        "terseLabel": "Gene-based and esoteric testing services"
       }
      }
     },
     "localname": "GenebasedandesoterictestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_GovernmentPayersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Payers [Member]",
        "label": "Government Payers [Member]",
        "terseLabel": "Government Payers"
       }
      }
     },
     "localname": "GovernmentPayersMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_HealthcareInsurersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Healthcare Insurers [Member]",
        "label": "Healthcare Insurers [Member]",
        "terseLabel": "Healthcare Insurers"
       }
      }
     },
     "localname": "HealthcareInsurersMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_MidAmericaClinicalLaboratoriesLLCMACLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Mid America Clinical Laboratories, LLC (MACL)",
        "label": "Mid America Clinical Laboratories, LLC (MACL) [Member]",
        "terseLabel": "MACL"
       }
      }
     },
     "localname": "MidAmericaClinicalLaboratoriesLLCMACLMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_NetIncomeLossExcludingRedeemableNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "label": "Net Income (Loss), Excluding Redeemable Noncontrolling Interest",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLossExcludingRedeemableNoncontrollingInterest",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_OtherAccountsReceivableRelatedParties": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Accounts Receivable, Related Parties",
        "label": "Other Accounts Receivable, Related Parties",
        "terseLabel": "Other accounts receivable, related parties"
       }
      }
     },
     "localname": "OtherAccountsReceivableRelatedParties",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_PatientsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patients [Member]",
        "label": "Patients [Member]",
        "terseLabel": "Patients"
       }
      }
     },
     "localname": "PatientsMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_PercentageofNetAccountsReceivable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Accounts Receivable",
        "label": "Percentage of Net Accounts Receivable",
        "terseLabel": "Net accounts receivable"
       }
      }
     },
     "localname": "PercentageofNetAccountsReceivable",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_PercentageofNetRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of Net Revenues",
        "label": "Percentage of Net Revenues",
        "terseLabel": "Percentage of net revenues"
       }
      }
     },
     "localname": "PercentageofNetRevenues",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "dgx_Q2SolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Q2 Solutions",
        "label": "Q2 Solutions [Member]",
        "terseLabel": "Q2 Solutions"
       }
      }
     },
     "localname": "Q2SolutionsMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_RoutineclinicaltestingservicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Routine clinical testing services",
        "label": "Routine clinical testing services [Member]",
        "terseLabel": "Routine clinical testing services"
       }
      }
     },
     "localname": "RoutineclinicaltestingservicesMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_ScheduleOfRevenuesByMajorServiceTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Revenues by Major Service",
        "label": "Schedule of Revenues by Major Service [Table Text Block]",
        "terseLabel": "Schedule of Revenues by Major Service"
       }
      }
     },
     "localname": "ScheduleOfRevenuesByMajorServiceTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "label": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt Instrument Fair Value Basis Adjustment Attributable to Hedged Debt"
       }
      }
     },
     "localname": "ScheduleofDebtInstrumentFairValueBasisAdjustmentAttributabletoHedgedDebtTableTextBlock",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Line Items]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestLineItems",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "label": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]",
        "terseLabel": "Schedule of Stockholders' Equity and Redeemable Noncontrolling Interest [Table]"
       }
      }
     },
     "localname": "ScheduleofStockholdersEquityandRedeemableNoncontrollingInterestTable",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dgx_SeniorunsecuredrevolvingcreditfacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior unsecured revolving credit facility [Member]",
        "label": "Senior unsecured revolving credit facility [Member]",
        "terseLabel": "Senior Unsecured Revolving Credit Facility"
       }
      }
     },
     "localname": "SeniorunsecuredrevolvingcreditfacilityMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_StockRepurchaseProgramAdditionalAmountAuthorized": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Repurchase Program, Additional Amount Authorized",
        "label": "Stock Repurchase Program, Additional Amount Authorized",
        "terseLabel": "Additional amount authorized"
       }
      }
     },
     "localname": "StockRepurchaseProgramAdditionalAmountAuthorized",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "label": "Temporary equity, Noncontrolling interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedTerseLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "TemporaryequityNoncontrollinginterestDecreasefromDistributionstoNoncontrollingInterestHolders",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dgx_TotalAmortizingIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Amortizing Intangible Assets [Member]",
        "label": "Total Amortizing Intangible Assets [Member]",
        "terseLabel": "Total Amortizing Intangible Assets"
       }
      }
     },
     "localname": "TotalAmortizingIntangibleAssetsMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dgx_UMassJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "UMass Joint Venture [Member]",
        "label": "UMass Joint Venture [Member]",
        "terseLabel": "UMass Joint Venture"
       }
      }
     },
     "localname": "UMassJointVentureMember",
     "nsuri": "http://questdiagnostics.com/20210331",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r275",
      "r278",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r454",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r178",
      "r260",
      "r262",
      "r399",
      "r453",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r178",
      "r260",
      "r262",
      "r399",
      "r453",
      "r455"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r264",
      "r275",
      "r278",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r454",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r264",
      "r275",
      "r278",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r454",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioForecastMember": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forecast [Member]",
        "terseLabel": "Scenario, Forecast"
       }
      }
     },
     "localname": "ScenarioForecastMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioUnspecifiedDomain": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Domain]",
        "terseLabel": "Scenario [Domain]"
       }
      }
     },
     "localname": "ScenarioUnspecifiedDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementScenarioAxis": {
     "auth_ref": [
      "r225",
      "r276",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Scenario [Axis]",
        "terseLabel": "Scenario [Axis]"
       }
      }
     },
     "localname": "StatementScenarioAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Accounts Payable and Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r104",
      "r380",
      "r420",
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Accounts payable, related parties"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r15",
      "r183",
      "r184"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for credit losses of $29 and $28 as of March 31, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedParties": {
     "auth_ref": [
      "r14",
      "r100",
      "r380",
      "r382",
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.",
        "label": "Accounts Receivable, Related Parties",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "AccountsReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r18",
      "r44",
      "r45",
      "r46",
      "r437",
      "r461",
      "r462"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r43",
      "r46",
      "r47",
      "r108",
      "r109",
      "r110",
      "r318",
      "r457",
      "r458"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r16"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r285",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares to cover employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r279",
      "r280",
      "r289",
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllOtherSegmentsMember": {
     "auth_ref": [
      "r148",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating segments classified as other. Excludes intersegment elimination and reconciling items.",
        "label": "Other Segments [Member]",
        "terseLabel": "All other operating segments"
       }
      }
     },
     "localname": "AllOtherSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r22",
      "r185",
      "r194"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r87",
      "r203",
      "r210"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization expense",
        "verboseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r98",
      "r160",
      "r167",
      "r174",
      "r192",
      "r313",
      "r319",
      "r358",
      "r415",
      "r435"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r39",
      "r98",
      "r192",
      "r313",
      "r319",
      "r358"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r346"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r187",
      "r188",
      "r196",
      "r419"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "verboseLabel": "Available-for-sale debt securities"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r331",
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r274",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r274",
      "r277",
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of interests acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "BUSINESS ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r91",
      "r92",
      "r93"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Accounts payable associated with capital expenditures"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAcquiredFromAcquisition": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).",
        "label": "Cash Acquired from Acquisition",
        "verboseLabel": "Less: Cash acquired"
       }
      }
     },
     "localname": "CashAcquiredFromAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r25",
      "r89"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]",
        "terseLabel": "Cash and Cash Equivalents, Period Increase (Decrease) [Abstract]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r83",
      "r89",
      "r94"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash and cash equivalents and restricted cash, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r83",
      "r359"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.",
        "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months",
        "terseLabel": "Net amount of deferred gains and losses on cash flow hedges that is expected to be reclassified within the next 12 months"
       }
      }
     },
     "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgingMember": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.",
        "label": "Cash Flow Hedging [Member]",
        "terseLabel": "Cash Flow Hedging"
       }
      }
     },
     "localname": "CashFlowHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashFlowSupplementalDisclosuresTextBlock": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Cash Flow, Supplemental Disclosures [Text Block]",
        "terseLabel": "SUPPLEMENTAL CASH FLOW &amp; OTHER DATA"
       }
      }
     },
     "localname": "CashFlowSupplementalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATA"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashSurrenderValueFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of the amount that could be realized under a life insurance contract or contracts owned by the entity, commonly known as corporate-owned life insurance (COLI) or bank-owned life insurance (BOLI).",
        "label": "Cash Surrender Value, Fair Value Disclosure",
        "terseLabel": "Cash surrender value of life insurance policies"
       }
      }
     },
     "localname": "CashSurrenderValueFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1": {
     "auth_ref": [
      "r342"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the increase (decrease) in fair value of the hedged item in a fair value hedge recognized in the income statement.",
        "label": "Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge",
        "terseLabel": "Hedged items (Long-term debt)"
       }
      }
     },
     "localname": "ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r33",
      "r224",
      "r421",
      "r443"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "terseLabel": "Dividends per common share"
       }
      }
     },
     "localname": "CommonStockDividendsPerShareDeclared",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r108",
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r13",
      "r240"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Balance, shares",
        "periodStartLabel": "Balance, shares"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r13"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.01 per share; 600 shares authorized as of both March 31, 2021 and December 31, 2020; 217 shares issued as of both March 31, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r50",
      "r52",
      "r53",
      "r61",
      "r428",
      "r450"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r50",
      "r52",
      "r60",
      "r311",
      "r312",
      "r323",
      "r427",
      "r449"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Comprehensive income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r50",
      "r52",
      "r59",
      "r310",
      "r323",
      "r426",
      "r448"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerAssetCreditLossExpense": {
     "auth_ref": [
      "r195",
      "r249",
      "r259"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for credit losses"
       }
      }
     },
     "localname": "ContractWithCustomerAssetCreditLossExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "General corporate activities"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r67",
      "r98",
      "r192",
      "r358"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Operating costs and expenses and other operating income:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r65"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total operating costs and expenses, net"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "verboseLabel": "Customer-related intangibles"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r31",
      "r102",
      "r241",
      "r242",
      "r243",
      "r244",
      "r369",
      "r370",
      "r372",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer).",
        "label": "Deferred Compensation Liability, Classified, Noncurrent",
        "terseLabel": "Deferred compensation liabilities"
       }
      }
     },
     "localname": "DeferredCompensationLiabilityClassifiedNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r87",
      "r99",
      "r292",
      "r296",
      "r297",
      "r298"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income tax (benefit) provision"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r87",
      "r215"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DepreciationDepletionAndAmortization",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r87",
      "r155"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "totalLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivatives designated as hedging instruments"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "FINANCIAL INSTRUMENTS"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "auth_ref": [
      "r329",
      "r332",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of hedging relationship.",
        "label": "Hedging Relationship [Axis]",
        "terseLabel": "Hedging Relationship [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r324",
      "r325",
      "r326",
      "r329",
      "r330",
      "r335",
      "r337",
      "r339",
      "r341",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "auth_ref": [
      "r96",
      "r105",
      "r324",
      "r325",
      "r329",
      "r330",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.",
        "label": "Derivatives, Policy [Policy Text Block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      }
     },
     "localname": "DerivativesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r274",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DividendsCommonStockCash": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.",
        "label": "Dividends, Common Stock, Cash",
        "negatedLabel": "Dividends declared"
       }
      }
     },
     "localname": "DividendsCommonStockCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DividendsPayableCurrentAndNoncurrent": {
     "auth_ref": [
      "r9",
      "r11",
      "r416",
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.",
        "label": "Dividends Payable",
        "terseLabel": "Dividends payable"
       }
      }
     },
     "localname": "DividendsPayableCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r62",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r121",
      "r123",
      "r129",
      "r130",
      "r131",
      "r135",
      "r136",
      "r429",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "verboseLabel": "Basic(in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings per share attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r62",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r123",
      "r129",
      "r130",
      "r131",
      "r135",
      "r136",
      "r429",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "verboseLabel": "Diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r96",
      "r132",
      "r133"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r132",
      "r133",
      "r134",
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "EARNINGS (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r112",
      "r118",
      "r120",
      "r138",
      "r193",
      "r240",
      "r245",
      "r285",
      "r286",
      "r287",
      "r293",
      "r294",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r457",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvesteeMember": {
     "auth_ref": [
      "r189",
      "r403",
      "r405",
      "r407",
      "r409",
      "r411",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity that issued voting stock held by an investor and that is accounted for under the equity method of accounting by the investor.",
        "label": "Equity Method Investee [Member]",
        "terseLabel": "Equity Method Investee"
       }
      }
     },
     "localname": "EquityMethodInvesteeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOtherThanTemporaryImpairment": {
     "auth_ref": [
      "r190"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents an other than temporary decline in value that has been recognized against an investment accounted for under the equity method of accounting. The excess of the carrying amount over the fair value of the investment represents the amount of the write down which is or was reflected in earnings. The written down value is a new cost basis with the adjusted value of the investment becoming its new carrying value subject to the equity accounting method. Evidence of a loss in value might include, but would not necessarily be limited to, absence of an ability to recover the carrying amount of the investment or inability of the investee to sustain an earnings capacity which would justify the carrying amount of the investment.",
        "label": "Equity Method Investment, Other than Temporary Impairment",
        "terseLabel": "Impairment of equity method investment"
       }
      }
     },
     "localname": "EquityMethodInvestmentOtherThanTemporaryImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentRealizedGainLossOnDisposal": {
     "auth_ref": [
      "r63",
      "r64",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of an equity method investment.",
        "label": "Equity Method Investment, Realized Gain (Loss) on Disposal",
        "terseLabel": "Gain on sale of investment, before tax"
       }
      }
     },
     "localname": "EquityMethodInvestmentRealizedGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r26",
      "r161",
      "r191"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "terseLabel": "Investments in equity method investees"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r346",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r347",
      "r389",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r351",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r346",
      "r347",
      "r348",
      "r349",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "FAIR VALUE MEASUREMENTS"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueHedgingMember": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.",
        "label": "Fair Value Hedging [Member]",
        "terseLabel": "Fair Value Hedging"
       }
      }
     },
     "localname": "FairValueHedgingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r265",
      "r266",
      "r271",
      "r273",
      "r347",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted Prices in Active Markets for Identical Assets / Liabilities, Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r265",
      "r266",
      "r271",
      "r273",
      "r347",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs, Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r347",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Fair Value, Inputs, Level 3",
        "verboseLabel": "Significant Unobservable Inputs, Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value, Measurement Inputs"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r389",
      "r390",
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r351",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Recurring Basis"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfAssetsAcquired": {
     "auth_ref": [
      "r91",
      "r92",
      "r93"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of assets acquired in noncash investing or financing activities.",
        "label": "Fair Value of Assets Acquired",
        "terseLabel": "Fair value of assets acquired"
       }
      }
     },
     "localname": "FairValueOfAssetsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "verboseLabel": "Weighted Average Amortization Period"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedLabel": "Intangible assets, Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r211"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r204",
      "r206",
      "r209",
      "r213",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r204",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r209",
      "r400"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r197",
      "r198",
      "r414"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, Balance at end of period",
        "periodStartLabel": "Goodwill, Balance at beginning of period",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r199"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Goodwill acquired during the period"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillPeriodIncreaseDecrease": {
     "auth_ref": [
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Period Increase (Decrease)",
        "terseLabel": "Adjustments to goodwill"
       }
      }
     },
     "localname": "GoodwillPeriodIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease": {
     "auth_ref": [
      "r338"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cumulative increase (decrease) in fair value of hedged liability in fair value hedge, attributable to hedged risk.",
        "label": "Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)",
        "terseLabel": "Hedge Accounting Basis Adjustment"
       }
      }
     },
     "localname": "HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_HedgingRelationshipDomain": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature or intent of a hedge.",
        "label": "Hedging Relationship [Domain]",
        "terseLabel": "Hedging Relationship [Domain]"
       }
      }
     },
     "localname": "HedgingRelationshipDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeAmountsAttributableToReportingEntityDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Amounts Attributable to Parent, Disclosures [Abstract]",
        "terseLabel": "Amounts attributable to Quest Diagnostics\u2019 common stockholders:"
       }
      }
     },
     "localname": "IncomeAmountsAttributableToReportingEntityDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r103",
      "r160",
      "r166",
      "r170",
      "r173",
      "r176"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes and equity in earnings of equity method investees"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r56",
      "r87",
      "r157",
      "r191",
      "r423",
      "r445"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "terseLabel": "Equity in earnings of equity method investees, net of taxes"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r274",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails",
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r99",
      "r119",
      "r120",
      "r158",
      "r291",
      "r295",
      "r299",
      "r452"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r84",
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.",
        "label": "Increase (Decrease) in Income Taxes Payable",
        "terseLabel": "Income taxes payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net",
        "negatedLabel": "Other assets and liabilities, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingCapitalNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Redeemable Non-controlling Interest [Abstract]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r124",
      "r125",
      "r126",
      "r131"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Stock options and performance share units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r205",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r205",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets Excluding Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Intangible assets, Cost"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r202",
      "r207"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Total intangible assets, Net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestAndDividendIncomeOperating": {
     "auth_ref": [
      "r430"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the total of interest and dividend income, including any amortization and accretion (as applicable) of discounts and premiums, earned from (1) loans and leases whether held-for-sale or held-in-portfolio; (2) investment securities; (3) federal funds sold; (4) securities purchased under agreements to resell; (5) investments in banker's acceptances, commercial paper, or certificates of deposit; (6) dividend income; or (7) other investments not otherwise specified herein.",
        "label": "Interest and Dividend Income, Operating",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InterestAndDividendIncomeOperating",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r55",
      "r154",
      "r368",
      "r371",
      "r432"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "terseLabel": "Interest expense, net",
        "totalLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaid": {
     "auth_ref": [
      "r90"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.",
        "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r38"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "verboseLabel": "Leases:"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letter of Credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding, amount"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r21",
      "r98",
      "r192",
      "r358",
      "r418",
      "r440"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and Stockholders' Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAssumed1": {
     "auth_ref": [
      "r91",
      "r92",
      "r93"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails": {
       "order": 2.0,
       "parentTag": "dgx_FairValueOfNetAssetsAcquired",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fair value of liabilities assumed in noncash investing or financing activities.",
        "label": "Liabilities Assumed",
        "negatedTerseLabel": "Fair value of liabilities assumed"
       }
      }
     },
     "localname": "LiabilitiesAssumed1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r30",
      "r98",
      "r192",
      "r314",
      "r319",
      "r320",
      "r358"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Credit facility capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r28"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Remaining borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LitigationReserve": {
     "auth_ref": [
      "r33",
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying amount of the estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs.",
        "label": "Estimated Litigation Liability",
        "terseLabel": "Litigation reserves"
       }
      }
     },
     "localname": "LitigationReserve",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "auth_ref": [
      "r10"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.",
        "label": "Long-term Debt and Lease Obligation",
        "verboseLabel": "Long-term debt"
       }
      }
     },
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.",
        "label": "Long-term Debt [Member]",
        "terseLabel": "Long-term Debt"
       }
      }
     },
     "localname": "LongTermDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSBalanceSheetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r31",
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r224",
      "r225",
      "r226",
      "r228",
      "r229",
      "r230",
      "r231",
      "r233",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of pending claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Pending Claims, Number",
        "terseLabel": "Class action lawsuits"
       }
      }
     },
     "localname": "LossContingencyPendingClaimsNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MalpracticeLossContingencyAccrualUndiscounted": {
     "auth_ref": [
      "r224"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the accrued liability on an undiscounted basis for malpractice claims (including general and professional liability) at the end of the accounting period.",
        "label": "Malpractice Loss Contingency, Accrual, Undiscounted",
        "terseLabel": "Self-insurance reserves"
       }
      }
     },
     "localname": "MalpracticeLossContingencyAccrualUndiscounted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r37",
      "r98",
      "r192",
      "r358",
      "r417",
      "r439"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Noncontrolling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest balance from payment of dividends or other distributions by the non-wholly owned subsidiary or partially owned entity, included in the consolidation of the parent entity, to the noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.",
        "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners",
        "terseLabel": "Ownership percentage by noncontrolling owners"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSNarrativeDetails",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r139",
      "r147"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r83",
      "r85",
      "r88"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r48",
      "r51",
      "r57",
      "r88",
      "r98",
      "r111",
      "r113",
      "r114",
      "r115",
      "r116",
      "r119",
      "r120",
      "r127",
      "r160",
      "r166",
      "r170",
      "r173",
      "r176",
      "r192",
      "r358",
      "r424",
      "r446"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income attributable to Quest Diagnostics",
        "totalLabel": "Net income attributable to Quest Diagnostics"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r48",
      "r51",
      "r119",
      "r120",
      "r316",
      "r322"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Less: Net income attributable to noncontrolling interests"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r122",
      "r128",
      "r131"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Earnings available to Quest Diagnostics\u2019 common stockholders \u2013 basic and diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Standards to be Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r245",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling Interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Non-operating expense, net",
        "totalLabel": "Total non-operating expense, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r160",
      "r166",
      "r170",
      "r173",
      "r176"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating income",
        "verboseLabel": "Total operating income"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r374"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r373"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r41",
      "r42",
      "r44"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Net change in available-for-sale debt securities, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r49",
      "r52",
      "r54",
      "r58",
      "r240",
      "r360",
      "r365",
      "r366",
      "r425",
      "r447"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Other comprehensive loss",
        "verboseLabel": "Other comprehensive loss, net of taxes"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive loss:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "verboseLabel": "Other Nonoperating Income (Expense)"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingIncomeExpenseNet": {
     "auth_ref": [],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations.",
        "label": "Other Operating Income (Expense), Net",
        "negatedTerseLabel": "Other operating expense, net"
       }
      }
     },
     "localname": "OtherOperatingIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted": {
     "auth_ref": [
      "r128"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of earnings (loss) distributed and earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Participating Securities, Distributed and Undistributed Earnings (Loss), Diluted",
        "terseLabel": "Less: Earnings allocated to participating securities"
       }
      }
     },
     "localname": "ParticipatingSecuritiesDistributedAndUndistributedEarningsLossDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r72",
      "r75",
      "r106"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedLabel": "Increase in investments and other assets"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Purchases of treasury stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "negatedLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsMinorityInterest": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends provided by the non-wholly owned subsidiary to noncontrolling interests.",
        "label": "Payments of Ordinary Dividends, Noncontrolling Interest",
        "negatedLabel": "Distributions to noncontrolling interest partners"
       }
      }
     },
     "localname": "PaymentsOfDividendsMinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Employee payroll tax withholdings on stock issued under stock-based compensation plans"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedLabel": "Business acquisitions, net of cash acquired",
        "terseLabel": "Business acquisitions, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r23",
      "r24"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDividendsReceived": {
     "auth_ref": [
      "r81"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends received on equity and other investments during the current period.",
        "label": "Proceeds from Dividends Received",
        "terseLabel": "Dividends received"
       }
      }
     },
     "localname": "ProceedsFromDividendsReceived",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r77",
      "r80",
      "r106"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Other financing activities, net"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r76",
      "r284"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r1",
      "r48",
      "r51",
      "r82",
      "r98",
      "r111",
      "r119",
      "r120",
      "r160",
      "r166",
      "r170",
      "r173",
      "r176",
      "r192",
      "r310",
      "r315",
      "r317",
      "r322",
      "r323",
      "r358",
      "r433"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      },
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r7",
      "r8",
      "r216",
      "r442"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Carrying Amount",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityFairValue": {
     "auth_ref": [
      "r236",
      "r237",
      "r238",
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate fair value as of the reporting date of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Fair Value",
        "terseLabel": "Redeemable noncontrolling interest"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r272",
      "r379",
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the sum of all other revenue and income realized from sales and other transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party during the period.",
        "label": "Related Party Transaction, Other Revenues from Transactions with Related Party",
        "terseLabel": "Income from related party recognized"
       }
      }
     },
     "localname": "RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r272",
      "r379",
      "r382",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r377",
      "r378",
      "r380",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "negatedTerseLabel": "Repayments of debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r17",
      "r245",
      "r288",
      "r438",
      "r460",
      "r462"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r112",
      "r118",
      "r120",
      "r193",
      "r285",
      "r286",
      "r287",
      "r293",
      "r294",
      "r457",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r151",
      "r152",
      "r165",
      "r171",
      "r172",
      "r178",
      "r179",
      "r181",
      "r258",
      "r260",
      "r399"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Net revenues",
        "verboseLabel": "Total net revenues"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r261",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "REVENUE RECOGITION AND ALLOWANCE FOR CREDIT LOSSES"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r66",
      "r463"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "verboseLabel": "Revolving Credit Facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r375",
      "r376"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Leased assets obtained in exchange for new operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r301",
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.",
        "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]",
        "terseLabel": "Supplemental Cash Flow and Other Data"
       }
      }
     },
     "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUPPLEMENTALCASHFLOWOTHERDATATables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/EARNINGSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for fair value hedging instruments of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.",
        "label": "Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block]",
        "terseLabel": "Schedule of Fair Value Hedge Accounting on the Statement of Operations"
       }
      }
     },
     "localname": "ScheduleOfFairValueHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FINANCIALINSTRUMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Changes in Goodwill, Net"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r101",
      "r381",
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r160",
      "r163",
      "r169",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r160",
      "r163",
      "r169",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Summary of Segment Reporting Information by Segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense Intangible Assets"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets.",
        "label": "Secured Debt [Member]",
        "terseLabel": "Secured Receivables Credit Facility"
       }
      }
     },
     "localname": "SecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r148",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r160",
      "r164",
      "r170",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r180",
      "r181",
      "r182"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/RELATEDPARTIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r148",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r165",
      "r166",
      "r167",
      "r168",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r176",
      "r181",
      "r200",
      "r218",
      "r219",
      "r220",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/BUSINESSSEGMENTINFORMATIONDetails",
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r36",
      "r108",
      "r109",
      "r110",
      "r112",
      "r118",
      "r120",
      "r138",
      "r193",
      "r240",
      "r245",
      "r285",
      "r286",
      "r287",
      "r293",
      "r294",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r457",
      "r458",
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r108",
      "r109",
      "r110",
      "r138",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r12",
      "r13",
      "r240",
      "r245",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options, shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesTreasuryStockReissued": {
     "auth_ref": [
      "r13",
      "r240",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of treasury shares or units reissued. Excludes reissuance of shares or units in treasury for award under share-based payment arrangement.",
        "label": "Stock Issued During Period, Shares, Treasury Stock Reissued",
        "terseLabel": "Reissuance of shares for employee benefit plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesTreasuryStockReissued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r12",
      "r13",
      "r245",
      "r281",
      "r283"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Issuance of common stock under benefit plans"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r36",
      "r240",
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Share repurchase authorization remaining available"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r13",
      "r19",
      "r20",
      "r98",
      "r186",
      "r192",
      "r358"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total Quest Diagnostics stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' Equity Attributable to Parent [Abstract]",
        "verboseLabel": "Quest Diagnostics stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r98",
      "r108",
      "r109",
      "r110",
      "r112",
      "r118",
      "r192",
      "r193",
      "r245",
      "r285",
      "r286",
      "r287",
      "r293",
      "r294",
      "r308",
      "r309",
      "r321",
      "r358",
      "r360",
      "r361",
      "r366",
      "r458",
      "r459"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Balance, value",
        "periodStartLabel": "Balance, value",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' equity:"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r97",
      "r245",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS\u2019 EQUITY AND REDEEMABLE NONCONTROLLING INTEREST"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTEREST"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/REVENUERECOGNITIONANDALLOWANCEFORCREDITLOSSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r367",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r367",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r367",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r367",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://questdiagnostics.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r385",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENTS"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUBSEQUENTEVENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental Cash Flow Elements [Abstract]"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r34",
      "r98",
      "r192",
      "r358"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "periodEndLabel": "Balance, Value",
        "periodStartLabel": "Balance, Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityNetIncome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of net income or loss attributable to temporary equity interest.",
        "label": "Temporary Equity, Net Income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "TemporaryEquityNetIncome",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "verboseLabel": "Intangible Assets Not Subject to Amortization - Tradenames"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradingSecurities": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading) and investment in equity security measured at fair value with change in fair value recognized in net income (FV-NI).",
        "label": "Debt Securities, Trading, and Equity Securities, FV-NI",
        "terseLabel": "Trading securities"
       }
      }
     },
     "localname": "TradingSecurities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/FAIRVALUEMEASUREMENTSRecognizedAssetsandLiabilitiesatFairValueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r35",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock, at Cost"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r35",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r13",
      "r240",
      "r245"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "negatedTerseLabel": "Purchases of treasury stock, shares",
        "terseLabel": "Purchases of treasury stock- shares"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r35",
      "r246",
      "r247"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedLabel": "Treasury stock, at cost; 86 and 84 shares as of March 31, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "auth_ref": [
      "r240",
      "r245",
      "r246"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "negatedLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock, value"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://questdiagnostics.com/role/STOCKHOLDERSEQUITYANDREDEEMABLENONCONTROLLINGINTERESTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnclassifiedIndefinitelivedIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Costs of contractual or legal rights meeting the criteria for capitalization as intangible assets apart from goodwill, which have indefinite life and that are not otherwise specified in the taxonomy.",
        "label": "Unclassified Indefinite-lived Intangible Assets [Member]",
        "terseLabel": "Intangible Assets Not Subject to Amortization - Other"
       }
      }
     },
     "localname": "UnclassifiedIndefinitelivedIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnpatentedTechnologyMember": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Technology-based innovations or scientific advances that have not been patented.",
        "label": "Unpatented Technology [Member]",
        "terseLabel": "Technology"
       }
      }
     },
     "localname": "UnpatentedTechnologyMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/GOODWILLANDINTANGIBLEASSETSSchedulesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r140",
      "r141",
      "r142",
      "r143",
      "r144",
      "r145",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use Of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r122",
      "r131"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in Shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r121",
      "r131"
     ],
     "calculation": {
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in Shares)",
        "verboseLabel": "Weighted average common shares outstanding - basic"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://questdiagnostics.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://questdiagnostics.com/role/EARNINGSPERSHAREDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 5
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(n))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=117311354&loc=d3e32014-111567"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=121548190&loc=d3e32787-111569"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130551-203045"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130554-203045"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130558-203045"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130550-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(f)(3)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(i)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)(ii)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4EE",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109999712-113959"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41675-113959"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121549185&loc=d3e80748-113994"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.4)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.1-5)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(5))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r464": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r465": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r466": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r467": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r468": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r469": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3337-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "230",
   "URI": "http://asc.fasb.org/topic&trid=2134446"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>63
<FILENAME>0001022079-21-000070-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001022079-21-000070-xbrl.zip
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M3PSF"@?/4VZ/*[U-"HN@5+($)TEDF=08T&(8W[0^Q;#=A?4X;+EV7!\,XG
MR,<>]_H;;; UUTHO1H-A#XBY&]O%X5#9."UE>RWGA"$V@@8C0&@:K> 4@"U.
M@O*HG"U!^&R!Z?LP>SY#D$ISGF2P7(1HB:;>.\N$XY(EN_AJM"0DFV5?8P=4
M"\E%Q[GSWGH@EL_MS[PB1I<*%?X([8J\=.<D#N/Z83^.O<=EU*9"$2P#J,U@
M U<B&("'*>1.2H:ZD,J0#EU<\CZ(,DV8"V^,P<%BSH2PUJ6@20 X*B(G84F5
MZ:-3;(;-K3&/T1B7HI&<&@H4\T$FXI1E1(:EAZ;ONR<V'S(:0S/ZHVZOW3L\
M6T9=JD/ V@IIC0E<.VYEC"126S11\)-:XHJ\"Z1+*0<2)0$K*33(*-6.*"M4
M5 DSPE()3F\H!\5FF :CQC+LHR.)<YEHUJ$*/K),8I-"6'9=6A0=7[]]&94I
M91P3H2W31O/<#)WG/IX6H _\+S*_I,KTD>C[,,A46_#R=<XQZMRNP7*>R8=#
ME%H94H:ZE'*0;';J-!!!A,( 3%WB@%.<R#L,&5&)!<L"759UFJ/?S=[0MM<[
MO?ZP]65<>[[T2M4YZ1@GC"H*2M4[;:3RRE)A4^#@H"R94IT+E1]$M?( SH0*
M$HRAY=FG8$ FH8PD(6)/2Y"(*A7A9J=@18HAY7/Z).4<2VLIH%3IK-;<,^KU
MXDO<=C?$]"-VL=FW(39L)Y9%R+0"N&F8RH=+<LQR?9UV!B?'3;""Z,47LD6G
MU0R/1<6@"@W15N/$1?+.6"PCR^Z[E"*5P)+],*W>=WW^,+\^7#RD?=-#2B)X
M2E*%N0(?3PJ>O +GGG@GL9#<$/#UEUCP%H68LY1,XG*VD*9\.!+3CG+, ;S(
M?.JYX6GQB;D)D_UDA\6&[L&P/RIR#:]MJ_NF-P!2_AG#(0"2RUG=:WE?.SAZ
MU>Y]GMQ8$KIA Z D'S$L)>-* ,XTDL4H4D8M@I6@MWF9Z#9#U$*9)<K3D CA
M*1\EB$T@C DEG;>F!%F'GZ7;1:WGG0AWYW&]M&W;]7'O*,;AFYZW%\5STSO>
M]+J'S=CO;$97EO[KFN1>'=118C1/U-CH>$R2):^54JD$9XE7[/*(5H%3)6T,
MA"BPXXY+G5N%* _FP5 9:9GJ@,;=6<[[4MQ,HB*8V^AU>[!&<#G''?*WMDY/
MX'%+>=*A(#A0(356(7(LD@G*,FPE=8QY'%B)NLTM/H7GTGX.2\8X$#E*H;DF
M0</OB8D4-* %*6V)9'A1=?_B<]Y<=(LW-!^9ZFDT)J,,)PS U1Q,,SBR:$JD
M6RK.*Y7.\R2(0+ +UH$WB[T)V$1C$WSDI'1NPGE\RGF2X07<\<3OOFX2,3R#
M=9,F!\&=R&:"N^ LT]%; 1YF\-+RZ4XQ-5TWLY#KINZ^;F8VZT:35IA9P3 X
MX%'D<V>Y<3Z**)3AGHS7C>"%WF%'\*/OL!,A]\)@T?N(.97:!&(9(%$+Z"01
M8B;8A#TB-OD!R\H>W;(F(@UW1"BK(H]8V."24U0&R:P)R4W6C4[7C5*]@.M&
M[[YN%%$]BW6SN6^L\"&:Q*4E\!-')ZQ21H@@2I"/S4&$X22(T#P[B5<M_5[N
M<!##'2(,=W[A!CRO-7QE?:L-ZW MHA&',):=-+ZG)"$P'[77H*H=B X'S>)$
MP#3GH!S 5":?$ \L"D6"<:#/+/'<19Y8WB&! W9&<LLY9B7HJ3<S(9D1#^S&
M3[WV)T#Z5P=6$GY@%E"Z!Y241,[N6Q<"$QXG %C9DPR+SP\W4R?7->W%;JO7
M'X'?54AI?THH7Q J+3RASGO"^+9M=;YJ"9.G6%R9?OW.'6%<\/E<6&6!K-RG
MK*0CL81H CZ)/F]0A!<" 5X-MN,9!=NM=MH2)@&2< $:$0-2B32RE!3 %+;X
M;'^I \N;EG4%*U^KZ]LZ]>U1B(/#V(W]G#())_U>BH-!<3A!>_JM@H?*4L!B
MP%$F!"OFP/MCW&G@6&<M"4$0Q6@)DFJE(MSLTEO416P")LD'R;G!.O"DG'?6
M4$.92B4(4.9V5+NV>S@Q,?G/>JO;ZHPZLT(:Y\'%:3.9O?'@+O'&9LL>=GN#
M8<MO=U.OWREBD'NQ_PG ]F#ZM66,,VJ<&\Q8Q1*5'*CJ)  528WVP@LE60ER
M*Q4#S3-%8GTTBCAP/2D'U..TQH)$1?(I?9X25P(&JLA\!X]&)N&TI)8FR1DV
M^=0^D8@+6H.7HWD)#$W)R#P?<Y!X,")@(7S>OXIMS.?G"L<(L]R?A[.70)K/
M#T1JMXOLXO3J,@IO/NO84<4=RZW_+,^G\3CFL4\,,V_)\@COG*@Z%UEEN9FV
M%5A$97DDT@;.J&)*$<NI\65JRW)'JF[T^B>YO>-2UIHHH86D,0G+,I**FKD@
MC0=D+KB,."Z?D#X6.>=S"*Z)DB:2#.!CGL^?)SY0*Z@.0;.8? FD,WM2;_N]
M,/+#G?X$_5Q@I-W>: C$]9/.J\,XR(4Y@PE(6D8)I<(:G2S#,@9.'#5241&8
ML,302/CU+L0521=?2JE.Q@B3J,Z=/US2@4L!MC20H+A,92@/_S9)-W;^WMXD
MICDFY=X22R<@6:8 W5)G'6>"Z>BBYSXPQX3TJ0P@=P%).9^";Q<2>"@NJ40Y
MM<Q%X6(PU"OJA?)EB"E]FY2O8S<Z.XC!=D,<](:YA_D3,*">!QXLDP0L*#?@
MA]+@@7J"J)!5L"V]B,Z?KG.15TF2-18'2:4$^YDTSSMO .]J(@QWO/3RNMZU
MPUZGY4_L\*CH-O@$A-69*$1*WDA,.=/.&?!A0$Q#5."=$E=Z89TS4><BJ41A
M[P$DJ< U#Y$['*4.N3R%&6\-+K^DMMN]'/A;9LG$4:7@M+78*0YJ%GP8&BB@
M)<N%T<:77S(?EXASD43A@Q.Y6I=3PCTC3H*^C3@1GLMN5)DR+<6FL1C>PK*=
M-?NV.["^V$/V\NSRE:NQOZU_1T65(*C>L-W]!)HW+F54UWI"$HAE) $#I96V
M20@N@O,))!7C$LAJR<@\GUP,YRHD!PZ-XUS 3^D)U=X%%C!1R2U^Y>/B4O=A
M>OT"C+6*$T.HY#I0RU0^9\LZ,*J2LA+T^BT%P6;8Z3=QGK3 3'G*,<!710@)
MPCDAA-9*E<A>WFG+\UYLM\$9>3TN5EWOAO70:75;@V&_V,0]V?K\/6BT!-PT
M?QN.HW!,.!4MCQPXSW#X3W!4)E*XQB6RX17KE0M7$$6,E9RQI"/'U.;F]#$1
MFF1,,9@2'&_U_:Y2;_OQQ+;"E*V WXK2G8U1OP^ONE/OR"7@M0=!.<[17(_K
ME:*!&QMLHM1*Q;BTR=-8@K;;%?O,LWF:H)$ZJ7)'3<ZL<4Q2@WT2EEI+8JDJ
MS$9N\%69[Y_1MH='WO9S3YQ1/_9_FE&^'==Z%6/J3:-:U>:$1T@X!M!M07M)
M=>(R"G#O:.02AWR(:XIEJ-BI&'A!&'@^583@WZ:H>+#Y^&&2C"111Q*H<\IP
M)RH-?,\:&GO2RNP6GACSSD7[\EP5J:,3$8/2%<89K,"7\=KF=KVX#'FJBGD7
M@'GG4]-BJ<8Z1B(PYHH:XUG,/?B2,M;I2O.6GJOF$TJ40&%KA2<$\TBC40Q^
M<)(X]: 3R[!?O^*JA=-5(8(_DW)>Q$4>O'78*0E>3R)"&U!79==5KWN?8K^;
M/WQKSYX>3\VG_,^;$ VU6@)XPQ88B6I*"0E$<N5DZ375$^>I^30UUHHS[;70
MH*N2$<XGXRR1$A 5<9,MCB764QOMUE/EI[GHJ*BY,,*8Y(3GN9S.8ZF2"M1Q
M(F@09==13YB?YN/S:8+S]GF:.WD&+ SG))].Y9*(Q(DRG29](S^]!4K&[W=#
M6#9>FD_P"YA)))VD!UY2(A>8Y<W?/D5P 96F9==-3Y27YE-=BAVX= Q0MZ.@
MD4 O@=G3!D>12)2D]+AI<V]*O=E5%2UFHYBYJ** @7-L3)X$GEM1:"."55)P
M%17#H@P[HROVF:/VB30QC7,<W' OL0U!&B5!'_G<Z;P$-6A5J')*B8<H,@-/
MGDL9K$XF<2N!(RASSD< T#S%P!:_R*SBCZ_Y8X8]BCVA,GOD"1-NB'21.B.2
MI29W=Z"\I/KCZ040'T1[2*.-=AP\[R X#DE30D!Y<!^"$%2$DFJ/)\T=L],=
MA"K/DK6,.L6I"L89$ZT06D6B9"C!H>Y58.^!S@'GA'G!0&,4L=_DL,)2RYRU
M$E[$LJ*.)\L9L],9^=0E%QQG+.<!0C!8$^>L=)1YI[ MJ<YX.@&W!]$7-CA&
M/,4X"LR5 =AAB<(N$&MI"H&75%\\2:Z8G:[P6(>8(I&@#[@@40.+>&8H-0YK
M@WT)=$49"#8[,<;.$_ +J++6<*ZBE4PG(); R1$^:;2PV&)<!H+-$L%319.3
M)A#P[P30*N]"S.$ $AQ<*8&$/;F8\X-(KC"6L.CS*5616^6T)Y3G8ZIH #LL
MRPK8GPHCS$XC,..U$H8E91C7//?K35(HD6QTE+IIKQR.%Y81KG51N+Q'N>B6
M$%K#XDRYS=; MWLY>#QX>09_G/0&MOVZWQN=#. 1[5%H=0_S/; ZK>XHAAU8
MQ4+77^*O=W2OUQX5'\Z,O3(?_SN"D6]]@A\W',![]8:'5C#\4DKK9[ <)R2J
M:'('4AZPMUA%FKS"(7G#\?0H,S[-DDN&%XW!\OZ?<[;:\[%K8?87QYI-/WG5
MZT=O!]\C3,GY>0:Y=G[W7+M$#-\W6?J\=?H"UJ(WZ@,N&_]Y%&TH!A]:G]9^
MAQ^3')FVW N25)2&*TL<"Q0G3BT15&,O_LFZ[N([@^%9&YBNT^JBH]@Z/!J^
M8/)D^-OG5A@>O2 8_^^5XKZUWP<GMCN]V_?:O?Z+_P!'XI1^2S!(E&RGU3Y[
M\7^:0/-!K1$_UW9['=O]/\\&MCM  YC6Y,9!ZTN$!\,[BC\_CU_*,?ZM#09H
M.@A"\?_^+4\=A>A[8]*^&'5APODN&)-=F+'4COHQ_;'RG^^OO%I9:UK7CK5>
MJFUDRH(EK?W^W (]\NI.R?(U<6S_$.CC>L-AK_-"P' GGPQ[)\6?Q>!LNW78
M?0%R.XQ]6*!A\:;)$URO#\-%L%9M>S*(+Z:__!9 M-KV#)1A,>/B2[]]BOUA
M/I5A\DAXRX0?#%_5DF26& +C#</T\1-N62VXY?DP?'W-Z%6#;[^,5\GYM>?%
ML\?/AW'FE?ECA:U,OW!B0Q;^%_3DM$9NFOOUX8^7;>56#@9J_PC7\&M<HZYS
M33'=]XWMYM9F;:^YWMS:.R?STDUS;VOC_>YV<WMKK[;>V*QM_<_&G^N-UUNU
MC9UZ?7MO;WNG4<:YTSO-_</ZWI_;C=?-G<:SVN9&C6+!S4VSG8YK^F40W)7;
M5F BKUF^80%J@UZ[%6K3J4R7!^?%N2(USPOYO4&#W*0@9KM6^GMK1?-:O=K9
MK==^!^/5[74;HTYN6E^;V+C=K$1;.K@8>-0D!L*-9(Z#XXX%)43$J VYJ?ZP
MUK49-X78>K'9\Z/.!&BN3$K2V-]G;K/WZ0W=_;3/ZJ-PO/7IX+4YWCE^Q_>;
MN\>-YJM.@[ZG.\UW;+_YJE6G[\[JK_=QO;-UVFAN\_KK.GG#&NW]+SV\\WH+
M[W]Y?WIP'-J-XX^X0;=.]X\;'^O'+SN-S;^.ZLWW9SN;+X\;?^O3-_3@;/^#
MEP>=5_".QL>#SKO3QG&=-EZ_:NW35\?USO;GQI=ULO/A[^-Z\^CCP8?WG\+K
MOWGX\Z_V 6U_<L<GG?T/=5*GNYV#S2U:_[*/]S_\=0R?G>T?K[/ZYGMQ\*%^
MNO-ZMWT []MI;M-_<.ZLS6) "GN'N(L..6<Y2D)Z8J1,ELB5-8+1NP)"7%!A
MK7;5!MV!=]9^=_WG:[=^[:K1TE>-EBX8=[8<>-V,W\R!O]1M_V-MIQM_O7W&
MWQOZC?;VCI-9[[=LN_:^V_*]$&OUO;OJW9M ";QUUJ(TC@'"MV&"X'V 9NVU
MG<U-LEWO]"9)>S<"K M(Z&PWGO3ZPZ<G=.P?J:5REDDDK;>(2Z.04Y0C*ZFU
M6@FBJ%Y9^^__&,7E;]?E;LJ$=V2?#Z#XL_(?_ R87;F0]GF(X+OWZ[O-K=TW
M^[7=K;<[N\W:V_>[>^_7&\U:<Z<&2*()<*%&6&UGMT;$+^'7VLZK6O//K=HE
MD'$.,-8WFODR,8S?6X$]]KS!EZX-CV+MWZG(U,;>7@V<P!AF;Q8OR?*+D!UN
M>.)1L&=GT?9C]R9A?EN,9VOLDSXM468P'MIH'I[6OWR$>P_%/UJZI(DC2"2B
M$3<1(Q>,0538I!RC22BZL@;FQ!_5&'E6RPO_D](]0X=U9?86?5'D:*=?6>X9
M6.ZBJV01;GNJIIO_ \L:% X144T3F&X!>%EH@1)/)E)C(LF1V\)T\P<WW=?=
MS04TW<W=]<;>=F&@GZ;M'IX+S=1XIWZO4SO_S["WK%IWH]?IM 8YFE]+K7:L
M=4=%C/\!G?FM(OS^"E[6*-[U]!24^"=%2IE3#JD /SC' =G(P+=(20GK\R'>
M/J>&""*4$E'ACY^9&/UNL/-A3/=UEM^-AT4+_.ZP 5>>'-O7/_\3A5&!1(9<
MRBZU 0"N-<;(.Y=X=!9;*\"1',7!L'91PC2H;7?]=1&8GOP>[@@:YYA>$<2L
M8CP."]^<7[F(]WYU$8M5*KYQ_9M?_M9%2A[HP5I,9SOC!PO]0 ]F\J'6&-]C
MD>^<3S +EU'Y+M3 C^(;#7+]P4F_]REKWJNAD+$&SF4*8[V1RR'SW1N]47?8
M/]L WZ^4"OE5R[U^+_>;C4[]PS:M=_998_,(GEUG^3L[F^\_[W^!67RIBX/-
M_<\'S>W)=_Z&=XGN0?/DJ$[W84S[9P?''L8+\_@2LA+GC2:,Z]A_J7]I?VP<
MOVS7V_KSF^;ZL+Z'3^'??W@T@FG'D+)1(IY40II[B4)@7LB@,6=F96TSMNUG
MVX^W(9BI6'PC77@E'S:S6Y^HR%R7B*8]W9Z4&XV/QB@Q)G]L67A_+@MY9U $
M\(* %@SQ2!DR5F"$J35&. <B 7">2$285EK2;TK#8]@! "</SM%?N0\%1_]2
MJ-U<*G-%&?]:'H4PQ[7;7MU=W5NM;75.VKTS\-*OBFYM++N_+B4WS4D_KH?0
MCX/!Y)\W, !2Z<;OZ<:SRSA!,45#DA+)$ 3BGBJDK0/O#Q2A#SZFX,C*FL"X
M]K9MO]C:9K_U:?'@PM=%.5_+E/Y&Y<\W9*J?O_WT1&H#?MWI-WN?NY5 ?4^@
MOEP6**D%2(L'=,$)"%3,P%LD@;3C"23*8._DRMI>]';D1X-G/R%*E0$XY]8"
MM>STWX)SV>KZRE>\"\MN7; L%SPE&I%.-J)\?!:R6'+DA><&,X,=YRMKC;]F
MRZOMF)Z@7GW;&PQM^Z!U4L4T[LBGVQ=8)<#*,^#3I%@N^1("6:L9\L0F^(5C
M*H!/L<*&EQ*A\!DBE&6-BV1<LMZ/MA*?NX@/OH),A/&4&(X8=@QQ[CTR/%KX
MTR=!39(NIW=^,8K]>F?QD3^JZ9>5/_,9MNVW1[UNF=/GC\VC%U!$L*0)U@8E
MBC7B-B9DB4G(,Y\S[\+B7!HD*$842%L"+?_5YI#YE 6 OS'JMX8M>&*_R'/'
M?@RUDU%_,++=86W8J\$=192*T%_<KSD F MOUOWPQ>)G<+5>Q4+\R 8YAE<Y
M%W?:('>?QU*Y*C"=^6.9656"S6([WV3ALV*^8:O3G?9!+5J&YN:8;+,U'._\
MC-8?U7S;#@9W4!)/9WGZ-H^VMG?6<;WV+X.[Q/GOM#C]\4N6>>URE= Y9\53
M?V2[A_!!M_;YJ 6?7*C9^VS"G*S/1*?>NG[+SYD/"-$FMO",4%>HAQ)#M,:'
M@Z/]+^NT<;S;/F@>? 2(1AN;[8_U#_G[?\&[#S[6-_^&Y[Z[!M%Z)+^OOKD/
M]_W=;G3>X5PBMO/AW>E^+A7KO*?PV>?&ASIIO-*G5]P(Y0&'V8122AQQ<!V0
M]2DARJEU(6JGK1H7KH(L[ U[_N.SVG_A54QJ;VV_]K=MCWXD?U )QL,+QL0:
MC(U!)15WD(H+QR6I$*C5#@42%.+**J2-]D@G(72R+G'#5M8V7__/O'C_"5CD
M!Z]@RU;^Z^*UJ3W9FF" TI8//[;T7$1VL<EM.35#V"<'-D4+I*.R*)] 0B0G
ME.L(B O89+_7_SBV*K7I>G^_7.?6#@USWRY_L[>^W0VY:"36W%G-'T68:R?O
MG_]\%',[N,(S[Y]7J[^H_4)^K1W90;%#)-1LNPU7\]ZR[.O_.VIE3Q\<?!<G
M-\!#SYU]5NOU)WN&)B[_I4C!=(%S&"!?SGN&:@&N@L>0;SWI1Q\+_X'06K'/
M=5#[!9X'8E,;C  ##XYZ><_M=-/.\,@.KPV^]ME>'66QRZ7X\F0.OSZKV6ZH
M_4+'<W0@?'#='<,,\OW%K?"E/(K)<XI>><4@BD':P;!F<"W8L\'JPV^<V1CU
M^_#^\>:^;$R'=C@:E%(=_-1N@M-_.#4L:*V1,=R"3.=07C0&J>@9+*KWE.F5
MM?TXN+4IQHRWB-YMI]]YQX E[A!P\\L;O058>?[;#V\S+H.R+G08J*].:S@$
MA1?;H,;ZO6Y&4.VS6@0T=5;;SL#*@H+^%&N;=FAK>3/>=55^\8S+0=S=$=S)
ML<C:>C<>CMKCRL,]U*S]\M__(5+]1AE=G=PP/&H-8,3V!%[WZT/K]?%XS]5U
M'/SZ",KXTDKFA9SHYJ>GC,_^P5HQ9E) C@&V M7,D28,_K0)6\6-Q=PMC3*>
M[8;*2BT^@EH$361K;1AWK%GO02T6FP<+3='/ /#&3VO I^C&"X,.Z%-X2W\*
MPT"Y=& 1SIYEO N/ Y"8U^BP=MCO?1X>32^O OR-Q=A"3*UNL>5\D'7E?_]'
M4PK3O&6$Q67RV_2V[]YP^_BF-V;,NW++*$&!=<>JGE"'Z!2Y7X;KJR7(VIE5
M(N6/9.TX737Z;FTM[Y6U6U6&S_RI7*QR=;>DW;T>N\IFDPI<S+J->05X"MA0
MB&S678>]_ME-&Q4S(.MO3&XH)9P8AWIV7M=%_;C=:7SQGP^.MT5C<[<%SVG5
MOQR>';S^JU.G[T7]RT'KH'EX/=3#][]\/-OYL,\:7UYVZGF,</_^A^TO.YM_
M?=SO['\Y:'[\TNC\U=YY=75CHG+>,BP5"EAJQ!V)R%KX09G V$I%;8PK:V]N
M5K0+5RT],U./;X [LZNKG:O4KG]-Q>6C&O_MQ_9UP93!MH]_IXM<-GU+$OPF
M!/8$Z%N::O>;I[1W&_Y\"-+=5_G,EGKS:_DVQ@K%4D_/>:FPPO>P F"$^D5:
MR#-N1."(,P=8P;.$M#(2!9=4#,EKP^1W&\7]:#?PV6Q27BRYW[K9H;Q+#MKZ
MC_"E43>@R6!3\9^'3Q$OESJ84N!U08"-<X>^4@O?5 MGE]5")$)YHCF*-II<
M@<00D"XASZ4PQ&#LO;B'6BA==CA](X+UK-:Z.?#62C>E(HH$!."V;J_('XP&
MX^@7B,2X/?(-G1=[_>)=[;/\\L\M>#6\MM:%N?4RH/C4&A0XL&N[/@LNH,/<
MQ"??G$]^"K8?!K7<!:@5;JM 9[_87V\,:M6J2.SC1&('1['=GK)4[1=@E"(>
M"@3[;N3QU]7:?AS,EU#S5O)[>?G*K-M_*MOTY1_'2%#14.2P"X@'0I'!22!!
MB(W8>&-]F%6#WR5,]LC2J9CU(DFR?M)OM7.:&?]&Q+@U^[.L'_JQ]CG_Z(V&
MA0G(MF BHJ^*]"PH_5&W-1;0P9'M1W"4K@BMX5@KCZW0GO*@B/4X2I4P9S9Y
M0Z9'OG,B5D!3^1;X7(,_5K8;KZ[VX^^..J$WG-QP0^U.4;-<%)?M%:/8N1@P
M && L' [?FH"O;G/_A'1&A=)0#A2A3C%%EG*/%+&R*28PE[G$VX8?B:9?D:P
MF0KUE+YKM=J8L%.3<6%Q<L:+J-\&V=SDDO'!I&0\5XR?V'[M4ZX8OSV?->%#
M2E=S\NJD-T8K+_HQUSY\BE^=J7>1Q2I$"%]\Q;I!/KGPZZ_<WB?W^M%Q=SL+
M4*U,OW/4OW A#R-R_6@_(IO :WIAVY_MV6#E^6T'!G*ZJD1U9N!BG1FX*&W#
MWZ[O-FO;-51[M=U8;VQLK[^I@3+<V:VO-R^?"K>PN6%C5O4XO7E3;OA;.5.\
MJNGLD[C:K$HU^WVB:A5@YBR3N*6(55T_M.ZVJ'O&$7-/)<RT[\!;FZO5O[<;
M\(=[*LQO8MO#V*F1U=JK<[?__+#A0>V74=>.0FL8PSVVE\YH/\HBL>]L"S$6
M:69+T>7SH>E:"MU\QSS"-F"JTR)@.!7M[*\5LCI) T_UP.!"#TRVIPPRJA^>
M%R"/4Y O2J+H*R993@->/KJ>I]'FX?/A!?+YOCV6N_M\A.5=ZY>4V"4( \IJ
MYR2.'WZQM:P)SXYCM["L$ZZ/=W=LC<_"+/5,ID="EGH6.6A:Z@F04H^^*+LO
M-P%*SC_XABC;C+'0C\7K*E-Z/T+26PA9 >$*"%= >*&E5WX3".>ZAGX\BMU!
MWJ"<CXGIQ*6!Q/(J)"[U1&IC2%SJ.; 2XTD8_K-RXWE9:CPOIW@>EWH.M(+$
M2V)4V;<A\;6*%C;;O0D_>59!A>O*SX+F&JY[:=NVZV-M[RA&P':V@'?EU97F
M(@A8ZDF4'#284H,&,P$-F]''?'Y#CBB7&D&8"D$LC_KF55"M"JI5X&MAQG)W
MZ:7TVT$U.SBJO6KW/E]DETMK<O)4BSA@J6=06X[4>)Y*Z5%QGD2Y47&>0;G7
MO^2I\3R%DO-/A>*7! >(*@Y80=$YLJ#X)A0M]K\>]=KPX,%D;V9MZ]]1:WBV
M+%G>O !+@N[$,J [47IT)TJ-[D3Y$Z5Y#E68<UFLDZP 4@60YLB".C<V'<*8
MAKW:%:1TT_[6S*LW[G&M%%!IJ:\>+<_R)#?'_N0.]T?0<S=M<Y\7I]]S+'?G
M="TF._?I:JUNN_:P4&CG_7@V6P,_&@QR=Z:,#M>[MGTV:!4^XH4>!/48QOT!
M\SV[<3!J7]\O-RM45E)FK]*P%5T77M\]"<NNBVC)PNNY"OS-ET4HJ=!?A?X6
MA=4?#/W!@R;PCZW6WN4FS*UAT3*QT'#P07OZ=U:0[=Y@E-LWKKO>:)AW%GV,
MP]IN:_"Q0G<5NJOHNMCZ[,F8[GQZX]2CG1RU^(" ;W)68X7[RL\\A3%D%?"K
M@-_"\/H# C\V 7Y\M>ANW <"%5KN;;_G8\@XKT)U%:JKZ+K8RNJ)&.9Q6[Z'
M5%(5\)HS?;\-O&X]G^O:20@/<O;#]\A_TZD0<ST0X.8#6L@LSJT@>&7MYP^N
M8/*D.K7B'F-Y.J=6O'N_M=>L;6ZOOV[L[#6W-_9JVXV-G=VW.[OKS:W-VGIC
ML[;W_N7>-MRQN[VUMT!"=_-\-G8:>SMOMC>+T>\UX9_Z5J.Y5]MY5=MYN[5;
MG,6Q^+-XM;-;:_ZY!?_?W=JJU7<:S3_W:EN-39A3?7UWX\\Q]AIODZ>DH!+\
M@FL+/[%;:[86<:RM;@T>V\YAIV>U>.KCR3"?R#@^5:D6[-#>?Q*WV:X[6@.V
M<L.[%N8(&; MJWAL7VXZ0^:;Q[+H5:IG?]J+7M7\;J>]W.^:8+>_\V?&>N=C
M=&Y VU-:=7N%-5V .W_6'S2/=P#Z3(]F&>_5N;+=Y5*K[._& .:[Z ]U+,Q<
M*9+-Y*P.PGER*X<?G&?G* ?W+?B?!PT:<9A/>8[=T:53?J]9B3NS'*XMUI1O
MCB[^UT]/\_+T^OG)"S6_6\]B'0W"M8-8?^CTY(L369&\PX&LHP$ZM/;DQ>Z8
MRU[U>YTB  BC^] :'FV,!K!4L;]UZMNCO,3K@T&$_X6F/3T_I57.^936^IGI
M^,ZK[L[QNCC87,=P_]G!L2?U+[NMG0]_M1JO=X_@<[+3;+?JQ^'X8-.+-VSW
M:+]SVMXY;K<./OS=J3=?=NJ;?\,8=UOUS6W1:+X\/OAPT&[01JO^NM%I-.MG
MT^_ NT8']+V$9[<//NR?PAP^-S[42>/U]N?Z\4<"][</.N_9/MW^O$_W81Q_
MI7H+G[YI;@WK>_CS/T)AE8SDB!E!$7<.(PT@&$EI:7"2"2 G*.!G*FO@:V>[
MWIQ0^ 'S4[NGL/Q HK724$NNH9+ VOCD@Y*86YJ<9S@Z;IGR,6&N"@V%IQH*
M5QIJL374EW,-%:)+PG&'"! 5<6LY<IA1)"*C0GF@KLY-=IYI2DNAH186I5Y+
MKRS(]MJ?OG5AUWL9O())45SW$"8R&(X3M?'T)'9!\15_](9'L5_KG=_6*LZ-
M^,EC'Q?/4#WRX:@E7H!*'!^0"AL@A#D+"%__U/*Y4N(6>M ;IW<CZ%T\7EM0
MOS4O_DZ:8,,*[]T#[S7V+GFD3@!>]R(B;S1!G'N*=/(<!6H%BU1'8W.K\6>2
MROOAO<=W.I^<N#VF$U:)VT^(VX5[I7B*GGN-C# ><1(M,C((I$2@+!++!"O<
M*ZKN&0!Z@A[4,D"(O=B&#P^?U0YC%T![NT#Q-G1:W=9@V!]O#*Q@Q<_#BJO*
M;++JK\=KOMX-ZU=6?&OL4E5:[CY:[G*8VS"'DR$!!6LQ:#EAD#$*D(4+S@ E
M(U%\98UCM2@ZKH(4LX,4E:@]O*A=  JKD[1:!X#N42!.#4<N)89X,HYAZ8"
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M1@USC9CFQ6[TNKT;"Y$J=78O=;9_&3$D2UUPG".6@LTA'HJ<"PI);772":M
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M,(1C'[+858G$RG-:K/5>!MQV2_;@*9J0QT)NDR7_RI)41N1>1N1*H9HR4?H
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M:V(>F:[*3#]*^+H2JAD)U87Y]4X*S;5!1'*/.)$,F<@4\D%@G3CES+ L5'/
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M-SF./,,GF4KFHI+S-P!%:QVP.W(NU6J6AB!%G4:<$&*U$Y8V5+*J*,^J><'
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M&_\::^33@PIIEI+Y52Q\Q_X^ZIF1KX;!_V/QVUKU"GAL![AA\(_KA[9KZB_
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M!?W3*1C?Q;]O?DR(X_?Q+&3^F(<_9G>@(M9$4^Z1P@SX WX#9<T%$IIYCGV
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MX[-%,8]%<7CN_)CEWA$;(K*&@D6A)0;CGU*DC E41Q[*J!+\%27T50[H/?F
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M7C)2<FVB22;V0IW-62:UOUFE_*Z>3]4'JB=ZF\A"J.N=>#K4.4IW6VHX5V[
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MUSE OMA<='9+!:4EYYR5J&3&(ZYUB90M->+I!N"(K;!4 1?=[C*>S$:9C1Z
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M>=D0?&Z07\PK_N\<S5KQ,C+C(N>*8TT5+C4EB@5KL59*930O')IG8U#>FY1
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MMAM[.WSK>X,V5]=.F@=_=AJMG9/M@R:T^V.G>;I& ,O3!ES[P:-2D>*(M$Z
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M[L-7:Y!8")!XW*#;&CH>'3JF]'S#%?$F(!^$1MQP@EQR!B6E(Y>:&$OXPD0
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M&,0*_B$]$Z%61>=5^A[7BUM+W^-(WT1'54YZ(J- @1A@R]D&:VS4*!A%5?+
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M;G]B4]B)R/6CW4>E;>^M[1S;D\'2O\ZG<;2[XX?KK&Y?'+(K>YC2H_7PNJ2
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M@B'+3$3, F8HQAB*TA+ [I00''_7=-*H)"X-+S'5+'!OC&7:NL #EYJY2@^
M&JBG\WQF\68ZOVLZ-<7,8:S 5&4:II-'9+4RB,@R*(Z#@(^_:SI_\#QN,YW?
M-9VVQ":43"!)2@!;;14"*QRCTMDR"*^MQ2:I=7[Q5.UW?' )$U@&"O_L-L->
M@"F7I3"%.XP'[L ,0V/2/6SSMGM3LOTFV $0Y=/LA*E2]MW2J.O4135\OC0U
M*Q=G'@TK:4X^M\ET'E?3F3;$KJ7>Y\_>>*<-+H-S 3,JE/8$-( /)GH5"=&U
M<5=>9]S-AV;WQD>^/ZHO6"AYG-3";/G5JV_#^YSNUW0WLN]W8SPZZ ^2ZW"J
M*/1/IR@V^,[NQV^MW;VSUEGK=&?C,]? P:W42!DI$%.,@](P"K&2J! LUIC2
M.T761B)TBHR01@86,#?>1BNI\*(TVD=;SSJ=S#JEJIGUQYYU93GFPA+$I/.(
M,:60\F"728QCFG,N8;S6+Y:!N2+$UE8YX->**XM9K]X).8)@"@QV'"6A3($1
M:4D$R@]MCB&2P*ZHE*9NL7(6@KXNK)[WD^HJLV4SNZ9:4.0G7D=[>&=WF[;/
M4H#X'FN_^RRUDT'BY#]*Z<.=$D@'D&S# ^ \ [L\E"OK=(U?I(_UFJD+VB27
MSV3/H,C%.>8U6!T2=HEJ,O4\Y2V"M:)(N<:OOZB CXI>OQB&O.?7J3*&%VD?
M)0R..KWJSQ3S>7%CZ+GPEV?*:Y:;U0Y?YJ[0W780%XCEG(SYXDIXS^(X/(?P
M)/HR< ?6:F3,$6: (!)B8\1 %PU5-YW:XW> ^MW$<\>#TPSY>5:'&^Y_QYUY
ME\%3'\IY8BSGR7T02Z5\5,@Y+1$CBB!;XA)Q'E09-57> Y:7:Q>3 4YJP%3(
M.YS8$1/G0!KVO,MZ%PKPHPM$?.\"R6?U)^OC=7\X:@70'LU*F6C]UKO/1!KL
MA+1($,T0"P2TOG<26:65#D)%&\7*.B/XRI5R8_FY[T?7<XG/FC)T-Y6A*YLR
M=$O0EJ8,75.&;IDZUY2A^[XR=+<[)?2,30!\7R9 -*&DOO12D\A*(55)!941
MZ":3TN,;D_8V)L"/$CMWNO/NLZ E$0YCA*46B#EM$"Q;@@P-')1/=-SIM&LH
M'X7V_^BB:&C__:T.VCKYS$L?N"86<>HB8DQPX'_*(2>48,98J02L#GF)?^]R
MIO]2O"9+Z*H:%N]#9SA,I;[CH']43)9WD=?WRYR&W85=SN.\^%S(+EX;0B_'
MAZ<AF4#4?-PX0-76T7&W?PHZ+P]1\7:Z?]V%+OZRLO7A[=N57_/6:MX731<!
M. YS:H"C=%RD4OR3_=$\[-> X4'HYG0#H\G, #C:T]S"%$#9@[&Z^NZUHMCN
M%7^97M[NO>B+LV'?W-QAZ%'NSXU] :,W=$^K+EW;B2IL__L/(<R(1+UX[\8B
M?K32R%U81%XEV[F55<SK6UC-?5])WX(VF4CB3ZP^X//]SQ3^5Z9,C<11BY@H
M-5(R,F0E"51RBUW:'\)K%R.2SI.+M&CNR"]_L"A$LS(>:F64[?W/, G61R";
MI> ,,4PDK ROD>7$F.AAG',!B+6+>]#G5L8J(,?P.+CDUIL UA1@)\B9$*K*
M)#.\,GE,!6_]DUX8I)SU><4M0B-H!7C=]'P@D8^2,&:9B,;/GM#@?? A'&7O
M6[O?2W SZ,-BA+6T79\C7?J1^-Z(,^AL+U2X>](95;7B\L&^=+BV=S4V V[:
M,#A_&D-9&8C$4C+' HV:@[P#("ANK:&E30$>A*?P_7E(+L_#;JO3ZP\ZH]/)
MX.],A!?@-WFDS'[XXW1QHJI+INB+Z,\&OX?;23&7SL,* '5LRZ 1\P[L.BP)
M*BT7WAAMN07%3-3:Q:QZ_YT.5LXO_>D1ZG3P<W;8\C2AX\>62;XX(*YC .?,
M  E?)'Y -WL)+ZM+TS<Y\UZZ>Q"R/;YP.7P\"^SH=B=4>;X1>6G.FF%&\_5)
M$ID-@,O0\%F;*)[$CLQN.PZ#I/^'!?RYW^L/P;* AU>4(*N?,/@*QD9UWK7(
MAU 3T0X#6)%]N#])R:0Q20%4D5'#H7$'XV$8C=)!TP^=GJNZ-P!D.:JRF]5G
MJ*X<91C/\0A:&297SK1)?<,J#,G,"*K/3D/CYNX;+B3/"3EY3AJI]+Q]4)_U
M"<%LA9C!X#0UH3I#GZR6]/%L3*$C5P9^936Z&5Q(*'"9(W$P@]2K>GQBAG.=
M@$9>>'W2[W$\J,N.SN9H4=?/K8)ZY&Y^^9R^Y[?9M6SV)N]S;Y)=O3=Y^^1V
M@DR3VS4;FLV&9K.AV6QH+GM;GV9#\ZE3GUP^&/JI\H*^-L.#-]W^R8?Q\7$W
MV^^F.\L*.ER2M*"T-<GG?=@Z:_V9K 5WLK/YD;8VWYVT-ENL35, U[NR_<\[
MTC[;XZVS]N%Y"P+N/-E+UL+9!FOO[IVT-S=.6F?[Y:?#=[R]Z<BGS8\EM..L
M1=M@03BR\^XSL5QBS3P2V!K$"-5(Q5*BZ%FIHBRY+\/Y%)K<E(((8ARU,#<!
M6T(""8P138./5%Y("_KQ[=N_,^( ^KS>^/#OXLW?._]D8-W9_??6^P(0:N/Z
MU)_7KNE+=_!O;.02VN</G2'7'00_[H:=>)-,)#W^,PM&^]WG0!PM!68@"9XA
M9K!'ACJ"?#22.EA/W+ +N66]PXK)4')8<Y);6_)2"@D&NHW:QWA!,.:&?RXA
M4[*ULII(YQ=,WGS_CGV9;&_!?Q%,H?Y)JMUYY]RZ-_;G"67HZF/*1V:P#X2_
MMK.2<59_DJH*UQ5T,U&=&F2YYC TO&N.A^'5Y)??)SGX.[W\^GS3^4H"\,R9
M.;&&*Y.BKM!4/[_^>BU_=:Y\0?6=5&M4\2N_QFODRN^N>ZQ:4^SJ.Z][ZO7?
M\?+J=_Y(6]EMG_I\JC6<K]5UAS*U^C9EO2I^NU0UA7<S3+4JF-J:P50!"'6+
M.EY/.^BS2^]2B7S)9R2IA5N,_*UZ_-.-''[P-?N$<O <*EIMIJRAKE/1DCJ]
MZQ7%@&Z]\IYW+:_;=_/%%/KZT?B@2PI]S5;5L@1Q?*^I4]?TVCC9^6>;?/KG
MS<&GHZTS,&U(>_?3P<X_+=[:/#C8V=S .YOMSM[AQK?S-;U:FQM\[_ _W;U_
MWAR!F03M^DC:1UM\[^S+";2?P?M9B_[5:6V^B:T._C:MZ26T\@2SB$I##6)6
M23"2.$$*>Q>D28$[;&5=7CQK>"[>X#O7]Z/6 FS Y:6"RX^&F#7@<H_@,BLH
M2BF+QE&!8$848H999%D4"-0 -H(SKTNWLBXN'D]=1G!I*.(#ROK&41\:<W8M
M19QVD5[:Q4M!^UFCVKU3IOE1WHG;O9'I[7=L-VP,AV$T;'#N+CAW.D>BN+?8
M:Z>05@!Q#*8"64L5*IF+6CK,J(Q@BEX\N74MSCT^3_KI).S>>4,C8?<I87.E
MR97B$I8BXB(50!2!(ZVU0(J6C!%FI!,*).SB\;<GDK"&+#R6/REMEIE;L(?&
M!GSA-N"#.IC@]VY(OVST_#S&-XA^!T1OOY[C3%$(1:*,B!CN$/.E09HIC1RC
M# =,'3=\91UFZUD8AXWGZ2=%G0?U/#6H<S^H,^.1&%-IL$QY4D/*F(8M4E@9
M!%,GHRH%UY:NK*L[\LC&([5(,L\=KR!UR,X];NC3']G>?H)7+NU4O01[8'+J
M\ ;J_W+T[#-2I;\\)8.?+(RM:ETT:O,N:G-^E]A0[9,+!C'L0OKA4N8(B2PI
MN82)QC[5FRK5!;7YZ]+X-AL0>!X@<.^$N@&!'P*!&7=FS OGE$>TY 2QTG)D
M'<=($:HH%P[,>;VRSB[6JGQ\$&CHUF/0K:I8<[--^^.T93Z_T5D8]+T9'ER%
M8QL]/ZF\MYTG8.<XI$._O?T&VNX";?,;N-)X)Y0.R 62G &,(QUE"4O+1%>F
M(IO1IT-?BA+Z^[+L,36[N ]-&1I1NR]1F[$(98SBQH&4*<,0T\$FOS]#U*M2
M1N 7+-4YNZ/7OV$2SYM)U(Z;U:(71LW&[4O80GEDO\\0.@R_707D%7K7%F [
MC!KXO@-\[\QOVY:F)"75$?D(H,W*(%.92I>"WHP3I<.&T3MY@IH-VP9MGIN#
MJ4&;!T6;&5F,)8V.JH DCABQH#VRJE3(*1ELZ>$_A5.!JV5'FZ5ED<U.[;.9
MJA=%^(]-QS?;M,O3A678I7T+:Z)1E7>)D-_=2&JR(N<;GXGWUO" D><E 65I
M&5)<8X0=4TYK%4FJ>E5>W)]9,O]E@P// @<>S.O:X,#WX,#I% >DDQ'H,D4!
M8PZ&.2""!?%'I< .:U]J3 R0YHLF>N-B?8F,*]FBQ<A\@V<VK&NYNO"TK"LM
MC-VT+AK O3/@;LT3+Q9=-()%Q$GTB&$ND1'*(M"/A*N("1/EROK2G_YMD.!9
M(,$#\*X&"7X("6;4BUM&A-4.42T "4H2D=%, S"$Z)G1I=,J57-9%BA86NKU
M0'[))[]T:0?\)7#=#>=279S$<T]S>F S'/;34;K@JU)9SARGRF-5N('OC%*F
M[(8/+T\7GI(/OZ[6QM;<T@#%.!X,@O]C/&KW1WNA\4S<73VVYHFR$BY&1E*R
M0>P0"T0@*SQ-2<%L4,$(S^+*>GG'?& -4VXPXG&8<H,1#X41,PJ-O:;:V1(%
MHR1BQ$:D F,I D 2(;@N4Z8?T@2(?B^C6[X&/Y<K7Q!5GH2U3[ER0X.7IPMW
M4'%!,.6(3]A(F:+"6!)I23CF,4026*K?>ZM<1Y/U\+9:#J^34NNE Q"I:F_U
M1Z/5[J35/LXS7^ZT)$%(%)DGB GX3:=31H9R!?]G@C&YLJZ:O?D&%NX#%DK#
M(\,B.,5@89721$>4\B*8R&WI8X:%VR0C:F#A 6!ASE_,(Z$D8F0DQLE?S)#2
M%"/EH^5E.F?M[,JZ;-):-O[B)1OPYT6"+ZL-=%WYYC_&0_AW.(1W&?>_XPX8
M^*]N447HFLX_HCI1M](FER/(_2SL%]7_1@0?D-.\,9U!\=5TQ[GHN,E9LJ<B
MU]BDR].%Y<N'D9;.?]+*V8E5=O6->MDTA/1.A'1_WD[UU$H?K$+1TQ(QI32R
M07@$1%6+4"KMI7DVB3 :O'@6>''OVS0-,MP;,LQ,50<3$ZEUJ&2I D,P!AE/
M2F2<P;XLJ>#.KZR3LMF8^?EX6[=C;*?;&762O30<CH\N<K>?+BG1([&@OV=#
MOU&-/&E0[DXH]V6>_PAMI9/>(1D3RO'HD+*>H<AE--PS)HQ^-OSG9<C<DR8/
M;<3K'L1K+K@C HG01",C="H(J0/2FDK$ V&8,L$%L:EF=Y-"]&>B#[TPNLGU
M<PF4_5B*GN7#N>7A%G[_V[P-U0ZCQHSZ?@0\7#RD+TNEB*&(2R\1PR*94=@C
M:K7VCHM0<O&=!&/),FDU(OL@S*01SOL6SKF3\U$+KRU#I0T@G)P8I)TH$=/:
MB.3ET+),L:?/HR;9LV,PR]?@YW)E,[ -Y[Y)6?T=AL-7Q6O@>7=AV2];*S^2
MDRX-^D0_OQGTC_+OPTY3RN_.ZGKA.)D7)!*6*J[KE(L69@PI8R,R''-"H[=:
M-LZZI96]!SB=U4C9O4G9C!03$WW)0T0._JU" K3S$84R.LTLUB$"*2Z71;X:
M#O& XCV)BZP81"5;PYRU/_GQW'7<XEY< $LW("\]L?;R<:FWYO0H]$;#W7Z-
M];-8W788[<1Y+=# _IU@_]U"4BL-<V.B0;$T&K$RELA(XQ W2AH9";&Z?!F.
MR@:97C@RW3O3;##H(3%H[G@4J).2@($7:)FH)Z9(88<!@R0/7I-H/5E9)_B.
M^;0:?^RC')YJB@#\[$;$78]=_1T,0.A=3EHU!_.:/8!F8)_IE<W -@/[O*Y\
MEEKXJNU T+5^$G?7MR,#E_BBTRO"-W=@>OLAN6.*'KRM/ZEZ6W333?/A_LT1
MS>7IPE-FSWR?VK$3/PY#CD;:J9?3=F^K7DQO^H-I\>2\]":1U:>-@7P7 _EL
M(?.\93J:J A2UAK$M/=(4QP1\RE>21##E5Q9+\6R;,XT)S6?-6S<NR.M@8U'
MA(V97\U0CYT)#D41 V+<400:P2/#K)8^&A=3G./R5 I[=D1P^1K\7*[, _O;
M*"4;@W]]Y^MZ7H0)ACJ]<?887?9)OK!:E7;PV_ITA>;/IU\^(K3268Z9BS^O
M:-ZU;;_BRPK[F#+,<1)E$)I)0VSI@08P:@BG"CO^6;"51QR-"WZ_/!H$KQ57
MCD@%-.WQ$3S;W0-9/1<:U#\ZZHSRGLU&S[_.2V<_]!Q8,)N=H>OVA^-!V(4W
M_M'MNR]/K%#:KVN%<M1B>X=;H C>@ +X]*6U^X[LI>?^\Y].>]/AUF'[H+W[
MA;5W]S HAV[X]_O33__X8TN9V#L[Z+1VOYRT_OFKTSYZ]ZV]^9^#UN'^MT__
M;./V&;23;I&=W7W2/GP?=W:W3UK[GXW63FJ6DL\1@AB+%!EK"#+&265DZ1F5
M%1\ L0M^(^W3EXYK"A=H'R*S@1DNB>*$"UY*:8U>*0)HZ6.8B=%@##+^>J?5
MVMYM;;5W/Q0;[<WB]0X,5/O/K?;K[:T/$VU3+X*[",(Y/*CF[^;&+79&PU4V
M>@V<F3/-K E<6\TH@V5F@S(K2XPD#]2F_,17*>=YQ]U"PO\.HU$8#%,LT.M!
M\)W1]P#=L@SM[D$H #>@1:>%@V9UAL-Q*+JS+KK<Q6+43\/3VR_^ZRY,VH0@
M*'<^P*H3AL!/8-+<2*DY]UQ=GK=WN_UF,4BF-S[R_5%]P<6SR[VP$ZN)>&-<
M9LTM\ZUS-#[ZHS\8]$^@T:_-,7RS1&SZL<&OM;OU[;/RTH%.<4B7/!5P,P$9
MHCSB,G 7P9 .7B;]=55A"EB5W6K"?1@4G='P3FO!!>64X:65@;$2$\L]IE)0
M:8-.V>Z;M?!(:Z&]V>+)XFH??CQMPS7MD\^@,"BU4B-3DA(QH2U2A!L$1BXM
M#0BJXG%E7=RX,H;! </PQ2"XT/F:V.UP@A^QGH["]/R=UHW7E@AMB$O*+9:@
MZBSVV&K!#&.XY,VZ>30,V<.?,1 +!90!*1<LT*<0D(V!(>\EIHE;F5RW@C\,
MAI3&6N%@448>&8_&>E]RAV-I.( (\U?G@?^AI? ^')E.#]9 LQBN !'<WOAL
M&+>::(X UBF ",")!2V/8B3<8N5UB6G*\GPSB/0Z_0$L@QF:?.UWOR;N<0Y+
MUHKB#5P9QX/1 :PF,+3=>#A,SQB$?3-(;IIB-.,W_QK>&J!NWX95N#84[?XH
M%*0$EI1?:,9P24C>@%X.SLFUV6*G9\ 6,UV@?O!!-M/21M1B"Y-'L=CH <7O
M%N_#<7\P*J _T,VC@F#T?]>6G$XN-N]2#\:Y."S&X87'_2K*_M4@=.'*K^'W
MDXX?'4Q\MW-W58ZT5WAVB[$PQN/1U;?,^>9<2-775Z[W-=QPVV,/->'G!G7N
MY\%@YI;<!R@>!/,%F0B-?66Z)^9TN/+;0I^..KW)PU7:=#@_9%?V,,8'Z^%U
MH5+_8Y:F+<7!(.F@_W.S%PI(]&XNS)@,Q*2^0-#_YS>S3"OM<L/VW<>M#[O%
MYO;&G^V=#[O;KS\4V^W7.^_?[KS?V-W:S*Z,#Q__^+ -5[S/GHPE[T][9W?K
M0[&[DQPP'W;^WM[,W7BSW=YHO][>^+OXL L?5&Z:'.%/?J]=-1^W-I>^<[^,
M>[6:^77YVPIJKE;OPU70JMUTN*J?E/9)9QA "?J.,Y?VY#M=QM?XRV[T?YWS
ME]%2BX"IX$!S6<38$BD$6")@(-$8HEA&?]DVM&1\7)&'F%GVH#/\4L#[0$LD
MXE$<#_K[ W.TFAA+Z"6_\#P/R=(@?Q\6QV&0F7// 9H-4A6M?'>F.9V!AP\&
M*3YF]1$\ 7=C\97_:D+D=\8CX%R]1 @WCE+QW)^7MQ^^PY\%H08;S%)6.HT8
M#1A90<'<+S4FP6A.4H%2>9&H3X0XT=:++L+*IDO+Z#8T^R3 FNO/)J8P^5DM
M,W 'U2HNR6JBPP1H?O)27GSA\0#F?@!B!2\Z'H1A6IH@>L @PP#H<PKLJJOW
M9%(?QZF6)9!S()!]V^G.0KPJTG_2'WR!%]2+'YYT= RB44%'MS\<3I;_\"H2
M_BP<OLOE2Y]N4HV*'/A0[%A05WG,A\]D()>T>?.._4%V8(#Y.[:'P67\=K.!
M[\^&O)9A%P8I1 7N2V7$L[E:!44"TG=ZKCOVTS#)(0B\&572G"E&CJZ$%]C3
MZ6- -@&G0><G@<Q-2BF44R6,U*)AQW?,X#1),WQ?6] S@WCN#':Z)</+]":
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MFSCU37_ 9^G:SZ6FV A"D)86(Y;BL75*R5021YW749&4DHFLXK*I)=K R7W
M">5&JVA*+,#J)Y9J(2GW)3=$TT"8N/-N58,9#XX99PN883'U+%B+8DP%Q3CS
MR%JOD7+*1UY2(8)<6=?L">J-OB Z]7KG/]N;B.@;:=1/%]=)5=2:ZTB55$S9
MJ#P3/!"17*!,Q'CG@)T&01X60=JOS[$.[%+)54:0D]PA5E**E(H"82X#@(AU
M5+*5=47OF!RNB:E^<-G#I2LE8X9:8UG)2Q5L<,SYTI8\G>EKM/?RR=ZB]C;$
M&Z9*A6R:)"9![+1/HLA-*IX'K)^)E77Z!*D/7I#R3G4VD36P7JO<T</^*&]\
M_=+IU>NY,/ZKZ3FXP,]BEW]ME/T%P+' *8FU44;*J"EMX#9X39VDCDMG&V6_
M;(#SX9RR=YII1CQ!T1J=BG4J9 C3*$1&.'>*E<E<$)>D26R4_1/7]6:>>5,*
M K8ZTP:TOG<@89Q(G]BW:93]\LG>V3FBK:Q1S" 92XY8) $9+BDJN122^^B,
M!&4OV!,<7GQ!VGZC9^#EH-Z/S>@ WKE_VNCQ\U@B2#3:8"^H$&"N1X!]A[WS
M5!&NF66-'E\V+.F<U^.1"&^,0AIF"3&--;*6,B2,]#(PCR-.M?G*.V9M:?3X
M@\N>U8'S&)T6F+)26:N%):#!?9#,!6(;/;Y\LG=.C^-2"FI\]K$CAJ-%FI8!
MZ6 ,IC)ZY622O<9J_R$]WNU6$;\_O;8F$CO'&" [4\P'9G$0RDNE8JF=T;C1
MULN&&.<W]C%GFAOFD39!@K:V$METE!9[Z4VPI<6J7%F72Y,_H5'6$X=7 #BW
M*@7V2P8$645-/;51&L:UTJY1ULLG>HO*.AV[!<R,"$0-E+7$&!D?*:(A8FP<
M)=YC$+TGV-SZCCJ.<DWR)5?;N_V1Z>;D_Y,S!_=]<+8Y/_]B#\_?0_:/)KIQ
M29!X9Q9G@-N[^^RS4811(CTBVF/$A-$(**U 5)F@O9>.:+:R3E<E_;Y4LS\H
M1<\C?T@#?B\6_.XA<T@#?LL#?F<+X"<%*:7F%I61@07(8D!*,(T\BSPZ@B/8
M\RFT6]$[AG8_+?C]>%*/N^;:R$OOYHP*Z33HN3/=CWV&G="U1SZ!/9/N;CH<
M_]8,1J>[ ^A"M9"&FYVAZ_:'X\&R',$N6Z\GLOSF:.?/=K=-_W/4^J<%,OK^
M"]P+,O;'E];FWFGK['UWYY\WW=;FN_+\$>R]?T">Z<?RTS][W_;.0$;_? ?M
MW,>M/]^=M ^WS]I_?N1[_WP\:6_ZV#ILE3L;GPU@*XF<(N>T0DQS, J5+9$#
M$2V-\UI*=O[8-=&X%(H*$[&'*>$V*LFDY0QSR8F4YX]=O]_Z.V>/>+OQ?C?G
MOKCA7/4=$P_<V)PE3#RP>Q"*U_TC:-'IOX9758XKC@>@L0;0JC0!P\XPEY'K
MC(9S9]D&'5!Y1<*+ ?S9-39E7^D/3J<[O,5AO],;%:#D1K#:BU^&(13M_B@4
MA/VZ6IBY,"]X<:4UT\A>?OMJ#AN#8>Q,ZSVE*GBFB&/X?'1@1L7Q>. .#.A*
M&&IH2MB'!Q_TNSY7R8-KH4]?X6/H4>I])^0/1S <!\%T1P?.#')2"U"_@].U
MHM@<#])^=;I@E(\''U7'@\/L>' UHB59+1(*Y!8F5K":;ZH'&4QPU]_OP<SY
M!8L\#>A_W8&9<.<MU[#<4O%'D!PK=. !1\(, >*N'\@LFX,Q&+%EX1^/CUEG
M[\AG&'#I$DXIH N(>2N1P1*C2$H>N?=*!;*R?O&0QR2+2EX@=YESXPB)C.M
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MI^08T-4=,FWB!U74' ZJ;,6:P]]19T!?1$-"%'D:,$GFB@Z")IR.0Z?% .@
M?RT$]D"5)VS!5&D)<DD63:GY0GT6SS@+ST>H [:C!D8%/4#[W!7V.+" "*@"
MCH$S.J< V#:=DE+J6EEN\%07Y%,NYIJV=1'@RZ<1=US\X23SE'0DMY-'V#A
MN*Q^I*BMY ;K6_782Q][JO6=.*O4?[?PI_9B?^K,3Z);4[#]?<Z^-=D$=OB6
M.??L(3CY,=NWTW;5BKI&:X#GE0?U2LA,)GN#C(@#6*AR$<Z^C5"""#K];U::
MM6@S']6TOSU^1(.3GZ@9+M+I>]3P,*_AOW]D/QV4Z10AW\$\\E<AGVM&ZV4
M4K0$%9)J8C8,R)JV@5K61^8"):%0^Z^_#0U]\"[0T'Z,@@!U=V3.YRYS'@([
MP+/]8+O,-<'LQE.VB(G1/5_(WJ!;8HLSV$C7,T8MHW=H=:_XQ*XC/U;<GB)$
MRJ*>[AGEZ(UO[1#DC;D!5"]L-G4]4*],[<H5UAMBT8V4[D=I(/P6H>F>[#S0
M^'SAW7,_T!;< ]V37 /L&]>DS0Q_VG/45;DVHQ:CFA>%H*:"]J-I_^9:% "K
M!?0DQ2D I4.S6,A0V2-]5GG(4)7U)6G"*X&OTZW)"=CP,"P?KLZ8F!@$3[D
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MT8XWA]Q*Q#LNR+:?2L$2?9^,JGJO4K@Z?$R](8">6JB%^*1I2NL\."NB^L?
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M3L_/=H%%1B& VMIAT65CU0.DEI%/+<FZ*HO.O;WYMIX VTWA63I<>[,!"+<
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M"^I.6'P!+O%I=)7,)8-,DG";2C09#AO][PI[EL></=Y=6WAL0;R $G\]244
M,X],KBN0JJI)0/W=P>,/,)"D10I_TQ_X[1J($*>_4B21Y5/CNN(#%PZ)3?,=
MZVUAIZC>(&*%3L3R_[OV-ID4U1Y$J$O_#LHO/%)4>1#QH98YA'LN/X+[B-K7
ME0Z#ZGJ(IS \?OW>4,5U3]3Y2BA!3K!7G'RJ0Q$+_U!U5917422)N.C'VK;
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MST:]V4@[7WX^H4Q9=E.F"D61#0VL8,(*UKR3C4)+M92LV-U:4K0>VZ G@4"
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MY!JR!96)QW^H:H>>8J'OM'KO$M_RZ()CZI.;T ?_]WUYJ>"NN;I'Z,21XWZ
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MH4XAXM/0?H1-_-*T*:RPDD?YKK=Y%S#ZGQ9WS'6_QJD?@B@&7HEH H9(R"6
ME11!UL!W-!"E+#'$NBHG=9]$]@/D]XNSJ*BVBENCX[AH*WDZ@8@G;T'DEAXP
M^7RO[NH,H5ZT1E,*J91;I@5I +=E*$@FL61&\5AGR[HAX TW OY4EJNJ<HM3
M$1;G81;+.,QNVE@1!5<>O&7C93X<*PPLUH8A184GA <A2)6^YX_#:E5#T1W3
MJH"B:I+G7E\@@;$101-$#0%64Z.0B31!C$UX2EXS3:J$&VM@^Q'V$W9 HZU4
M5L6QNN'\+=(VJX0@0F#".IJOD]>(,PK?,9$;.1!%A#;*R5K56YO@_ 'V$FHZ
M7:4UN=.#UC</VIZ<]O?^Y[?^X7[W^*3[C_<'I_^Z#6FK\\(K!J]]</BI^90Y
M=+W?/=D[/C@Z/>CW^F]>OS\YZ'5/FART7CU.*1FM@;*,.$[>OWO7.?X72/_@
M;>_@S<%>IW?:V=OKO^^='O3>'H&>]@ZZ3>2SYL"E!-9D'KN4X-%D-%Q<JEE+
MDM</V*U$5\^KC&2[G>,>/.KD" S";YWC;@/9W1NBE'0>QU9G_J<YF=^$00\,
M5$L6JW#6D<A^OE)E5$(D5R/5DLE*I(5Z8GQ8>&HQ=#['J?T8>Q?G+DZS-SVZ
M@-\N0OM9_V(^F]MQ#O<'F&&/.:=(. 6!&3A&" 8%WYH(+"AG++ J$?2&.+=U
MWQ]XW+WGO+:SH1](PP0V,B#"?;Y,W%GD-$081FL(57WR0539V=P(99M.9]1D
MW5W_O9XJRVZ?Y\#B^@:P!;C;78^_I]DNHY#.=)K/CB][?GFE& U8(Q^-19Q0
M!T&NQRBQW/TX1653E33]]M#;= )DE[S<L=)+[LU_OR:J\QE6IB74&^F[RU[>
MEV(;**.PX#9?(24!IG?Y#D2(B+TP5@<7*4E5SA]MC+2H: 8R,2(D\2BJ?.D[
MQAY9AG,:R@@G GQ/JQRGOH6B35:_+G-6-,-HJ(R"">4I>';#3XNBG9/H+Z:+
M%-'^<+9\Q\'0C,-[,"77/U_=[Y<Q7PO!ZVB2!CWGBY.YT1(YK"*2BF+C R.^
MSCVT1="W;;-_AP3<O?:KIQ.OLDF=O7^\/S@YR"FF)OF=E<.4BIZ>QE@FGGS3
M.3C^O7/XOONNVSEY?[S,1#80QNIQ2DEC#905Q=$XZ_#8:%5%4R__L/)QQ]%/
M/HZ'_P%;L&@ "W[EC0,)=O[&#J>+:QB;9RO*/+>JT+>30J%,R/+1WQ\UG/G1
M9'8QC8-(/4OY!DQ!1$"<:X5<5 [$G._RDD)27*5Y_8.(MK]>U89;:]) :FLB
MLX B&)UO!PC(!2L1]4$I0K@-J<KVXSTD;?)7RS#B_A6KVPB_W%E_.SL[6=P-
M 3)=S&_51*57W&-/D=(0UO* \UVR\&,PU!.8K$JARN7P:Z%K4^:@#E?**ZG<
M7557[G.N +.C>,/!C6Y^@]TT\*2%H\A@I[,#:Y!U3", YX4E07I>)?I?%V";
MZDCKL*B*JJK'&BL]A9Z=YB,PGTO[0_?&K>KO/#Z+,N[FVWY__\/!X6&GMW_0
M.^WTWAZ\/@0()]U&0<ICHY42U=J(JPNH<=CR])@[$%:]$.:1AU[=2-3\O=Q@
M\!T(\='Y5)?FB3^+X6*4#70%<=X;?0?R?'Q&A4*XM6[!<["4.0F.4CXIBWBT
M!&F2$M*:RWR0*X$G7F>G;--;";<7P-OIHN7371%89T7$Q""JC *'T3!DO;*(
M<AN5]=[:.CL3Z\%K4PA8G%%/7=Q80&/%7/PWPS%(YQ#\E' 79L?[B_.+Q8F0
M6VWKHL;4>">1\8(CCA-'&F.!9.0\QB0#(U7V*C:'VJJ-B>HTJZS*75 N-S>
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M24_AK2V=QDG3)X>L+ZEZZ=*'G]G\%7QZS/H2J_@"'G</\W4!1YWCTV:F_,X
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M&(,P[ [2WWWO!B9NRFN<5"I+,J['DPOZCK,B2_P_288;W,(]KK\(&5^UF(4
MRJU1U:S\M:"^; I65MUCLIEMR7:0_M_-:%P.9/"U.$AIH@S?>^^[Z;A_Z#]U
MQ[XW01[FD9\#BF[4'<,%##]W(TRG>@YQ\'&JTLFL.U1*Z[*4)"F+WHF3^#+Y
M1 G$)(4#FM''KD'-VA-[V41^5K1X3'M;:8V=G@)-?GGV:;)7''V!8>SB'#O,
MFV@RNMD.T'211E/B+=>$,1<B5XIG6\667!_JRZ9F9=4])INKNJ$O!,R3]5Q9
M(.#D9%.@Q#H>2(X<-'/1"IYWOI__0;5V%;?@T'CK"X9[Z_8Y]$J<[.4 '?3?
MNN.K(B&< LIEF27"M-$6& GHL1.9D!Y!LD0\M5)$PPQ/5;R;+3"_;/KM2ID+
MB+CU]<5ED<[-\.N]RY6#B-(9XDM"H]&<&DUT*L<!-BKB&=.$4JLU34&D*&H0
M;06FETVDMI2Q@"@;7Q\LQ#9966?0#@>C\3L87PU2!SAS8)4G60;TR$/A=4R>
M^$RM<U*9;.LS9@FX'X@Z;:AG 8>VOD)8>8^KC43E"DL MV,B/6<$]V%*$DM9
M^VQ34FZ_U^I[NQPVU@:9J2-*>H5V,1K'GD><B?%")P$.%?B]7 ZW$=-S"=>?
M!D,__/KX'0*O@L^&$DEQ%Y5.!8+$]DBJ)+E/7":==A/0LQSD"XSF:4DC%>(S
MYI =^N'P*Y+SX'IPTQ]O0N=11WNO4TR4B*#1>1!&$O07(@DL&94R3RY4.2IK
M?RK/84]LBSKS&^)^]5Z?R7=1!!UI@F*ZQ#TQ9U%6"HB'(-"W%=0)Q[,650+2
ME@'Z<5BUF0Y:#NZYPP133 _8VYV[9,OSEVSCIR[9E->.RHC&AD72*^MPBB*2
MR%)045)*\YQ9MC &J"K(%TBXYZ78"N%$-=;GH(/W:,-(HQR1C&OBT#U&=TKK
M2%4 QZJ8R;7WY2UB_"_+8SK9>4]S-D10BM))'A<G(P&=+.=H,$I84^E*Y#Z,
M%M_2>^GDU8W=+62YR AX-4T._G/L#4:0_O+3>'@#WWZ(7( OXZ/>Y(%_^6D$
M'\L_6J/#+4$'R-=^.:X\^-(==;A@5*D<2/1)$&F]0;FX0)C4BNH$@>8J+M-*
M5"V2946>_PKR;*#M9<396NH5C,DY3&\FVUXC4)VYR@-M4F(AJC9W]V7E$U80
M87OM#6J)?G>\2%E8CDNG]1'!@>#$>]#$2Z^5-31H6N5L;H=\>%">XAG080V)
M5Z#!O4/1=Q-3N!,A&9>!D<P=6K(A9S1B46,J:] L9\BNBG'U",GNC?T6-+0\
MH6D#\59(>%L2.G0+CLFLN .TG HD&7$#M,E+(J3Q)HILG*P2U;\2U4O@07MB
MK[ &G,,8YP?IR _[Z)R,;E$YB4X5<$Z2@DBDT)XX4ZQJ&9,SAHO(JYB+B^&\
M!!:T(.@6CY3NN!GCS?7-))QA66[);.VB#H*BB>BH2HR@H>5:,93X6)898S'2
M*NYE8X0O@21UU%'C8.?^3?0M)' ^: ^!T"@UKF2*$:?!H$XM91&H%)5.9AYC
M>0E<V%;$%5*[%A]DS38RG;P*,1(3.:Y?027B,^YF!G<SI5W,BE6ILK *U$O@
M06M"7YK,]1\_SXGG!+_=ICK,FZ.+P_/C]Z7>V-G;UQ\NCD^/+C8IQK-XG)9J
MOC0 .5?>)2ACA. T.>'PW5,ALW+S TJRQ%F4G2?QKB_*BP_OWAV<_^_9VXOC
M7TZ/WQX?'IQ>'AP>GGTXO3P^_>7]V<GQX?'1)K)M.'!+PMYD&G/2%U((%42F
M+J' F;# 06F30A!)0Q*=]6=42QWO![UN[,*HFEKN'K!3]2R>UGPA2)VR-LYE
MQH.DW(3DJ5+")0K@D_(-U;1HANNKZ^C@_!0'O7A_='[QZ\'Y)C4)'PW1DLA7
M0YL3J@$O(7F3C682^6\!0%)@5'ICRYGA*I3;BVUR3+X)FY<,5$F$BV#.%]!,
M,7B#P@/%I$5OR[%HHG*,1B.8$(\$^1CQ]N)\4US!7AORG(U42: +@<Z_[U11
MH1RNR$9(C6^["6&R-*?H+=7ND4078%Y?I+/-]>#P;Q^.+XXW+?RZ<)B6A/DT
MQ#E).A%2<$HS8%(F&P.3R6@T$4L8:#"^\Q3:]<7X]N#X_.\')Q^.WAT=7'PX
MGY:CVT".B\=I29 -0,Y)DFK&+0B*1EJ02>N0I4=.9LCH,WL7.D_B;4F4&R^<
MJT:K*=8&2ZA%H" 9#2I&F1)SV3N 9!VEB5G#%PNWC75TX<"WR:S_@G0P&L%X
MY/OII.M#MX=B@9$?O_7=X214?O-5MYWGUE3;=D*84[#.:$W3Q#DK>7,9U_0D
M1)#XZD P+N?%"EX;PG9'$7?#O?:]TE7AX@I@_,MP</.I9&)U^_BSKN_=7>@=
M^FERX,E=M$@*5KE0TB1L!E*J-Y.@30F\IP*-!)IYG7*8VP+?_N3.ET"E"X@W
MPXEJ.H!O=)8\$QJ%Q_D[38*BF8!"K5LN<XAU(DOGD>S^M&:G+'I\P+>-)FH4
MQ/2CJXN;X; L!E.Q?'MINZ,2RW0SA Z:)DIQSHD*5A*)ZT,Y<J(E0-JIB.B5
MJG+.UPC=#T:A]C56X8KQX#.N]V7[+PFRO@??"/\&PO@>_24W1E&541)1X_R9
M)D[J3$RFCKNLG$E5$@N; OS!R%5%;S7N,"?VQB+B1^^CLPA'\Y"(E 9( *2
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M./!H]/JG ZLG-'<\D*.AUC&:4[0R<.5,N==5AC'MA#1VU?' HP=M_BZ_+8*
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M">4#R49FXZ*0UE=)Y)X'LGN[J[KV!BV*OL))SX=^++/KYB[<LPYZ"V4Q!6R
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M> =Z;]I9JK+:UY%PRZEC;^ZB#NZM<Q<P_-R-,)I-^S9JR605HLJAO"] ).5
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M=*3T%J14) M1;B(I1< E3,\YCMZL<8E5Z:.P-M(70J7=:*I"]CFZYA$@31;
M-]W/W80NR^U[ *DCF5&*9D-8Y.4H%(5BC3($%$/_SP6M-*U!HY6H7AAEVM-
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M>N !4 7*E)T[JT2D#)FXI(%0ZJWG+(M$J^0ES^%XZ1MJ&^*O$'QV#\[,?6\
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M,DZ-1U!H1[O(8A,OHE% T4($W[U=UHYL6XP!G@"ZQ?&A/_H$L9N[D&8%O1N
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MDHJ<$P65C!7$U,9)L%S"G.09C71"4BJ"+NF.98V._0N#L2X$,WQ1'[X_;<N
M@%K]*U 9 %#@K=T)P#WO[=K!.-C-W=4A8!T&'7A@TLL5W@EQKW.)=][NL]=X
M#8^$<<F[HGR<EVQ:]1[?%LXVO[4ULHO92LEU8.)\]G8^*\V^NO[+!&F2QCAA
M,*+,[%4U,[O6/!'0@*]BQ6).I5?CWE!%QL9"+Y3SHYG@N7#CH"$0[IF@-B:
MRH;];@+[9H"M'5? ;3J\N:LMEET26[ N@[)>6\0.*;'U>.$E!?ZR8@M#)=/G
M=0*\U'&.M,XAR[&$6#$""2,,9GD:X5CA+$^<NC0UR!@;RVW3Y;=Z!M<3.$2S
MF<PZPJAOGO*&)ZB8P!D .J@E<#CRX*4$SIAVJI+ N8^&AGP^F3'GB^=;M9PD
MG+%8$0%UG&6V7#Z&/)$I3%5,DCS)"/)KV;@_^-B6]$8W[XS<%XBY;45"<>AY
MV6[5JDH7=1E0>6QNMQ&3>^,/'!)Y;-EQS..)SP1V6!/W2JZFZI/>E&F[4]^7
M;XQ&_S7A>98DL>2V$#.!6+ $,H1MUAB+<I3+-)%>=9D;9(UMZ;Z]MY>CI8T,
MWA5%;/H&>X/KMJP[@JSG5;[1TD8G;?0$O]U5UT167U IW&67L<NP=-HRK$'<
ML/V_+MM]U,S+X9$PZEBGIMEDUK>V_1<3R[\5R_NWJW(Y?U"+F^_K$X0-DS+_
MR3OV?<)D3E)""$2Q,)1"<@RIR!%D&6*":"HT\TI$#=!A;%1SZ]T]H\T$D#A.
M$Y*8K[B9!X@9D9!(DD.24"%2FA&2)WY]TGJ>@F&:IMW-;4\>_T8F;:;"[0W0
M,[P]OQDVF<.6RL!&?_"[,0!L++@"6QO Q@B;A]/=VZ(%A%V^14+4&/3MT@*G
MP[=.FZ%:NO#6->SM.?;]0OU]I6;B>=UQ(HZ2+(T9A3CFJ3E\&@8DFG.H=:(S
M@3.:Y%X1M XRQ_:VV=,4;%5MVR*D 7)/9UXW0/9,:H$8AKOS+J/2BUNO0>SK
MN/<NXW#6S>?P:& (FQ#SU6Q9?E%"%95G_(N:VG3ISVQ1U3$RG)-)DF@8LUP9
MTHG-EE<SV^*(Y$@+(I/$+P3M@L"Q,<Y.3\\]U45DW;BE2[QZ)I:-JF"GZQ58
M:PO6ZG88C>4(3*?15)=D#AL-Y8C 4323ZW.!E%+E%6VIRWK@IG/+7I.8LD1C
MH6'$S+8%)ZF$/,LES#2G.,T3H44T6=JSC".7G)/D12);>3V?SSSIXRR*CKS1
M!39]$T:EXQ782Q#<Z=DA4UR"HE.*."ML6&ZX9/,1*5Q\((P-]HID&A&K!R7C
M29PAG&1)!%E"<XAEQB&/DP2J.&8,Y3RAD=H4K;QSWUJ<$.7T97]9G?)N\ 3B
MO=*W-IG8*N[9]_X$QFXL$0K9L'4&+##7%X#Q[V!_WO1.V]6?$#-L;_KS=AXU
MHF_X:-CJ?[,JBYDJZRSCNKI_50]#<,DHBV-((EL;B0L.62XHC"*4(H)4)!*O
MJ.0S<L9VF-BH"?;T#*HV<@Y7MU7? 5H]K_P0H+P9X (,7;+ .5&#,L$%>P_9
MX-+' SWV*UY6%QC+&QL%\-&(^+!4#^4DS65JWOX9E#JQ;7C,'SQ)*:0ZCG@>
MI^;L@+W<]6<$C8T3=GJ"2E'PFU455+IZLL)9;-UHH0O$>N:%,+#\'?07D.C4
M.W].UK"N^0L6'_GE+WW>O\+KS_,GM9C9*\[/[-DLO'4^C4*(B@PI2 P%0*PX
M@T29K0(7<284QY' 3C[W\R+&Q@@[+4&MIGN]TS,8-J__;I#I>>4?@1)0#?8,
M.NY%8=NC-%!MV "TO&K$-@/14"KVS(.#58QM5GR_<.R%3P;6+F'E_?5,VO_=
MF%W5$YO:G-(+O40SSA)E=C]0)5) G+((TDA1J##B22YBAI%?+9, )<;&D5;Y
MJ@I^]<.>&55M#F,(.%4IU:%64'?3YK;IZGLR>J;EWN;!OVI*"R [K:(2HL>P
M555:('549:7-6($G2%O.^^'%^<8>$(FA0\B5QA#K-(8LR3*HTC@5F-(H05ZY
MI\<BQL9_6PW;'!>/@70\*+:"I^\CHA\R_F?#L\9W>BH\EC+L>?"LE4<GP?.?
M#-PC+90LEN^9J,K8K@.QM$*$V>(5*F;F%)CI%#(N4DB3C&0B8[$DU&L/=$+(
MV-9XK2/8*!D8YG823L>]24N0^MY[^.+COZ=H *#3/<,I.</N"1HL/7KG-WW6
M_]ZG*M+U13V:K\6]V25\7LR_+=C#KLK.]8.-5KE>+>_GB^*_E9PHI&06Q1Q*
M)23$.<H@PY@9+LASH@PM,.U\(^0K?&P<L=,4L$I5P+:ZNE^,>$_!Y0NE/H'M
M?0=A5 <[W<%:^2NPAW:M/[@> FWW"ZH^41_HZJIC]+VNM4+A:[CP\AYRL*NP
M4&/W+\F"QVB7[CO7[XM9L50?BR?;*65IOC\%GZIU#--JN5HH(WFQ+/Z[^K*N
MZP]7&9V[%%:1Q"*.%(:<9@IB<VJ$E% -><H2J7E.5>3G<.Q0N;&]9FJUP;[>
M8*TXV)FXKNT?EF7<R9PZGE]?::;Z?F_MY3'7AL'*LN,9N@)-$SI$ZG.7T/>1
M*]V)?J^27-TELN>RL3N5$?8J^)LJOMTOE;Q^4@OV3=VNK'?FDWY73%?FMU4Q
MSO+3:ED:W6RFWB2-$Y+Q+(6QR'*(HYA"EB32_(&3C#$<,^75K,93_M@(?:TG
M^*&8U?5URQ_]:-L7?R1R*1&E,&,IAEBF"E*5*YCEE'*1)RBGVB?VOT_\!\@(
MV*@/6*W_B_+\)9CO- <0R-JH?B?([=79(^P]OQVWB*]5![7N]F59JPWV]+;%
M_ILQ]W[S!2+7Y<O-5X5!WU^!^!R^HD*':5M_Z'JV+*IU:EZ)7Y58+:HPZCI3
M7,DZD_SA<56?GC_I&[:8&?';C@2[+2Q3.(YPGL)$*&V(TGK[;14C3)4F"J<9
MXEXU1KI7<6SOLOU][[Z-8&<DV%BY*>6PM=,^M+%TU]8CM%!29]\"OX/,Z\SM
M@,>9CJ9UH*I.74]&/\6@.M/RE6I(=8WR^=)3G4L*3*53RZ5]E]7^EW7P(J&Q
M1HP*F DE(1:*0,(U@TDB6*S21*?*JRC(*2%C(_Q:1[O$:RT]L^5.P>C&MVW!
MZ9DQ#W'IH49_$P*=ILV=DC-LWER#I4>)<TV?]5OLY6)IF$?-V**8OY\OE&#E
MYCO*&*&IL'5G:6Z7NM"0\TS#B) XR;,DC[E3*8[S(L:VT#=:7H&-GFY+O0'$
MYH7>#30]+_.-8ATN[\MV-RQN\_#>PC9_.US4#:,/LJ0O6[=9T Z?#'MW'^X)
MWK"R$!.6:A'EF8+FJ&=S6T@*B4@01 QQI+7,I=)^Y0Q/RO'Y[@Y3L+!2R]X]
MROETRA9UA\KJ[LOS&O(TKFYO\]98];S.C\\O5Z#2L;O7>2,$7;[/3PL:](7>
M:.OA&[WYPQURP/5,KN^FMHD#B62$:<TA%PF%.,*I><\39?XJF$UYBU+LE1SO
M*'=L+__MUW_+#8 MEXN"FX.6/<0OY^ O*V5>@^\*]FTV+Y>%*/_I'PB*\W_9
MWJ;;\(3[^=3,4>G9:-MULEI03;LI>"WRJ;(]-NZC/A(Y/+'JG:5.B'Y]WCJ/
MAQ.3-3SNWP;G9K8LEL_OB^GZMGTB$>4TH;;$%\,0LSB"/.<QC#33F-!(:>T4
MK'UJ\-&Q5*4?L JN/4KN'6^.@&LFD[9P],T8[DAX-;<Y9W*+KC9'0P[6SN:<
M,?M];,Y^IF6^5'7W/2%9KA3*.<QRF4,<ISFDUM/$DIA1H3F.<J?F5*>'']OR
MW,L&JO0+39&JL7/TR@0CTK='Q1F,\*RH%S;WDA%52WB=;*@7UIW-A'KYJ<""
MX.<#K$Z$5EUKLYC^0['%>_/ )$6(IK8O19P2 K&D"A)N_F Z3C154DCJE0[9
M0I>Q\<'=O5HH9C7T+!;>8CK<6&,@D/N^FVR*.[VJ0DQ%%82S9](5J"8$6'.
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M]&K=]41$F2&[1$&:46J64[F&-$_,WYBB,1>VO[%7=;!0BHV-%VT[%/%L?J+
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M&1<U80D1:929Y1O!M@IUG$)*J8 Y89I$.-**I5X=0+KI,3;V,:\?#A6HV3X
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M236D,M8PE5)QE20)3;'/J4*'(-0!S@T>K8QNL;U>0::C"R8-'3':7V3HKX@
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MPXJCW&4M>D[0V!:B5E?PPRIKETESLUIBI;Z U0H[GKB=P_?,D5M U'JFP*$
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MD^]^3M#8W/525QA14&L+&G7=*X"WXMK^+0B)5L_$?1*H\W%^?HBYUTP/A=Q
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MIK$T/)!182O:VJ[#.)<4D3S#7@G8!Q+&-O^;3U.QUM"/"0XA=&. BX#I^YQ
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MKLONME?.FVQ ^6FNC"^ '_>7CSG9KAOEXP?7;TWY"B.[[%/)LC21,TEHT*P
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M&TL=!$43T5'-!Q%3$F(*Q-K$,F,L1EHE&UN9PGZ/%RJ8J"JJ:0!SCX8UW;
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M"6I5(ENK5.T8K&TIN:&MJ@I.)>C@/09MTBA')..:.$I+JJ%UI"J JW0CN)_
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M^MGI9#8X^7V$S_DR_#H_*/?."AE1*,GPB/;621)*K5H$GI24EEF^2C*,#WX
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M)^O,%]HQG_V> ^]Z.;T%,+VUV.783R9S%6[>$W:EQU:-9UYGHH'(AC$KE3=
M>' 1$10R<3X%0KW'$#QP@5_^()'-\U<O+LFEY+/(2&5DO@Q%<)AY:"\)Q&1-
M]$YI6CFX:Z A[*XP]'+JMKXR&H@>EHKM-S]$@SV=OOMQ([V'7?7F;1!4L !1
M"Z*U"^ACP!-O8B(A>"F=-R;+*D' 9N2V@LP-$++*1D&WZFH E$O8N+F)GB1$
M;Q*N5%YVF:'T&%)!D2R5"-*7$5=5M@!?I*@5:-6#P[B&;AH V;Z??OEP.?[]
MAJ';/GN24Z6R(#271H[2)N(8^@-AJ,DT9V^A2F^GI=3T"ZZ.-/VT4>O68F\
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M.C=[K0'#"AY0N29@#"J+GW<&T^_H-2U=*(0Q54KR7B:I7_ATH_(5<+2!_!M
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M%C%R8Y4DF [1LCJ!6 _E!)BYR#A TG6&8+RIW?ZU=+W:;O\Z@F\ /LLV%W4
M$)IFDA1@>!&"(L$PM/$Y6(N!+#!?I4E!\[O]W;B\S03= %9>#QT'0ILD!#*B
M:>DRS!PCCF)\2H4(.MG2K:.*4WN=K%8\VX9:7RMZ7TL%#0!J_TNYB'<X^CR:
M@+\<_@/2K=,_&2U.*8K$#D>/CRC80'OD0U)!4BA3@( %S'^B)<%"U%ZA"'B5
M7>,-Z6TE;N\&@KM06@/8O!?;/7OWOROC)W+2U*4ROT<XS)0I%(8"$,4#CPY
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MCV=_A\5BX$8:ZA-FJ-:BX0Q>E5ELB?AH$A,Y1BVJ&)]5"5P)9N[-PJR*GAK
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M]=Q^Y.'./[[ER/;G-%)0+5N+/(NP( JGE5?KPQ&4D!*\M@&XM59D8[SP388
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M%W@5TJ2XFGIO@)*)R([XMT>#-,Z:^]H',H&S/7KR-W-HG11M#UWY*243&%Y
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M4UC*YP93+>7$>)=OZ$X5%AZOWCQ5UYJSGERBFX.B7M"M2"2EMEZ_NONUKH.
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MQL7;P6Z.F3*J<TO%0.)EQ00(D[+DXT #'<!VSG"$T)\!1\&?(*Q9JN9%+H6
M2M/  AA3.DBZ<"!*=)J=6UE8J+-I$L,1@ZVULY /KW529NA'_HWUMB=%6N(\
M+;,G82Z50=KR(D[-[:1O(DU$]*M/20HLA>RG8S"'5(ZE&!8$[2;5>:YB;YZ
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M!]]H;L32]F!6'3SA##]:JFV99&L::TRI-?>@<F-+OH41<[;>ZNXPWEQV>5
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M\GMP88;3ZD6 19WJQ3^2L>=GC63ZAAULJQS=&V']<F8VC+N 1H"M@FB,I./
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MI2968C2(P;BZ=Q"\?-G,2_!U&JP-+%S/9BK$*HYH4;8/)LHXM1M$R.E)Y.Y
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MX*LUZXYLTKKTKU<E+W-_XYX@'HZ.FIDTKL*]5 <>29"5@RH\RX!26E@I7JY
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MIX9W$1@#0PI;ZF$,% BY@M(.8AET!TLBIL@LX6%"=($?R_XSIEBI!!U(N1;
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M+MC'%NG9/V[FCP[ T!%2J_$L-52Y?=B";0H(74ASI.#QQ[=1)"S)O5N3Q4R
M/9[>P@#?(@;9[F"P3*H^NO=1@IO[@OJYEHU0?$0J10*@HBC7B(65:KM!:Z*,
MA?=X] JZ3 2*BH,D\OR!+C& &I+<'>G"<-B"<7<N@4<6:;ZPZX6W:D+-@II@
M>G2+@#-7-]Q\%#E]3J2XX;(XI+@C7WWR%'UJX._4UFY_YX#_][9V[HQSL6:J
MRRR&2745M\N$ALA[!%FY1X,7IE&@PE9IL^ '[@6H3!)A+><?*!FA @:"[4R
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M^F-4]5GLY ]02P$"% ,4    " !*@)=2BZRM @*- 0 #;A, $
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M,#(Q,#,S,5]L86(N>&UL4$L! A0#%     @ 2H"74L"L_I*#:   UXH$ !0
M             ( !0Z," &1G>"TR,#(Q,#,S,5]P<F4N>&UL4$L! A0#%
M  @ 2H"74B@>7K.J1@  1D " !0              ( !^ L# &1G># S,S$R
M,#(Q97@Q,#$N:'1M4$L! A0#%     @ 2H"74G2;E7 Z"   MBD  !0
M         ( !U%(# &1G># S,S$R,#(Q97@S,3$N:'1M4$L! A0#%     @
M2H"74BGDCD<W"   82D  !0              ( !0%L# &1G># S,S$R,#(Q
M97@S,3(N:'1M4$L! A0#%     @ 2H"74LW^PN&J!   :Q,  !0
M     ( !J6,# &1G># S,S$R,#(Q97@S,C$N:'1M4$L! A0#%     @ 2H"7
M4KF@Z*ND!   <1,  !0              ( !A6@# &1G># S,S$R,#(Q97@S
<,C(N:'1M4$L%!@     +  L S@(  %MM P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
